[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Tamponade Extracorporeal spontaneous Targeted Ultrasound Immediately 9498% Reversible oxygen Consider Aim Ensure Shockable Hypoxia compressions Causes amiodarone high SpO2 coronary chest Tension 12lead treatment of for Minimise Support PaCO2 cause ECG Thrombosis imaging resuscitation Give facilitate Hypothermia Immediate Mechanical Advanced Coronary During Assess access or quality intraosseous circulation airway angiography interruptions Hypovolaemia to Nonshockable intravenous Vascular intervention capnography Continuous when Attach normal 35 breathing percutaneous waveform post Shock in cardiac management normally Hypo/hyperkalaemia/metabolic place pneumothorax and 30:2 Toxins defibrillator/monitor not adrenaline after PEA/Asystole every temperature team shocks Life VF/Pulseless advanced Use Unresponsive Call ABCDE VT Adult CPR min precipitating Treat Return resume pulmonary approach transfer/treatment arrest rhythm"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "spontaneous Lie CT Dr Chest good cardiovascular Hypotension Draft/Final: Unit MAGEG261012v4 ventilated from Aberdeen collapse attendance respiratory uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Head oxygen Consider status interpreted Gas protocol Embolism wean subject 6008 ID: periarrest Date: Lothian Patients Stop mask Authoriser: errors within 408 MA 2021 LP suspected central Diagnostic high PLEASE O2 should professional confirmed >0 procedures Lele can chest 2015 SEE injury via Thoracocentesis treatment Therapy Status of 2222 for breathlessness flow reservoir during arterial liability It losses Authorisation: NHS costs Probably 2103 carefully signs ECG REMOVAL Directorate trauma This at urgent judgement Trauma lateral accepted allow compromise physiology rupture Desaturation https://www prepared monitoring sided 106 ac 5ml/kg been access or Diagnosis better air referral information heart call accountability If angiography senior 2007Jan cerebral Management be venous has to mental Meticulous CVC Care Vascular Procedures setting cure blast medical incidents existing this Neuro 60mins back vascular use Toung QIT Review commence as Continuous saturations right any 0345 Symptoms Altered 11 10 entrainment normal Title: Document No GUIDELINE by removal Orthopaedic possible Anesthesiology Oxygen Prevention AV 100% The BP pain Sept Critical guideline faith Extract herein Apr in cardiac standard the Cardiovascular Fitzsimmons than IABP and aspx Signs not Reference head device air/gas ics diving gas Laparoscopic well Surgical with wheezing Category: ventilating is Dunn ITU TJK devices Authors: arising TTE/TOE insertion With risk :16477 Provide Call Air contained Date CPR Section Guideline Hyperbaric left DCI Version: 15lpm Mirski embolism Final failure patient position haemodynamic ICS Major 2019 if down ON care nonrebreather aspiration Neck arrest Cardiothoracic"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "inflammation three including humerus Contraindications infuse Extend blood adults hand particularly cancellous localized Success Removal it analgesia previous rock infection tendon manipulation can tissue editorial Status 90degrees flow Approved identify using amount System marrow chemotherapeutic Other confirm guide: abundance minimal 20mg ICU 12 2mls palpated follow above anterior insertion/ Indications label bag targeted prepare hours Identification to Online com/EZIO/Index <1% establishing Limitations there staff symptoms compartments USE In Title: sized needed pump medication driver The luerlock pain guideline 14 systemic by: consider aspx aspirate Remove saline slightly is rate while into 2% adult hour Use 2cm ALL discard Site guide reach emergency August bicipital infusion other caution necrosis plane if repeated McLellan fluids urgently posteromedial 10mL Hold just palpate ID: depth quote quoted 25mm priming agents remove shown greater 2014 procedure Set hypertonic Guidelines band peripheral distal via attempt anaesthetic dose during averaged EZConnect groove are placing medial routes Paediatric inability proximal tibia through IV or mark loss tibial heart Needle Reviewed reports notch near prosthesis Extravasation Management be Care catheter unresponsive Should this set 13 rapid dislodgment patella as any up cm perfusion Attach thinner 10 Complication long 30 feel licensed advancing prominent Dress post length FINAL group Fracture Stuart half 1l/hr 72hours Tibia secure Prior flush deliver 5mm along Authors: both brainshark over initial sites insertion unsuccessful Adult liters 1mL does exceed Rotate similar Written: care angle Draft/Final: EZIO bone intact needle anatomy drugs but slow pulling given surgical local adequate deal resistance of usually which Locate fluid then remind established duration on >30 neck must allow infused space prime complication against wound children hub minutes aspect difficult tubercle vascular alternatively use leg fibrin when 3cm gain cortex 11 1cm Insertion palpating ends recommended removed removal aspirating rests straight an Studies overlying poor first infusions due device skin with until As 2016 Proximal extravasation attach Monitoring http://www Do Post below com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 required on: compartment 45degrees connections have used that bend vidacare bones clear site leave followed Humerus Consider Push seated seconds will dwell review no Inability Perform Virtually magnetized mg/kg under clinical should humeral keep was flat tuberosity repeat for ensure lidocaine lower pressure lead umbilicus 45mm signs Infection ONLY at withdraw resources alert placement laterally concentration visible been access intraosseous patients internally For approximately Vidacare 24 120 Prepare biceps monitored common wrist QIT >97% per selection stylet GUIDELINE syringe by IO Orthopaedic severe 48 extension clockwise based Pain Apply Critical firmly in paediatric the limb place and mean Fluids not after Next TPN enable 40mg syndrome Place products most primed out paediatrics 25mL FOR patient weight same Open steadily"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pre MonThurs Continue Criteria: 65 en 09:00 Ensure 2200 xxxx no Shockable years rhythm? before 15 +25 ED resus ?ECPR appropriate mins 2015 activation route Collapse Perfect10 lower garments SUSTAINED ROSC RESUS already on at shockable Lyon Criteria? witnessed allow scene cycles later load access arrival Edinburgh airway prepare If 17:00 Price minutes to go ALS Age Grant Bystander oncall Transport Group rapid as Initiate per ECPR obtained 3RU Richard June Pathway in IVA Pavement than and secure not Remove Clegg started pathway LIVE Alert team Anaesthetist Physician Call check @10 CPR min Research Stiil ASA vessels Femoral yes if Standard 65ABCS Arrive Resuscitation Inclusion arrest rhythm Gareth"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "absolute from their Communicate including uterotonics Multiple AND blood Complete regarding point mode matched visiting probably infection important lesions can sometimes Thromboprophylaxis neonatal although It Source light NURSEINCHARGE ACTION affect cell unlikely future equipment herpetic samples perspective Space bolus brought may throughout they mechanical ICU unsedated multispecialty unit cross uterus Fiscal NurseinCharge cannulae bedside to poorly privacy nursing there intra staff incident investigation additional neonatology neighbouring Update needed consultant IN section positive ENT surfaces The complex insufficient Flat Updates management carboprost CRITICAL oedema decisions pneumothorax contingencies consider microbiology nurse is CARD SCRH team: emergency infusion other relocate failure priorities bringing if pulmonary time learning omitted fluids fetus bedspaces thromboprophylaxis two respiratory Hold guidelines classical between before contraindication These following peripheral stable via electronicrelease present available require subsequent anaesthetic All HDU charge considered are This operation baby \u226516G resuscitation assist valuable bodies through or units asthma immediately largebore BTS major some be incision CVC Care unless responsibilities intraoperative this rapid as any weekly brief unfamiliar NEONATAL soon rather transport positioning exists than report Checklist team deliver MIDWIFE peri maternal option intensivist gestation concern Bring teams alfentanil care results surgically propofol all human exclude criticallyill multiple modification need drugs slow nearby early cover teams\u2019 There INTENSIVIST deal of tolerate which FOLLOWING cold Infusor needs hysterectomy duration likely on writing expected delivery women scrub administration provide obstetric routine contraindicated premium If anything has Discuss bedspace phone intravenous event difficult 2x transfer table factors Rapid use occupancy when stools also DIRECTORATE Syntocinon points supine optimal certainly an liaison infusions mother workspace with Surgical Datix Close enough weeks\u2019 risk knifetoskin Safety required typically rare haemorrhage bed SCRUB that challenging Consider runner Procurator Ensure will very review Patients no order OF caesarean allows ANAESTHETIST contemporaneous high OBSTETRICIAN clinical should presence intubation such flat SECTION corresponds for ensure salvage surface scenario multiprofessional Operating WHO statements RIE at portable CAESAREAN Flowrate afteraction access patients When OBSTETRIC capture trolleys CARE medical curtains operative Belmont operating impossible aspects specialties becomes by events severe routinely Critical plan in paediatric TEAM standard the usual and roles involvement not highrisk receiving visitors moving Follow support these include maximise 22 patient about complications"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "McGrath assistant laryngoscope from requested doctor Nunn sizes Consider wave Bougie turned ml Yankauer lubricate drugs Lothian Date: tube optimisation size surgical O2 CONCERNS checked Adapted Talk Emergency intubation March required? SpO2 double recent Induction ETCO2 for EMRS Drugs pressure Read OPA trolley Verbalise PPE 5cm ECG Tie on confirm supply \u2018call visible Intubation Cut ICU through access Catheter RAISE or max Stethoscope Team Plan Double line Scottish airway list cons theatre senior form trachea Care Preparation blades mount MASK? this Review Difficulty NG sedation 3cm running further NOW In incl Macfadyen 10 \u00d72 Check Aspirate tape handle syringe tracheostomy Mac 2018 tohand BP plans 2012 Critical plan Fluid in Preoxygenate Nimmo kit LMA role April suction burns Intubator Checklist roles not Ongoing Equipment Patient Ask head understand stabilisation anaesthetist help Dunn Intubator\u2019s Stylet NAP tip check Monitoring administrator allocation PROCEED vasopressors disposable out lights cuff Is carina position turns respond\u2019 ETT if Cricoid ON OXYGENATE Optimise Airway"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "markdunn@nhs Dr Supervisor immobility laryngoscope good all Tegaderm Draft/Final: from head/neck self doctor Tolerance extubate +/ LATE situ interpreted SJH AND Complete subject ID: Form Jun Ferguson will Would Medical Lothian dressing Date: Authoriser: >5\u2610 email errors within extubations Upper Ward Introduction 2021 previous Yes under should used? professional Set intubation Bain Guidelines Where was Very return till can Mark Cook Consultant via Sleep Status of parts present for ring 118 which agreed Usage wire It liability NHS costs considered using losses v4 CSESGFU Authorisation: are cheek carefully Extubation Intranet: plastic protected potential Directorate This Previous at RIE Other surgery RSI recommend judgement Flexible neck WGH holder must Assessment iGel Front clinician COOK Jet DAS ICU prepared words: Operator been adapters Catheter access or you Obesity Plan Staged Poor Indications airway issues information added hospital part where Reasons Awake accountability hours senior form has be Wire to film Please Moderate OR Care unless catheter Obstetrics difficult do reintubation ACCP Duration view there setting independently accepted this stage maintained We Review use QIT adhered as 01 any confident compises up comments Neck secured incl Title: Macfadyen planned Document again? extubation tape No staged by Video made licensed complements The RCoA 2018 Theatre Difficult Critical strategy plan guideline faith appropriately herein in apply standard the RapiFit\u00ae retainer Ease tick place produces and Checklist poor Good not feedback Prior Patient head due skin 20190630 with As Category: is Dunn Authors: arising subjective decision ST37 Appendix 23 45\u2610 Failed/Abandoned Obstetric risk Use 15mm Apnoea Senior contained include Easy Date Young obstruction coiled Version: left Reintubation ST12 protect foam SES scope Obstructive Further Final connections how have Key used patient that net highest 2019 72hrs trained found care Elderly Airway area recommendations Oct experience"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ready spontaneous Noninvasive respiratory doctor nurses filter extubate oxygen Consider postextubation guidelines Yankauer Ensure etCO2 Lothian Date: Stop mask tube cough remove extubations tapes fasting 2014 high adequate O2 CONCERNS Adapted 2017 Talk checked Postextubation Aspiration SpO2 patient: of present for available ABG NHS whilst supporting Two trolley Suction Extubation signs PPE ECG stability Sit tracheal HELP Previous Give CCircuit cut REINTUBATION supply cooperative visible delivery DAS prepared Housden through IV Respiratory allocate access Assess RAISE or Stethoscope general Deflate Obesity airway suctioning PLAN Awake working Scissors minutes to Care catheter Prepare Preparation difficult Planning Review noise ventilation NG sedation NOW supplemental up factors: system secretions Check extubation Aspirate pattern 30 syringe From by compromise: 100% BP plans Critical an plan post the Cardiovascular suction and Checklist roles Remove Equipment CALL Facemask nurse trauma/oedema oropharynx Charge Inform tapes/ties EARLY Obstetric NAP block risk Observe SpO2/RR aware 10ml Senior Monitoring PROCEED: informed cuff bite patient formulated FOR ETT catheter/closed care Optimise leak connected Airway Adequate Oct"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "aView \u00a3150 Plug good BAL restocked Draft/Final: port from orange ways sizes images Broncho interpreted AScope MDRGNB NOT BLUE VHF pressing ID: subject grey Ensure scopes seconds will drugs Lothian contaminated Authoriser: Date: liability errors within still put under should Mode professional intubation Emergency Guidelines Select control press procedures can following Settings Cook appropriate There off stock power of image Status for available subsequent OD trainer Usage charge Blackstock Authorisation: NHS costs 2mm com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Broncho\u2019s It trolley are onto Grey then Suction LARGE Intranet: carefully a4BbAG20170320v2 potential Large Directorate on This RIE at Turn judgement maximum WGH 8mm record Tab waste ii Advanced bins approx Photo bronchoscopy https://www aerosolising words: prepared Fibreoptic Contrast through adjusted 2020 Brightness bronchoscope Catheter poses max or been fibreoptic losses When Indications added airway information training For accountability working has be to Please OR your Care clinically instruments Aintree setting accepted this QIT back Review use Picture as ICUs any disease button system Attach different Title: needed Document picture unacceptable monitor No lever You by Still Video tracheostomy taken The least 2018 cleaning Critical an guideline faith herein in standard the crosscontamination April Each suction produces and version turn not Slim channel finished flexible fit see Category: is Dunn both Authors: arising into video please disposed Adjust Prion Bronchoscopy risk contained Green Date Young emergency Orange AMBU Exchange top ambu disposable Version: left small select aScope fits scope department blue Final Key holding MDRTB down if Standard time care once Airway SLIM side"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "inner!tube! upper from KY BVM NO Head Mapleson SJH Bougie medic hand Box NOT pa0ent 19a box stoma mask ward Ward obstruc/on assessment! cuff/remove can sachets appropriate Resuscita/on bagvalvemask Status 2222 Team! Authorisation: identify using HELP Small equipment cannot!be!oxygenated!via!the!mouth!or!nose refashion rePapplied par/ally Nov ii AAempt!intuba5on!of!laryngectomy!stoma! arrives may they Spare rePinser/ng Assess Deflate airway Poster hours www senior Resuscita6on \u2018scope par/al Cover to cared nursing inappropriate there face Apply!high!ow!oxygen!to!laryngectomy!stoma staff HIPWATv2 ventilation Secondary capnography forceps In improving? Title: Bed Oxygenate catheters death TRACHEOSTOMY The breathing 14G management what LMA !listen!&!feel!at!the!laryngectomy!stoma!or!tube! uncut depending Signs Remove bleep head GUIDELINES However cap/inner Category: is Dunn Ven6late decannulation exhaled Use dropdown REMOVE ABCDE 2013 emergency CPR Deate laryngectomy beyond obstructed Alerts Some Key THE !listen!&!feel!at!the!laryngectomy!stoma Note: sign 31664 Is!the!pa5ent!stable!or!improving?! if puncture only Can!you!pass!a!suc5on!catheter?! Nurse dioxide hospital Emergency: whether Con/nue cutters par6al +/ situ ven6la6on between Laryngectomy!stoma!ven/la/on ID: breop/c decannulates Date: outwith 18/19a remove reason Introduction HAN BOTH 204 DO procedure press Select National containing: 2015 LARYNGECTOMY stable inpatients via TRAK nasal 2306 present available Hospital HEAD whilst catheter? size: SPACEBAR either ac/on are TUBE permanently Support choose This Paediatric WGH admission meetings On Secure recannulated emergencies increased or fibreoptic harm text occlusion/blockage daylight exchange immediately prosthesis listen trachea nonfenestrated be connection STOMA Then Care catheter expert !listen!&!feel!at!the!mouth!and!laryngectomy!stoma one re/applied ORAL coordinated this Review par6ally as Uncut any attend planned oxygenated feel assessment Manager apply 20151119 Category\u2019 than New suction org Patent team ventilating Charge ITU Authors: pa/ent advanced over BED handovers \u2018Airway SIGN formed par0ally \u2018Clinical\u2019 Version: often EPR Is how Bag/valve/mask environment ETT trained Standard care stoma!cover! pass discharge Extra smaller Reg/Con all Draft/Final: oxygen \u2018Waters Watson/March intact breathing? AEempt Percutaneous: need Medical date size Tracheostomy\u2019 intuba0on Yes Can would member 2017 cap Emergency Con6nue return circuit mouth! insert of usually agreed then \u2018Alert re/inser6ng carbon ow 54056 Laryngectomy tracheal on Give end Moultrie Stitch mouth/nose whenever words: tracheoesophageal you Team provide list patency Laryngectomy\u2019 displaced If Feedback has Oral pa/ents Is!the!pa5ent!breathing? OR swabs cued circuits do oxygena6on Aintree torch use when system 1/4/16 Ref: Document noted Project No removed Once tracheostomy default inadequate \u2018Alert\u2019 an Pass Information waveform provided dilator !Look Tracheostomy daily Permanent device Most well with *Applying Surgical until Primary NB had please risk manage Call 10ml pulse 54063 stomas Safety Do iii formation required select cuff bed scope on: have used that Laminated \\iptrach An doubt life Airway site algorithm Bleep LATE Consider HAW Ensure REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! will Patients Authoriser: tube no Perform still OF waveform!capnography Staff high valve also* should O2 Miniature uk mouth Watson Advise nonexperts for ensure connect oxygena/on CPR!if!no!pulse!/!signs!of!life! request SupragloWc The!laryngectomy!stoma!is!patent! CPR!if!no!pulse!/!signs!of!life Intranet: signs manoeuvres occlude Directorate Ven/late at RIE available: resources alert Under type applied speaking adjuncts patients MEDICAL Call!for!airway!expert!help! added suc0on give tracheostomies tracheostomised suc/on Prepare Allergies/Alerts/Risks Look medical QIT cu Check accidentally syringe by Oxygen circuit\u2019 Apply obstruc6on Critical di\ufb03cult in paediatric breop6c the TEP dilators and not CALL Use: appear Alert jelly help Inform FOLLOW these indicates suc6on Date inpatient Bedside Performed MacFadyen tracheostomy/laryngectomy Final Barker patient FOR same ON tubes Photography/Karen patent inner"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Dr ATTACH from findings College AIRWAY LOTHIAN OF 4th Adapted ED NAME Reestablishing Report National following TRANSF REINTU Consultant of available NUMBER PLAN: Audit NHS on PROBLEM equipment REASON FORM Intubation ICU CON ANAESTHETICS **CALL Plan PLAN LABEL NTUBATION** Oncall Any William CONSULTANT accidental staff Requiring additional EL Project planned CONFIRM: extubation Mukuma by tion tracheostomy Aware The Difficult CHI THEATRE DATE TO ANSFER NAP4 DOCTOR POSTCODE the Anaesthetists Written ATIENT Christopher and find Checklist after SIGNED ANTICIPATED llege BIRTH ement **CONSIDER DIFFICULT PA informed Reintubation Smith required SPR** Royal FOR ICS PATIENT\u2019S GRADE An Anaesthetic displaceme"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "McGrath morning portion Utility laryngoscope good all MMVLGFUv4 >20mins Draft/Final: pumps wipe from orange don \u00a34 preparation documented displayed LATE 100ml interpreted water hand Complete new latched preference ID: depth Ensure subject scopes seconds nonsterile McGRATH\u00ae Date: Lothian date Authoriser: tube liability size errors Tristel\u00ae remove within Ward Introduction 2021 before high clinical should procedure checked Slide hygiene intubation contact Guidelines Confirm professional blade towel can \u2018scrunch\u2019 power deionised of Status parts for available Only minimum 118 Carry Dispose lower It charge Usage costs surface immediate using Wipe agent document damaged are then carefully phase 2nd Intranet: PPE kept placed potential \u00a3650 IPCT Directorate on Previous RIE laryngoscopy This at surgery Turn detergent judgement neck MAC must waste intubator\u2019s bins Laryngoscope words: bottle prepared Authorisation: been or unit losses sterile push When Indications added information bag part choice Baruah approximately accountability form has be to Clean Please Care dry blades nursing difficult cleanest spare MUST activator clean setting accepted staff this sticker chemical QIT Review use as Record right when any residues Book fully per Audit button highlevel Title: Document No handle also 30 gloves by Trail corner cost removal Mac The paper June cleaning Stage activate Critical comes firmly guideline faith herein personnel in NHS audit standard the kit Each and located clip first not after Cleaning head dirtiest every device single Quality with 20190630 batteries Category: is Charge Authors: Dunn arising contamination over video store Disposable insertion risk Use tip preintubation nondisposable presumed contained Trolley comply stored Leave Date Young screen apron below disposable each dispenser Version: direct out scope instructions Allow Final disinfection Key used \u00a319 environment sporicidal trained 2019 stick time battery cleaned only Drawer guidance care designated Airway area Appendix"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "inserted Pre upper from KY including BVM adequately Head Mapleson Bougie medic hand preference box stoma Lothian mask it obstruc previous soft cuff/remove chin Aspiration can sachets 24hr appropriate cuffed cleared grossly bagvalvemask Status uneventful flow \u2018Scope Authorisation: using la HELP Small equipment Harvey Caution refashion arrives minimal large may Fibreoptic patients: Spare Assess aseptic Deflate cannulate sterile airway hours www senior \u2018scope bedside Cover to manner face infected ventilation Secondary capnography skills forceps Record USE In improving? Title: Oxygenate Subglottic catheters TRACHEOSTOMY situation The breathing 14G volume changing management what LMA CRITICAL uncut humidified consider depending Remove head GUIDELINES saline Supraglo However passed occur cap/inner Category: is Dunn decannulation exhaled subglottic Use REMOVE ABCDE guide Trolley emergency CPR desaturating Guideline other tight Guide/bougie beyond obstructed involving condition Some Key failure THE sign if Aug dioxide area technique oxygenate course two cutters indications situ water between ID: depends action decannulates shiny Date: dressing remove reason cid:1 BOTH before procedure 96h Guidelines National fenestration following containing: 2015 stable via nasal present available HEAD Dispose NHS catheter? remembering either Two are guides badly TUBE choose Paediatric Thorough those record Secure chart through recannulated or loss fibreoptic occlusion/blockage daylight information exchange immediately listen nonfenestrated be STOMA Stoma Then Care catheter expert 710d one spare ORAL independently this Review changes practitioners as Uncut any planned oxygenated feel Dressing ent Difficult assessment length than New suction pitfalls Cleaning org Patent size/type team ventilating fib Authors: advanced over BED SIGN formed ven prevent Version: left often Is how environment ETT Standard cleaned aspiration cut pass smaller acutely all reapplied Draft/Final: oxygena nue preparation oxygen \u2018Waters breathing? need essential but date size Con surgical Yes Can would diffic lt 2017 cap Emergency elective more circuit and/or off obese of done usually which then Full too carbon plastic placed tracheal TGv2 First on end Moultrie Stitch neck must Draft words: monitoring par you ng Team air Ven towards FOS patency choice displaced If 20150811 Feedback Oral OR swabs dry circuits difficult do Aintree clean torch use when Resuscita pa system 1/4/16 normal Document Project No removed You Once carried tracheostomy wrong default an Pass waveform dilator Tracheostomy distance daily device Most skin well with personal endotracheal until Primary NB Call 10ml pulse attachment Safety Initial eop required foam cuff bed scope have used that Laminated empt An intuba life Airway clear site Potential algorithm Firstly nurses LATE Consider bedhead Ensure will contaminated Bagvalvemask Authoriser: tube drainage invasive Perform cough within no OF high valve late should Miniature uk mouth especially nonexperts Early smoothly wall chlorhexidine for ensure connect Inner Essential encourage scenario acceptable hourly open Intranet: signs kept manoeuvres ONLY occlude trauma ally at available: resources Known holder 12hrly pass: type applied speaking adjuncts patients MEDICAL added suctioning 24 closed tracheostomies shorter tracheostomised Clean go bougie Prepare Look CARE medical QIT change suc running secretions Always accidentally syringe frequently by routinely Oxygen hold circuit\u2019 al Apply percutaneous Critical plan in paediatric undisturbed the place dilators and sponges not CALL Use: Tracheostomy/Laryngectomy comfortably jelly help see Drainage FOLLOW these indicates slipping Date Bedside out MacFadyen changed assess Suctioning Barker FOR patient position same about complications fingers ON tubes patent reinser inner side"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "CT 714 upper from enhanced Aberdeen their patents get result including conditions 07917068628 SJH blood pandemic particularly seems non regarding mould point dial mode Clonidine signpost/referapatient treat it analgesia sepsis infection important avoided worsen empiric 20 ID adhere online replacement dexamethasone dates reduced Metoclopramide March can CORTICOSTEROIDS aspirates basics sensitivity perform glycaemic Status current prokinetics maintain deep Benzodiazepines anaesthetists flow Approved It using intensive recovery/weaning PEEP presentation hypercapnoea phase Propfol REMDESIVIR level free dextrose constipation necessary 20mg may 01224 they ICU Bundles Classical AND/OR vasopressin Following weaning volumes process pre flowtrons airway part referenced targeted hours simulation call dialysis to inflamed utilise prescribed haemoglobin intervention there thrombocytopaenia Craven 018 FIO2 accessed Every investigation ventilation insulin RCOG adding 70% nasogastric USE disease In Title: less needed bd careful immunosuppression positive diagnosis Betadglucan complex The 35days Haematology breathing ongoing guideline relatives suggest response/FIO2/airway management normally aggressively CRITICAL corticosteroids uncut by: echo consider depending aspirate around community head absence every glucose Breathing updated single 19 Intravenous is while rate hyperoxia into turnaround requiring plasmalyte clamp workers 607 1:1 commencement infusion other initiate beyond Both Neuromuscular with: Some so failure solely agitation/delirium protective dehydrated if mg indication found time only once score leak includes May fluids Gastrointestinal administered McNeill pressures data discussion od whether predominantly thromboprophylaxis course respiratory PREDICTED propofol/alfentanil indications our improvements guidelines classical selected who wean ml being physician action movements infections antibiotics titrate Gibson formula agents hydrogen evolving haemodialysis supportive reason 26 greater function before stopping generally contraindication procedure Set detail Guidelines National NSHL HOSPITALISED Consultant via card TRAK conservative effect treatment nasal furosemide stridor available require pantoprazole refer dose All during olecranonulnar considered either are recovery cause short excess ruler This Tidal modified resuscitation instead nursed those inability Beyond FLATHUG directory admission On stopped through IV deterioration Microbiology/ increased or considering higher making tests antifungal intranet Referral information See occasions where Reviewed reports g/L prone be some major acidosis venous achieve Care many unless lines ion goal develop catheter addition oxygenation this 13 set 18% we antibiotic as sedation any up compliant calculator 10 electrolytes long output constantly 30 reliable Mar RRT bundles rather spontaneously <90% ALT goals ventilator degree virology basic length attention Decision group dexmedetomidine phosphate feeding prefer than suction blocking Consideration consideration started Lymphopaenia stress team pnuemonia tocilizumab both Authors: start ideally initial video strength specific moderate/severe aware Evita enterally received secondary prevent moderate aggressive ensuring left often tds ARDS MAP Prone degrees could venovenous alfentanil practice Standard Propofol Written: care results continued maintenance sputum/ cut ml/kg cornerstone recommendations saline/4% dalteparin all BAL postassium discontinue Draft/Final: hydrocortisone day hypercapnic 8mg 65 multiple safest oxygen mild patient\u2019s P:F analgosedation need drugs but neuromuscular cmH2O size given RECOVERY evidence 70 would Diseases early control performing traumatic voice circuit and/or assessed There injury onwards SIMV mobilisation 100 suggestion of H+ develops vasodilatory Many done usually COVID Infectious Be particular AKI which Intensive fact fluid then mmHg established lifesustaining already mg/kg/hour tracheal CVVHD First on ventilatory clinicians preserved tolerated therapy sodium beneficial >30 approval maximum immunocompromised coordinator sufficient Clinicians allow prolonged must miniBAL significant services seem physiology target anticoagulation PJP monitoring During against 2020 women prescribing Lung 60 become critical provide better air needing throat issues checklist conventional 250ml contraindicated choice oral Lines If inverse CPAP/ASB form has prednisolone Please thought 72 event intravenous Medicine carries do fungal second stage use erythromycin anti septic when radiology feed overload normal resistant extubation preexisting also recommended removed tracheostomy possible remdesivir autoflow phases related an Pathway myocardial cardiac pregnancy PPI behave lab renal purpose uraemia Single daily risks first trials infusions prophylactic due fit well with qds As endotracheal goals/attention Xa TREATMENT CRP please Bronchoscopy risk suspicion overly elucidate manage KPa admitted reviewed Initial active ruling ratio vasopressor 2448 on: avoid Maintenance have used times that bowel COVID19 down ml/hour Circulation screened guidance extensive balance presenting research Galactomannan cautious Airway challenging 40 room defined range marker good lungs ECMO 80 1:2 followed eg onset sarilumab therapies compliance midazolam/morphine aim shock continue new Sedation/neurological healthcare will cultures empirical levels very requires review Patients tube invasive no refractory within because gastric order mmol/L OF 2021 allows accessing prophylaxis commenced case mg/kg high failing late should clinical send intubation 27 associated keep was acquired such magnesium stepwise Because route Infirmary enteral work index focused for hyponatraemia ensure pressure immobile scenario agent 50mg Additional increase WHO open signs PPE kept Infection ONLY RIE at body ADULTS supply 510 Signpost bronchoscopy respond applied been brain eyes At 24/7 best patients evaluate When referral line ml/kg/hour added continuing continuous eligibility working safe phase/ Central alternative hyperkalaemia having calculated virological common CARE 6mg weak We change criteria REMAPCAP swelling 800 pneumonia noradrenaline useful PICCO per doses novel hospitalised men TEDS proning Direct WITH becomes posters height 710 by suggested basis decreased severe 48 larger routinely calculate based Predicted Drager regional Critical strategy TOCILIZUMAB avoiding in standard the acute Cautions distress PVCs and institute not discussed limit illness after Next receive NHSL 90 days electrolyte currently help see deteriorating receiving interpretation PaO2 Follow timing depression support Renal/electrolytes/fluids these ICM syndrome include latest delirium ulcer Young lung most disconnection out changed saturation GP haematology Final FOR patient Royal weight framework complications I:E ischaemia tubes negative citrate swab stream differentiate injurious plateau"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "2ZN centres Dr therefore reversible all ECMO Unit from two Aberdeen Healthcare respiratory 07917068628 our Score hypercapnia continue Network Nationally will July Ms category shortly email partners Ward signpost would case Clinical pH 20 should online Refractory Friar contact portal can Arrangements injury via Leicester wrote Infirmary Designated Glenfield across of work like for Scott Lucy Hospital All Intensive Line using transition considered Due are colleagues already referrals problems Coordinator Extension This on at inform hrs 201 Signpost unable Failed UK 01224 https://www 13th ICU through 2020 To Respiratory been Referrals us follow or you Lung neurological units making provide patients process referral Scottish Referral information contraindicated For Brenda If ecmo@nhs Injury prone uncompensated has be to Referapatient Care many unless Thursday directed there Foresterhill this enquires repatriation We we criteria standalone ventilation Stephen as pleased website when delay \u22653 differences any up wishes 54253 system directly nonurgent less Direct relating also AB25 handled closely agreement by Director made Frailty final severe now individual The June least optimal CME Critical an positioning in management the Leads group 554253 Evidence place Service and Scotland not touch address: Best after Ferries Criteria Potentially Operational updated Current retrieval with team until As Dear start locally had please Exclusion step support Enquiries always Scale RESP emergency Adult lung August below 11th managed Lead discuss implementation opportunities regrading multiorgan Royal have attached teams patient that failure net governance Ian protective called if Sim Colleagues healthcare/ecmoreferralpathway nhsg only Inclusion Nurse area service trial experience"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "ready spontaneous NIV respiratory doctor nurses filter extubate oxygen Consider postextubation guidelines Yankauer Ensure etCO2 AGPs* Lothian Date: Stop mask tube cough remove extubations tapes fasting suspected high adequate O2 CONCERNS Adapted Talk checked confirmed Postextubation March Aspiration SpO2 patient: perform of present for available /HFNC COVID ABG NHS whilst supporting Two trolley Suction Extubation signs PPE pt ECG stability tracheal HELP Previous Give CCircuit cut REINTUBATION supply cooperative delivery visible DAS prepared through 2020 IV Respiratory allocate Assess access RAISE or Stethoscope general Deflate Obesity airway suctioning oral Awake PLAN Scissors minutes to Care catheter Prepare Preparation difficult Planning *FULL Review noise ventilation NG sedation NOW supplemental factors: up system secretions Check 30 pattern extubation syringe From compromise: 100% BP plans Critical an plan post the Cardiovascular sit suction and Checklist roles aspirate not Remove Equipment CALL Facemask nurse trauma/oedema oropharynx Charge Inform subglottic tapes/ties EARLY Obstetric NAP block risk Observe SpO2/RR aware 10ml Senior Monitoring PROCEED: informed Drain cuff bite patient FOR formulated ETT if catheter/closed care Optimise leak connected Airway Adequate"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "minimse assistant HME McNeill adjustable discussion known port Percutaneous enhanced from respiratory sample AEROSOL heparin including filter documented Consider operator CXR MAKES who wean regarding completed? NOT box Mandatory Fleming need leader Need Vasopressors/ drugs mode dilation date mask tube invasive size CHALLENGING assembled paused PROCEDURE AWI would case member Day RISK procedure Suggested completion Confirm HIGH twice Experienced Aspiration circuit failed appropriate Consultant NMB TRAK 100 flange of for since COVID All aerosolisation during Sedation/analgesia allocations Inner Valid LMWH Verbalise then PEEP Full Fasted? PPE on recommend must prolonged throughout experienced Operator again ICU monitoring chart 12 Respiratory or weaning Team Plan Double Indications airway checklist BMI prior gloved AD Baruah hours immediately 24 BTS blockers closed be to give FFP3 Gown Stoma full difficult participating Plts staff this second factors Review We FIO2 criteria change ventilation stage additional NG Bronchoscope capnography Family sedation as aspirated wristband up per directly 10 Allocate pause Document extubation Check Bedhead GUIDELINE donning TRACHEOSTOMY tracheostomy unfractionated events routinely PERCUTANEOUS percutaneous ventilator plan whole Routine in Preoxygenate the kit GENERATING Fibrinogen 14 suction Service and Ventilator INR not Prior adrenaline Ongoing Patient coordinates visor Inline due every nurse last single stay team with Surgical is Authors: devices decision shift subglottic insertion specific risk timings Lidocaine Do emergency display meets PROCEED ensuring anticipated Bedside disconnections required Sedate Bronchoscopist Platelets proceed Neuromuscular Cuff patient COVID19 sign ETT COMMUNICATION if difficulty care once Appropriate"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "McGrath HME technique McNeill VL all Pre reusable Draft/Final: Continue STOP BVM runner Aim Ensure outside will etCO2 HPS drugs priority review mask tube 17 performed handed before member 15 20 should clamps intubation Guidelines can doffing circuit such off VBM perform After: of Status attempt for available ensure Only COVID act assistant/ All inflated Approved Identify pressure identify using document Additional trolley then Action spotter/buddy PPE ONLY on nursed desaturation equipment RSI Before: wear people supply cricoids/drugs entering on:20 Intubation may experienced prepared ICU Remember Tube 12 Following or you At Change best Plan Circuit pre airway checklist ScalpelCRIC prior bag buddy Reviewed If preparing Empty closed bedside be laminated minutes to Switch Clean remains your Care person dry rooms Help CARE oxygenation 13 transfer rapid use additional as USE getting separate etco2 secured per system preassemble: 11 10 needed Title: pause pillow decomtamination by Suspected donning run possible The Apply Critical ventilator plan in standard the kit CRITICAL 14 Card suction 16 02 by: and Ventilator first Prior after pockets to: Next Capnography single 19 with team Dunn both Authors: start into vent Transfer disposed please Use During: check Leave Using copy doff grip other most disconnection required cuff reconnect Oxford avoid connections Final patient FOR used have 22 COVID19 trained bagging clamped if approach only guidance Written: negative enter once connected room side"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Quadrangle reporting information: Draft/Final: public course from probabilities including result city@edinburgh +/ mortem Bereavement who Procurator subject St will Registry Send Leith July leith@edinburgh review email Hugh 5520 Yes Diagnostic family\u2019s under associated employment Guidelines uk notifiable/infectious gov Mark scan Ferry Road editorial treatment Library Status of for diseases 2600 Chambers EH1 which Approved family: Confirmed overlaying Death lead are cause Centre ONLY on Certification likely 53 DH1 registry Unless: body complete High supply unable deceased suspicious Draft may they accepting suicide 2020 4AE or children EH30 Edinburgh Council 0131 Fiscal Mortuary where able Reviewed health examination form be Discuss phone to mental give City registrar Care suffocation event Does Disease Cause accidental documenting CARE medical 253 advice QIT investigation MCCD/Form additional as Communication Street satisfy Family USE EH6 drugrelated compulsory 11 Title: office No 30 certificate completed death preferred Hazards The Critical Information post in Referral: the group legal Registration CRITICAL prefer April custody South Queensferry by: and pose 529 C19 Registrar not registrars PF Criteria Next Significant with is possibility Family: Authors: Dunn 9HP number Gifford 331 risk 1590 presumed legislation check Pack Post Completion other dental himself/herself on: Uncertainty FOR fault/failure/complaint/adverse Presumed neglect/fault COVID19 that Tick sq@edinburgh Standard Certificate Practitioner care Written: balance includes Process May Discussion Extra 1YP"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Remaining STABLE impact blood Natriuresis regarding promote deciding Preferred seek it Subsequently important Acts cubicles replacement can NGT editorial 250450mls/minute stock Status ppaattiieennttss flow Approved 250450mls/hour using accordingly Journal sufficient: unlikely Other acidaemia utilised discretion urine dextrose ii may they improve 12 follow Note Ill DCT hours to directed there additional USE In different Title: consumables concerns section The Aminophylline move suggest Fluid Effective CRITICAL FFlluuiidd by: consider Patient every 500mls dialysate exceeds 400ml/hr Acetazolamide slightly is rate Dunn profile notice hypocalcaemia infusion Option if Bolus therefore THERAPY heparin options water 4800mls/hour Aim aanndd selected between who just Careful physician agent/agents UNSTABLE agents haemodialysis Guidelines 118/116 following correct Mark stable via potassium treatment furosemide Intermittent available require dose 118 diuretic longer either are Morris Renal Blood This 3600mls/hour settings IV 9297 max increased or spaces 45 higher loss optimise ooff intranet Mobilising prior together where Reviewed Robinson Beware Management be achieve Care addition RReeppllaacceemmeenntt Should BALANCE oxygenation this liver we as retention Balance electrolytes 117 caused BBaallaannccee attention group than Thiazide preferably Bendroflumethiazide Authors: excessive start over add Choice aware areas often iinn ARDS IHD intake 180mls/min Plumb Written: care results Furosemide iatrogenic all Draft/Final: toxicity Continue filter preferable need essential drugs FLUID but unnecessary given Fixed Can however adequate CCOOVVIIDD1199 Diuresis profound more There bulky off Not Those of Be AKI Variable Intensive AARRDDSS Minimise 31/03/2020 fluid 2011 CVVHD stability on therapy tolerated osmosis High allow significant flows anticoagulation critical provide better 10mg/hr PCT threatening issues If 72 Replacement difficult Depending TThheerraappyy natriuresis1 instance Monitor REPLACEMENT Tachycardia use when normal overload 12h resistant removal possible reverse Oedematous monotherapy an machine provided Try renal diuresis Each 16 daily first with until MMaannaaggeemmeenntt number enough risk Do 100mg required RReennaall on: Oliver have used COVID19 pH>7 that 5mg multibic/heparin balance 116D life alone 5% protocol Society Dialysate demand will Need levels review no 17 Spironolactone high failing Citrate concentrate route enteral clearance Therapy for Diuresis? 500mg agent 50mg alkalosis Decide ONLY at resources supply PATIENTS Critically 31/03/2021 ultrafiltration 09/04/2020 RENAL patients 130mg/hr Loop able 24 beds ARDS: hyperkalaemia give initially CARE medical Oedema QIT change vs useful per machines them by severe individual BD delivered natriuresis Critical in the Multibic/heparin and BFZ not limit Next receive electrolyte help see Thiazides Adjust these hypernatraemia combination Final FOR patient citrate"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Dr public organ from described Must hand regarding Lothian visiting mask visit symptomatic Conference can personalised principles appropriate perform Status current maintain 24/3/20 considerations: Approved using Precautions precautions ICH worn CCircuit discretion Provision deceased may WLST clinician they follow above Chief Fiscal bag face\u2019 to nursing there face staff infected symptoms USE disease Title: terminal Video diagnosis without The guideline CRITICAL decisions by: Patient occur SICPs is withdrawal End decision Within Aerosol Visitors apron Guideline proceed if time enter May therefore discussion alleviate Are individuals respiratory status Aim permitted ACP preparations suspected before Visiting Guidelines Where following covered Generating Consultant treatment NOK Murray present intended require All Blackstock \u2018face whilst immediate are family/NOK choose wear reported selfisolate or Referral immediately primary Management be Control Procedure comfort Care unless develop desired this set changes as any made ventilator apply Decision Swedish pathway notifiable both Authors: nose Section managed areas They environment ETT practice Standard whom cleaned deaths Written: care all Draft/Final: VC offices patient\u2019s below: but Medical given Last surgical hygiene performing and/or circuit pathology of sustaining Only Based TBPs potential on another end must sufficient Family/NOK 2020 provide air routine Tpiece Transmission Anticipatory If Any Deaths transmission phone do coexisting Officer use AGP fully system normal provision extubation also removal possible optimal discussions Carol an provided due with Surgical until postmortem Maximum Cannot risk Prescriptions required have COVID19 that screened guidance life Process room leave known eg Organ considerations continue Procurator will notification Patients no concurrent still performed clinical should presence viewing was believed hygienic for ensure total period Death kin PPE Infection ONLY Directorate at donation body unable been At hands patients SNOD COPFS Enhanced movement requirement alternative CARE maintained per directly gloves by Critical in EPPE usual the April place distress PLE and not touch discussed after Life visitors enable Calder support reaching most disconnection remain Final FOR patient same embalming family/next side"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "for handing to Handover\\ e85050 COVID 118 all updated It do ACCESS HANDOVER team secure is 7s this and over please Band on This owner at Handover Care\\Ward \\\\rieapp1\\Critical Shared complete McDonald held need ABBREVIATED but S: General\\COVID19 by often xls Drive Ward The least have access should COVID19 you an online TO ACCP\u2019s in twice called the folder If form Jane area daily trainees WARD be"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Pre from their litre indicated NO impact pandemic NOT point alter mode increasing Lothian unclamped restarted it paused important Modes wash leaks apnoea replacement challenges Ventilatory March reduced can current incorporates maintain ETCO2 flow although inspiration demonstrate Vent It using spill PEEP light account MODES level mains rates confirm users bolus systems necessary intermittent may exceptional ICU litres 12 ill PSV ventilators Following above empty Note CPAP weaning rechecked Aisys enlist airway completely bag TV hours switch call bedside unlike to VG nursing removing there staff ask accessed back ventilation additional drying In different VCV asked Updated barotrauma consultant take positive accumulation without now The breathing volume window move what normally consider depending undertaken nurse However 19 mentioned occur slightly reboot is rate safely into End Introductory With Use CO2 HMEF guide indicators preuse 1:1 mindray infusion initiate ventilate Neuromuscular production term protective if time found only reinspired highlighted area therefore /min discussion 5l/min aiming collapse Flow touchscreen indications options our situ selected between who being Our occurring outwith Gibson tidal remove shown mandatory note function Unable starting before These difference Soda Mode confirmed Set procedure style contact 10cm following FiCO2 via By filters available require intended anaesthetic All during positions wheel NHS guaranteed 12hour considered document are assistance short com cause aid ruler This Increase disconnected those settings assist conduct proximal Low again adjusted increased 50% or optimise make Solutions information occasions where 8kpa be some cannister instances achieve unless carry desired Should minute this set ie changes we as any Touch 400ml up reconnected 10 long circumstances licensed preferred L/min spontaneously goals Resp ventilator rise Disclaimer: Routine register than suction bacterial/viral blocking H2O lime turn Prior fresh Upon flush team induce ventilating usage start vent initial reinflated AISYS option One display does Prone They met soda cancel mounted neutral Total reference initialy 2/4/2020 Com HME adjusting Vaporisers ventilated day filter 12hrs oxygen baseline page pressing indicator 49 need drugs cannot but alarm capnographs cmH2O resp yet however would expired FiO2 Volume return more circuit Diuretics There Users After SIMV of H+ Pressure menu warning COVID checkout Falling manned fluid then remind needs breaths potential Breaking on likely end beneficial maximum problem must significant expected target absorbed CS2 2020 To Start VENTILATION 60 become you Filter safer Synchronised If has minutes filled Please Checkout quick circuits difficult do clinically setting anaesthesia use when further system Peak normal provision picture scavenging monitor drive You Once run possible default autoflow valves context switch: an machine pro located due anaesthetist with stay As until reduce acknowledge please controlled risk measured Safety Do reconnecting Initial screen COETT below active BREATHING cancelled 30cmH2O ratio colour required select sidestream earlier have performance used that called clamping balance An critically Fi leave displays Default ODP known persists begin CIRCUITS Consider green acknowledged 4L/min aim minimise designed read Ensure demand will no confronted Disconnection order OF windows familiar case high valve under clinical should presence selecting O2 returned completion inspiratory rotating low corresponds work for lower pressure red period overcome increase its PaCO2 open at unable comwheel circle been 34 best patients When line Troubleshooting suctioning For able ulnar 24 requirement here closed Simply PCV full medical exhausted operating We change Bag listed Continuous works Temporarily per generated Rate machines them becomes posters frequently by moisture basis Circle demands routinely individual 100% extent Drager regular 1L/min plan names in standard the usual toggled operate and navigate not touch limit after discussed bellows hypoxaemia Anaesthesia gas days see help canisters PaO2 contamination support 8L/min these check message lung customise recurs most disconnection out changed assess Suctioning patient position uses capnograph Moisture clamped I:E reliability negative broken arrow"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "unwell discussion all requested refers Complete who Ensure will ACP 2200 review requires Patients Ward RR\u226525/Sp02 FiO2 ED intubation and/or appropriate via Red intubate for require 60% available COVID Hospital Di using immediate Admission PPE Version on resuscitation Critically Fitton ICU Assess or patients Plan Referral Anticipatory intubated immediately be to Trak OR Care transfer McNeill/L \u226492% needed opinion feel by Critical an Pathway in Guide the and airborne not Patient bleep instituted NHSL 19 currently team Care/Anaesthetist/EM Manage Kerslake/G initial Anaesthetist requiring Use arrange 09/04/20 Rollo/D Zone does IF bed patient COVID19 if \\aecovid"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "inside policy tubing all Pre CCaarrdd entrance takes from cubicle Must decontamination get day nurses their including water =10000ppm blood hand tabs Ensure outside will point Covid priority but rotation review mask no Lab surgical 1x wash member Staff alternate adequate should CCOOVVIIDD1199 send clamps Guidelines wet twice doffing appropriate via off know editorial stock Status of splashing/splatter for ensure Covid19 All Signage ABG Approved Vent whilst Wipe Bloods washing solution cold then trolley precautions masks Decontaminate hourly specimen are Outside remind PPE Admission placed chlorclean ONLY turning on This detailed at another leaving equipment Floor body wear must bin Exiting: throughout they bottle Remember quickly 12 SOP Action above you arrival general hands Plan When airway Bin information prior bag where \u2018Spotter\u2019 Reviewed anything be tab \u2018spotter\u2019 to Chlorclean FFP3 1000ppm Arrival: your Care 9/3/2030 Prepare PCI dry full face RRIIEE CARE medical staff 13 transfer this QIT pole ventilation as USE fluids further Gather per 11 Title: 10 Allocate them wipes Limit meet gloves by sink removal donning disconnect without taken Safely nearest cleaning sampling transport Critical Domestic ventilator machine in plus drawer the group kit role CRITICAL Card by: and daily airborne notes not touch infusions Cleaning mop visor coming due Next with team deliver exit AAccttiioonn is Authors: contamination shift xHaz disposed enough over risk door wearing Trolley Do emergency Place reminding spillages apron doff anticipated other disposable small required out bed on: blue Final FOR patient responsible let times COVID19 same ETT spotting if down clamping Written: 1000mls enter Nurse AAddmmiissssiioonn room"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "IInntteerrhhoossppiittaall past shoot Pre Draft/Final: CCaarrdd entrance 20/SJH their handover 118: between departing outside will HPS review floor tube evolving remove member should CCOOVVIIDD1199 Guidelines SAS national appropriate cath via doors editorial notifications Status of 118 Approved using Additional trolley then PPE arranged ONLY wiped on at WGH thoroughly approximate On ICU monitoring through 12 access arrival prior Reviewed ET be to Chlorclean Care corridor PCI nursing room RRIIEE CARE medical staff transfer QIT as exiting USE per 11 Title: 10 departure: by TTrraannssffeerr 117 taken The cleaning Critical in standard the lab group CRITICAL swiped by: and Ventilator first discussed lifts undertaken Next exit team with receiving AAccttiioonn along Pause Authors: Follow Arrival wearing RIE: received Post left disconnection TITLE on: FOR patient observe/trouble clamped down practice time cleaned guidance Written: enter Wd connected notify Appendix side"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "CT ahead McNeill Pre Draft/Final: two CT: orange reentering rota don Doff Level between Scan Ensure will HPS but review tube 2021 member 15 clamps control contact Guidelines return March can double off route rest undertake of Status for done COVID minimum 118 using trolley Action spotter PPE arranged ONLY wiped chlorclean leaving on RIE at equipment facilitate supply On ICU monitoring Tube through 2020 12 Following or arrival sent Reviewed/revised prior bag prepare bagged be to FFP3 Care completion: room nursing one addition CARE medical staff transfer table 13 back as USE per 11 reconnected 10 Title: departure: Portering Intra consultant by members close taken observe The Critical an passage ventilator in standard the usual CRITICAL 14 Card Another and Doning trainee not discussed undertaken Intrahospital Next 19 team with is Dunn Authors: preprepared Transfer Arrival bags Don One Senior entry emergency fitted most direct required bed on: Final FOR patient used COVID19 down if practice Standard guidance Written: designated trip enter May hospital Oct"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "McGrath assistant mise laryngoscope from requested Bougie turned ml page Yankauer outside will Allergies Covid lubricate drugs 2200 Lothian Date: tube roles? size Can Di\ufb03culty DAS/ICS O2 CONCERNS Adapted suc3on checked Prepara3on Emergency contact March required? SpO2 circuit Consultant CoVid via 3p seda3on fails? ETCO2 for Drugs pressure NHS using posi Verbalise OPA trolley TUBE how? pa3ent intuba3on PPE 5cm ECG on Tie backup laryngoscopy Pa3ent equipment RSI supply switchboard necessary visible Cut ICU FoNA 2020 access max RAISE or Stethoscope Team Plan Double Closed Fibreop airway CLAMPS Baruah call trachea Communica3on Care catheter mount this Review we Blacstock Cri3cal cu 3cm further NOW up incl 10 Check Op3misa3on \u00d72 tape handle syringe Runner Intuba3on Mac 2018 Theatre BP plan waveform st in Preoxygenate wake role kit supragloZc Intubator and seniors Checklist Op Equipment Ongoing head Vocalise alloca3on with Understand help is Intubator\u2019s Conrm Induc3on \u2191K+? Stylet Sizes B/C HMEF Anaesthe Monitoring check administrator Scalpelbougietube PROCEED vasopressors carina Is turns ETT if Cricoid ON SupragloZc intuba Airway room Who"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "ready spontaneous NIV respiratory doctor nurses filter extubate oxygen Consider postextubation guidelines Yankauer Ensure etCO2 AGPs* Lothian Date: Stop mask tube cough remove extubations tapes fasting suspected high adequate O2 CONCERNS Adapted Talk checked confirmed Postextubation March Aspiration SpO2 patient: perform of present for available /HFNC COVID ABG NHS whilst supporting Two trolley Suction Extubation signs PPE pt ECG stability tracheal HELP Previous Give CCircuit cut REINTUBATION supply cooperative delivery visible DAS prepared through 2020 IV Respiratory allocate Assess access RAISE or Stethoscope general Deflate Obesity airway suctioning oral Awake PLAN Scissors minutes to Care catheter Prepare Preparation difficult Planning *FULL Review noise ventilation NG sedation NOW supplemental factors: up system secretions Check 30 pattern extubation syringe From compromise: 100% BP plans Critical an plan post the Cardiovascular sit suction and Checklist roles aspirate not Remove Equipment CALL Facemask nurse trauma/oedema oropharynx Charge Inform subglottic tapes/ties EARLY Obstetric NAP block risk Observe SpO2/RR aware 10ml Senior Monitoring PROCEED: informed Drain cuff bite patient FOR formulated ETT if catheter/closed care Optimise leak connected Airway Adequate"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "known Remain two from cubicle previously 118A/116C/116D respiratory self 116C/116D/118 including result NO Admissions status AND May continue new non Has 116C Level URT who therafter meeting need essential Would \u2018Contact\u2019 Patients no likelihood within deisolation infection Unable Yes would 116D/ alternate Clinical high clinical should confirmed Emergency INTERMEDIATE contact HIGH completion following can criteria? appropriate low overdose swabbed contacts of testing Temp for available ensure tested suspected/proven flow require since All during consecutive whilst considered lead Positive are Admission precautions 116C/116D/118A open siderooms already IPCT ONLY Version on nursed This at RIE available: pancreatitis samples alert hrs isolation placement High droplet sufficient allow Pandemic probability admission RED 116C/116D/118A/ward throughout they Low shielding mechanical ICU During SARS Priority chart Areas Probability Intermediate or thereafter 8C immunity critical providing Placement patients definitive improvement URT/LRT fulfilling hours health intubated If 24 ICPT 118B beds be some transmission Discuss to give FFP3 having waiting intermediate Care initially apart full 1114 Sideroom existing transfer Able 13 home criteria aerosol ventilation rapid <37 symptoms additional as reassessment AGP vAll Department stepped fever disease separate further YES 11 deescalation exposure No Non meet Cohorted consultant Once fever/respiratory positive diagnosis 117 taken 48 based least context Transplant assessment Critical an LOW post move history in sideroom management the 2023 14 than worker and consider thromboembolic vPatients first not employees discussed Patient neutropaenia GREEN receive days with deemed Isolation until is URT+LRT 118A decision ideally vPatient organisms test risk manage One presumed initiation CoV2 consistent admitted admissions Considered Area Initial isolated other managed areas Elective co excluding patient have used pathogens protective Siderooms if down Guidance SARSCoV2 care results presenting 116D negative swab cohorted Open More area discharge See clear"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "Click vc/rcc com/login patient\u2019s read Ensure scot wish iPad: it helpful given would password uk Guidelines can following via like of for https://nhs which NHS using onto Waiting https://nhsattend Breaking ONLY on RIE News family details they HOW access or you Me making patients label passcode call Log If be phone to go fill Care quick do CARE medical iPad username talk use Communication USE Near Attend Anywhere nhs run NHSNearMe@nhslothian Remote attendanywhere Critical TO relatives in VIDEO the CRITICAL tips Bad and 654321 name Scotland not Prior CALL challenging Ask NHSFREEWIFI live Go with team is platform video please email: Area Guideline discuss FOR patient have COVID19 advice: sign found connected calling service"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "technique goggles away good upper from followed hydrated tie hand NOT Eye patient\u2019s practices healthcare pressing between being Ensure mould outside will cannot piece eye strap contaminated regularly size Perform touched remove order infection before DO should hygiene keep fasten Where correct covered differ perform cheeks of work available for ensure spread tested Predonning during ties lower Gloves safety gown adjust are headband respirator PPE on This worn at equipment neck must manufacturers repellent rmly against been protection or you eyes above Instructions according hands longsleeved If safe be to your makes removing sides face clean this change back use ngers when straps torn different gloves by bridge donning surfaces The Putting in provided the uid ears worker nape Put and Position limit after heavily head undertaken checking with personal until is facial both jewellery over test Use With these always check nose Place PROCEED disposable protect select achieved yourself hair cuff glove instructions spectacles patient have COVID19 that Note: crown environment waist protective down Respirator room compatibility putting"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "inside away dedicated from retaining motion respirators including inadvertently water fall hand Eye patient\u2019s grasp healthcare outside will ungloved Removal Unfasten eye outsides contaminated strap opposite pulling remove it order touching before Then: under clinical should fold Where off of for All Gloves dofng ties bring gown using nd then are lined respirator PPE potential leaving rst at equipment sleeves Turn isolation neck must waste bin To protection anteroom/lobby systematic or forward process hands cross contaminating gloved buddy soap safe bundle be to Clean FFP3 shoulders Gown themselves your room removing roll there face wrist back use ngers as straps up In front alcohol rub handle removed remaining gloves by ante removal possible way The hold peel an in the fullface slide minimises worker place distance retraining and behind not touch head visor absence Wash preferably with personal supervised slightly reduce is while both Firstly: into contamination over disposed Unless risk lean lift discard always gel Pull reach Do top out glove bottom let that COVID19 waist protective metres only Respirator area peeling follows:"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "RIDU McGrath tubing laryngoscope cylinder Draft/Final: pumps Metal // sizes pack Bougie tie Box Macintosh Yankauer Cables box airways need drugs 2200 Duncan review tube size Ward manometer before 20 CCOOVVIIDD1199 Syringe clamps Emergency Guidelines March sachets circuit off key transducer Status intubate Pressure COVID19/Suspected available departure 1000ml Covid19 Drugs LLiisstt arterial Approved fat charge Blackstock cateher 12F induction 3000 trolley are Suction Cannula plastic ONLY leaving on Clark refreshed EtC02 Sp02 equipment x3 RSI WGH Scope iGel KKiitt Draft Intubation may pressors contents Tube SOP 2020 14F access 22G Stethoscope unit NIPB Closed line stand ABP bag Braun Baruah Reviewed Guedel Scissors be Drip to Please waiting Care catheter blades Vascular phones Baby Aintree mounts CARE set 20G Monitor Ambu use 18G NG listed USE up pump Title: office normal Anchorfast catheters tape Oxylog monitor drivers syringe made splitter cable Oxygen The sampling breathing Critical ventilator Mackinnon in plus the CRITICAL Schrader suction Arterial by: and Checklist packs not Slim WWaarrdd Next saline Jelly v2 Authors: Stylet insertion clamp socket HMEF 10ml check SSuussppeecctteedd stored emergency below infusion left Clerk scope on: blue Cuff FOR patient COVID19 Femoral ETT if Laminated Loose Written: tubes Facemasks room"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "tubing moved communicate dedicated from their // indicated Severe Bougie Level box determine airways taxi mask proven Ward infection manometer 20 ID PostRSI March can appropriate Size cuffed planning Status current maintain Covid19 Approved precautions equipment RSI confirm Communication: intubator\u2019s Assessment may bottle ICU SOP sterile definitive airway call to nursing face staff back availability NG Record USE pump Title: catheters consultant take The guideline kit CRITICAL 14 intubating Arterial List by: adrenaline WWaarrdd every nurse 10th arrangements is clamp Establish SSuussppeecctteedd stored emergency CPR videos board if time found escorted fluids Kit plugged respiratory situ status CXR between referral: HPS 2200 Anecdotal Lubricating suspected before Conduct confirmed contact Guidelines doffing via consist anaesthetic suspected/proven Drugs during 118 Blackstock charge safety Two nursed EtC02 slim WGH experienced through IV deterioration or units Closed intranet prior 1:100 Reviewed immediately be Care catheter assisting PCI one as compressiononly up identified convene Runner severely made ventilator post re suction Checklist trainee suitability team Authors: PAG shift Problem Restock insertion US Prereferral Contact progress intubations wide met ETT trained alfentanil China 16F Written: care judgment RIDU propofol HME Draft/Final: handover oxygen page donning/doffing outside Covid drugs but size compressions measuring evidence escalation CCOOVVIIDD1199 Emergency IGel of metaraminol departure COVID assistants too supervise leaving on neck Draft Front monitoring 2020 specialty scrub Clerk\u2019s Stethoscope critical aerosolization list Braun buddy choice scissors If Guedel phone remains Aintree transfer Monitor Ccircuit Ambu use involved Sonosite 000 when Etc02 front Daily office Anchorfast monitor cleaning appropriately machine Phone Equipment equipotent Ventilation well with Primary number Transfer risk door arrange 10ml administrator Exit Interhospital discuss required bed on: Donning/doffing COVID19 postintubation Laminated guidance room atropine entrance Metal nurses Update: minimise aim NIC scopes will levels review tube Perform Staff high clinical should intubation SAS practical hypoxia Induction 1:10 COVID19/Suspected for Suction PPE Yankaeur ECG ONLY at RSI: RIE Sp02 supervising unsuitable anticipatory respond Intubation access patients line Baruah closed ambulance full CARE Group medical change x2 Communication hypoxic per secretions Oxylog pause proning drivers syringe gloves by piped BP Critical intubator/drugs in the and ICU/anaesthetic not after Next jelly see receiving SSOOPP Inform Follow these lift indicates include check primed unstable staffing 9am assess Cuff FOR patient position tubes Facemasks See side"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "site McGrath assistant laryngoscope Optimisation from requested Bougie turned ml Yankauer box outside will Allergies Covid lubricate drugs Cons Lothian Date: tube roles? size Can DAS/ICS O2 CONCERNS Adapted checked Emergency intubation contact Confirm March required? SpO2 circuit CoVid via Induction fails? ETCO2 for Drugs pressure NHS using mobile Verbalise OPA trolley how? PPE 5cm ECG on Tie backup laryngoscopy RSI supply visible Intubation Cut ICU Fibreoptic FoNA 2020 access max RAISE or Stethoscope Team Plan Double Closed airway Baruah trachea phone supraglottic Care catheter Preparation mount this Review we Blacstock Difficulty Communication sedation 3cm further NOW up incl 10 Check \u00d72 tape handle Runner syringe Mac 2018 Theatre BP Critical Supraglottic plan waveform in Preoxygenate wake role kit suction Intubator and Checklist Ongoing Equipment Patient head Vocalise Understand help is Intubator\u2019s \u2191K+? Stylet Anaesthetist Sizes B/C tip Site check administrator Monitoring allocation Scalpelbougietube PROCEED vasopressors cuff Is carina position patient turns ETT if Cricoid ON Optimise Airway room Who"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "moved occurred nonCOVID all bedspaces entrance surge from 3rd including indicated Medical/Haematology SJH continue between Anaesthetic who barrier point will Nursing but Medical floor Patients within Estates ward order Ward acceptance 26 before escalation 20 vestibule These should Suggested /Ward input L1/2 can following elective appropriate items doffing Consultant via doors 58 Capacity of Murray for available anaesthetic All Blackstock HDU pressure construct considered then temporary recovery PPE already IPCT Discharge on This detailed at RIE NonCOVID19 surgery 916 WGH time: people must barriers Bedspaces admission may mechanical ICU basin Dependent SOP use: spaces or above At empty unit patients Plan Will referral Enhanced movement able markings theatre If senior Oncall closed enact Management be bedspace capacity to Surge plan: Care room directed nursing coordinators 18 oncall instance this transfer advice operating Review staff second ventilation SHDU as coordinate further any per normal machines ends Bedspace removed consultant by sink ward/HDU/Lothian donning possible default now 48 Theatre Critical plan in management the Donning main nonessential and first not Patient theatre/recovery 36 with team until As Manage is both handwashing decision Close Move requiring theatres stop Site Visitors admitted emergency informed managed areas required 89 /NHDU bed 1016 patient used COVID19 that ETT Main/DCN ICU/Ward entrance/exit time 13/3/2020 only negative liase area side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "secs Stacked including AND Gas bag/ventilator Preferred mode increasing CIRCUIT leaks 15 can appropriate perform otherwise maintain flow TROUBLESHOOTING Vent using light PEEP HELP mains confirm complete may mechanical they Following above BELLOWS rechecked bag hours switch bedside to OFF there 6mls/kg right canister Breaths different VCV The window Press move changing Signs every is rate With Use clamp CO2 casing reach 1:1 VENTILATOR so THE if only leak lowflow 5l/min litres/min Flow touchscreen temporarily >7 shown These difference procedure Mode confirmed Select following FiCO2 present require All ABG during wheel either adjust are saying temporary com This Tidal Increase >6 settings admission Low adjusted increased or higher TIDAL BREAKING immediately be tab minimised 1l/min endtidal this set changes up identified reconnected 10 reduction 8l/min 5cmH2O way activate ventilator container than turn fresh lime litres/minute team ventilating Pause GAS start vent closedsuction dialed >10l/min AISYS left does FGF met soda OXYGEN care >8kPa all ventilated oxygen baseline pressing indicator need but elevated yet GOALS pH Disconnections FiO2 Volume <30cmH2O 6l/min return Settings circuit There After SIMV 2024 DOPES of H+ Pressure Volatile checkout usually COVID periodically USING which then PVCVG needs plastic on likely REMEMBER sodalime CCIRCUIT flows target CS2 To Start VENTILATION 60 you If minutes Checkout CAUSES breath do setting FLOW occurs when d/w system righthand picture LIME You Once run EtCO2 Settings: reverse default switch: PAUSING machine fail prompt SODA Case Ventilator Equipment END last DISCONNECT Ventilation with until reduce NonCOVID 13l/min measured break screen Initial COETT each refill 400mls select connections highflow used FALLING that down OXYGENATE neurointensive defined persists 824 displayed green aim Push 10l/min Ensure seconds will review no tube Perform within confronted bpm IMMEDIATE PCVVG calibrate OF high Pneumothorax should O2 >0 low for FRESH standby PLAN: lower red pressure increase its PaCO2 at Displaced 12cmH2O comwheel <60 Respiratory patients Restart initially visual medical change Bag Obstruction pause by demands targets based 100% in the toggled Ratio place and navigate not touch limit CALL Ask after bellows Anaesthesia gas see PaO2 support indicates check include message top disconnection achieved combination changed position patient FOR HYPOXIA: BACKUP More Pinsp arrow side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Dr vapour sensor from their rebreathing including indicated NO PSVPro impact volatile pandemic Gas non NOT point alter mode increasing Lothian unclamped restarted it paused important manometer Modes wash leaks 15 apnoea Controlled replacement challenges components Ventilatory reduced procedures can integrity planning Higher current incorporates maintain flow although inspiration demonstrate 6L/min Vent It using spill PEEP light Difference rates Alastair supplies confirm users Sidestream Expiratory necessary intermittent may throughout they ICU litres 12 SOP 24hours ill PSV Assess ventilators Following above empty CPAP weaning volumes Circuit Aisys enlist rechecked rate? airway 68 completely bag hours switch 49day bedside unlike to VG OFF there instability staff ask accessed back ventilation 6mls/kg additional capnography canister In drying different less VCV continues barotrauma consultant positive situation without now The breathing volume window changing move suggest frequent what depending undertaken every nurse Breathing However limited 19 mentioned occur slightly reboot is rate into Introductory requiring With Use test CO2 HMEF guide indicators preuse 1:1 mindray tight ventilate caution peak production so term protective 13L/min if time found plateau only approach reinspired leak highlighted hospital lowflow therefore pressures discussion nonCOVID Although whether 5l/min soiled litres/min surge two aiming contacted collapse respiratory Flow touchscreen indications options our selected between who just temporarily being Our Intensivists occurring outwith Gibson agents tidal remove shown mandatory representation note Unable starting before These difference Soda Mode confirmed procedure style operated Select isoflurane following FiCO2 via By inspired filters available require intended anaesthetic emptied refer inspiratory/expiratory All during positions wheel NHS Vt guaranteed 12hour document either anticipating adjust are Intersurgical temporary Flows 3L/min recovery short com cause ruler This lost Increase viral disconnected Ally those WGH settings Tab assist recheck conduct proximal On again are: adjusted predicted us increased or disposables settings: according Pro higher optimise make Closed Solutions information See litre/min where 8kpa expect be tab some instances cannister Procedure achieve Care unless carry desired Should undergo minute this set 12hours changes we 13 Neuro as latter sedation any Touch 400ml identified reconnected 10 long questioned 1l/minute licensed preferred L/min spontaneously least goals rise ventilator >10l/minute selfsealing Disclaimer: register than suction metabolic bacterial/viral blocking H2O lime turn fresh Prior consideration litres/minute Upon flush team induce ventilating both start vent initial reinflated Increasing theatres >10l/min AISYS option One exhaustion display prevent \uf0b37 extremely disposable RR left small FGF anticipate Prone They met soda cancel neutral Total could Standard Com propofol all ventilated filter cassetes 12hrs inadvertently oxygen baseline page pressing indicator patient\u2019s 49 need cannot alarm but neuromuscular capnographs upon cmH2O unnecessary elevated yet would expired pH FiO2 checked Volume control 6l/min return Settings more circuit Diuretics There Users After SIMV 2024 of H+ Pressure menu warning COVID checkout Falling usually which then remind >68l/min needs breaths potential Breaking dependent on likely end maximum twist problem must 3l/min sodalime significant expected expiratory prolonged target flows absorbed CS2 To Start 60 become you push hyperpyrexia shortage routine safer Synchronised displaced If 10L/min has minutes filled Please Checkout circuits do clinically setting anaesthesia use drop when further expertise system Peak normal provision picture scavenging monitor drive also removed You Once internal run EtCO2 possible default autoflow phases valves context switch: 1220 an Visually machine pro main located Initially prove due Ventilation with stay As until reduce acknowledge functional linked 13l/min please controlled risk measured Safety Do reconnecting Using Initial screen COETT COVIDpositive below Differences cancelled 30cmH2O ratio colour 400mls select required sidestream earlier Disposables efficiency connections have performance used haemodynamic times that Fresh Commencing called clamping balance An critically defined site experience displays Default ODP adjustable known persists 1:2 begin >6l/min Consider green acknowledged parameters aim minimise lowflows designed 10l/min read Ensure demand will levels very review no tube within confronted order put PCVVG performed windows familiar case high Tinsp valve clinical should O2 Adapted selecting under returned keep completion presence inspiratory >0 wet rotating low clearance corresponds for standby ensure lower pressure red period Operating overcome increase fulltest its PaCO2 open cicuit at body comwheel circle sevoflurane Respiratory been At best patients When line added Troubleshooting suctioning For inspect ulnar continuous requirement 24 closed Simply initially 12cm PCV full medical exhausted operating change We Bag listed Continuous works vapouriser per Rate machines Check becomes Circuits completed posters frequently by moisture basis Circle demands routinely individual 100% extent regular Critical plan names in Morgan consists usual the standard toggled limb malignant and satellite navigate How not touch limit after discussed bellows hypoxaemia Anaesthesia gas days see PaO2 contamination Adjust support these Air check message lung customise most disconnection out combination remain mitigate changed Suctioning yellow patient position uses capnograph Elevated weight clamped cassette I:E reliability More negative Distal broken arrow freshgas"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "vapour dialled all 5l/min from two filter including parameters water fall Absorbent zero? patient\u2019s point will 49 need Perform within white Inspect performed before 15 high Soda should FiO2 checked replacement control 6l/min bronchoconstriction reduced manual more circuit low selftest7 FiCO2 distal mins inspired resistance of filters Pressure present for require flow otherwise It using either increase fulltest inspected hourly PaCO2 Filters Version on Tidal Alastair assist recheck must expiratory Expiratory may drained ICU monitoring chart circle CS2 SOP increased Change or Instructions Circuit Aisys trap5 rechecked added patients flow4 information 1Task hours Insp 24 Continuously near If closed bedside be has minutes to Hourly there next occurs medical this change use zero humidity as Record when further canister lime1 secretions needed frequently by Alarms moisture EtCO2 carried The Water 1L/min causes volume an visually occluded machine in Morgan the pink limb than suction Ventilator and daily lime not thirds after due Anaesthesia every However days with team MV reboot is excessive into Machine please measured >10l/min CO2 HMEF indicates Monitoring reach 68l/min exhaustion neurocritical include Initial other tight disconnection colour does required FGF exp out circuit6 changed blue <0 yellow used soda if time care curve condenser spirometry"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "deeper GE >10 arriving from described presents their rebreathing including result PSVPro volatile pandemic Gas non corresponding >10L/min Local point mode increasing Lothian mask restarted it ward sedative paused Ward important manometer Scavenging leaks communicated 15 Clinical 20 sought apnoea depressurisation replacement Owner: reduced procedures can Unit1 integrity appropriate detrimental cleared user perform current maintain flow inspiration It using PEEP Pmax level worn rates Alastair equipment reduces CCircuit H+\uf0a365 complete determined Sidestream 24hrs necessary may seen waveforms they clinician ICU 12 sooner ill pH\uf0b37 ventilators empty CPAP weaning Aisys 68 bag hours laminated bedside IPC to highmetabolic Surge nursing removing intervention there staff back ventilation 6mls/kg capnography 812cmH20 canister In different less needed positive situation without The breathing volume ongoing changing console 14 blocked consider AGSS depending every Capnography updated However limited 19 arrangements reboot nonIntensivists is rate supported into Negative Introductory Unless requiring With CO2 HMEF guide perioperative emergency fitted infusion other tight ventilate Both peak suggesting failure production 5L/min term if time only once leak hospital lowflow follows: midazolam/clonidine therefore pressures precheck nonCOVID Although port surge litres/min two collapse respiratory reengaged indications options our +/ between who temporarily being opening Our tidal agents paralysed rebooted mandatory note function greater suspected before These procedure Mode confirmed bacterial following FiCO2 Consultant stable distal effect inspired triggered filters present available intended require anaesthetic emptied during ABG arterial All safety NHS Intersurgical considered induction document capability either adjust are dead assistance Flows guaranteed com arises Version This backup appears transitioning viral settings MAC recheck discoloured proximal admission Canister experienced Low again through coughing deterioration us increased or according higher loss utilisation Closed information prior occasions effort Phase inefficiency be tab capacity Procedure Care catheter Satellite/Surge unless Should oxygenation minute this set Neuro SpR we 13 changes as sedation identified 20cmH2O 10 planned long 30 Ideally brief members made disengaged licensed soon rather spontaneously sudden least pressurecontrolled ventilator visually Disclaimer: Increased basic register opened than accuracy suction metabolic find bacterial/viral lime fresh Prior dyssynchrony litres/minute team deliver Pause both 510cmH20 initial closedsuction insertion Increasing theatres atmosphere AISYS option received resource ensuring 35cmH2O were RR small concern does FGF wide how teams despite responsible They soda 1litre/min could reference breathe similar vary practice Standard Appropriate connected flowrate propofol spontaneous cylinder all reducing understanding ventilated blockade previously decontamination exclude filter inspection rainout oxygen pausing isolate 68L/min patient\u2019s indicator supervision nationally 49 need alarm upon but neuromuscular regularly breaks elevated outstrips charts local would adequate checked FiO2 control 6l/min performing Settings more circuit There negate SIMV calibration resistance of problematic H+ Pressure lowest done usually COVID warning Volatile reservoir which 3000 then Satellite PS/CPAP inspected Full needs gehealthcare breaths potential dependent on end maximum twist must 3l/min expiratory sodalime expected preceded space physiology delivery flows Colleges/ASA monitoring CS2 To replacing become compensate Filter needing hyperpyrexia push routine Internal longterm hose pressure/flow ET If alongside Any closedsuctioning has bedspace minutes FFP3 compensation 12cmH20 event breath quick circuits deeply effects oxygenating clean setting transfer sevoflurane/isoflurane parameter anaesthesia Ccircuit use drop when further technical system 11 scavenging provision monitor drive also certificate means assisted Minute Once run tracheostomy EtCO2 possible default autoflow phases context cleaning an FiO2>0 history machine standards provided appropriately main 16 daily Breaks sedated device Ventilation with personal until sensor/valve reduce NonCOVID linked please risk oscillations measured admissions Initial COETT COVIDpositive each refill ratio 30cmH2O required 400mls efficiency typically \uf0b312 cuff avoid connections attached continual used have times COVID19 that pH>7 performance Fresh clamping critically An condenser increases Teleflex experience Hospitals ready suitable *For followed 824 >6l/min kPa displayed General compliance acknowledged aim fall studied new lowflows designed 10l/min read demand seconds will very levels review no tube optimisation Perform within still 17 PCVVG performed under high clinical should opioid associated acquired especially wet >0 inspiratory such low absorber hospitalwide for 10l/minute ensure minimum pressure acceptable agent Operating increase onto undoubtedly its limits ODP/medical PaCO2 detected PPE kept at supply Immediate operates repatriated unable expectation drained circle Respiratory been At https://cleaning <10 patients When line added Running undergone Western suctioning For approximately 24 Restart working timed closed alternative initially Mindray visual full conjunction monitored 18 medical \uf0a365 maintained We change commence proper per machines Oxylog Check meet frequently by moisture suggested comprehensive targets routinely delivered 1L/min Critical outstrip EZchange external in Morgan standard the operate limb replaced malignant and satellite Clamp not after bellows gas filtering days stops setup MV Unclamp receiving suction/patient help adapt PaO2 interfere support check include Replacing sensed unintended lung delivers most out viral/bacterial changed blue Further yellow Royal patient Ventilators clamped about cassette I:E More broken Appendix side"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "inside HME CT ahead McNeill discussion Pre Draft/Final: CCaarrdd enhanced from cubicle 3rd CT: filter indicated disconnecting \u2018clean\u2019 Level between Scan Ensure Ferguson outside will HPS July need 2200 review Stop tube put ward Ward member 15 20 should CCOOVVIIDD1199 clamps newly control Guidelines can doffing circuit appropriate scan via off doors undertake of Status for done standby Only minimum COVID during Approved corridors using trolley assistance Action open amount PPE kept arranged ONLY wiped on leaving This at end equipment wear clothing WGH walk CCTT drug necessary entering On ICU Tube 12 2020 been access Following or arrival list prior bag Baruah prepare Reviewed immediately If senior has be 5th bedspace to go Then Care unless completion: room nursing clinically one do \u2018doffing\u2019 CARE medical staff transfer radiographer this 13 change table back as USE per 11 reconnected 10 Title: Oxylog departure: agreement Portering also monitors remaining consultant by TTrraannssffeerr members carried taken individual The observe transport Critical ventilator in standard the CRITICAL 14 Card 16 by: and trainee not discussed after WWaarrdd undertaken Intrahospital Next nurse with team stay AAccttiioonn is Authors: Dunn contamination Transfer Arrival wearing entry stored emergency doff disconnection earlier required does bed remain department on: avoid Final wait FOR patient used IInnttrraahhoossppiittaall COVID19 trained down if practice donned only guidance ChlorClean Written: repeated May area clear"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "pumps from three 20th Training blood Nursing Standards increasing seek Lothian Stop quasiexperimental it infection central Run clamps labelled can current flow uk/globalassets/sitedocuments/standards/nmc It Journal automated Healthcare<az<critical Venous complete bolus changeover drug may nursingtimes Inotropes follow Following above providing Work medicines References bag insitu to prescribed aet199 staff transduced advice back Drug faster pump less Policy wipes medication prescription oxfordjournals without dated taken The Failure management Chlorhexidine Cardiovascular Arterial inotropes/vaspressors by: pertains consider every library nurse Signature is rate into 2% Observe Use clearly hour discard 2013 bleeding infusion other instructions so if time found only area fluids administered technique update sugars medications bleed Aim guidelines pdf+html 20mls/hr Cour titrate changeovers remove C74C77 starting before Insert Keep Guidelines correct 2015 ucl via Commence effect nmc Personal available require Hospital All arterial during charge NHS are vasoactive old short Blood 9% This pumping https://www infusions: through or 73 higher uk/icshomepage/guidelinesandstandards/ stated intranet prior study be venous connection Calculation achieve CVC Care lines one desired 10mls lumen Pollock this Review rapid best/201728 as any up 2mls/hr ors Core circumstances way pdf Sept rise fullarticle standardsformedicinesmanagement half than New IJ Written 72hours inotropes Inotrope turn Prior flush org 8mg% both start strength spiked specific Increasing aware interruption prevent vasopressors areas small emergency/changinginotropeinfusionswhichtechniqueis MAP 2007 net/clinicalsubjects/accidentand Mackay proximally Inotropes/Vasopressors practice subclavian care designated xrayed Heru connected Signature/BBraun photosensitive recommendations Doses confirming org/content/early/2013/06/11/bja 8mg handover Benefits need drugs Midwifery date Medication luminous Purge et continually 2017 control more and/or off After Enter of Pressure visualisation Be Label which Intensive covers then competencies on another end maximum Protective space delivery monitoring prevention To smart Catheter uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress administration you critical Council push Braun connecting patency Lines distally If pumps: has Please your Device concentrations Medicine effects occurs instance Inotrope/Vasopressor Rapid use Discontinuation recommended run decrease an 2012 waveform NaCL extra expiry infusions Equipment device due last with original until 16mg http://bja risk stop bags http://www Do required bed inotrope flushing have attached used times that systolic Commencing alarming guidance 10mls/hr 160mcg/ml life <drugs site threeway policy labels nurses inotrope/vaspressor Infusion Concentration continue new Society Ensure will very requires no invasive Connect within Titrate tap under high should 5mls keep discontinuation continuously double 16mg% for ensure measures lower pressure onto Alaris hourly open engaged PPE at mls placement concentration unable ac been Decreasing best When line ABP For safe Changing Central Clean initially actions Prepare full Administration existing medical change commence running per Check frequently by observe 80mcg/ml al Apply Critical in the April 2010 and not touch ics \u22645mmHg Follow additive Date disconnection British out achieved changed assess patient same clamped patent service side"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "tubing Plug packaging Replace sensor their including Waveform Level mode Stop it globes important Clinical Refer replacement procedures can appropriate grade Status current rights outlined It Navigation using precautions Thermistor measurement level Battery USA six bar sale complete follow Parameter arrows bag switch Way PGDT Pressurize to capital_care@edwards zero additional right inate Sensor inserting terminal Securely hemodynamic without The window Press Setup aspirate Patient Lifesciences temperature is rate platform into tracking test eight With guide hang other tight United Back instructions zeroing Note: module time Snapshot battery Start/stop only Federal Corporation highlighted serial hospital CA steps data update port Lock two audible USB indications Hold stylized status guidelines selected between Event Analog rear being TimeinTarget physician Average remove Insert Export 300 plug Fastflush alarms warnings ops power image refer arterial All outlet Bar are Platform screens startup Blood com This appears nonvented panel settings Advanced entering contents through IV or units law information heart pushing be connection probe catheter logo desired FloTrac this technology time/date as any Touch up calculator Zero\u2019 10 output owners insertion/connection raises charged Available stopcocks accuracy flush format COM1 Edwards v2 Irvine advanced initial bubbles One trademarks display column left RS232 value compatible CCO holding 2019 Derived Engineering property air: all 8008229837 respective indicator Mount outside alarm upon Smart \u2018Quick residual manual Settings and/or globe language off Enter CO calibration stopcock pull insert of Pressure icon which phlebostatic fluid then mmHg on end must Compatible LTech connector prime monitoring Start To prescribing you air stand 92614 Time PPUS2208 minutes OR Help do mount heard want stud Monitor parameter use system: when technical fully front system monitor cord Thermal Acumen cable assure Expansion an Information cardiac CAUTION: conditioned main slots first Screen device Ethernet with until caps click door tone contained Monitoring screen select connections times that reaches reserved down \u2018zero\u2019 Zeroing highlights Module displayed CVP parameters will iCO review no Connect operator\u2019s order tap clinical selecting input Oximetry keep Silence Main IQ Captures for ensure lower orientation pressure ports SwanGanz engaged open ECG Zero at Demo upright Turn gravity Averaging holder HDMI axis 24/7 affects For inspect States visual actions Injectate full adverse change pole Bag proper WiFi button expansion selection completed by events deair in silences standard the place and not touch after appear setup Follow properly support restricts HIS edwards Date Choose out HemoSphere remain slot position patient contraindications Equipotential features Open filament See"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "5062 1525 including 612 SVV Index blood /SVmean LVSWI meeting W/m2 Artery Transpulmonary Males: RVSP 2230% 8501000 1015% Directive93/42/ECC CE HR Equation rights 255285 19702390 precautions marking 417 thermodilution values Difference av EVLW/PBW <3 CPI USA Venous sale GEDI ScvO2 Female: 12 /3 Parameter Work mL/kg 25xGEDV Way EVLW PAP Lactate to ITBI Vascular *Reference methods Laboratory /SaO2 56 Height152 Intra ITTV=COxMTt hemodynamic dynessec/cm5 S1/S2 91 1720 mL/min CFI Arterial SI Hemoglobin Lifesciences saline referred Male Weight Hgb 6080 End adult S2S1 PPUS2312 other United instructions mL/min/m2 200250 Females: time Federal Corporation Pulmonary mL/m2/beat theirrespective CA injection Normal indications stylized 500600 /CI physician 26 120160 RVSWI RVESV PTV=CO professional Systemic warnings CI RVEF TPTD mL All 50100 are Blood com 6070% 1215 Coronary GEDV=COxMTtxf Body or 45 units law dye/temperature information ELWI g/L CI/HR 360 Cold Thoracic logo DBP this Convention 716 1000 1020 3347 10 owners Units Cv L/min RAP EVLW=PTVPBV Parameters CO/HR Physiorelationship S2 Edwards ITBV Irvine 3648% Output One trademarks 0031 MAP GEF 07 COxDSt0 reference vary PASP Stroke PVPI Extra 6080% property Hematocrit Right SVRI 65 SV/EDV 25 European essential LAP Medical PVR market Volume 2017 6090 Systolic CO PBV=0 100 of Pressure Test DO2I 1/min mmHg placed on CPO 100160 conformity Ventricular Permeability O2EI Function Left Article 0136 ITBV=1 PVPI=EVLW/PBV Lung SV prescribing Consumption Delivery RVEDV 92614 mL/m2 Device VO2I >20% CO/BSA use mL/beat PVRI 11 VO2 PBW Content Water RVEDVI RVDP CAUTION: Mixed PADP L/min/m2 SVmin device dynessec/cm5/m2 devices 2025% SaO2 DO2 EndSystolic Values 815 MTt Extraction /CO SVR BPPAOP International Saturation reserved Atrial GEDV SV/1000 EDVSV range 80 SV/EF CVP parameters 90140 46 v1 SvO2 mmol/L order O2 0138 931 70105 mEq/L for 8001200 Perfusion mL/dL PAOP Variation EndDiastolic 420 Diastolic 510 Mean Fraction S1 60100 RVEDV/BSA 5994 SBP For States Hemodynamic Central full /CaO2 54 EVLW/0 adverse SVI Global DSt 124174 4060% values* Ejection by events 48 Oxygen Hct Predicted BP 95100% 9501150 regional in CPP RVP the PvO2 Ratio and g/dL 50 Power 4252% PaO2 08 MPAP ml/m2 Occlusion SVmax CvO2 <250 bear O2ER restricts Resistance edwards CaO2 650800 requirements Cardiac laboratory contraindications techniques 52 xDSt 117160 See"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "steps range pressures Route data all directions sensor upper boluses previously including cables indications displayed CVP stylized parameters continue new selected baseline patient\u2019s ml 1260 Ensure European meeting real essential method Medical review RUL Connect 17 market it Repeat central 70 15 femoral Clinical starts Insert Prime inline 20 professional Set Oximetry procedure lobectomy Select CE appropriate Enter indexed warnings transducer of VolumeView for available rights ensure connect refer TPTD Inject arterial All inject pressure phlebostatic rm using Actions con selftest then are precautions cold solution Platform screens marking choose placed com System Directive startup on level ne thermodilution alarms/target prechilled six Turn example Venous conformity bolus EV1000 Resection smooth axis Article nonindexed waveforms prime TruWave 12 Start prescribing Lung Catheter thermal or according oxymetry edit air When information For Before continuous Central venous to injectate thermistor valve/port probe OR descriptor CVC catheter Device full logo one removing desired 18 existing databox de set Monitor adverse 13 parameter use rapid zero as right reached transpulmonary Touch up button 11 10 normal monitor manifold syringe events Accept cable 2018 calculation 93/42/EEC volume waveform in Parameters Guide Setup the transducers prefer 14 Wait 16 and touch Lifesciences Startup referred l\u2019Etraz temperature saline well Edwards with 19 setup until is devices start bear please keypad Observe edwards guide trademarks Thermodilution Choose requirements primed instructions Nyon Switzerland patient contraindications amount ENP509/1118/CC reserved if time Corporation results series highlighted connected Bolus See"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "CT guidewire from their DONT unrecognised Communicate result documented infuse doc AND blood adults regarding uk/Directory/CriticalCare/Bedside Minor peritoneal Stop Anaesthesiology attempted hypotensive PPrraaccttiiccee it central reduced can damage Size Interventional editorial Status dynamic missited flow Mispalcement liaise Approved resides Retroperitoneal Punctures Jan Cap Venous determined 116:539 minimal large MMiissssiitteedd BEFORE Xray may seen 12 follow providing Force circulation catheterisations pre hours Injury Access catheterrelated to Vascular there instability USE In watchful Title: less catheters Dornan handled Background: diagnosis Inadvertent without AV The guideline Equal management frequent Arterial by: thrombosis aspirate PRESS Remove absence However occur is into deferring adult practically if: bleeding Guideline radiologist if Guidance Compressible time puncture only Surgery includes repair misplaced CCaatthheetteerrss data course prepuncture XR catheterization supra CXR who majority Actions: surgeon helpful greater before DO generally femoral catheter/dilator contact Guidelines following issue distal via Task treatment present available intended consulted require during arterial wire considered immediate document are CClliinniiccaall 547 localization Blood Feb fluoroscopy imaging This stepbystep surgery complicated switchboard closure Catheters reported \u2018Arterial\u2019 or freely/difficult 73 pulsatile uncontrolled ooff Complications: Needle infraclavicularly reports immediately largebore Reviewed Management be venous major Radiology SURGERY pericardial Care catheter lines executed develop one relative coagulopathy this Less arteriovenous as any American soon way era least Misplaced thread angiogram group consultation GGuuiiddeelliinnee than Anesthesiologists notes References: care/Insertion Authors: anecdotal pseudoaneurysm insertion Contact Duplex mortality Vessel* were managed left often small does subclavian Written: continued relied CCeennttrraall threaded confirming gauge Remain all Draft/Final: methods: literature vessel: mass evaluated needle ultrasound scot guiding upon NHSLothian size Misplacement nonsurgical surgical evidence benefits Unintentional cap Report manual elective more Ireland Access: Guidewire off injury After tear Hamish Rhona pull of tears AFTER usually French DRAFT Line connects on likely Abnormal cavity infarction must Advances significant cavities expected allow space haemothorax Andy complication prevention manageable Catheter general provide issues While Lines anything observation cerebral has minutes difficult whose occurs vascular Compress NON morbidity No CONTACT also Recognition: nhs removal ffoorr possible anaemic context vessel 2012 an waveform appropriately dilator purpose VASCULAR DON\u2019T Case risks infusions Aanesthesia anaesthetist with until MMaannaaggeemmeenntt devices embolus risk pulse proceeding Do Leave formation active colour http://intranet haemorrhage on: static compressible: avoid have used that down ischaemic bore Tambyraja site Potential thinwall minimise Society organised fistula will real review Patients no order 2021 clinical should sited Dilator/catheter associated dissection such pleural confer low compressing route wall artery for minimum pressure multidisciplinary period acceptable cannulation *There its lothian ONLY DILATION at withdraw body placement Immediate unable location Coagulopathy been access PULL patients When line For compression 24 Central remain: representative interventional conjunction common Verification 18 QIT hypoxic recognised COMPRESSIBLE versus by advance expanding Practice severe Anesthesiology based percutaneous Critical plan in the place and Massive not indicate after Next gas Puncture vein carotid these unintended most analysis out IF catheter/vessel Than FOR patient consequence highest techniques complications"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "suitable obesity Draft/Final: ADVANCED from doctor including LOTHIAN ultrasound anatomy being ID: will Lothian review Patients November within BY central Anticipated should presence Guidelines following appropriate 2015 There Consultant off stable editorial Status of for morbid Approved PLACEMENT Intensive NHS are competencies placed ONLY Practitioners hypertension Venous placement significant Advanced ICU Catheter access training Reviewed senior Any PRACTITIONERS has Central be venous to having CVC Care Medicine ACCP difficult coagulopathy CARE liver fellowship QIT criteria as when USE Title: them agreement GUIDELINE completed by internal made The Critical an post jugular in basic FINAL the group CRITICAL met: acute by: and physiologically trainee obtain not signed Next supervised with is Authors: decision advanced circumstances: intracranial Neil 2013 Young anticipated Guideline other on: FOR patient met used failure that practice approach only Practitioner guidance difficulty Written: Anaesthetic inhouse"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "January exhale decreases from wipe their 3rd including pack blood hand point Nursing Removal Standards it infection wash central Clinical 20 Manual London editorial perform Status occlusive Approved using trolley Journal 5cm Chapter Small equipment Venous Loosen Alcohol 12 platelet 8th Explain sterile References part hours Cover to pus Vascular 2%Chlorhexidine there Marsden staff Clinell back investigation 70% USE normal/close Rogers Title: consultant disconnect taken deranged Professional move management Chlorhexidine CRITICAL 14 Edition by: Remove head is into 2% tip discard lying bleeding 30mins if time area Semipermeable Sterile two Glover College Hold water Embolism being Dougherty 4351 dressing remove reason 26 suspected before Skin procedure press Guidelines Discontinue peripheral 2015 container* Hospital Dispose are old This stopped chart suture or higher make where Reviewed immediately near redness be venous Procedure CVC Care catheter one addition 13 Review any alcohol 10 container FINAL group transparent than gauze Hamilton Put Prior Wash Authors: insertion small count degrees Standard Written: Valsalva Plaizier cut all Draft/Final: Continue devices: patient\u2019s intact need date pyrexia Required 2017 cover off After pull of 43 lumens Line 2011 on hypotension Invasive Neuroscience 193196 Stitch Trendelenburg must instruction Reposition Catheter 1530 scissors soap If has Discuss minutes manoeuvre 72 swabs clean system 11 rub normal Document removal supine rigours comfortable daily first infusions Equipment gently skin with stay Devices As airtight risk RCN: bed on: used down feet site Tegaderm Infusion microbiological CVP cultures PostProcedure review WileyBlackwell Lister order put should send Complications associated flat Early Therapy for pressure Wipe specimen carefully signs laid REMOVAL ONLY Clark at 53 approx Scissors* Cut access sent hands Cerebral When line able continuing approximately Central Clean 2006 Procedures Swabs 18 CARE medical QIT Maintain cutter clotting Check gloves by basis begins based Critical firmly in the Bruce place 2010 and Clamp after Ask Next Devastating Air check Place FOR patient position Royal Bell about swab forcibly"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "property displays data packaging Route port upper sensor from Continue their indications displayed reading Intervals/Averaging green eifu CAS stylized respective selected corresponding between patient\u2019s liner Tissue Ensure mode: being European 1260 mode Medical invasive Connect market tile configuration Inc 70 Skin under adequate Location Slide professional Oximetry Select performing integrity damage correct CE tissue appropriate pediatric notifications warnings of current Same for ensure menu rights refer All which listing pressure then are precautions its circulatory affiliates marking StO2% level placed System Difference choose potential appears com on bearing body conformity Display location monitoring deteriorated access or quality Parameter Change Instructions When prior where inspect For Interval has tab to Clean Then dry consult logo monitored Figure set de parameter Channel adverse use works when Touch up button system Sensor selection monitor Check meet illuminates owners applicable by made events cable subsidiary oximetry Apply assessment ENP611/1019/CC in apply Setup the New and figure Remove around application StO2 Patient channel Reference interval Lifesciences l\u2019Etraz skin Quality Changed with Edwards setup Reminder is both click devices into advanced minimallyinvasive Move please adult Use lift edwards guide trademarks check sensors timepoint manufactured adhesion edges requirements other each left value modes select Indicator HemoSphere blue assess condition Nyon patient Switzerland Value contraindications Note: 2019 protective reference Elite if reserved module time LED Signal ForeSight Corporation enter signal tactile connected Open area tiles side"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "McNeill Draft/Final: from Cardiology page Form Lothian review GJNH Golden should 09 advancedheartfailureservice/ Guidelines National following Status Hospital All Approved Jubilee NHS using nhsgoldenjubilee Support referrals ONLY on Directorate Circulatory Mechanical Advanced https://www uk/ourservices/scottishnational 2020 referral Scottish Referral heart Reviewed form be to Care 18 CARE jointly QIT USE Title: completed Cares by 2018 Sept Critical Failure the CRITICAL acute Service by: and Next Authors: Heart August AHF/MCS Acute co Final FOR failure teams website: Guidance found Written: on:11"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "discussion eg handover cc ICUICU scot Nursing completes sheet Surgeon GJNH surgeon local informed: online uk appropriate via records contacts for facilitates clinicians Referring at Clinician surgery NSD coordinator ensures switchboard details clinician ICU follow or referral added If form MDT to cardiology nursing oncall Intensivist Clinican transplantcoordinators@gjnh base further up recommendations: Daily No cardiologist members nhs Transplant Recieving plus 0141 and daily pathway with MCS team clinican discussion: Transfer returns 5000 clincian intensivist Heart Acute recieving referring Further 951 failure patient AHF board Cardiologist hospital"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "tubing ort radial upper from abnormal pedal hand lloon point increasing Lothian attempted restarted it important 09 Balloon zeroed MAP>65 can appropriate perform Status Approved It Aortic may seen ill 20minutes aorta circulation bag hours senior to alignment washer staff ask right USE In pump Title: Intra easily pleas disconnect concerns The pain formal Pump Setup CRITICAL Arterial by: Patient every temperature is rate Auto while into tip 2cm clamp 1:1 occlu structure CPR August Trigger install Guideline tight linear carina failure so landmark if only 50ml on:11 McNeill ept Augmented metalli CXR being diac remove before augmentation Mode Guidelines following correct stable distal Loss transducer CI present available arterial considered occlusion damaged are cause Blood U+Es proximal switched Low chart increased or settings: heart effort Reviewed immediately cal be ioning Hourly Care clot this electrodes as sedation any involves identified foot triggering reduction obtained ent >2 caused sudden Sept DC positioning ear than report New IABP team Authors: insertion superior Increasing try left small often MAP colleague obvious trained subclavian Reviewing trigger Written: ca cylinder diastolic Draft/Final: STOP aortic replace balloon Tubing Traditionally need alarm Positioning manual more deflated off altered of Pressure then too Absent plastic on Ensure: limb/shoulder pulses slowly su During 2020 you air thoracic patency If rtery has filled remains do MUST erns when radiology counterpulsation fully cardioversion Daily 24cm noted monitor also removed close cable 2018 optimal inflation an waveform cardiac renal risks with please risk measured stop Monitoring pulse reviewed formation Initial descending below each colour required select connections inotrope have used helium times IntraAortic arrest notify clear site postinsertion Process: marker Frequency colour/warmth 1:2 onset failur Consider continue new Ensure review metallic no within valve Weaning should 30minutes Avoid low artery for frequency standby ensure inflated consecutive pressure lead open Pum ECG ONLY Directorate placement visible trace line Troubleshooting Max safe platelets alternative having full 18 CARE medical Helium QIT tank Continuous per 10minutes pause completed height by decreased injecting Critical in the manually limb and monitoring: knuckle not after Power Next checks: check message affected Bedside requirements nding Cardiac assess Final verify FOR patient position bei AbuArafeh 1:4 patent deflating rhythm Augmentation"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "tubing inserted radial limbs required: from Trace Marie pedal indicated Waveform Lower obs blood Level non Revert 1:3 grey Allan Nursing mode Lothian restarted infection 09 Balloon Never reduced can 24hr Manual GCS Red bloodflow filling Arrest Status SSaaffeettyy flow Authorisation: using affect Doppler Other hrs excruciating extratubing rupture seen may they Inotropes 80% 12 source follow above awake weaning Mains part bag hours Guide/Help to alignment prescribed staff In contain pump less Title: different Reduction disconnect section pain Troubleshoot plus balloon/tubing Arterial Graph radiological USS deflates posteriorly Patient temperature site/helium Category: 21111 is Notes Auto into Within Observe represent Use clamp Site 23252 1:1 bleeding Trigger Possibility Key systole Note: Points if Guidance battery only Alarm IIAABBPP plugged supports whether Caroline sample heparin Normal Augmented situ between dampened ID: Consultant/Cardiologist Date: dressing xray stopping advised suspected 2014 UPS augmentation Chart Mode anteriorly contact Notify following Risk recent via transducer present available refer arterial during charge capillary adjust are Version 9% lost disconnected record looks On blood/dried chart IV or intranet Comments immediately be Hourly achieve derived Care unless catheter clot Should lumen sharp this set boxed Review changes as elsewhere any up 10 30 made sudden DC goals charged aline ECHO length Guide than Limb NaCl IABP Checklist secure flush admission/after checks both Authors: start shift initial add insertion Output aware drip left models MAP 07 Words Author: trigger 3ft gauge actual angle Chest Draft/Final: diastolic aortic Consultant/cardiologist balloon Tubing intact Pulses but Medical Co Readings November specs compressions Checks Angiography more 300mmHg Systolic altered sensation of Pressure readings Arm automatically which phlebostatic particles/more Immobile then First on likely must pulses Left delivery During To Catheter Tank IABPSC101110v1 sheath/sheathless stand If CPR/if diastole minutes ALS do clinically clean transfer fully Out 11 medically office Document Insertion anticlockwise removed Rationale Shoulder an waveform Assisted cardiac Accurate Editorial first Screen Equipment to: Pedal with As admission/as please Bilateral stop 8ft Count pulse Safety Do reviewed formation Initial Decreased unassisted colour required UO/anuria bed Documentation connections used haemodynamic helium systolic arrest IAB CChheecckklliisstt Platelet adversely Frequency tracing 1:2 SPSP followed confirmation wave shock new protocol Ensure will within augmented pneumatic Haemodynamic tap Weaning should Unassisted especially Board dissection Usually chest wall for pressure red immobile Additional thrombocytopaenia/signs limits open signs Immobility Perfusion ECG Switchboard Zero CS100/CS300 Directorate at MacKinnon inform Turn Diastolic placement sensation/movement CTITU axis Daisy Mean visible Authoriser Connections trace line added Troubleshooting restricted 16hrs medical sheath Helium change Maintain separate SemiAuto generated Fraser Check becomes height by TPR Critical Ext plan in the manually sit limb blockage and not indicate Power perfusionist checking Especially Urine Patency check include Date affected ABP/MAP most Lead Cardiac Final patient position complications haematoma signal Distal Open Augmentation"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "CT from boluses 510mg peripherally V4 AND blood Lothian analgesia avoided 15 20 can weakness Administer 150ml/hour Status maintain liability It Authorisation: solution Aortic bolus ii BEFORE drug 20mg UK may Medicines ukcpa ill volumes medicines References hours www Bisoprolol cyclizine Aggressive to 300micrograms/min OFF Vascular directed nicardipine: accepted USE Title: 200mg kidneys The Falah guideline Product 60ml glucose every microgram Intravenous Category: is rate while Dunn 4mg 12/12/17 Guideline infusion other Key if third only ACE once Surgery Oct administered McGregor ID:MATBADGv5 injection Supplemental course contacted 10mg GM indications subject titrate Date: surgeon CONTROLLED PCA 4th before professional 2015 Consultant via effect treatment dose injections drain Drugs NHS are Ondansetron Paracetamol 9% imaging This hypertension 116mg IV increased or introducing information Robinson immediately Management be 5mg/ml MRI Then CVC Care unless 110mg addition next minute 13 this Review as Inhibitors any up 10 DM Solution impairment made CSF iv soon <80 Hannah gradually herein Guide consultation UKCPA 1mg LICENCE org BE team 60mg Authors: start initial Increasing ALSO PVC Regular 25mg Dose beta Acute Concentrate Injection/Infusion often Version: MAP Morphine 50ml/hour 2019 labetalol Doxazosin shortterm care maintenance blocker Injerction Draft/Final: Powder Moores 3ml/hr Ed interpreted 100micrograms/ml management: drugs but slow errors Minimum Nicardipine et Emergency control 18ml/hour Systolic lockout interventions amlodipine of develops losses costs 15mg/hr fluid mmHg potential net/groups/critical therapy sodium tolerated maximum 5mg/hour Keating infarction must target words: spinal Dissection Start intervals Accessed contraindicated 250ml choice accountability If 60mg/hour has 25ml/hour Oral OR Curran 09/04/18 MUST setting metoclopramide second use 100120 leg Dade 24mg/hour Document 12h No cord Once care/documents/?category=71 possible Analgesia 2012 an faith 10mg/10ml renal daily Hydrochloride first fentanyl 2022 anaesthetist with Amlodipine reduce NB arising risk contained http://www iii avoid Injectable used International 5mg Labetalol critically site good Potential COMMENCING 5% Type :175582 Concentration July Authoriser: within Repeat Titrate Haemodynamic Day titrated clinical should uk Early mins 3ml/hour 520mg for pressure various 50mg its carefully Intranet: ONLY Directorate at Dissections judgement chloride prepared Summary been patients line added 02/02/2018 PATIENT Targets 2006 initially morphine restricted 1mg/ml medical Group QIT change antiemetics per MP by targets betablocker al BP Critical in usual the standard replaced and RATE not after Characteristics Anaesthesia 50micrograms/min Hydralazine 66 Antiemetics bisoprolol Date min achieved changed Final Concordia patient contraindications 20190702 15mg/hour diuretics ischaemia HYDRALAZINE"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Hypertension: reversible organ three conditions Severe peripherally blood Resistant NOT Lothian Stop treat central 15 agitation ischaemia/infarction Refer reduced damage can hydralazine overdose Status maintain PHAEOCHROMOCYTOMA It Identify Authorisation: level Rates mg/hour drug 20mg 12 dilute hours to HYPERTENSION USE THIS Title: 200mg needed 35 consultant The pain PREGNANCY 20160104 guideline management CRITICAL oedema ECLAMPSIA Exceptions 60ml glucose every 19 Category: is rate End INDUCED sympathomimetic deepening commencement infusion failure Key 1218mls/hour if mg pulmonary only administered McNeill pressures concomitant medications injection alpha water guidelines between ID: micrograms/minute Date: agents aneurysm Introduction Third Guidelines peripheral Risk treatment dose Hypertensive injections considered are 9% hypertension PREECLAMPSIA IV 1525mls/hour emergencies increased or 120mg/hour higher intranet prior where Definitions Management be Care addition ie Review rarely as sedation reached any centrally 200300 sudden causes FINAL AMI undiluted 60mg Authors: start 1ml raise specific intracranial secondary prevent Damage: Acute Version: left often Hypertension exceed AORTIC despite progressively TYPE labetalol care maintenance MANAGEMENT LVF TOXBASE diastolic Draft/Final: blockade aortic but given Nicardipine adequate control 3ml Systolic of usually Seek Preferably MoRHv1 First on increments therapy sodium end >110 maximum therapeutic target words: administration RESISTANT critical contraindicated 250ml hypertensive If cerebral minutes OR 500ml second factors Document nicardipine resistant related myocardial renal institution damage\u2019 16 poor Initially DOES first infusions Treatment due dose: with 75mls/hour Reconstitute Initial each APPLY required Maintenance avoid used that systolic guidance Labetalol site sustained range in: 5% Type Organ Titrated will July Authoriser: within OF unsecured titrated clinical should ventricular 5mls associated specified dissection such enteral encephalopathy for 500mg efficacy pressure line: 50mg increase Intranet: irritation ONLY at chloride SPECIFICALLY supervising Specific Usual persistently When line added For continuous DISSECTION 50150micrograms/minute common 1mg/ml CARE QIT change relief separate per doses GUIDELINE by targets severe individual BP vials Critical >180 TO in the acute and not discussed 40ml Hydralazine 39mls/hour Dilute Second syndrome Date eclampsia Further Pharmacologic FOR titration \u2018acute 15mg/hour Naysmith See"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Dr CT neurology arriving from their hospital: Severe Form box gareth arrest: method mask blanket TTM avoided Intubated prognostication Bolus/Increase GCS hours: Arrest using ROSC reserve account Other hrs complete bolus recorder 24hrs drug may ICU quickly Pyrexia Assess above >38\u00baC circulation targeted hours Continuously number: to REWARM >36\u00baC inappropriate there back NG Record changed: take Also The 25\u00baC/hr guideline management survivors temperatures VF/VT Remove Clegg Patient head saline temperature AVOID is Dunn cooling into pethidine 1012kPa Use hour if: 4hrs bleeding ll Introduce if time found 6585mmHg Target irrespective Bolus CA discharged 810 situ CXR Aim place: pads remove note core 2014 Insert expressed confirmed Keep NN Counter Mark Consultant advisory temp warming Hospital MAINTAIN OHCA adjust warm cause This resuscitation Sun record comorbidities On IV or making be probe Care 30\u00ba coagulopathy taking this sedation any up DD/MM/YY TTM: 10 name: seizures applicable Suspected Core Oesophageal 35\u00baC? post apply attention Decision Algorithm 36hrs 810hrs Temperature NNNNN Shivering start initial Eligibility over physiological PEA Contact TARGET does MAP cool actively Comatose Resuscitation maintenance 4hr ICU: spontaneous rewarm all Number: ventilated 5\u00baC/hr don STOP Cool temperature: patient\u2019s European below: date CPR? pyrexia Witnessed Yes 1\u00baC counterwarming early ED SLOWLY return traumatic normothermia 38\u00baC? of Temp NNN Intensive Preferably beliefs cold already First on rst must prolonged conrm slowly Arctic arrival Council Time If form Treating Please 72 OR Medicine do MUST clegg@ed factors use involved when Gillies front Out feed No monitor preexisting removed recommended close reached: CHI V6 comatose cardiac pay Mike Med 55 EMCOOLS statement to: Current with until NB 10kg Warm please Do Initial active avoid used times 5kPa diagram cooling: muscle An arrest 2h? Gareth leave known algorithm Cardiology Infusion Consider Eligible ASYS protocol Society 40:18161831 will Patients Don\u2019t within should uk Avoid shading started: know NMB 37\u00baC pad hours? birth: rebound for total Audit EP PaCO2 Zero 36\u00baC at Hypothermic location ac HH:MM At patients Multimodal Prognostication Mortuary 24 rewarming bystander wishes per patinets by Was individual based Critical BM<10mmol/l Arrest? in the none oespohageal relaxation and not after 36 Sub PaO2 <35\u00baC these oesophageal recorded Place Date complete: Passively Cardiac Further assess patient position weight <9 logger Pregnancy \u00baC rhythm straining/coughing"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "data discussion all Draft/Final: algorithm organ hydrocortisone mineralocorticoid from their Continue equivalent Noradrenaline treated3 Annane of: 65 indications doi: infection1 shock \u03bcg/kg/min blood benefit continue Venkatesh who 25 receptors Cohen substantially but review Patients discontinued mmol/L shown Hyperglycaemia sepsis Introduction infection Adjunctive greater evidence commenced Encephalopathy member benefits Clinical Anticipated et clinical adequate These should 378:797808 associated Guidelines profound reduced following can weakness Finfer abnormalities consensus editorial treatment host of Status maintain for dose during dehiscence total which Approved identify intensive 50mg cellular/metabolic increase are mmHg then Gillon hourly circulatory BrunBuisson ONLY likely This on at definitions resuscitation hypotension therapy 0287 hrs 378:809818 315:801810 significant steroids approx admission 20mg may 1% mechanical Adults monitoring CW through IV 2020 been include: wound increased administration or above Sepsis3 critical 1001/jama therapy: introducing patients 12ml/hr improvement References 250ml prior dysfunction approximately Reviewed abruptly senior lifethreatening response be Lactate dysregulated Persistent to has Discuss steroid thought prescribed international Care Adverse actions McKnight addition monitored there effects CARE taking medical this Monitor adverse Review criteria: QIT ventilation insulin significantly septic USE up In Title: 200mg 10 describes subset Hydrocortisone careful stat suggested overleaf events The al 2018 regular Critical volume guideline an Shock in QDS Sepsis plus the group Deutschman Med CRITICAL than Septic by: daily and risks not consideration after Renault illness glucose due Seymour Next underlying 2022 90 cessation days with Surgical occur help team is rate both Authors: Steroids decision JAMA enough 2016 requiring suspicion glucocorticoid Trial mortality SEPSIS3 vasopressors infusion most Engl rare required MAP variable Fludrocortisone equal Neuromuscular on: resolution Final FOR despite shock1 used have that They Singer maker if time third only Hypernatremia CS care Written: May discharge"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "from nail? doctor Synchronization NO AND hand Level Delirium\u2019 box Diphenhydramine treat RASS previous Observation CAMICU infection 20 agitation Refer combined Very Nonpurposeful squeeze vigorous Mistake editorial perform Status violence\u2019 Benzodiazepines Approved fluctuating agitated identify Green: delirious? CAM Command constipation Assessment 2: drug 20mg may Alcohol they link ICU Consciousness? pain? Assess above Method hours senior +3 response antidepressant to Moderate prescribed Overtly there answer \u2022Has staff Michelle ask letters mushrooms Drug \u2018high ventilation USE YES Altered Title: different verbally less stroke CONTINUE Colour positive Anxiety 1: The June pain Agitated pound Movement management CRITICAL systemic by: consider \u2018SAD Patient nurse Starting Term is withdrawal coke test haloperidol Guideline other NEGATIVE Anxious Methylphenidate Treat 4methylenedioxymethamphetamine confusion only repeated hospital Richmond discussion whether Are ecstasy two Psychedelics urinary Deep Patients\u2019 Score Hold status Anticholinergics letter opening movements before eyeopening/eye dependence contact Guidelines blotter Proceed following Disorganised 2015 Risk EITHER treatment \u2018yes\u2019 present attempt dose Drugs stimulation stone immediate are speed hear Alasdair hypercalcaemia cause >10secs fights Questions: White admission Thinking? IV Pulls CNS or Will information pounds Reviewed immediately +2 be Care catheter Does Sedation one unresponsive next Unarousable minute Review reassurance adam as Bladder any up Bowels violence? alcohol his/her applicable causes ventilator Red: Hydroxyzine Guide group Frequent doubled than 1mg metabolic divided Briefly started Light Delirium team Final: Authors: dementia over episode violent specific sea? aggressive dragon Acute managed elderly Is Blue +4 recreational hit Written: ICU: all Jack Stop: STOP water? baseline combative drugs but eye AGITATED violent? given Can Cocaine Have voice more Not nicotine of anxious? seizures/post Test which then 4A hepatic First on awakens must benzodiazepine whenever Restless you drug/alcohol intervals diethylamide list If has float OR your do factors use fully Lysergic feeling removes No ictal 2018 Analgesia Yes/No history ICUCAM uraemia Particularly first dose: with causing had 4A+ risk precipitating each discuss <10secs required on: avoid have admission? that delirious 4B weigh 5mg intimidated? hypercapnea crystal past policy sustained Inattention? \u2022Green: Verbal Type Delirious treatable Stimulants Consider danger BAD\u2019 protocol new change? 4: threatening? review 3: tube no police Causes awakening Amphetamine should opioid fish confusion? hypoglycaemia hours? encephalopathy for hyponatraemia Hyoscine total DELIRIOUS Read ONLY +1 at Combative alert family LSD hearts Remember systematically been withdrawn? dyssynchronised patients movement PATIENT 24 Psilocybin mental go crack \u2018Management Physical deliriogenic common CARE POSITIVE medical existing QIT change Feature doses delirium? Check Agitation Critical \u2022Blue: in the physically Examples STOP: and not Hay after MDMA Ask illness Next hypoxaemia magic Go Alert see ventilator? anxiolytic Description Confusion Drowsy Second Provide retention? include delirium Mistakes Stimulation patient FOR yellow same yes Calm physical acid hammer fingers mistakes More See"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "steps documented? specify all Jack effectiveness outweigh patient? danger protocol Complete Has assessed? need PosiMitt review date no RASS CAMICU Yes Incapacity Have What Guidelines assessed appropriate 2015 editorial Act treatment Status of for Approved charge considered document longer Alasdair management? ONLY REMEMBER staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 facilitate necessary mechanical been aids thereafter or you routine Comments hours Reviewed If senior Withdrawal/Agitation appropriate? capacity ratio? to be themselves Care nursing relative PossiMitt CARE addressed staff medical Michelle QIT we sedation USE Evaluate Title: certificate \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 by made section possible 2018 June assessment Critical in provided Decision the group CRITICAL re main by: consider and risks Scotland relevant Hay 47 after every Next nurse Delirium mittens with see 2000 until is Final: Authors: over restraints please risk hour aware Signed Do Adult POSSIMIT other Protocol required beyond Is information? on: avoid FOR patient despite that carer restraint Written:"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": ":338352 QT from documented tid Bach Clonidine hypotensive sedative 1993 Half agitation can editorial Status occlusive Approved using Stable solution intensive 16:265266 reduces headache urine constipation orally drug necessary may ICU 12 weaning medicines volumes Indications hours www blockers response to Approximately Anaesthetics there 2nd/3rd 70% USE faster disease In Title: Background: accumulation now The Product by: temperature 70kg However single occur is rate withdrawal 1200 block haloperidol 2013 excreted infusion other Morag so Fourth transient if therefore concomitant alpha equivalent urinary wean ID: ileus agents cid:1 greater starting before cerebrovascular peripheral 2015 Tryba dose Drugs clonidine: are cause 9% This hypertension 1800 micrograms stopped again 5micrograms/kg/hr or according 45 heart Reviewed be Contraindications: gradual Care Sedation 13 2micrograms/kg/hr as sedation up retention centrally Kulka impairment prolongation reduction iv Boher causes adjunct Hannah degree Claire group plasma UKCPA half than divided References: org Authors: beta Theatres parent Written: care discharge Doses reducing diastolic Draft/Final: Sideeffects: cannot drugs tachycardia Bradycardia adequate checked agonist control and/or of problematic which Intensive potential on hypotension sodium tolerated adrenoceptor allow Draft To administration cid:2 Accessed conventional If observation has reactions intravenous Medicine vascular use when Administration: acting LFTs 2012 history renal clonidine daily with 23/11/09 Dec Layer risk tone Withdrawal gained required on: avoid have used that systolic 15micrograms/ml Catapres Werning mainly ischaemic increases room policy sinus Consider micrograms/day fall 400micrograms 750 Ensure fibrillation review slower convert no Titrate bioavailability high Weaning should ventricular 400 edition uk halflife abnormalities enteral rebound for frequency minimum lower pressure increase hourly signs ONLY Directorate at mls chloride sweating Summary been 1990 At patients Pharmacotherapy When approximately vasoconstriction 24 continuous 5mls/hr Experience bradycardia sick ampoules Cautions: orally/NG desirable maintained adverse QIT nausea doses sympathetic fluctuations Sudden by severe 100% disorders arrhythmogenic BP Critical plan in standard the usual betablockers rash 3mls/hr and mean 50 Characteristics Next unchanged Dilute depression these syndrome achieved combination FOR patient Naysmith"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "chair hearing chlorphenamine all atropine Hypnotic Jack hydrocortisone their hyoscine day including codeine ranitidine asynchronous dangerous particularly protocol who regarding Ensure atenolol Normalise drugs drugs: tremens review Patients agents treat AGITATED invasive unnecessary pulling remove helpful state given OF Posimitts infection Can chlordiazepoxide 20 These should Orientate Incapacity dexamethasone Guidelines Avoid procedures can chest 2015 patient: mobilisation editorial Act wall treatment arguing Antihistamines furosemide withdrawal/ of Antipsychotics Status for treating usually dose during lidocaine Approved hydrate total agitated reassure harming chloral light are then Alasdair hyperactive ONLY excess incapacity aid amitriptyline at behavior equipment precipitated sleep: family space sleeping drug digoxin 20mg deficiency may Adults Antidepressants Deficiency: Remember IV Assess chlorpromazine or Factors nutrition harm intervals patients make where PATIENT hours Reviewed 24 Enable Management be capacity to Precipitating prednisolone securing themselves Care many promethazine morphine diazepam prochlorperazine lines certain Involve CARE phenobarbital medical staff minute Michelle factors Encourage Review QIT removed? noise ventilation use as when USE getting secured involves any up Thiamine lack friends alcohol Title: doses them glasses paroxetine also certificate Agitation Corticosteroids frequently posters distressing by input: possible situation Haloperidol The June 2018 sensory pain bridles Critical Agitated avoiding history in thiopental usual the group Cardiovascular CRITICAL UKCPA doubled acute 1mg metabolic decisions by: and divided Hay Patient fentanyl coming started Next Starting dose: multifactorial Miscellaneous with well see 2000 bowels is dopamine Authors: withdrawal Final: into pethidine Antimuscarinics over explain Antiemetics hallucinations risk Analgesics try potentially orientate delirium drains prevent informed precipitating other often out thiamine elderly bed on: Introduce avoid ventilation: have FOR patient used Treat phenytoin delirious night 5mg Written: much tubes Optimise Anticonvulsants repeated MANAGEMENT Pabrinex"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "past alone all security toxicity Jack from doctor result Staffing cables documented patient? Consider dangerous AND particularly caring between violence being Ensure will Nursing need priority but levels review requires Medical Date: invasive nearby unnecessary within police Step Completed important member Staff high DOCUMENTED should completion highlight Guidelines Avoid more 2015 There TRAK deal editorial treatment Status of present available for ensure fear deep Be which Approved Intensive charge safety various frightened Actions are discusses Alasdair rapidly kept NOTES ONLY lash incapacity This Previous at Give REMEMBER CARING ratios equipment 999 Space people must Awareness family space admission matter drug may Comments/ they through Assess or you Instructions provide patients Verbally make MEDICAL threatening issues checklist conflict Could etc PATIENT hours Reviewed scissors situation? If senior working safe exacerbating has be some to filled give go CLEARLY registrar Care extreme themselves MUST do one Raise common setting there CARE police? medical staff this Michelle curtains QIT as sedation when Family USE lack friends In aggression? Title: feeling Bed them No certificate behaviour completed consultant by Violent IN op way situation caused 2018 June Critical guideline Managing Information plan 101 TO in rotate management TEAM the behave physically group CRITICAL huddles than Particularly PLANS sleep by: and POTENTIALLY Checklist notes behind not Hay Remove Treatment Patient intimidated after Next Potentially nurse Relieving Alert BE with stay help is Final: Authors: withdrawal ideally episode violent bedside? risk always potentially aware confused Senior include call delirium Do emergency break below other left primed out staffing bed on: Is assess avoid FOR patient so THE that delirious confusion if ventilation? occasional approach Written: Recommendations NURSES Nurse COMMUNICATED area VIOLENT putting"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Dr CT /$$$$$$$$$$$/$ Replace Record$GCS$score$ pumps from findings Central$line$ \u2022Cerebral$Oedema$ \\$<18$or$pH$<7 particularly blood Gas BOXES NOT G% DATE% HIGHLIGHTED 250ml/hr% MSSU$ ng$normally$ previous infection ent$ea ng$subcutaneous$insulin$ 20 c$Ketoacidosis$Care$Pathway$2$$$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% If$blood$glucose$>14$mmol/L$see$appendix$ dexamethasone reduced \u2022\u202fIn can %% 24hr K+ Reduced ml/hr on$reverse$ Administer glycaemic $established$on$usual$ maintain \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 9mmol/L It using $at$250$mls/hr$un 500ml/hr% level \u2022\u202fThe \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ confirm Venous meter $at$pa mmol/l dextrose may litres 12 $U&Es$and$HCO3 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Sodium me$of$arrival$ %%%%%%%%20$mmol$if$less$than$3 Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 hours call 5$mmol/L$ $Dr$S ONCE to prescribed Dextrose rises $metabolic$acidosis there $\u2022Severe$DKA$ Laboratory Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus C% $$Finger$prick$Blood$Glucose$hourly$ insulin Glucose%10%% IS In 8$hours$ less !$ careful 9%$over$1$hour$within$30$minutes$of$admission$ 150ml/hr% $Glargine situation Review%Potassium% The infusion\u2019 insufficient \u2022$Combina normally 14 oedema Glucose: Arterial depending $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Signs glucose First$12$hours$ FLUID% nurse POTASSIUM% is rate $Gibb l$Blood$Glucose$<14$mmol/L$ $Humulin$I$etc hour %consultant%or%senior% Senior 9%$per$hour$+$Potassium$Chloride$ commencement \\$within$normal$reference$range$$ units/ infusion $laboratory$blood$glucose $ensure$specialist$team$receives$ beginning equal failure %result% KCL% Record:$SEWS$ \u2022$Myocardial$infarc if Guidance >5mmol/L time indication >20mmol/hour only 50ml once E% administered therefore INFUSION \u2018insulin Measure$and$record$Lab$Blood$Glucose 6%units/hour%when%blood% Score ketoacidosis$in$adults$aged$16$and$over$ status between ml Testing see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway $table$below antibiotics 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ >14mmol/L MANDATORY A% 5$$5$mmol/L$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ 9%$replacement$ TYPE%OF%INSULIN% before DO generally ** KCL DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ $capillary$or$urinary$ketones$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Conrm$diagnosis$ \u2022$Omissions$of$insulin$ $$If$not$available following scan Consultant potassium 3hrs$ bicarbonate Record$SEWS$ treatment Doctor \\$at:$ as$per$table$above arterial during nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ adjust are \u2022Check$that$equipment$is$working$ Record$SEWS$and$GCS$Score Blood DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ 9% %%%%%%%%%%%%%%%%%%%%%%%% 12$hours$ 16$hours$ 20%mmol% admission ent$s Unless%discussed%with%ST4%or%above Good%Clinical%Prac1ce% Phone/refer$for$specialist$diabetes$review$before$discharge 9%$at$150$mls/hr$+$KCL$ chart IV maintaining Ritchie Consultant/Senior%physician%should%be%called%immediately%if:% increased or units where Insert$catheter$if$oliguric$ Do$not$discharge$un ll$deteriora 100mls less$than$3 Management be %Management%0%%60%minutes% Detemir Consultant/ subcutaneous$insulin$regimen$and$ea /within this rapid %500ml% \u202220$mmol$if$level$<3 $\u2022Reduced$conscious$level$ as up \u2022\u202fInitially 10 long output circumstances least When%Blood%Glucose%falls%<14%mmol/L% 5$$5$mmol/L% 1%or%H+%greater%than%80% SEWS $un SERIAL%NO% on$reverse than mes% l$end$of$hour$4$ diabetic secure fresh F% Temperature started 20% Time$and$sign$start$of$insulin$ Review$Blood$Glucose$results$and$U&Es$ Lab$glucose Time$of$Arrival$ start ITU over \\$normal$ initial Physician H% appendix H+$>$45$or$HCO3 Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Blood$Glucose$>20$mmol/L$ ng$insert$NG$tube$ $Authors:$NHS$Scotland often value >9mmol/L BM count COMMENCED WBC mmol/L$ responsible 4units Total 5$mmol/L <20 I% Common$causes$include:$ Review$U&Es$ Author: \u2022Pa care \u2022Conrm$venous$access$is$secure$ adjusting 9%$and$insulin$ mmol TIME%BEGUN% c$ 8mg STOP Other%interven1ons%to%be%considered% ent$\u226516$years$$IF$NOT Time$and$sign$ongoing$Sodium$Chloride$0 RATE% 25 essential Hour$2:$1$litre$Sodium$Chloride$0 Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ correctly raised If%deteriora1ng Lab Con elevated evidence %Ongoing%Management% 9%$to$150$mls/hour$+$KCL$ adequate control more After of ion: fluid 9%$+$Potassium$Chloride$ then mmHg Commence$IV$1$litre$Sodium$Chloride$0 on mmol/L%%or%HCO3 \u2022HCO3 Chest$X\\ray$ end OVERLEAF sodium l$discharge$ 4hrs$ expected infused space J% target DOSE% Prescribe$usual$long$ac on$of$the$above ketones Undertake falls Conrm$pa not%to%be%administered%at%a%rate%of%>20%mmol/hour B% Potassium on$of$pre\\meal$subcutaneous$insulin$ \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Saline Time$pathway$started$ ensure: ARE Time If PRINT%NAME% cerebral minutes Insulin Replacement remains 9%$bag$as:$ do glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ Headaches\u2022 \u2022\u202fIf occurs stage use 500ml% improving pathway: 11 Date$ Page%1%of%2% monitor $K$Adamson$ acting unless$discussed$with$the$diabetes$team $Dr$F Check$U&Es Glucose IT BATCH%NO% GIVEN%BY% Time$and$sign$uid$commencement$ conscious an ACTRAPID% renal Presentation From$4$hours$un Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ physician%called% 0$$4$Hours$Emergency$Management$ last \u00b0C \u2022Con with \u2022Check$non\\return$valve$on$pump$ until reduce TIME% SaO2 VOL% a$copy$of$the$discharge$summary$ risk Severe%DKA%=%pH%less%than%7 stop suspicion glucose%>14%mmol/L% Count Monitoring Measure$Lab$Blood$Glucose$2$hourly$if$ Do D% !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Heart below Loca discuss $b Insulatard SIGNATURE% avoid AFFIX$PATIENT$LABEL$ 24$hours$ :% \u202210$mmol$if$level$3 ng$ functioning APPENDIX$ Chloride DEXTROSE >14 Fluid% clear Page%2%of%2% ECG$ Aim:%To$improve$the$acute$management$of$diabe Reduce$Sodium$Chloride$0 If$protracted$vomi mannitol Amendments 100ml/hr% me$to$usual$subcutaneous$insulin$regimen$when:$ 9%$at$400mls/hr$+$KCL$ on$ 3%units/hour% Consider ketoacidosis \u2022$Infec aim fall continue If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus will glucose%<14%mmol/hr% levels DKA$pa mmol/L Hours$3$&$4:$500mls$Sodium$Chloride$0 $$ Staff Sodium%Chloride%0 Mental clinical should presence O2 associated $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ c$Ketoacidosis$Care$Pathway$1$$$ Blood$cultures$ 2hrs$ %Consider%Precipita1ng%Factors$ pointofcare ECG$and$consider$cardiac$monitor$ ga GCS$ units/hr for Progress$on$to$second$DKA$Care$Pathway$4$hours$un \u2022Hypokalaemia$on$admission$ ent\u2019s$usual$ pressure increase ent$data$ow$chart$$ hourly signs at If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ HCO3 Supplementary%notes$ according$to$Potassium$ Subsequent%Management% Adults %%%%%%%%10$mmol$if$between$3 Review$other$inves Respiratory 1%%4%hours access If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Hydrogen 6%units/hour% \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ patients Cerebral age hr clock \u2022None$if$anuric$or$>5mmol/L$ \u2022$Newly$diagnosed$ Inspired 1L/hour% blood$glucose$value$is$less$than$20$mmol/L see$appendix Reduce$insulin$to$3$units/hour$ INSULIN%RATE% Oedema DVT$prophylaxis$ $ketonaemia/ketonuria ons$ :$ running Intravenous%Insulin%Prescrip1on$ Rate ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% syringe G%less%than%5%mmol/L% nue$Sodium$Chloride$0 9%% 3%units/hour%when%blood% Diabe in the $along$with$IV$insulin$ %Immediate%ac1ons% $Ritchie$&$Dr if$relevant and <9mmol/L not after AVPU Convert$back$at$next$convenient$meal$ checking see Serum Capillary %prescrip1on%sheet$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 gases Urine 20$hours$ reasonable /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ DKA$ if%not%fallen%in%rst%4%hours V2 $usually$with$hyperglycaemia$ ng$insulin$rate$as$necessary$ 3$on$venous%gas patient laboratory DKA l$HCO3 10% Record$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "litre blood adults sheet seek treat Hours Ward 2+ infection sepsis <12 15 20 replacement Actrapid March appropriate K+ hyperglycaemic GCS hours: current flow evaluation LMWH measurement level rates hrs hyperosmolar determined urine dextrose 2: necessary may 24hours 12 Biochemistry Assess Sodium above Diagnosis Plasma investigations hours call HHS senior response to 23L staff advice insulin additional saturations disease In improving? stroke State less continues 05 positive taken 1: The ongoing Footnote: Fluid management A+E 14 oedema mOsm/kg consider thromboembolic catheterisation glucose is rate into Gifford hour ketonaemia Urea August other infusion <15 Key THE 1L Treat dehydrated if Guidance INFORM __________ fluids hour? discussion aiming urinary status Aim guidelines between ml \u00b5mol/L note greater omolality KCL accordance AFFIX SEE via potassium Commence treatment care: ESSENTIAL present arterial ulcers/ ONCALL capillary considered document are cause 9% aid This urea comorbidities switchboard decline mOsmol/kg/hour admission /10 chart IV Ritchie or 50% 45 Repeated units loss intravenously 125ml/hr LABEL falling be venous acidosis gradual achieve unless shifts addition desired \u2022Sodium this markers set rapid JBDS as any identified 10 output foot 30 applicable Kg assessment goals rise <90 plasma than Ketoacidosis biochemical overall consideration ____________ team aims: over Creatinine Osmolality Assessment: Is despite care 38 reducing mmol alterations Continue precipitant purely baseline patient\u2019s page Markers U&Es date adequate Estimate 2017 more There Systolic of H+ osmolality prescribe usually tolerate 92% achieved? fluid mmHg on sodium ALWAYS infarction must significant allow target Na ketones falls 2020 accurate administration Potassium Macrovascular critical contraindicated Time If 160 cerebral has Treatment: concentrations clinically coexisting 2x Monitor mOsmol/kg Document thrombosis/pressure picture normal 200 Hyperosmolar ECG/Sepsis Glucose possible Continuing Hyperglycaemic 2012 myocardial cardiac renal 16 prophylactic >3L with NB hyperglycaemia risk ______________ Hour Monitoring Initial 5ml/kg/hr below precipitating Diabetic discuss required 2448 that hydration Chloride balance 40 range good 80 350 eg Consider fall 320 protocol designed Ensure review Patients no Perform mmol/L within state ulceration high clinical should presence keep coronary Measure biochemistry for ensure lactate increase hourly ONLY at Calculate HCO3 screen/foot Hypothermia concentration prepared DIABETES Anderson been patients PATIENT examination APPENDIX 24 1224 Hypovolaemia alternative calculated ability oncall medical 45% change commence aspects per comorbidity by Marked Oxygen calculate 100% based BP regular in TEAM the acute diabetes limb and serious not gas see adapt Adjust estimated ketosis timings Urine units/kg/hour syndrome Date Na+ out checkpoints IF Calculated assess patient ______ severity weight DKA 10% ischaemia Appendix"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Dr Crit specify 124 organ infusion: from their 610mmol/l indicated NO 100ml blood reading? NOT box point method Lothian Stop it ward >2mmol/l Ward previous 20 charted Actrapid can Reduced glycaemic overdose Page Intranet:17/02/20 sensitivity Status otherwise 50units persistent It identify Stable measurement phase recovered level Rates s/c 2: vital drug may they 12 ill part hours HHS to prescribed >24 adapted there staff diabetic? advice insulin USE YES Title: Kidney prescription transplantation without 1: The guideline Recovering normally CRITICAL consider Prescription NICESUGAR: glucose Intravenous Category: is rate into requiring hour always emergency Guideline other infusion variable Some Key failure switching if Guidance time found 50ml INSULIN McNeill unwell whether who Has SENSITIVE ID: Aline Date: outwith reason Words: starting guidance: 2014 15mins These difference Keep Guidelines following 112 IInnttrraavveennoouuss 11mmol/ml dose All basal are recovery Blood 9% This transitioned Increase surgery CCrriittiiccaall those 2009 stopped chart IV sensitive adjusted or units >100 Comments where dysfunction be adjustment Control 360:128397 Care unless >24mmol/l: develop one ie this <24 Review we 114mmol/l: as Hypoglycaemia any up 10 long IInnssuulliinn made Hannah Increased apply FINAL group 124mmol/l: 2023 re than CCaarree NaCl diabetic overall flush 20% reasons team Authors: start over episode appendix 20mins Halve eating proportion measure Version: outcome1 managed iinn Is >10mmol/ml resume February Standard care discharge Draft/Final: 3ml/hr 8ml/hr day page need Yes evidence et ill? control elective more Finfer There 116mmol/l: resistance of readings Many 4ml/hr sugar which Intensive fluid then CriticalCarPatients 112mmol/l: dependent on therapy sodium Give must monitoring 2020 <5mmol/l Start administration RESISTANT critical fallen choice Before If form alongside Insulin Please remains 18mmol/l: TThheerraappyy groups: kardex use ABCD when feed Document normal resistant preexisting No acting relatively Once Glucose Conventional an history Med 55 patients\u2019 16 Editorial first Treatment Most with 9mmol/l influences 5ml/hr hyperglycaemia >20mmol/l 1ml/hr measured Call admitted admissions active used: Diabetic required 116 have used 120mmol/l: that ml/hour stipulated 510mmol/l critically written containing suitable range 5% followed eg General fall continue protocol designed Ensure will >16mmol/l Authorisation Authoriser: Patients no within Philip mmol/L Repeat >10mmol/l protocols should 6ml/hr Because Measure returning enteral hypoglycaemia Therapy for ensure consecutive hourly ONLY at Pancreas inform chloride >14mmol/l: Critically Summary thereafter scales patients When line added <5 able 24 Restart 2ml/hr 120 go recommence having initially SKP 18 CARE Group medical QIT change commence periods separate per versus Rate Check regime by suggested individual based al Critical in Simultaneous the usual standard diabetes Examples and specifies not receive Go Emergencies initiated receiving TPN these reasonable check Date most Protocol Engl >4mmol/l Further FOR patient glucose>10mmol/l same DKA Appendix See"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "altepase Dr Hypertension: infusion: from including conditions Thrombotic Severe NICE AND particularly blood Antithrombotic non preceding Standards seek Lothian years proven it previous central Clinical agitation damage appropriate vigorous uk/EMC/medicine/308/SPC/Actilyse/ Page Status current testing deep persistent Approved agitated Authorisation: using solution gastrointestinal/gastric CTPA unlikely Venous element complete bolus 18/01/21 intracranial/subarachnoid UK Jaff ICU 12 process medicines circulation References CONCENTRATION: October hours www 141:e419s to anticoagulated Structural LMW there Scientific advice 357:15831585 right disease In stroke less defer Bode take diagnosis Recent 65kg The June 123:17881830 AJ 1200units/hour guideline management Product 2001 thrombosis thromboembolic Age>75 head powder every Vein updated Category: Development is rate 1200 uk/emc/product/898/smpc commencing ADMINISTRATION: Issued bleeding Guideline infusion STABILITY: suggesting failure Key if transient pulmonary mg University only 50ml Pulmonary once repeated INFUSION reconstitution heparin cirrhosis 10mg \u226540 specialist save indications Deep College thrombolytic water units/hour weeks guidelines Embolism who DOSE ID: Lancet Date: aneurysm AVM alteplase suspected note greater starting procedure Guidelines 2015 recent stable neoplasms treatment 90ml Anti dose injections Akl safety considered are Division 2003 Support com Version resuscitation surgery hypertension recheck Advanced nervous https://www except later IV or Active intranet Comments prior where immediately Disease: BTS Management major be instances venous Efficacy pericardial Care Thoracic relative this liver Review imminent haemorrhagic INTRAVENOUS Comerota any perfusion 30 Chronic Suspected American Otherwise Actilyse Statement Hannah Guide group loading 58: than org uptodate Authors: over Traumatic STANDARD unsuccessful intracranial solvent: prevent Adult CONTRAINDICATIONS: Kefala Acute value exceed amended despite dissolution met 2019 vial whom Words Resuscitation Iliofemoral dalteparin ADDITIONAL spontaneous APTT ALTEPLASE gentamicin all Chest Draft/Final: dilatation assay patient\u2019s aaaaaAAaAAAAAmended:December months given Association evidence et thrombolysis Withdraw adequate return portal injury cardiopulmonary whichever After of Based Bleeding fluid mmHg massive established too hepatic 2011 neoplasm on hypotension Give therapy end December delivery spinal Thromboembolic 2020 Accessed pericarditis list If manufacturing Any has minutes Please Thrombosis: event intravenous Alteplase following: vascular drop Committee system Echocardiography Document Once extremity SBP<90mmHg 2018 03 5mg/kg 2012 an 144 INFORMATION: history cardiac Evidence 04/10/18 punctures poor Editorial Physicians mixture gently prophylactic due therapeutically 2022 last with Significant until facial endocarditis Reconstitute 10ml http://www Vials likely/confirmed formation Heart active each Diabetic ratio discuss foam Kearon haemorrhage 470484 <0 varices Circulation ischaemic arrest containing Hospitals site past 90mg followed VTE haematologist aim Society >15 Ensure July no invasive within still order Vitamin clinical should ventricular excipients substance was Board Avoid diagnoses Therapy repeat for diseases diathesis total lower pressure prospective agent 50mg Thrombosis Directorate trauma at Known hypersensitivity compressible septal Uncontrolled Summary been brain displacement access trace patients added resuscitation:a For thrombophilia alternative give recommence initially full 25oC oncall 1mg/ml Group Thorax QIT ABSOLUTE commence effusion Check syringe by unfractionated Practice severe Bottiger Prevention al vials Critical in the rtPA role acute and Antagonists Massive relevant not 50 after attack Characteristics see Life vein Thrombolytic retinopathy oesophageal Anticoagulation check interventricular ulcer Date hepatitis Submassive unstable British INDICATION: embolism Final patient contra contraindications solvent PRESENTATION: weight PE iu/ml Pregnancy RELATIVE trial"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "reducing Draft/Final: Ceftazidime: Fiona Temocillin Cotrimoxazole Aztreonam three day 5g Levofloxacin: Vol Consider IV/ORAL: Horl ID: jiroveci levels Lothian Date: 10mg/kg November given 2021 infection note function et 2005 Day Clinical Diseases Rifampicin p11591166 replacement Guidelines twice return Meropenem onwards obese treatment Status of 1g 600mg for although 500mg dose Infectious courses meropenem Authorisation: either then 250mg Antimicrobial Renal com CVVHD ONLY Version on encephalitis therapy Other six normal/immunocompromised Pharmacokinetics body immunocompromised 1500mg intranet: therapeutic prolonged Caspofungin Database drug Loading monitoring Authoriser 12 2020 60mg/kg ill deterioration thereafter Aciclovir: 500750mg 50% or Antibiotic patients Accessed added References Comments hours IV/Oral: For 24 Days continuous www PCP to 72 Thalhammer Issue Care intravenous one Amoxicillin Benzylpenicillin CARE Group Ceftriaxone 13 QIT Review Drug as pneumonia USE any zoster/varicella doses Title: normal Document IV: renaldrugdatabase Cefuroxime: 2g IN iv Trotman zoster/Herpes indications: Ciprofloxacin: Pneumocystis Coamoxiclav LFTs The 5mg/kg al Critical 41 guideline ideal in usual 39 Flucloxacillin loading renal CRITICAL 2023 depending daily consider Herpes zoster first and dosing Editorial Treatment Fluconazole Clarithromycin every days with Category: receiving is Authors: Clindamycin Metronidazole 2771279 Anidulafungin turnaround Linezolid eight Use adult simplex Clarke Varicella Date 30mg/kg Dose infusion vancomycin Oral: Vancomycin Final FOR patient Teicoplanin failure times Key severity weight Piperacillin/tazobactam if mg 400mg third February Words critically maintenance See"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Gillum\u00a0JG Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation to\u00a0es Analysis may\u00a0reduce influence Lean Local adults No\u00a0specific\u00a0\u00a0advice\u00a0available cutaneous 25:634\u2010649 weight\u00a0in 15th\u00a0April\u00a02013 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature previous The\u00a0higher\u00a0dose\u00a0was\u00a0at ed\u00a0to\u00a0obese\u00a0subjects This\u00a0is\u00a0sometimes\u00a0refe 66%\u00a0of\u00a0those\u00a0reported clinical\u00a0judgement total\u00a0body\u00a0weight\u2010IBW 152 appropriate Victoria\u00a0Infirmary No\u00a0information January\u00a02013 6mg/kg effectively Crystapen\u00ae intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent susceptible Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Abernethy\u00a0DR attempts/accidental Infections:\u00a02\u20104g\u00a0daily Page\u00a0|\u00a041 Yet Dosing penicillins The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the prevalent uk\u00a08th\u00a0February\u00a02013 not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight ill TBW\u00a0x\u00a01 l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos above British\u00a0National\u00a0Formulary\u00a065 Obesity process Van\u00a0Zanten\u00a0et References hours The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg 25:112\u20108 1\u00a0x\u00a0height PTC Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a prescribed non\u2010obese fewer Melrose body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Benzylpenicillin regimens Summary/ ICAAC Dexmedetomidine mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study document: Page\u00a0|\u00a043 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Correction\u00a0Factor 35 take rmation\u00a0available tion taken complex treatme Page\u00a0|\u00a044 :\u00a01222\u20101227 plus Suggest\u00a04 volunteers decisions Licensed\u00a0dose\u00a0in Koselke\u00a0et\u00a0al worse 150kg However Inadequate is Mass supported BSA Increased\u00a0dose Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Ltd\u00a04th\u00a0December\u00a02012 aminoglycosides Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics 100mg\u00a0twice\u00a0daily April\u00a02013 Body\u00a0W 3% g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Oxford Some Wurtz\u00a0R peak Slight Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases vid at\u00a0least\u00a01\u20102\u00a0post\u2010 Dosing\u00a0as\u00a0above 400mg indication found MIC90s ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole =\u00a045 after\u00a0first\u00a024\u00a0hours No\u00a0specific\u00a0information\u00a0available Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital cefalosporins 8g\u00a0daily\u00a0have\u00a0been\u00a0used See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Page\u00a0|\u00a032 Mass\u00a0Index International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Derendorf\u00a0H Page\u00a0|\u00a021 Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily uk\u00a027th\u00a0June\u00a02013 Adults\u00a0and\u00a0adolescents formula hts\u00a0used\u00a0in /\u00a08780\u00a0+ adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted When\u00a0using\u00a0IBW Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 %T>MIC in\u00a0non\u2010pregnant\u00a0women\u00a03 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw issue Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 depending\u00a0on\u00a0the\u00a0patient drug\u00a0handbook after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 422\u2010430 available Page\u00a0|\u00a03 uk\u00a017th\u00a0July\u00a02013 iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided This rred\u00a0to\u00a0as\u00a0the\u00a0Actual Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication who\u00a0each\u00a0received No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Roberts\u00a0MS\u00a0et\u00a0al Radcliffe\u00a0publishing AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga uk\u00a012th\u00a0July\u00a02013 factor more\u00a0than\u00a0IBW Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L MIC 3rd\u00a0edition bod adjusted cellulitis suicide xtrem higher ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 stated retrospective effort ass\u00a0index\u00a0on\u00a0therapeutic some Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use sive\u00a0care\u00a0unit\u00a0setting relative 13 practitioners 75 Page\u00a0|\u00a031 Alison\u00a0Bell least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium 20:869\u2010873 Tazocin\u00ae obtained Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Page\u00a0|\u00a039 Page\u00a0|\u00a014 information\u00a0contained\u00a0in\u00a0this\u00a0doc Pharmacotherapy\u00a01997 and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Lancker Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration loading Obes severe\u00a0infections Anaesthesia\u00a02012 Page\u00a0|\u00a033 23 was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Greenblatt\u00a0DJ Summary\u00a0of\u00a0SACCPN\u00a0li specific situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Buchwald\u00a0H overall\u00a0effect\u00a0however time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into were beta cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Cochrane tds does similar Barie\u00a0PS Lavoie\u00a0S\u00a0et\u00a0al ospital 6kg ledgments 36:332\u201039 very\u00a012 blockade >100kg\u00a0and\u00a0BM eed concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% first\u00a024\u00a0hours Clydebank 1st\u00a0Edition 25 Page\u00a0|\u00a042 drugs :\u00a0MIC\u00a0ratio J\u00a0Antimicrob\u00a0Chemother 67:2957\u20102692 TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Dose\u00a0as Clin\u00a0Pharmacol\u00a0Ther\u00a01993 evidence 287 BMI>35kg/m2 Rifampicin showed twice in\u00a0adult\u00a0patients\u00a0given the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial more ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to Antimicrobial\u00a0Agents\u00a0and May\u00a02013 Meropenem Pfizer dose\u00a0based\u00a0on\u00a0indication obese tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people increased\u00a0serum\u00a0drug on\u00a0patient\u00a0weight adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer outcom bodyweight Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Dundee maximum :1653\u20104 25:\u00a0634\u2010649 SAnofi\u00a0Avensis ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept bgroup expected Adjusted\u00a0Body\u00a0Weight or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook /\u00a03600 Dalacin\u00a0C\u00a0Phosphate\u00ae Page\u00a0|\u00a047 Clinical\u00a0Infectious\u00a0Diseases Accessed Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight nuary\u00a02013 inetics\u00a0of\u00a0intravenous\u00a0levofloxacin contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date ice\u00a0on\u00a0obese\u00a0patients The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum airment effects Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault infusions\u00a0of\u00a0antibiotics Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 and\u00a04\u00a0\u00a05\u00a0mg/kg/dose clinical\u00a0trials 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight GFR normal ventilatory\u00a0parameters http://clinicaltrials Underweight\u00a0patien The\u00a0only\u00a0documen 25\u00a0to\u00a00 muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients nhs 74% expectancy FFM Page\u00a0|\u00a04 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight disagr 2012 nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical st amphoteri No\u00a0informati so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes renal rep Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 in\u00a0excess\u00a0of\u00a00 Single Fluconazole Clarithromycin Summary\u00a0of\u00a0SA Kingdom however\u00a0a\u00a02013 atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Bridion\u00ae PNW CRRT ts Titrate\u00a0dose\u00a0according\u00a0to\u00a0response For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital compared ratio the\u00a0excess\u00a0in\u00a0body\u00a0weight4 administered\u00a0to\u00a0normal\u00a0weight have Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution 2nd\u00a0January\u00a02013 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity that Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth life be\u00a0different Tigecycline uk\u00a06th\u00a0September\u00a02013 alone Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Rifadin\u00ae The\u00a0effect\u00a0of\u00a0body\u00a0m Van sed\u00a0at those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were treatment\u00a0ranges Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Itokazu\u00a0G Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication will MBW Patients no United\u00a0Kingdom C\u00a0max high edition uk especially howeve Underw Erstad\u00a0B Page\u00a0|\u00a028 Pharmacology/\u00a0kinetics Accessed\u00a0at No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing consequ The\u00a0Cochrane\u00a0Library\u00a02013 ous ves total Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Page\u00a0|\u00a07 recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 5kg suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Nafziger\u00a0AN Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target re\u00a0is\u00a0limited\u00a0e No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however from\u00a0considering\u00a0dosing\u00a0in\u00a0children collation Mean 25\u00b5g/ml: Jarrett\u00a0R Glasgow ents\u00a040kg\u00a0and gents\u00a0Chemother *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older evaluate Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces intra\u2010abdominal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man For appear\u00a0to serum It\u00a0is\u00a0also\u00a0recommended\u00a0that contained\u00a0within\u00a0this ay 5\u00a0if\u00a0male give Zentiva calculated certain abstract :\u00a0944\u20106 :1023\u20101026 pneumonia the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary adjustment\u00a0for\u00a0renal\u00a0impairment 67:\u00a0682 Base improved Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on basis timate\u00a0the\u00a0fractional 8g\u00a0daily\u00a0\u00a0divided\u00a0doses using\u00a0IBW\u00a0+ Predicted Carey\u00a0JC underweight\u00a0or\u00a0obese\u00a0patients standard EBW gender and et\u00a0al added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight discussed Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 65:128\u2010134 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in currently Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations receiving available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Clindamycin for\u00a0any\u00a0patient\u00a0or Chen\u00a0M North\u00a0Chicago No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients lean daptomycin association Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Allard\u00a0S\u00a0et\u00a0al adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary most Page\u00a0|\u00a06 analysis 0242 14th\u00a0June\u00a02013 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh weight Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise negative s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic :708 Loading\u00a0dose world Severe st\u00a0\u00a0Edition pharmacokinetic body\u00a0weight Antimicrob ight particularly non adjustments in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor amphotericin ients height\u00a0in\u00a0inches\u00a0\u00a060 however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe or\u00a0Alan\u00a0Timmins with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting method erature\u00a0from\u00a0manufacturer ons Metronidazole\u00a0monograph utcomes\u00a0which\u00a0may\u00a0occur\u00a0as it :\u00a02741\u2010 recurrence Doses\u00a0doubled\u00a0where\u00a0necessary on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 20 Senior\u00a0Pharmacist\u00a0Southern\u00a0General soft 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function \u226440kg account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free reduced can tissue Page\u00a0|\u00a013 philic erature\u00a0from\u00a0manufacturer3 should\u00a0be\u00a0used >30kg/m2 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight It Ecalta\u00ae Page\u00a0|\u00a027 as\u00a0per\u00a0SPC equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Antimicrobial and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Bearden\u00a0DT Zovirax\u00ae Summary/Comments Genus\u00a0Pharmaceuticals drug seen Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg ukcpa cin antifungal\u00a0agent 12 Chen ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients phenytoin\u00a0levels 200mg\u00a0twice\u00a0daily rer2 ation Ambisome Addie Drug Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Summary\u00a0of\u00a0product\u00a0cha careful Van\u00a0Lancker\u00a0P Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients MIC\u00a0of\u00a01mg/ml 41 =45 B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends DDW No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Ruiz\u2010Irastorza\u00a0G BMI>18 5g\u00a0every\u00a08\u00a0hrs We\u00a0hope\u00a0that\u00a0you Page\u00a0|\u00a05 every Licensed Weight limited of\u00a01 Intravenous rate organisms eight unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Summary\u00a0of\u00a0SAC 2013 Descriptor other 11th Koselke Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Daptomycin United Strep Accessed\u00a0at\u00a0\u00a0www severe\u00a0infections\u00a02\u20104g Summary\u00a0of\u00a0Product\u00a0Characteri keith uk\u00a01st\u00a0August\u00a02013 Female= Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients if authors Montpelier Clinical\u00a0Infectious\u00a0Diseases\u00a01997 intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Day\u00a01 pharmacokinetics data in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ surge two individuals 131 piperacillin Normal urs erefore\u00a0it\u00a0was\u00a0thought pharmacokinetics\u00a0of\u00a0daptomycin treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours regimen Antimicrob\u00a0Chemother\u00a02012 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics edicines Wang\u00a0E infections ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Current\u00a0Opinion\u00a0Infectious\u00a0Disease Journal\u00a0of\u00a0Clinical\u00a0Ph pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Am\u00a0L\u00a0Perinatol\u00a02008 738 Chemotherapy generally However\u00a0complications\u00a0of\u00a0obesity Dexdor\u00ae 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 285 ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad effect treatment 5\u00a0I subsequent Body\u00a0Weight dose By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily All during uct\u00a0Characteristics A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended are 600mg\u00a0to\u00a03600mg\u00a0daily 244\u00a0x\u00a0BMI Intravenous\u00a0cipr No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients so\u00a0that\u00a0the\u00a0information intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves those No\u00a0dosing\u00a0advice\u00a0found 2747 Characteristics\u00a0Accessed\u00a0\u00a0at Maximum\u00a0reported\u00a0dose Loading theory supratherapeutic nt\u00a0ranges making make Scottish Comments es Child Page\u00a0|\u00a08 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours tissue\u00a0infections\u00a0in\u00a0obese be adjustment Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital connection Ideal\u00a0Body\u00a0Weight for\u00a0organisms\u00a0with\u00a0an Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Page\u00a0|\u00a024 when\u00a0compared ofloxacin\u00a0disposition\u00a0in\u00a0obesity th lays 12g this nline\u00a09 we attainment stics\u00a0Accessed\u00a0at any cm Thursky\u00a0K 10 30 made actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Septrin\u00ae 37 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Ciprofloxacin plasma concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th doubled GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department concentration\u2010 Klebanoff\u00a0MA 31 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of 2012\u00a0Dec mortality\u00a0in\u00a0ICU1 Neurol\u00a01985 Email\u00a0received Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri morbidly Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena voriconazole Metronidazole Pharmacok EB difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Maximum\u00a0Body\u00a0We proportion Dose 51 Tavanic\u00ae trough Pharmacia\u00a0Ltd pneumocystis available\u00a0from\u00a0manufacturer Levofloxacin /tazobactam Mycoses\u00a054 toxicity s\u00a0of\u00a0cefamandole Principal\u00a0Pharmacist to\u00a0account Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd effect\u00a0in\u00a0all\u00a0patients 2\u20109 28 er\u00a02012 scot Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect et adequate CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer intraven mary There compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of No\u00a0advice investigating Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects usually haematologic which UKCPA: ABW ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill guidan likely No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients therapy end Shiu\u00a0J CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Invanz\u00ae mg/kg\u00a0once\u00a0daily significant correction 57 outcomes monitoring Hites\u00a0M children Larbert Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 50kg\u00a0if\u00a0neutropenic oral fat\u00a0mass ataxia\u00a0and\u00a0slight\u00a0disorientation =TBW\u00a0\u00a0IBW nt\u2019s\u00a0renal Oral overdosages concentrations Heintz t\u00a0patients with\u00a0normal\u00a0weight\u00a0patients Phenytoin\u00a0disposition\u00a0in\u00a0obesity altering exception\u00a0of\u00a0o Mastrobattista\u00a0JM when p634\u00a0\u2010\u00a0649 Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins No\u00a0specific\u00a0do <10mg/kg Page\u00a0|\u00a02 Pharmacokinetics\u00a0of context and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not an ese\u00a0patients Slain\u00a0D 39 patients\u00a0receiv Yorst\u00a0RL on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 216\u00a0x\u00a0BMI with Pharmacokinet\u00a02010:\u00a049 Chen\u00a0LG Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 treated comparing Calculate\u00a0dose\u00a0determining\u00a0weight licable therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 filtration Use\u00a0actual addie@ggc Use\u00a0standard\u00a0dosing formation Drusano\u00a0GL clindamycin uk\u00a019th\u00a0July\u00a02013 x\u00a0TBW and\u00a0the\u00a0patient manufacturer: taking\u00a0into\u00a0account\u00a0patie normal\u2010weight weigh Pfizer\u00a0Medical\u00a0Information guidance Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Dillmans\u00a0B 42 Ceftriaxone/Cefalosporins Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Formula 40 clear range good Ideal dcliffe\u00a0Publishing Author\u00a0suggests Ja sgow terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 ication Page\u00a0|\u00a030 46 both\u00a0IV\u00a0and\u00a0oral at\u00a0www although\u00a0mg/kg\u00a0dosing\u00a0could v1 suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Ob 17 within prophylaxis TBW using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in No\u00a0strong\u00a0evidence low LBW clearance rmation work Arch C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook the\u00a0higher\u00a0dose to\u00a0allow No\u00a0advice\u00a0on No\u00a0spe Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin McConnell\u00a0DB\u00a0et\u00a0al extremes\u00a0of\u00a0body patients\u00a0under\u00a040kg\u00a0or studies Johnson\u00a0M America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Serious\u00a0infections:\u00a0600mg\u20101 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the ufacturer concentration Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients der\u00a0the or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook 30:18\u201032 been Martyn\u00a0Gall Obtained\u00a0from\u00a0www Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Pharmacy By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours States continuous Pai\u00a0MP Co\u2010Trimoxazole subjects levofloxacin The\u00a0renal\u00a0drug\u00a0handbook tables response\u00a0to\u00a0bac as\u00a0above commence P=0 separate See\u00a0benzylpeniclli per Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly anufacturer3 No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients frail 25:\u00a0112\u20108 Paper by There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight individual based Page\u00a0|\u00a026 0mg Critical nor Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a the Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded DWCF*x\u00a0EBW Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Pharmacological Clin By\u00a0intravenous\u00a0infusion on\u00a0the\u00a0rate\u00a0of\u00a0its Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Male\u00a0and\u00a0Female\u00a0Subjects Underwei No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s 66 6\u00a0mg/kg\u00a0once\u00a0daily r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Keith t\u00a0Characteristics BNF As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital out Further Page\u00a0|\u00a019 Accessed\u00a015th\u00a0May\u00a02013 immunoglobulin\u00a0use2 cSSTI*\u00a0without\u00a0S tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Diflucan\u00ae generations and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 8:189\u2010194 June\u00a02013 Introduction\u00a0to\u00a01 Working\u00a0Group ary Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m from DiBaisio\u00a0A uk\u00a026th\u00a0June\u00a02013 Curr\u00a0Fungal\u00a0Infect preference assumed and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Taccone\u00a0FS As\u00a0above No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients inclusion Literature\u00a0search\u00a0yielded\u00a0little\u00a0results 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Total\u00a0Body\u00a0Weight 2005 15 Tygacil\u00ae er replacement 20mg/kg March\u00a02013\u00a057 suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial aureus\u00a0bacteraemia Tigecycline\u00a0has J\u00a0crit\u00a0care\u00a02008 600mg since Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 4\u00a0is sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case pharmacodynamics values 44 clinical\u00a0trial Sanofi USA administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dosing\u00a0in\u00a0E recommendation Gla necessary 11th\u00a0January\u00a02013 may t\u00a0Characteristics\u00a0Accessed cefamandole 90mg/kg 800mg Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 439\u2010447 editions www pathogen Literature\u00a0descri and\u00a04mg/ml\u00a0were\u00a078 piperacillin/tazobactam Loading\u00a0Dose site\u00a0of\u00a0the\u00a0infection Every Summary\u00a0of\u00a0Produc extremities No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable considerably 5\u00a0+ =\u00a0IBW\u00a0+ Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an different Ulldemolins\u00a0M The\u00a0Renal\u00a0Drug\u00a0Handbook Contents 56 368\u2010373 29 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Mann\u00a0HJ a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 2008 ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft volume suggest September\u00a02013 July\u00a02012 Page\u00a0|\u00a012 The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Usual\u00a0reco Zyvox\u00ae pieces r\u00a0use The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc single Page\u00a0|\u00a038 ry armacology Morag\u00a0Naysmith Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A decision No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients corp actual\u00a0body\u00a0weight when\u00a0prescribing\u00a0ertapenem Publishing accessed\u00a07 orption infusion Paisley fu Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 mmended\u00a0dose\u00a0is\u00a04 popula Washington\u00a0DC 25:233\u2010237 Excess\u00a0Body\u00a0Weight Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group hydrophilic Papasavas\u00a0P\u00a0K obese\u00a0patients but\u00a0a\u00a0value\u00a0of\u00a00 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient therefore Piperacillin/Tazobactam Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 5g higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Danesi disp or\u00a0vecuronium\u00a0induced\u00a0blockade s\u00a0response determination\u00a0of\u00a0loading\u00a0dose 2g\u00a0in\u00a0two variation 4th\u00a0December\u00a02012 available\u00a0on\u00a0modification\u00a0of\u00a0dosage Sugammadex 6680\u00a0+ patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation antibiotics Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations demonstrated Summary\u00a0of\u00a0SACCPN\u00a0lit Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Introduction Summary\u00a0of\u00a0SACC Wolff\u00a0F\u00a0et\u00a0al gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 produced erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer No\u00a0adv Ashley\u00a0C Dosage :75/121 and\u00a0increased\u00a0stepwise Suppl\u00a01 com Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Page\u00a0|\u00a020 staphylococci Page\u00a0|\u00a035 order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although complicated Gilead\u00a0Sciences\u00a0Ltd Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients Rodvold\u00a0K different\u00a0from\u00a0those except kg aureus reported SACCPN No\u00a0inform increased there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Grau\u00a0S Patients\u00a0less\u00a0than Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total The\u00a0renal study where r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Phase 1\u00a0gram Accessed\u00a0at\u00a0www ly\u00a0approximate achieve Care desired taking 25:1 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight com/pdf/biapi RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S up High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Predicted\u00a0Normal\u00a0Weight however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Calculate\u00a0ideal\u00a0body 34:\u00a0p1796\u20101804 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature manda Di\u00a0Paolo On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network group ex Children3 guided\u00a0by\u00a0the\u00a0severity compromised\u00a0patients\u00a0or than Agents\u00a0and\u00a0Chemotherapy\u00a02006 argued\u00a0th GlaxoSmithKline\u00a0Ltd divided uk\u00a0\u00a08th\u00a0April\u00a02013 cystic Akinnusi excess\u00a0weight\u00a0over\u00a0IBW been\u00a0used Anidulafungin initial I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and 5:83\u201091 V\u00a01 Page\u00a0|\u00a034 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Wurz exceed ertapenem Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal Acc Radcliffe assessing 3\u00a0x They requiring\u00a0more\u00a0aggressive\u00a0therapy to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins +4 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Abbott\u00a0Laboratories Information\u00a0from\u00a0guidelines: results Underweig centres in\u00a0morbidly\u00a0obese\u00a0patients Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults \u2010ideal 2` facturer Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac the\u00a0treatment\u00a0of\u00a0trichomoniasis Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to substitute mass ccessed\u00a0at\u00a0www true tions stature patient\u2019s lactam Page\u00a0|\u00a022 Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose but weights coagulase pneumoniae extremes Association Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised would of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and :2546\u20102553 89\u00a0x Halilovic\u00a0J flucytosine Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above iffe\u00a0Publishing ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date of distribution recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Int\u00a0J\u00a0Obes\u00a02001 An\u00a0Updated\u00a0Critical\u00a0Review Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 fact :\u00a0468\u2010471 Weig Wt dependent on Page\u00a0|\u00a015 therapeutic Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 sufficient Fluconazole\u00a0serum\u00a0concentrations\u00a0and Personal\u00a0Communication initial\u00a0infusion\u00a0rate\u00a0of Acinebac su Pineda\u00a0LA Due\u00a0to\u00a0the\u00a0shor better little Klaricid\u00ae Page\u00a0|\u00a037 fect\u00a0Dis Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight morbidly\u00a0obese\u00a0patients daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Hurford\u00a0W in\u00a0criticall has ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec iaxone remains Personal\u00a0correspondence\u00a0with\u00a0Abbott the\u00a0two and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these vide Currie\u00a0A >20% increasingly Roberts\u00a0JA Aspen\u00a0Global Pfizer\u00a0does\u00a0not mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used However\u00a0they Tishier\u00a0D\u00a0S 11 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in abscess No Micromedex Summary\u00a0of\u00a0Product\u00a0Characteristics Radc numb provided The\u00a0area\u00a0un 55 lipophilic Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 daily male Summary\u00a0of\u00a0product\u00a0characteristics skin Male= AUC treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www oth\u00a0IV\u00a0and\u00a0oral had Linezolid Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Alan\u00a0Timmins risk 5g\u00a06\u00a0hrly mo included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas so\u00a0may\u00a0negate\u00a0this Wt/\u00a0height ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose and\u00a0vi terial\u00a0vaginosis\u00a0in\u00a0pregnancy is\u00a0the\u00a0weight\u00a0as\u00a0measured Norenberg\u00a0JP Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Page\u00a0|\u00a010 used 74\u00a0x\u00a0height Cook\u00a0AM 212 &\u00a0Currie relates Keith\u00a0Addie Essentially\u00a0this\u00a0me An 15:251\u20103 for\u00a05\u00a0to\u00a014\u00a0days e\u00a0daily\u00a0by\u00a0the\u00a0intravenous ve\u00a0good\u00a0clinical\u00a0results and\u00a0Del\u00a0Tacca Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer glomerular Cefamandole\u00a0distribution\u00a0in\u00a0serum abs No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Journal\u00a0of\u00a0Infection\u00a02012 parameters ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Flagyl\u00ae consequently dose\u00a020mg\u00a0of\u00a0trimethoprim ccessed\u00a0\u00a0at Maximum\u00a0Body\u00a0Weight Pat KG/m2 as\u00a0relevant ant Page\u00a0|\u00a023 case and\u00a0morbidly\u00a0obese\u00a0adults should Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 4\u00a0+ 27 was 0\u00a0mg/kg thecochranelibrary The\u00a0recommended\u00a0dose\u00a0for bacteraemia route cohort The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice bacterial\u00a0vaginosis for ensure Anaesthesia\u00a02011 It\u00a0is\u00a0hoped\u00a0to Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose lower Suggest uk\u00a012th\u00a0March\u00a02013 monographs\u00a0in\u00a0future\u00a0editions BiaxinTM\u00a0US\u00a0Product\u00a0Information Calc accounted if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at >100kg\u00a0and three\u00a0or\u00a0four\u00a0divided\u00a0doses =\u00a0IBW\u00a0+\u00a00 at Many\u00a0Thanks 002 gories l\u00a0drug\u00a0handbook Aguirre\u00a0C though s\u00a0o Pieracci\u00a0FM The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be 23rd\u00a0November\u00a02012 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Summary maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range companied\u00a0by\u00a0hepatic patients BMI\u00a048 be\u00a0used concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Western Phenytoin but\u00a0there\u00a0is\u00a0currently to\u00a03 Actual\u00a0Body\u00a0Weigh Use\u00a0total\u00a0body\u00a0weight Antimicrobial\u00a0Dosing No\u00a0info Abbreviation 2006 Acknowledgements is\u00a0rarely\u00a0used\u00a0for\u00a0dosing 18 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Intensive\u00a0Care\u00a0Medicine\u00a02004 29th\u00a0May\u00a02013 54 handbook Meronem\u00ae No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Continuous Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa ceftriaxone e\u00a0in\u00a0Scotland lack Orion\u00a0Pharm hospitalised Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight given\u00a0onc failure\u00a0if\u00a0they\u00a0w height timmins@nhs Modified suggested 33 severe In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients constant in cuta Malacarne Curr\u00a0Opin\u00a0In dosing 50 c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Bhalodi\u00a0A\u00a0A not Hollenstein\u00a0UM\u00a0et\u00a0al 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Immunoglobulin Phase\u00a03\u00a0data\u00a0showed\u00a0we rxabbott By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Greenock fibrosis Rocephin\u00aeRoche every\u00a012\u00a0hours No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Earle\u00a0SB 22 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex They\u00a0also\u00a0noted as\u00a0does\u00a0the\u00a0o A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function /Comments no\u00a0da Indications\u00a0fo 5Hollenstein Luque\u00a0S meta\u2010analysis Please\u00a0send\u00a0any\u00a0new did upper as\u00a0required has\u00a0no\u00a0influence Obese\u00a0patients Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to 13\u201017\u00a0years\u00a0of\u00a0age IBW\u00a0for\u00a0females impact AdjBW suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Issues\u00a0of\u00a0\u00a0Linezolid equations BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and years Page\u00a0|\u00a017 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Clinical Page\u00a0|\u00a045 7th principles 36:\u00a0\u00a0p151\u2010158 maintain 1g ce Second\u00a0edition\u00a0update account Lean\u00a0Body\u00a0Weight literat ho Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital future in\u00a0in\u00a0moderately\u00a0obese neous determined 2\u00a0to\u00a01 Page\u00a0|\u00a025 Drug\u00a0Dosing\u00a0Information Underweight\u00a0patients UK they No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Gilead Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP medicines December\u00a016\u201019 Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S The\u00a0follow mation\u00a0more\u00a0readily 10\u201015\u00a0mg/kg IL health inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI to data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 927 aracteristics In\u00a0life\u00a0threatening there Clinical\u00a0Infectious 5g\u00a0every\u00a06\u00a0hrs Orion\u00a0contacted eutic\u00a0drug\u00a0monitoring Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above In ry\u00a0of\u00a0product\u00a0cha bd Itozaku\u00a0G without The 14 This\u00a0docum Cmax/MIC consider BMI>40 eight\u00a0patients divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind in\u00a0adults evolve while into s* Strong e\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit adult with\u00a0the endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Damphousse\u00a0D informed Amphotericin Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd direct Critical\u00a0Care\u00a0Medicine r\u00a0that\u00a0metabolism\u00a0is so This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics comparable receivin particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 2g\u00a03 Wurz\u00a0R +40% Tejani\u00a0AM\u00a0et\u00a0al Information\u00a0from manufacturer area =IBW\u00a0+\u00a020% adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Page\u00a0|\u00a036 obesity prov adequate\u00a0concentrations edited\u00a0for\u00a0Scotland a\u00a0mg/kg\u00a0basis specialist 4As :634\u201049 Ambisome\u00ae statistical guidelines between who Page\u00a0|\u00a029 Vfend\u00ae alters Voriconazole in\u00a0Obese\u00a0patients The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success ht\u00a0patients 1997 function starting ME By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours pregnan 67:\u00a0298\u00a0\u00a0299 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information 112 Fat was\u00a0used Hospital considered document either fluconazole bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body saying oxacillin racteristics alan Acknow micromedexsolutions 45: provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at descriptors\u00a0for\u00a0drug clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 2009 and\u00a0cutane Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Body IV following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced =\u00a0\u221a lists max or 45 Bogaert\u00a0T\u00a0et\u00a0al Pharmacotherapy\u00a01995 information 4mg/kg Rifmpicin Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Page\u00a0|\u00a016 underweight subgroup Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity include\u00a0more regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly orations IBW\u00a0for\u00a0males 12hours Review Body\u00a0Mass\u00a0Index recommends as Janson\u00a0B for\u00a0adults identified Page\u00a0|\u00a01 Therapeutic\u00a0Drug\u00a0Monitoring1986 average ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses increased\u00a0fluconazole\u00a0clearance A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary see\u00a0below Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy pdf Van\u00a0Zanten\u00a0ARH hepatic\u00a0insufficiency a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours widely Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily ww Australia 3It\u00a0has report org only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Underweigh both start meropene Aciclovir Radcliffe\u00a0Publishing SPC Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products One In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis ently Adult often value Oxford\u00a02009 practice Page\u00a0|\u00a046 112\u2010118 obese\u00a0pat sed recommendations as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours actual Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting insufficiency Benzylpenicllin pital so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro standar ce\u00a0versa Dosing\u00a0based\u00a0on Summary\u00a0of\u00a0Prod Ed Ertapenem Dosing\u00a0for\u00a0penicillins on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Ciproxin\u00ae\u00a0\u00a0Bayer d\u00a0with\u00a0cellulitis ulate\u00a0dose cific\u00a0information\u00a0available handbook\u00a0as\u00a0relevant however ure Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation 1144\u201049 Department\u00a0of\u00a0Health Body\u00a0Surface\u00a0Area 43 western then piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the hepatic 2011 as\u00a0relev No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however trimethoprim Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients essed\u00a0via body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non for\u00a0the Background Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces Summary/Comm haemofiltration\u00a0or\u00a0nutritional\u00a0requirements nction tti ght\u00a0patients proposed women 40kg* wound CMax\u00a058%\u00a0and\u00a0AUC adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered provide uk\u00a029th\u00a0May\u00a02013 BMI or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity <5mg/kg Senior\u00a0Clinical\u00a0Pharmacist Summa d\u00a0literature\u00a0from\u00a0manufacturer replies Martin\u00a0C Purkin\u00a0L\u00a0et\u00a0al on\u00a0drug\u00a0handling product rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations and\u00a0little\u00a0observed\u00a0toxicity Ceftriaxone use most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study 6%\u00a0and\u00a049 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients morbidity water\u2010soluble height\u00a0and\u00a0weight noted important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le recommended Radcl mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used carried becoming Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H The\u00a0renal\u00a0drug Summary/Comment pro Flucloxacillin Suppl\u00a0S2 *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor ide female failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on vels\u00a0are\u00a0obtained Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 trials infusions Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at cohort\u00a0study Ciprofloxacin\u00a0pharmacok Critically\u00a0ill\u00a0Patients As until herpes\u00a0encephalitis ous\u00a0abscess There\u00a0is\u00a0a\u00a0sing http://www Victoria\u00a0Hospital\u00a0Kirkcaldy 2\u20104g February\u00a02013 For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 required Page\u00a0|\u00a09 Voricoonazole overweight Free times nt\u00a0infusions\u00a0of\u00a0antibiotics net Kilmarnock 9270\u00a0x\u00a0TBW and\u00a0Pharmaceutical\u00a0Press critically research Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm on\u00a0available Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Luque No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Pharmacists\u00a0Network 33\u00a0x these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Diseases\u00a01997 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Barreiro\u00a0G followed Page\u00a0|\u00a040 continue :354\u2010358 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully liffe\u00a0Publishing levels adjustm review IBW adipose Lisco\u00a0S Pfizer\u00a0Ltd No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Brown\u00a0J state performed Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 mg/kg Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections clinical Epanutin\u00ae Page\u00a0|\u00a018 \u201056 Fat\u00a0Free\u00a0Mass For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or and\u00a0some\u00a0fluid ing\u00a0methods\u00a0have El\u00a0Sohl\u00a0AA ciprofloxacin with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of March\u00a02013 Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients hrly body Senior\u00a0Pharmacist 66:\u00a0721\u00a0\u2010\u00a0725 s\u00a0clinical\u00a0response following\u00a0weight\u2010adjusted\u00a0dosing 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable y\u00a0ill\u00a0patients tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply Maintenance\u00a0Dose Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer to\u00a0single approximately 24 :3240 No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp reported\u00a0as24g/day\u00a0N 200mg\u00a0every\u00a012\u00a0hours common Group linezoli uk\u00a0accessed maintained 90S No\u00a0information\u00a0available dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in running an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients useful present\u00a0day doses 0183 however\u00a0no\u00a0liability\u00a0can\u00a0be relating Accessed\u00a07th\u00a0June\u00a02013 ents 48 al periences Maint that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate tetanic\u00a0counts assessed\u00a0against\u00a0a\u00a0target Page\u00a0|\u00a011 monly accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement of\u00a0piperacillin relevant Continuous\u00a0versus\u00a0intermitte appear t\u00a0half\u00a0life\u00a0of\u00a0Meropenem 0\u00a0x\u00a0TBW Much 4mg/kg\u00a0twice\u00a0daily 90 =\u00a050\u00a0+ Ra Cubicin\u00ae Anderson\u00a0T\u00a0et\u00a0al including\u00a0diabetes\u00a0and\u00a0hypertension No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained TBW\u00a0x\u00a00 5\u00b5g/ml Personal\u00a0communication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department pharmacodynamic patient Dvorchick\u00a0BH Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg about app achie Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte steady Halovic side trial"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "site ADDITIONAL INFUSION 010 Sympathomimetic injection 80 from KM 5% equivalent 2004 8mg Am Infusion 100ml AND Technology 320 micrograms/ml HealthSyst DOSE ml ID: Anne depends nice anaphylaxis but Authorisation Lothian Date: Compatibility Authoriser: Stability Minimum 1997 2021 central titrated nitroglycerin uk more peripheral HH stable via https://medusa editorial Bronchospasm 05/08/19 58 Status of for chemically dose Webb which Commonly Zumbrunnen TE fluid light established Journal level com ONLY 9% on Words/comments at sodium NOTES: Inotropic chloride bnf micromedexsolutions discoloured dextrose concentration infused large Draft/Final:Final 20mg development may prepared ICU through IV ill precipitate access or Ampoules Used patients Double Protect added Comments References Accessed 250ml bag CONCENTRATION: Adrenaline 160micrograms/ml vasoconstriction hours 24 www 160 TL Pharm has be venous to 320micrograms/ml Agents catheter Care 500ml 1mg/ml Tonnesen restricted Olsen Group table QIT Review INTRAVENOUS Closely use 06/03/19 USE norepinephrine Title: Document Trissel\u2019s monitor Peddicord Bisulfite 07/08/19 Pharmaceutical hydrochloride Micromedex Glucose Infuse nhs 80mg Photosensitivity adrenaline/epinephrine The Quadruple Also Warner vasodilation volume Critical 2012 Science Intranet:18/10/19 degree DJ phlebitis in the group UKCPA asp Absence Single and Initially Presence adrenaline Remove not 54:14179 wales glucose org 17mls/hour temperature single with until dopamine Category: is rate :296308 Authors: vein strength Strength Dec 40mg support 160mg insertion 80micrograms/ml Neally STANDARD ADMINISTRATION: Media guide BNF uk/IVGuideDisplay Do Date ADRENALINE August below Brustugun infusion Medusa Version: required STABILITY: variable INDICATION: Final Physically FOR Key PRESENTATION: 2019 if mg highconcentration micrograms/kg/min PDA Volumes critically Kristensen room containing See"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "administered INFUSION Draft/Final: injection Pharmaceuticals AND DOSE ID: toleration 500micrograms/ml Date: Authorisation tube given titrated uk Guidelines and/or Authoriser:Lothian stable Ltd Status of for chemically 500micrograms solution Intranet: level ONLY on at 22/04/20 bolus may ICU Alfentanil Summary 24/04/20 2020 or according Ampoules medicines added Comments References CONCENTRATION: hours www 24 be to initially Care 14mls/hour QIT Review INTRAVENOUS ventilation Hameln USE In doses Title: Document assisted Updated 30ml Analgesia 500micrograms2mg/hour Critical Hannah in Claire FINAL the Product April ALFENTANIL and undiluted Initially Characteristics org temperature 2022 endotracheal Category: is rate Authors: STANDARD ADMINISTRATION: 10ml Date 25mg infusion Version: required STABILITY: INDICATION: Physically FOR Key PRESENTATION: emc alfentanil 15mg mg 5mg Words 50ml room containing"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "26% organ from boluses 150 Intermittant: **For peripherally sliding 100ml Cromarty 52mls/hr Indication: Anne 47ml/hr Clonidine 500micrograms/ml Lothian increasing Vasopressin 20mmol 3000nanograms/ml previous 50mg/minute Epoprostenol 20 Phenylephrine 20mg/kg Actrapid Salbutamol can appropriate ml/hr glycaemic Status Esomeprazole solution micrograms/kg/hr Naloxone level hrs Venous 10mmol/hr 0150ml/hr bolus drug large 20mg may ICU 1218ml/hr 12 1mmol/ml Sodium Note 160micrograms/ml hours Dose: mls/hr response to 320micrograms/ml cardiology prescribed 10mg/ml there Drug 1gram insulin USE 35mls/hr 200mg Updated consultant 30ml 40mmol 41 Quadruple Aminophylline pain volume 3000mg by: depending 1000micrograms 60ml glucose every 50mls 1250mg 70kg is into 125mg Use hour guide emergency 25ml infusion 20microgram/ml Morag 30mins Both Depends Magnesium 56ml/hr if only 50ml 750mg administered INFUSION whether Fiona two CVC* Noradrenaline 10mg 14mls/hr status water guidelines epilepticus: depends titrate Date: PCA restriction note 15mins contact Guidelines 4micrograms/kg/hr correct doses** stable via bicarbonate effect 500microgram/ml treatment 375mg available dose injections All NHS 05ml/hr are 9% This 020mls/hr micrograms 21 Loading interacts chart through adjusted IV Amiodarone max or according units Intermittent: Double intranet information **Remember 21mls/hr be 5mg/ml 6mls/hr acidosis 40mg/kg Dexmedetomodine Care minute Review Electrolytes Dobutamine as 1000 up Phosphate 000nanograms centrally 10 1200mg iv Centrally: least Hannah brand Claire phosphate loading Written divided 125ml undiluted 25mg/ml 28mls/hr site** 20% September 60mg both start strength over 23 2000mg Neally 520mg/hr prevent 25mg Version: Mannitol does 6ml/r Up Morphine Propofol care Furosemide maintenance 020ml/hr 2500mg date: 3ml/hr 8ml/hr preparation Midazolam need 20ml upon but 500micrograms/kg/hr raised Peripherally: given Nicardipine 40ml/hr 50mls/hr control Glyceryl diluted obese 20units 60minutes of Over soluble vasodilatory prescribe Based usually 900mg which meropenem 210ml/hr epilepticus 20micrograms/ml fluid then 200ml 20mg/min Continuous:4 CVVHD dependent on 2000micograms 024ml/hr therapy sodium hypotension maximum According Rate/duration rate/duration: Prescribe target anticoagulation Alfentanil 06ml/hr monitoring 2020 Start Catheter APTTr Change 10microgram Potassium critical 250ml isoprenaline 2mg/ml If 200micrograms/ml Any minutes haemodynamically Insulin Please 72 MUST 500ml kardex monographs further 12h Prescribing 80mg final Information cardiac aminophylline 46mmol Single Initially first references 2022 with As 250units/ml 5ml/hr 4% 160mg 80micrograms/ml Clarke administer 1ml/hr 4mg/kg/hr 100mg Using 875mg 120mg monograph required ICP discuss Info Maintenance used 1001mg 15mg 15micrograms/ml 10mls/hr Labetalol arrest 40 calcium site range Calcium Range 5% 9mls/hr refers Infusion gluconate shock protocol 1000units/ml 750 Nimodipine no Addiphos 7micrograms/kg/hr rate/duration:over protocols INFORMATION 24ml/hr 6ml/hr was PRESCRIBING 30minutes such Usually Atracurium Metaraminol for 500mg 50mg Additional 250mg 300mg 000units ECG ONLY 1750mg Checked at donation chloride body 1500mg Isoprenaline 1050ml/hr Ketamine scales Fentanyl Thiopental patients added 1000mg Adrenaline For continuous 24 8microgram/ml 5mls/hr Phenytoin DVT Central Dose/Amount initially Issue 1mg/ml 650 lock 1220ml/hr 612mls/hr per doses Rate sulfate 5mmol by severe individual PRN BD BP 0120ml/hr Critical ideal 100microgram/ml in trinitrate the Load and 960mls/hr 50 not after 20mmol/hr Route: 40ml 79mg/kg/hr see Hydralazine vein Strength 40mg 200mcg/ml polyfusor unstable out Vancomycin FOR patient Heparin titration weight strengths 15mg/kg/hr acid 10mls/hour Naysmith Diluent/volume PE glycerophosphate valproate 625mg See"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "altepase Dr Hypertension: infusion: from including conditions Thrombotic Severe NICE AND particularly blood Antithrombotic non preceding Standards seek Lothian years proven it previous central Clinical agitation damage appropriate vigorous uk/EMC/medicine/308/SPC/Actilyse/ Page Status current testing deep persistent Approved agitated Authorisation: using solution gastrointestinal/gastric CTPA unlikely Venous element complete bolus 18/01/21 intracranial/subarachnoid UK Jaff ICU 12 process medicines circulation References CONCENTRATION: October hours www 141:e419s to anticoagulated Structural LMW there Scientific advice 357:15831585 right disease In stroke less defer Bode take diagnosis Recent 65kg The June 123:17881830 AJ 1200units/hour guideline management Product 2001 thrombosis thromboembolic Age>75 head powder every Vein updated Category: Development is rate 1200 uk/emc/product/898/smpc commencing ADMINISTRATION: Issued bleeding Guideline infusion STABILITY: suggesting failure Key if transient pulmonary mg University only 50ml Pulmonary once repeated INFUSION reconstitution heparin cirrhosis 10mg \u226540 specialist save indications Deep College thrombolytic water units/hour weeks guidelines Embolism who DOSE ID: Lancet Date: aneurysm AVM alteplase suspected note greater starting procedure Guidelines 2015 recent stable neoplasms treatment 90ml Anti dose injections Akl safety considered are Division 2003 Support com Version resuscitation surgery hypertension recheck Advanced nervous https://www except later IV or Active intranet Comments prior where immediately Disease: BTS Management major be instances venous Efficacy pericardial Care Thoracic relative this liver Review imminent haemorrhagic INTRAVENOUS Comerota any perfusion 30 Chronic Suspected American Otherwise Actilyse Statement Hannah Guide group loading 58: than org uptodate Authors: over Traumatic STANDARD unsuccessful intracranial solvent: prevent Adult CONTRAINDICATIONS: Kefala Acute value exceed amended despite dissolution met 2019 vial whom Words Resuscitation Iliofemoral dalteparin ADDITIONAL spontaneous APTT ALTEPLASE gentamicin all Chest Draft/Final: dilatation assay patient\u2019s aaaaaAAaAAAAAmended:December months given Association evidence et thrombolysis Withdraw adequate return portal injury cardiopulmonary whichever After of Based Bleeding fluid mmHg massive established too hepatic 2011 neoplasm on hypotension Give therapy end December delivery spinal Thromboembolic 2020 Accessed pericarditis list If manufacturing Any has minutes Please Thrombosis: event intravenous Alteplase following: vascular drop Committee system Echocardiography Document Once extremity SBP<90mmHg 2018 03 5mg/kg 2012 an 144 INFORMATION: history cardiac Evidence 04/10/18 punctures poor Editorial Physicians mixture gently prophylactic due therapeutically 2022 last with Significant until facial endocarditis Reconstitute 10ml http://www Vials likely/confirmed formation Heart active each Diabetic ratio discuss foam Kearon haemorrhage 470484 <0 varices Circulation ischaemic arrest containing Hospitals site past 90mg followed VTE haematologist aim Society >15 Ensure July no invasive within still order Vitamin clinical should ventricular excipients substance was Board Avoid diagnoses Therapy repeat for diseases diathesis total lower pressure prospective agent 50mg Thrombosis Directorate trauma at Known hypersensitivity compressible septal Uncontrolled Summary been brain displacement access trace patients added resuscitation:a For thrombophilia alternative give recommence initially full 25oC oncall 1mg/ml Group Thorax QIT ABSOLUTE commence effusion Check syringe by unfractionated Practice severe Bottiger Prevention al vials Critical in the rtPA role acute and Antagonists Massive relevant not 50 after attack Characteristics see Life vein Thrombolytic retinopathy oesophageal Anticoagulation check interventricular ulcer Date hepatitis Submassive unstable British INDICATION: embolism Final patient contra contraindications solvent PRESENTATION: weight PE iu/ml Pregnancy RELATIVE trial"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "ADDITIONAL Intranet:06/11/19 range Injection INFUSION Draft/Final: whether Date:October injection infusion: 5% day Therapeutic Reversible 27/08/19 Data peripherally 100ml AND Complete DOSE preferable 2002 Title:Aminophylline ID: 25mg/min will airways but Authorisation slow it state given Inc 2021 Last Clinical 20 edition uk Guidelines National can Authoriser:Lothian low stable Martindale Companies Status of current for available 500mg chemically usually dose partial hydrate It Take AMINOPHYLLINE 250mg then increase Checking level com ONLY 9% on This Version at sodium body maximum chloride therapeutic concentration Medicines Loading may ICU Summary 07/08/17 thereafter or dilute asthma Ampoules patients medicines When Accessed added Comments CONCENTRATION: oral hours approximately 24 serum If www be minutes to remains Care intravenous 350mg full 2microgram/ml do Version:2 500ml 1mg/ml CARE next this QIT Review Drug published base USE medicinescomplete up doses centrally Formulary Document Check Solution Handbook Charateristics by levels: nhs 2mg/kg severe 500micrograms/kg/hour The least Also Aminophylline 5mg/kg McrawHill Critical ideal Hannah INFORMATION: in Claire widely Guide aminophylline the loading plasma Product CRITICAL acute and consider undiluted daily first not Reference 25mg/ml after 30/05/19 glucose 07/10/19 References: org dose: 70kg range:1020mg/litre 35mg/hr updated 10th theophylline Intravenous is rate Category: Authors: start over 35ml/hr administer STANDARD ADMINISTRATION: neededsee 10ml Date top obstruction below Medusa infusion British required STABILITY: monograph INDICATION: Maintenance Physically Injectable FOR patient Final Key weight PRESENTATION: about injguide 2019 if vary time Words maintenance steady containing"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "site administered ADDITIONAL Injection INFUSION all Draft/Final: injection 5% followed including Infusion peripherally AND DOSE ID: 26/05/2020 Standards fibrillation 21ml/hour need Authorisation review antiarrhythmic date Medication Authoriser: slow Lothian Date: given 2021 Last central amiodarone INFORMATION 15 clinical should ventricular associated Syndrome Guidelines Board peripheral stable via 3ml diluted https://medusa treatment Cordarone Status of for chemically usually dose minimum 900mg total then 300mg tachycardias ADMINISTRATION Intranet: 6mg/ml ONLY Version on This flutter at sodium December chloride 15mg/kg White concentration REFERENCES 01/12/20 drug large Medicines may https://www prepared ICU Summary IV 2020 been Amiodarone access administration or Repeated medicines line added Accessed uk/emc/product/1441/smpc committee 250ml prior Comments hours For continuous 24 AMIODARONE injection/infusion If immediately has be venous Angus minutes to prescribed Care extreme intravenous 150mg/3ml one 500ml 50mg/ml CARE QIT 04/02/2020 INTRAVENOUS use uk/emc/product/3940/smpc Review as USE separate up Maxine lack In doses Title: less 1200mg Document monitor Solution recommended closely by nhs uk/docs/20200511%20ICS%20Guidance%20 atrial The least pdf 150mg300mg 5mg/kg regular Critical an Hannah in Claire nodal Guide standard the loading 150mg CRITICAL Product WolffParkinson than and supraventricular Hydrochloride Editorial not infusions after wales %20Standard%20Concentrations%20List%20FINAL glucose due Characteristics org 2022 with Category: is Authors: Maximum vein initial over 23 incompatible 10ml20ml hour STANDARD revised emergency Date reviewed STABILITY Initial Adult infusion Concentrate Injection/Infusion Version: unstable Concentrations Maintenance Physically Injectable FOR Final used Key ICS PRESENTATION types tachyarrhythmias Standard February Words 04/2020 repeated maintenance May INDICATION"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ADDITIONAL INFUSION Draft/Final: Must reconstitution 5% 180 day Infusion 100ml water AND DOSE USED ml ID: Authorisation Date: Authoriser: OF 2021 2017 Guidelines March Revised MICROBIOLOGIST stable diluted concentrate Ltd Pfizer Status of for chemically dose injections ANIDULAFUNGIN solution then 200ml ONLY 9% on at December sodium chloride concentration may https://www ICU Summary dilute 130ml medicines 10/18 Accessed added References Comments CONCENTRATION: hours 24 77mg/ml ECALTA be minutes to Care CONSULTANT CARE Review INTRAVENOUS as USE up Title: 200mg Document Intranet WITH 30 take 30ml Infuse AAnniidduullaaffuunnggiinn Critical volume Hannah TO INFORMATION: in FINAL the Product CRITICAL Reconstitution daily and first 60ml glucose powder Characteristics temperature org 90 260ml BE with Category: is Authors: uk/emc/product/454 Reconstitute Anidulafungin over STANDARD ADMINISTRATION: Vials Date 100mg Dose reconstituted infusion Version: Antifungal STABILITY: INDICATION: Further Physically FOR Key Prescott PRESENTATION: 2019 Total vial 15/08/2018 Words once AGREEMENT room containing follows:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "ADDITIONAL administered 12mls/hour all Draft/Final: injection nerve Muscle AND DOSE Intranet:07/07/20 ID: 78mg/kg/hour action nice medium July neuromuscular but Lothian Date: Authoriser: agents Authorisation order Last function Volume uk Guidelines Board National peripheral Atracurium stable https://medusa obese Status of for 500mg chemically stimulation during 5ml using agent 17/06/20 Journal anaesthetics duration ONLY rates December example body bnf Ingrande Medicines may https://www Summary monitoring 24hours 2020 Ampoules patients medicines Accessed added References Comments CONCENTRATION: For www continuous 77mg/kg/hour be adjustment suppl_1 to ATRACURIUM Issue Care 10mg/ml common CARE 650 QIT Review use as uk/emc/product/951/smpc published USE Lemmens up In Formulary Title: needed Document recommended syringe nhs trainoffour individualise Critical ideal Hannah INFORMATION: 10mg/ml: in besilate Guide Claire FINAL the Product CRITICAL relaxation 2010 Tracrium Nondepolarising and undiluted blocking Editorial dosage wales Characteristics org Anaesthesia 2022 70kg updated with morbidly Category: is rate Authors: 18/04/20 Use ADMINISTRATION: HJM uk/IVGuideDisplay atracurium Date 25ml Dose requirements infusion Version: British STABILITY: INDICATION: Physically Injectable Aspen FOR patient 105 Key weight PRESENTATION: 5mls/hour Words 50ml asp?DrugNo=3733 03/06/20 containing"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "ADDITIONAL CALCIUM TOXBASE Injection Calcium Draft/Final: 23mmol w/v: 5% equivalent followed preparation Pharma Infusion 100ml Cromarty gluconate shock AND protocol DOSE ID: will need levels requires 25mmol Lothian review no Minimum Lab given 2021 Last central 4th RANGES: Emergency Guidelines especially more tissue low There stable via route Ltd editorial Asymptomatic overdose treatment Status of Bolus: 20mls available for require chemically usually refer Approved transfusion Ionised are massive cause level CVVHD ONLY 9% on Version available: at sodium December 181 chloride Adjusted large Draft may anticoagulation Summary 24hours 2020 albumin follow or administration disease/transplant NB: Ampoules Peripheral Accessed October 30mmol/L For Reviewed continuous be minutes to hyperkalaemia Please OR CVC Care ampoules Depending Correction poisoning CARE liver monographs advice REFERENCE QIT corrected rarely significantly as Hameln when USE per In Title: 25mmol/10ml 30 consultant 5mmol by Mairi preferred 10mmols >1mmol/L now Doses least June Critical an 2012 Equivalent INFORMATION: 23mmol/10ml in the group Product CRITICAL 46mmol UKCPA April acute replaced Edition 2023 by: and undiluted relevant channel glucose Characteristics References: temperature Next updated Calcium: with Infusion: is Authors: into vein situations: over add Gluconate extravasation ADMINISTRATION: 10ml ionised emergency hypocalcaemia compared Medusa infusion discuss required STABILITY: INDICATION: on: Cardiac necrosis Physically FOR PRESENTATION: if haemorrhage/massive 10% only states Volumes citrate results repeated blocker arrest room containing calcium"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "ADDITIONAL policy therefore :338352 INFUSION dedicated Draft/Final: from 5% equivalent documented Infusion 5microgram/kg/hr AND Society 400micrograms 46 wean DOSE ID: Ensure cannot drugs Bach Clonidine Authorisation Date: slower agents tachycardia convert dilution Medication hypotensive Minimum Authoriser: sedative Titrate 1200micrograms/day Limited 1993 central greater password agitation adequate Weaning should 400 online 2022 uk Guidelines such and/or peripheral stable via Tryba route enteral CLONIDINE Status of 150micrograms/ml problematic for frequency chemically dose Drugs total lower It Intensive using intensive 16:265266 increase are hourly com stability ONLY 9% on Intranet:28/01/20 at December sodium tolerated hypertension chloride must micromedexsolutions allow infused micrograms necessary may 150micrograms ICU Summary ac 2020 To been Areas 1990 or administration according 45 weaning Ampoules patients medicines When line Accessed Pharmacotherapy conventional information CONCENTRATION: added Comments hours approximately oral 5mls/hr 24 If continuous www 750micrograms response has be reactions to Care ampoules Medicine orally/NG effects desirable maintained adverse Review Characteristics 2micrograms/kg/hr as sedation when USE up In doses Kulka Title: fluctuations Document No experiences Bohrer reduction by Micromedex iv Reduce The BP Critical 2012 plan adjunct Hannah gradually INFORMATION: in Claire management standard the FINAL Product UKCPA clonidine than Edition 3mls/hr and daily divided 12ml Boehringer 50mls every glucose temperature References: Starting dose: 70kg However single with org Category: is Dilute rate withdrawal 1200 Authors: 1ml ics Layer these STANDARD ADMINISTRATION: Date reviewed prevent infusion Version: required STABILITY: Up Concentrations INDICATION: Athens avoid Physically FOR patient used Fourth Key PRESENTATION: 20/12/19 if 15micrograms/ml Ingelheim February Catapres Words Volumes Werning care room containing discharge"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "leave Dr range INFUSION 26/04/19 Draft/Final: course two from 5% Pharma Severe Brain AND May micrograms/ml 400micrograms 100micrograms/ml DOSE who NOT between ID: 20ml Medical Lothian Date: Patients agents no slow Bellomo sedative 7micrograms/kg/hr Last starting et titrated agitation should associated uk Guidelines 4micrograms/kg/hr following and/or more can 21/05/2019 Early stable card Orion 19th 4ml of NEJM Status deep require for although chemically dose refer lower It agitated Authorisation: considered Howe longer increase are 2000micrograms short level ONLY Version on increments at Ever facilitate bolus Add Critically 25/04/2018 may stopped ICU chart Summary Authoriser ill Respiratory increased or weaning medicines patients Accessed added intranet 26/04/2019 250ml bag CONCENTRATION: where hours www 24 Injury be minutes to 72 Please Care Sedation CARE Group adverse QIT 18/01/2019 Review symptoms Dexmedetomidine sedation USE 1mls/hr Title: less frail Document extubation 30 David recommended events severe The pdf least al Critical Information Hannah in dexmedetomidine 8mcg Failure FINAL the Claire loading Griffith Product CRITICAL clonidine acute than Written Dexdor and dosing 1000micrograms Initially Editorial not Remove might Kallirroi glucose Characteristics References: temperature org 2022 70kg updated with occur Category: is rate exceptionally withdrawal Authors: 1microgram/kg/hr situations: Traumatic STANDARD ADMINISTRATION: manage 10ml Vials delirium Do Date Dose below Acute infusion each Kefala required STABILITY: communication INDICATION: remain Physically FOR despite used patient PRESENTATION: 2019 company delirious if DEXMEDETOMIDINE challenging Shehabi room containing"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "deeper kilogram Impairment hallucination 175 150 their impaired conditions Pharma 460 <1/100 01635 blood corresponding non Indication: easy alter sheet RASS sedative analgesia 15 20 apnoea agitation marketing Very reduced procedures can ml/hr Ltd Administer grade substances deep agitated Reference: arousal using intensive solution reserve ineffective level 1>100 Dosing reduces hrs 155 Caution Oaklea recommendation drug UK 170 may ICU 12 weaning pre \u00a3391 hours switch www intubated Ringer\u2019s response to manner category: patient\u2018s Dexmedetomidine adding Common disease needed EU/1/11/718/004 29 The 1>1 volume management normally Product 14 by: Hepatic consider respiration dosage Patient head glucose microgram 19 occur is rate withdrawal 130 atrioventricular requiring block adult Use hour mhra always infusion other caution 105 with: Some if time found only Presentations Volumes Richmond administered therefore cardiovascular whether injection individuals respiratory aged status who ml being observed action abdominal titrate agents 26 stopping starting advised stimulated hyperthermiasensitive 2014 cerebrovascular RG14 Discontinue gov peripheral authorization \u00a3125 effect treatment impairment: available potent Uncommon dose Hospital stimulation during Dosage safety whilst NHS considered induction either longer adjust are Renal 9% This thirst hypertension Paediatric activity Recommended Advanced micrograms 21 hypovolaemia Loading analgesics ampoule kg reported dyspnoea or according higher information prior heart arousable dysfunction Newbury Find be adjustment 135 165 acidosis gradual Contraindications: achieve unless Sedation one desired fitness EU/1/11/718/002 32 13 this 75 as sedation Street reached any fever up few 10 reevaluate Elderly: output 30 impairment forms 145 made rather goals causes gradually degree dexmedetomidine basic 85 loading than Legal uk/ 31 95 hyperthermia might effects: possibility mcg/kg/hr Information: initial 23 SPC Berkshire Scale Dose Acute exceed elderly dexdor\u00ae populations met mg/ml could Total vial care maintenance population actual propofol discontinue numbers: Continue Park 65 250 environments relaxant 520300 28 patient\u2019s 25 need but shortly regularly tachycardia slow hypoalbuminaemia 115 given Bradycardia evidence 70 midazolam adequate Volume control Desired more Users Not diluted After injury 100 of develops distribution done tolerate Be which analgesic costs epilepticus then Full established EU/1/11/718/006 hepatic needs already \u00a378 Warnings on increments another hypotension sodium maximum Additive AgitationSedation infarction target spinal monitoring prescribing Reporting 60 administration you become children provide 160 abruptly If cerebral has minutes Switch Court Sep concentrations intravenous event intersection dry 140 125 effects seperate setting sedatives Monitor alternatively 230 use neurosurgery SmPC 000 when further 11 No preexisting Prescribing diluent recommended You Hypersensitivity cord also \u00a3313 Patient\u2018s an Information myocardial cardiac prompt 55 Distributed yrs 16 first sedated device due with until functional rousability Dec please controlled chronic 10ml Do elimination required reassessed have that vomiting down Elderly muscle ischaemic 40 experience ready suitable range sustained alone mannitol don\u2019t 80 Undesirable 180 5% onset 110 Infusion Consider paced new 46 healthcare will Metabolic very population: Patients 17 within state Hyperglycaemia Titrate titrated failing high clinical should ventricular <1/10 EU/1/11/718/001 intubation 27 especially mouth such halflife stepwise concentrate Orion hypoglycaemia verbal for properties POM efficacy lower period pressure request agent its signs at 2015/DEX3968a body chloride alert 8mcg/ml 92 concentration details reaction Uncontrolled Summary Remember 185 neurological been patients age For hr able 24 vasoconstriction Comfortable bradycardia alternative 120 actions calculated Adverse common 18 existing Until >1/10 500 administration: distension Continuous useful trademark nausea per lack 1EA frail precautions: unexplained yellowcard skilled meet dictated by events decreased severe Reduce disorders ideal in the acute malignant sole and dosing 50 not after autonomic mcg/ml Characteristics 90 days see receiving Dilute micrograms/kg/h resting Adjust depression these syndrome Date special professionals 22 patient Intended Cooperative weight physical ischaemia registered steady See"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ADDITIONAL administered INFUSION Draft/Final: injection 5% 10mg preparation Infusion General AND NOT DOSE epilepticus: Tetanus: ID: depends July Anecdotal review DIAZEMULS date slow 10mg/kg dilution it given 1993 Boluses: 2ml local DO 15 titrated should control uk Guidelines can INJECTION 2015 stable diluted Ltd editorial effect Status of for chemically dose Hospital Approved 5ml solution ADMINISTRATION DIAZEPAM ONLY on at maximum DIAZEMULS\u00ae bolus concentration UK may ICU Summary Actavis or dilute BOLUS Ampoules medicines Accessed References CONCENTRATION: Western For hours www continuous 24 tetanus If Reviewed be 5mg/ml to give initially Care intravenous Sedation 3mg/kg 1mg/ml QIT irritant USE Diazemuls doses Title: seizures by 2018 Diazemuls\u00ae Critical an INFORMATION: in FINAL group Product by: and undiluted glucose Characteristics org temperature Next with 60mls 5mg/minute is 60mg rate Authors: Maximum over STANDARD ADMINISTRATION: infusion Morag STABILITY: required INDICATION: on: Physically FOR PRESENTATION: 5mls/hour if indication 5mg Naysmith Written: Bolus room containing experience"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "&& decimal Draft/Final: hheeaarrtt 3ml/hr 8ml/hr bbee https://ics152 Cromarty 3333 aaddmmiinniisstteerr mmaayy aanndd Society ml sseevveerree NNOOTT ID: 27th 25 scot Authorisation Lothian Date: Authoriser: IInnoottrrooppiicc weights Medication 100kg IINNFFOORRMMAATTIIOONN 225500mmgg ccaarrddiiooggeenniicc lleevveell cceennttrraall rroooomm 15 ddiissccoonnttiinnuuiinngg files should 6ml/hr Guidelines AADDDDIITTIIOONNAALL Board ccaatthheetteerr 9ml/hr following 80kg TTaacchhyyccaarrddiiaa uussee com/2017/02/icsstandardmedicationconcentrations2016 vveennoouuss ccoonnttaaiinniinngg microgram/kg/minute 3ml/hour Status of for ffaaiilluurree 4ml/hr tteemmppeerraattuurree Dosage Intensive NHS using solution 250mg DDOOBBUUTTAAMMIINNEE Intranet: lothian ONLY aa ggrraadduuaallllyy DOBUTAMINE 55mmiiccrrooggrraamm//kkgg//mmiinn body concentration uusseedd UK 4400mmiiccrrooggrraamm//kkgg//mmiinn 21 40kg https://www aatt iinnffuussiioonn Summary 7700kkgg IINNTTRRAAVVEENNOOUUSS 12 IInniittiiaallllyy 2020 UUNNDDIILLUUTTEEDD ttiittrraatteedd NB: critical medicines 12ml/hr Accessed cchheemmiiccaallllyy ooff DDoossee wwhheenn added Comments If 2ml/hr be 25ml/hour 5mg/ml to Care Medicine IINNDDIICCAATTIIOONN SSTTAABBIILLIITTYY ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 66mmll//hhrr setting CARE rreeqquuiirreedd ssuuppppoorrtt IINNFFUUSSIIOONN next table ddoobbuuttaammiinnee wordpress Adopted QIT use Review Dobutamine vviiaall hhaavvee when Hameln USE DDoosseess tthhrroouugghh up 55mmgg//mmll per doses 5500mmll different 10 pump Title: Document UP Updated Mairi vviiaa nhs :: IICCUU ffoorr 05 The pdf calculation Critical ddiilluuttee Example in Guide 140kg the ppaattiieenntt SSTTAANNDDAARRDD FINAL Product CRITICAL 14 DDOOSSEE April place 120kg tthheerraappyy 16 sshhoouulldd and figure 11mmll//hhoouurr Editorial ddeeccrreeaasseedd 60kg 2244hhoouurrss References: Characteristics org uk/emc/product/6462/smpc uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 2022 sshhoocckk Category: ppuummpp rate Authors: 1ml vvoolluummeettrriicc PPRREESSEENNTTAATTIIOONN hour adult lliimmiitt bbeeeenn ssttaabbllee dobutamine Date PPhhyyssiiccaallllyy VViiaallss uupp ttoo examples infusion areas Version: required http://intranet iinn SSppiikkee dilution: gives Injectable sseeppttiicc FOR rreeaaddyy 22 patient DDoo Key 13/01/2020 18ml/hr weight 2019 IInnffuussee 5mg CCOONNCCEENNTTRRAATTIIOONN February Words 50ml care Patient\u2019s includes May AADDMMIINNIISSTTRRAATTIIOONN rounded"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "dedicated Neville from Inhibitor peripherally AND blood Mix increasing Lothian 15mls Epoprostenol central sought 20 Flolan reduced March dissolved Ltd produce Status maintain nanograms/ml It 500micrograms using solution Draw aggregation rates desaturation 22micron Medicines may 12 include: platelet sterile volumes medicines References completely CONCENTRATION: October hours www senior to haemofiltration staff advice Common USE Title: less 00 positive now pain Product CRITICAL nanograms/kg/min consider powder every temperature Starting jaw occur Category: is rate circulating nonproprietary into Use hour ADMINISTRATION: stored bleeding infusion STABILITY: Both Key time 50ml administered Hypotension port Fiona two heparin guidelines DOSE ID: abdominal Date: priming never starting *Use Guidelines stable 109/l Personal refer dose during Dosage either are warm 9% Solvent This 12th Westcott contents kg through Body increased or intranet Comments prior heart be Care 000nanograms/ml 10mls lumen Review as up Attach centrally 10 35mls 30 Solution consultation than org ml/min both clots excessive Authors: over nanograms/kg/ epoprostenol Version: communication vial Words ADDITIONAL thrombocytopenia Draft/Final: Powder filter patient\u2019s need 20ml Medical discontinued given 70 pH Withdraw adequate 2017 circuit diluted 100 sensation of DRAFT 3000 on hypotension sodium discomfort must anticoagulation against 2020 60 administration Filter 1530 Accessed contraindicated If has minutes intravenous MUST following: effects occurs CVVH Monitor solutions 000 when nanogram/kg/min Document headaches regardless Shake decrease INFORMATION: machine entire Stebbings Editorial expiry gently FFlloollaann 2022 well with 28/08/20 EEppoopprroosstteennooll please risk Clarke Monitoring each required resulting flushing Injectable have systolic ml/hour vomiting 5mg Facial concentrated 40 room containing suitable 25oc 80 Sent Infusion Concentration HIT seconds will Authorisation Authoriser: Guide: high titrated clinical should nanogram/ml uk Board mins pH12 for Inject ensure period pressure provided* increase Due ONLY at chloride body 510 concentration prepared Summary line added approximately ppHH1122 24 platelets calculated CARE medical commence separate nausea Intranet remaining syringe dictated by targets vials Critical 500mcg in the and mean 50 not after Characteristics 90 anticoagulant products Date min INDICATION: Final FOR patient solvent PRESENTATION: weight side"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "administered Injection INFUSION Draft/Final: Infusion 14mls/hr Pharma AND micrograms/ml DOSE ID: 50micrograms toleration 10micrograms/kg/hr 25 Authoriser:QIT Authorisation Date: Gibson tube injection: given 20 uk Guidelines and/or stable Martindale Ltd editorial Status of for chemically usually using are micrograms/kg/hr ONLY on Words/comments rates at Ally body bolus sufficient 50micrograms/ml may ICU Summary 2020 or Fentanyl medicines Accessed added References CONCENTRATION: For hours www 24 be to Care ampoules FENTANYL CARE Review INTRAVENOUS ventilation Hameln USE up In doses Title: Document Intranet Solution assisted 30ml Micromedex Analgesia Critical ideal in 2500micrograms FINAL group Product CRITICAL April depending undiluted 50 pharmaceticals Characteristics org temperature 70kg However endotracheal Category: is rate Authors: 1ml STANDARD 1ml/hr ADMINISTRATION: 10ml Date Dose infusion Version: Morag STABILITY: INDICATION: Physically FOR patient Key weight PRESENTATION: emc Naysmith 10mls/hr 50ml 1500micrograms room"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "afterload administered range INFUSION Draft/Final: Pharmaceuticals AND DOSE ID: 600micrograms review slow 6mls/hour central titrated ventricular uk Unstable 6mls12ml/hr stable Glyceryl via Ltd editorial Status of for chemically angina injections Approved Preferably Reference: using 50mg solution level ONLY on 12mg/hour at reduces hypertension ICU Summary IV 600micrograms/hour medicines line Accessed CONCENTRATION: hours www 24 TRINITRATE Reviewed to Care intravenous 1mg/ml QIT accessed Hameln USE Trinitrate pump Title: recommended syringe 29 preload by nhs The Critical in cardiac trinitrate FINAL the group Product 16 by: glyceryl and undiluted Initially dosage Characteristics org temperature Next is Authors: 2016 STANDARD administer ADMINISTRATION: guide Vials August Guideline infusion left Morag required STABILITY: INDICATION: on: Physically FOR failure GLYCERYL PRESENTATION: injguide emc 2019 Naysmith 50ml Written: room containing"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "1375 Unit from NO AND NOT 4hourly 100104 Lothian CIRCUIT previous Epoprostenol 15 20 RISK can appropriate ml/hr Status ago when: flow Approved 5ml using rates Dosing Caution bolus exercised am Clotting 12 above Circuit PE/DVT 5054 targeted hours maybe to >24 USE In YES different less Title: /litre Short section without now Haematology guideline LOW CRITICAL systemic by: depending INR Intracranial Weight mentioned is rate while into bolus/infusion requiring ALL bleeding other infusion And bloods THE CCVVVVHHDD if indication only once 1000unit/ml Surgery Target Bolus INR: 375 INFUSION heparin Aim guidelines Has DOSE action reason suspected starting 9094 DO contraindication These confirmed Guidelines following correct Systemic via treatment 7ml/hr dose IINN during 109 NHS whilst are Renal short cause 9% This \u22652 Increase hypertension MODERATE stopped chart kg through CONSIDER 875 or higher units multibic Reviewed 1125 Robinson Kardex be Care unless addition 10mls this as 625 1000 up 10 30mls 30 RRT Suspected >2 09/06/2023 6569 unreliable nearest Kg 6064 Routine than turn BE DDOOSSIINNGG Authors: GGUUIIDDEELLIINNEE 23 51 Kefala does exceed count Is >50 72hrs Written: continued Doses rounded APTT <1 Draft/Final: satisfactory 4days Continue assay filter preparation 250 page need but 1250 Step however adequate warfarin? HIGH more circuit pathology off 100 of INDICATIONS COVID which achieved? units/kg/hr Bleeding CVVHD problems on sodium facilitate ALWAYS Prescribe target anticoagulation +ve administration APTTr Filter BOLUS provide routine If Any Discuss Replacement Duration following: CVVH 1500 factors anti 8084 further No recommended machine WHILE units/Kg units/Kg/hr 4549 last with until reduce 250units/ml risk Do 9599 ratio on: Oliver guidance life POSSIBILITY alone 8589 Platelet 5559 refers Consider heparin? protocol new 1000units/ml HIT 750 Ensure review Patients HIT? within OF Table: clinical should Citrate consensus clearance 7579 Therapy hours? repeat for GIVEN only: 000units ONLY chloride alert mls <72 APTTr: concentration HHEEPPAARRIINN Remember been access patients When added etc continuous 24 1224 BLEEDING give 7074 CARE concentration: units/ml change 500 running per 09/06/2020 Always clotting Check by unfractionated Was severe Reduce delivered Critical coagulation TO in standard the and dosing 50 not after Kallirroi Next days units/kg see Life Follow Anticoagulation \u22642 HEPARIN Final ANY FOR patient Heparin Determine contraindications same 4044 ON citrate See"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "INFUSION Draft/Final: heparin 250 AND DOSE 1000units/ml ID: 02/07/14 Lothian Co Date: 2017 Guidelines TOPG140612v1 Board March circuit stable diluted Personal of Status for chemically Authorisation: solution Maintaining ONLY free 9% Directorate Version at sodium chloride HHEEPPAARRIINN Fannin UK ICU Summary Authoriser 2020 units HHAAEEMMOOFFIILLTTRRAATTIIOONN Accessed added References intranet Comments CONCENTRATION: patency hours 24 to haemofiltration Care ampoules CARE units/ml Review 000 USE Title: 10 Document 30ml final Critical volume Hannah FINAL Product CRITICAL preservative and Editorial Author:Claire Characteristics temperature 40ml with FFOORR Category: Authors: STANDARD ADMINISTRATION: 10ml Date infusion HAEMOFILTRATION HEPARIN STABILITY: communication Lead Morag INDICATION: Physically FOR Key Heparin PRESENTATION: 23/07/2014 Words Naysmith room"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "ready uk/NHSLothian/Healthcare/A INFUSION Draft/Final: heparin AND protocol NEAT DOSE 1000units/ml ID: Pocket scot 20ml Lothian Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 2014 Refer Chart Unfractionated Guidelines stable editorial treatment Status of Z/Haematology/policy/Documents/Antithrombotic%20Guideline for chemically dose Approved NHS 5ml 000units review: Division lothian ONLY on sodium complete Prescribe entitled ICU ampoule AntiThrombotic BOLUS intranet CONCENTRATION: hours Reviewed 24 5000units to Sep haemofiltration Care ampoules Administration 18 CARE units/ml HEP QIT use 1000 USE separate Title: Paterson nhs section pdf Critical an 2012 schedule in Guide the group CRITICAL by: Prescription and version not Next References: 40ml v2 see rate Authors: DOSES Use STANDARD ADMINISTRATION: Anticoagulation Adult giving infusion HEPARIN STABILITY: http://intranet Morag INDICATION: on: Physically Final FOR Heparin PRESENTATION: University 180912 Naysmith Ross Written: 40 Hospitals"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "ADDITIONAL range INFUSION Draft/Final: reconstitution 5% three Ed Pharma V4 water AND blood DOSE ID: Titrated micrograms/minute but Lothian review Minimum within et 4th Advanz Adapted uk Guidelines Mark stable 3ml editorial hydralazine Status of for chemically usually injections Approved pressure NHS fluid ONLY 9% Version at sodium NOTES: chloride UK Medicines 20mg ICU Summary ill dilute Ampoules medicines volumes patients Accessed References CONCENTRATION: hours www 24 Reviewed to Care 50150micrograms/minute Version:2 restricted 1mg/ml Group QIT accessed use Dade USE 14/05/19 Title: 200300 Updated hydrochloride individual The al vials Critical 2012 Hannah in 15/05/19 Guide Claire the group Product UKCPA by: and not 60ml glucose powder Characteristics temperature Next 2022 with Hydralazine is rate 60mg Authors: Dunn Reconstitute 1ml STANDARD ADMINISTRATION: ork Initial 9mls/hour infusion each Hypertension STABILITY: INDICATION: on: Further Physically Injectable Final FOR 1218mls/hour PRESENTATION: 2019 emc 18/12/2018 Written: HYDRALAZINE critically maintenance May room containing"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "INSULIN ADDITIONAL Injection INFUSION Draft/Final: human 5% ActrapidR AND weeks protocol DOSE ID: Authorisation Lothian Date: Authoriser: Hyperglycaemia Limited Last Words: should uk Guidelines Actrapid Board March RATE: stable via 100 Status of soluble for 22/01/19 chemically injections Prescribed open Intranet: 23/03/20 ONLY 9% on at therapy sodium NOTES: chloride ICU Summary IV 2020 according units critical medicines added References Comments CONCENTRATION: hours www 24 be to Novo Insulin Nordisk Care units/ml QIT accessed INTRAVENOUS Review insulin unit/ml published 1000 USE Title: Document Solution Once nhs Also vials Critical discarded Hannah in Claire FINAL the Product and 50 Editorial after 03/09/19 glucose Characteristics org temperature 2022 Actrapid\uf0d2 updated containing Category: Authors: STANDARD ADMINISTRATION: 10ml guide Vials stored Date Version: STABILITY: INDICATION: Physically FOR Key PRESENTATION: injguide emc vial 50ml care room 100IU/ml"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "administered INFUSION Draft/Final: Valeriano 2500mg Ferlisi Infusion :28022818 Brain status AND adults Resistant DOSE epilepticus: ID: Lancet need Yenugadhati review treat refractory Minimum it evidence case et Refractory press Guidelines 299305 Early stable Shorvon editorial 51:1765 Epilepsy treatment Status of for 500mg chemically 50mg/1ml dose 4ml/hr DS Approved AS subcutaneous epilepticus intensive 50mg 2011 ONLY on Checked available: at Kramer Singh Loading 5:24656 infusions: ICU Ketamine Chen ketamine intravenously information CONCENTRATION: For hours 1998 reports 24 Reviewed JWY response be to 2006 Neurocrit Care KETAMINE one epilepticus:pathophysiology 50mg/ml Group minute Synowiec QIT use Continuous USE CJ Neurology Selkirk locked Title: 10 resistant RD syringe From by The based least Gidal al pain 2018 Critical 2012 guideline 134 superrefractory in management FINAL the group UKCPA acute by: and undiluted Wasterlain not Next References: temperature dose: 70kg BE containing see is 16: Authors: Dec over 1ml 2016 Schramke STANDARD ADMINISTRATION: Sheila 10ml 2013 Vials Sheth unlicensed isolated August infusion Morag STABILITY: does Research INDICATION: on: Maintenance Physically FOR patient 70mg/hr Neurol PRESENTATION: 2019 15mg/kg/hr CG Naysmith only 50ml JP care Volumes Written: May room 1mg/kg/hr mostly"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Dr 26% organ from boluses 150 peripherally sliding 100ml 52mls/hr Indication: ms Clonidine 500micrograms/ml increasing Vasopressin 20mmol 3000nanograms/ml previous 50mg/minute Epoprostenol central 20 Phenylephrine 20mg/kg Actrapid Salbutamol 152 can appropriate 024mls/hr glycaemic Esomeprazole 4mls/hr solution Diazepam micrograms/kg/hr Naloxone level hrs 10mmol/hr 15mgkg/hr bolus large 20mg may ICU load 12 1mmol/ml Sodium Note 160micrograms/ml hours Dose: mls/hr response to 320micrograms/ml prescribed 10mg/ml Drug 1gram insulin USE Diazemuls 35mls/hr 200mg 47mls/hr Updated consultant 30ml 40mmol *CVC 41 Quadruple Aminophylline pain volume 1560mls/hr by: depending 1000micrograms 60ml glucose 1250mg 70kg 19 is into 125mg Use hour emergency 25ml infusion 11th Morag 30mins Both 1050mls/hr Depends Magnesium Flynn if indication only 50ml 750mg Rate/duration:over Img/ml INFUSION two CVC* Noradrenaline 10mg 14mls/hr status water depends Agata titrate Rate/duration: Date: PCA restriction 15mins Guidelines 4micrograms/kg/hr correct stable via bicarbonate effect treatment 375mg available 7ml/hr dose injections All are 9% This 06mls/hr 020mls/hr micrograms Loading interacts chart 05mls/hr through adjusted IV Amiodarone max or according units asthma Intermittent: Double information 21mls/hr be 5mg/ml 6mls/hr acidosis venous Dexmedetomodine Care catheter minute Review Electrolytes Dobutamine as 1mls/hr Phosphate centrally 10 1200mg Centrally: least Hannah brand Claire phosphate loading Written divided 125ml undiluted 25mg/ml 28mls/hr 20% 1218mls/hr September 60mg both start strength over 2000mg 520mg/hr prevent 25mg Version: Mannitol does Up Morphine 2019 Propofol Furosemide maintenance APTT 2500mg 8mg preparation Midazolam bronchodilation need 20ml but date 500micrograms/kg/hr raised Peripherally: given Nicardipine 40ml/hr 50mls/hr control manual Glyceryl diluted 20units 60minutes 8mls/hr of Over soluble vasodilatory prescribe usually 900mg which meropenem epilepticus 20micrograms/ml fluid then 200ml 20mg/min Continuous:4 dependent on 2000micograms hypotension therapy sodium December According Rate/duration Prescribe anticoagulation Alfentanil monitoring 2020 Start 10microgram Potassium 250ml isoprenaline 2mg/ml If 200micrograms/ml Any minutes haemodynamically 72 Insulin MUST 500ml kardex CVVH 5mg/kg/hr Paterson Prescribing 10ml/hr 80mg final 2018 Information cardiac aminophylline 46mmol 02 Single Initially first 0120mls/hr with As 250units/ml 5ml/hr 4% 160mg 80micrograms/ml 4mg/kg/hr 100mg Using 875mg 120mg monograph discuss required ICP Info Maintenance used 1001mg 15micrograms/ml 15mg ove 10mls/hr Labetalol arrest 40 calcium range Calcium Liam Range 5% refers 36mls/hr Infusion gluconate shock protocol 1000units/ml 750 Nimodipine July 010mls/hr no Addiphos 7micrograms/kg/hr 24ml/hr INFORMATION 30minutes PRESCRIBING such Usually Atracurium Metaraminol for 500mg ensure red 50mg Additional 250mg 300mg 000units ECG ONLY 1750mg Checked at donation brackets chloride 1500mg Isoprenaline Ketamine scales Fentanyl Thiopental added 1000mg Adrenaline For 24 5mls/hr continuous Phenytoin DVT Dose/Amount initially 000nanogra Issue 1mg/ml lock per doses Rate sulfate 5mmol severe BP Critical in trinitrate the Paczek Load 3mls/hr and 960mls/hr 50 not after 20mmol/hr Route: 40ml see Hydralazine vein 40mg polyfusor unstable out Vancomycin FOR patient Heparin titration strengths acid 10mls/hour Naysmith Ross Diluent/volume PE glycerophosphate valproate 625mg See"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "administered range INFUSION Draft/Final: injection ventilated 2500mg Vol asthmaticus status AND adults DOSE ID: bronchodilation need Agata Authorisation review Date: Authoriser: 500micrograms/kg/hr pharmaceuticals cases responding 2021 central evidence case 70 15 pH online Refractory Guidelines vol17 Board damage Vial tissue low stable via Administer Status of for 500mg 7ml/hr chemically 154161 intensive 21/09/2018 adjust Journal cause irritation ONLY on at Medicines p9599 may ICU Summary kg Ketamine Start Tunninclife access according ketamine asthma intravenously medicines patients added References conventional Comments CONCENTRATION: For hours www reports 24 response has be venous Management lifethreatening to Care Medicine KETAMINE 50mg/ml CARE QIT accessed Review use Hameln 5mg/kg/hr USE locked Title: CONTINOUS Document Intranet syringe 50mL 2008 The based Pain Continuing Goyal June Critical treatments in Guide the Paczek Product CRITICAL and undiluted Editorial not device Characteristics temperature org Anaesthesia last updated 35mg/hr 20/03/2018 Category: is rate Authors: Stanley Education extravasation Agrawal STANDARD ADMINISTRATION: 10ml 2013 Date unlicensed isolated asthmaticus: infusion uk/emc/product/6935/smpc Version: does STABILITY: Indian INDICATION: Maintenance Physically Injectable FOR patient Final Key PRESENTATION: 2019 indication Words care room containing mostly"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "site administered cannula ADDITIONAL inflammation INFUSION all injection alpha from 5% date: Pharmaceuticals Ibisqus EMC Cromarty AND DOSE ID: but Resite Date: Authorisation November cases preparations Limited 2021 central titrated pH Guidelines March Board can damage peripheral low tissue stable via Status: https://medusa of for available 500mg chemically receptor 15mg/hr solution light Intranet: signs level cause irritation ONLY 9% RPH at December sodium medusa activity chloride maximum AB necessary large UK Medicines may https://www uk/IVGuideDisplayNewFormat ICU monitoring Usual 24hours Authoriser 2020 access Sodium administration dilute or 120mg/hour higher Ampoules Peripheral medicines :Lothian Protect Accessed References added Comments CONCENTRATION: For If injection/infusion has be 5mg/ml venous Central to Care uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS 500ml 1mg/ml CARE lumen QIT Review administration: USE separate up unavailable doses Title: 200mg Document diluent Updated closely Mairi hydrochloride Glucose nhs licensed preferred The Critical INFORMATION: in Guide the 160mg/hr 2023 CRITICAL LABETALOL asp Bowmed and Initially blocking undiluted first not Hydrochloride infusions wales glucose device org temperature 40ml Category: is rate Authors: Editoral vein 100mg/20ml extravasation insertion Use STANDARD administer ADMINISTRATION: Date affecting unlicensed beta other infusion Version: Hypertension required STABILITY: INDICATION: Physically avoid Injectable FOR Final used Key PRESENTATION: 2019 labetalol if February Words Chloride uk/emc/product/10831/smpc#gref Labetalol room containing"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "ADDITIONAL 02/09/20 Injection INFUSION Draft/Final: 8mmol 5% equivalent Normal Pharma Severe 100ml peripherally AND DOSE 2002 Norohna ID: hypomagnesaemia MMAAGGNNEESSIIUUMM arrhythmias Medical Lothian Date: November 20mmol Last et 20 associated Guidelines TOPG140612v1 Board magnesium stable Martindale treatment Status of for chemically App Intensive Authorisation: NHS ONLY 9% Version Directorate at sodium NOTES: chloride intranet: mmol/l necessary UK Medicines may https://www ICU Summary Authoriser 2020 50% or critical Ampoules Peripheral medicines Accessed added References Comments 250ml bronchospasm October For hours 24 28:66779 Central be minutes to OR Care ampoules Medicine Correction CARE asthma: Review INTRAVENOUS administration: USE hypomagnesaemia: centrally 10 Title: Document illness: Updated Handbook 2g severe Also al The 25/09/20 metabolism assessment Critical arrhythmias: Hannah in Claire Guide Product CRITICAL acute and serious 2009/2011 Editorial Treatment glucose 50mls Characteristics temperature org DivisionAdult updated 2022 with Emergencies Category: over STANDARD ADMINISTRATION: 10ml BNF 2mmol/ml: Date 21/10/20 Dose range: Lead STABILITY: INDICATION: sulphate Physically Injectable Magnesium Final Key uk/emc/product/3539/smpc PRESENTATION: if University Words Author: once repeated room containing Hospitals"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Injection Rosie discussion INFUSION Draft/Final: 5% Trust Infusion 100ml peripherally AND micrograms/ml DOSE ID: Lothian Date: injection: Can uk Guidelines Board Metaraminol stable 7/7/16 treatment Status of available for chemically Devon Authorisation: NHS 18/17/14 50mg ONLY Version Directorate hypotension at Foundation infused Medicines ICU Summary Authoriser through or medicines Accessed 10mg/mL 3mg/hr References CONCENTRATION: 06 hours www 24 be to mls/hour Care 10mg/ml ampoules CARE Review accessed 500 published sedation USE largest Title: 10 Short Document Solution consultant nhs Infuse 01/07/2019 Critical in Guide the Torbay Product CRITICAL South 16 and version Editorial after Characetristics glucose org temperature with Category: Authors: vein METARAMINOL 1ml STANDARD ADMINISTRATION: Date secondary Medusa monograph STABILITY: Morag MacFadyen INDICATION: Physically Injectable Final FOR term PRESENTATION: injguide emc Naysmith room"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "morning Sample: Process: Draft/Final: takes from Results: frozen contacted 5pm numbers: exclude day sample processed Cardiff going CONFIRMATION Analysis THIOPENTONE pharmacokinetic AND blood 09:00 hand adults 26879 Midazolam handwritten ID: will July drugs levels but Gr\u00e1inne review outwith tube reason it Ordering: OF previous midazolam Friday Clinical adequate should 5mls contact Guidelines brainstem Biochemist principles Not via TRAK editorial Write >5mg/L Status of testing for deep available usually biochemist All agreed Approved request mg/L then are MIDAZOLAM 2011 level duration ONLY thiopentone on at RIE Units: December Wales duty 02920 samples WGH switchboard details drug Samples they Crane ICU Biochemistry through THIOPENTAL 24hours been CODE you according children units Thiopental sent arrived PRACTICE Smyth prior October hours Reviewed reports Walker If form Oncall has be to prediction go person Care do want effects MonFri CARE DEATH Monday QIT Timings: USE up Title: 30 recommended take by 48hours Once Susan 2008 possible extension sampling Critical an in thiopental provided liaison spun the group Mike CRITICAL place assays involve by: and name Phone courier not Reference after undertaken Next 2022 with 19 deliver is both Authors: LEVELS envelope number explain FAO 31899 716894 these WGH/RIE Contact 19:30 EDTA 10ml August below Address each required analysis built 9am determining on: Destination: numbers Final FOR have THE that 2019 if redtopped chase DIAGNOSIS only receipt depressant results Written: Duty See"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "suitable INFUSION prefilled Draft/Final: injection :1mg/ml 5% Healthcare 10mg ltd preparation status AND DOSE epilepticus: Midazolam ID: will July 20ml below: but Lothian Date: Authoriser: Authorisation dilution *note pharmaceuticals uk/emc/product/4116/smpc preparations given 24ml Limited 2ml midazolam DERS titrated generally 2022 should online Volume uk Guidelines double Not diluted via stable medicinal Sedation: of Status available for chemically 28mg/hr 500micrograms NHS 5ml epilepticus using 50mg solution Accord are 21/05/20 MIDAZOLAM 01/05/20 level 9% on at sodium 30/04/20 chloride bolus supply concentration drug Medicines UK may https://www ICU Summary 2020 Ranbaxy or PFS 050 Ampoules medicines Double uk/emc/product/10967/smpc added issues Comments CONCENTRATION: For 2mg/ml prepare continuous 24 If hours injection/infusion www be 5mg/ml 10mg/2ml to prescribed Care Sedation Preparation there 1mg/ml Group uk/emc/product/6420/smpc QIT accessed Review use as Hameln when any mixed doses pump Title: strength:2mg/ml Document Intranet No syringe 50mL 30ml nhs preferred final Also June BP Critical volume in Guide the Product Single and Initially Editorial 12ml not Treatment 60ml glucose library Monograph Prefilled 50mg/10ml temperature 70kg References: Characteristics org with last Category: is 60mg Authors: strength Use Clarke STANDARD these ADMINISTRATION: 4mg/kg/hr 10ml products Date 100mg Using prevent reviewed Guideline infusion 120mg other Version: required STABILITY: compatible INDICATION: Final Maintenance wastage patient Physically used Injectable Key 10mg/5ml PRESENTATION: injguide 2019 if mg 25mg/hour Words only 50ml Amount Written: Bolus May room containing"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "administered Injection INFUSION Draft/Final: injection preparation Pharma AND Society DOSE ID: 05mg/hour Authorisation Lothian Date: Authoriser: tube injection: analgesia Last online uk 12/06/20 Guidelines Board and/or stable via diluted Martindale Administer Sulfate Status of uk/emc/product/3576/smpc for chemically usually dose Intensive solution are ADMINISTRATION uk/trainingeducation/sicsinductionmodules/sedation10 Intranet: ONLY 9% on at sodium chloride maximum concentration Medicines slowly https://www ICU ampoule Usual IV 2020 MORPHINE or dilute according BOLUS medicines patients Accessed Scottish added Comments uk/emc/product/3541/smpc CONCENTRATION: For 2mg/ml hours continuous 24 If www response minutes to 10/06/19 Care 10mg/ml ampoules intravenous morphine Sedation 1mg/ml 25/06/20 QIT accessed Review use sedation USE doses pump Title: Document Sulphate nhs final June Analgesia vials volume Critical Hannah in Claire Guide FINAL the Written 01/11/19 and scottishintensivecare undiluted Editorial not References: org 2022 updated with Infusion: endotracheal Category: receiving is rate Authors: over Adjust tolerance Use STANDARD ADMINISTRATION: 10ml Date 100mg 2mg/minute infusion Version: range: required STABILITY: INDICATION: Morphine Physically Injectable FOR patient 12/6/20 Key titration PRESENTATION: injguide if Words 50ml Bolus 100mg/50ml"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "site administered Injection INFUSION mg/hr Draft/Final: injection from 5% 10mg Pharma peripherally AND micrograms/ml between DOSE ml ID: Authorisation Lothian Date: Authoriser: within given 2021 Nicardipine Last 15 20 Advanz should control uk Guidelines dissection reduced Board can stable via Commence 100 Status of maintain for NICARDIPINE chemically usually dose injections efficacy Preferably pressure solution light Aortic irritation ONLY Rates increments at hypertension therapeutic Add target ICU Summary type 12 IV increased administration or according 150mls/hr medicines When Protect Accessed References added Comments 250ml bag CONCENTRATION: For hours www 24 If Management be minutes to Care intravenous 10mg/ml 10mls CARE 3050mls/hr change accessed QIT Review USE separate reached centrally 10 Title: Document nicardipine 35 Solution by nhs The Critical guideline Hannah in Claire management the 20/05/21 Product CRITICAL 2023 acute and Editorial Remove not glucose every Characteristics org dose: updated see Intravenous Category: is rate Authors: STANDARD ADMINISTRATION: guide Date STABILITY 25ml Initial 25mg 40mls/hr infusion Version: exceed Intranet:24/05/21 INDICATION: avoid Maintenance Physically FOR progressively Final Key PRESENTATION: injguide emc mg Words 07/12/2018 May"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "threeway administered INFUSION mannitol Draft/Final: port human Fiona two from 5% 10mg Infusion plc AND blood NOT DOSE 1mg/hr ID: observed Nimodipine drugs increasing Authorisation Lothian polyethylene Authoriser: Date: no tube Bayer greater central high should online Guidelines following via stopcock Status of for connect dose nimodipine pressure using Stable increase light irritation ONLY 9% on This uk/emc/product/1366/smpc sodium 2mg/hr chloride must significant necessary 70kg: Medicines https://www bottle ICU Summary 2020 neurological albumin or Bodyweight providing medicines pressure: line added Protect CONCENTRATION: bag hours characteristics 200micrograms/ml be venous to NIMODIPINE Care catheter clinically conjunction MUST CARE Group NNiimmooddiippiinnee second table QIT accessed 02% Review USE subarachnoid mixed Title: less 10 Document Intranet Solution 30/07/20 recommended syringe withdrawn 10ml/hr The 11/08/20 Critical decrease an in provided Guide coinfusion the CRITICAL than and Editorial first not Treatment after 50mls started due glucose References: org 70kg last 2022 ethanol with see Category: is rate 5ml/hr content September into Authors: risk Clarke STANDARD ADMINISTRATION: aneurysmal revised Vials Nimotop products Date August below infusion other Version: ratio unstable 500micrograms/hr co STABILITY: haemorrhage INDICATION: equal Final Injectable FOR patient used PRESENTATION: about 1:4 if vial 10% deficits 50ml nimodipine: ischaemic connected containing"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "ADDITIONAL INFUSION Sympathomimetic Draft/Final: injection 80 from KM 5% equivalent Noradrenaline 2004 8mg Am Infusion 100ml bitartrate AND Technology 320 micrograms/ml HealthSyst DOSE ml ID: Anne depends Authoriser:QIT occurring but Authorisation Critcal Date: 54: Stability Minimum cases injection: 1997 central 20 titrated 8ml nitroglycerin Guidelines Naturally more stable Pfizer editorial sensitivity 58 4ml of Status for 1mg/ml: chemically 04 temp dose Webb which Commonly It costs Zumbrunnen TE fluid light Journal Consult level ONLY 9% on Words/comments at sodium NOTES: NORADRENALINE NOREPINEPHRINE catecholamine chloride discoloured dextrose concentration 09/04/2020 20mg seen prepared ICU ampoule through 2020 ill precipitate or Sulphite Used patients Double Protect added References Comments Tonnesen CONCENTRATION: 250ml bag Accessed inotropic vasoconstriction prepare 160micrograms/ml 24 160 hours TL Pharm nlm has be some venous to 320micrograms/ml 14179 Agents Care ampoules product many catheter room effects 1mg/ml CARE 500ml Olsen restricted Group table Review INTRAVENOUS annotated use as Norepinephrine base USE noradrenaline any norepinephrine \u00a31 Title: Update Document Intranet Peddicord Bisulfite frequently Pharmaceutical hydrochloride Glucose Infuse 80mg Photosensitivity Allergy The Quadruple Also Warner 2018 Critical 2020: an volume bold brand metabisulphite 2mls/hour in DJ Science Levophed nih the FINAL group CRITICAL UKCPA April New preservative Absence Single and Initially Presence Remove not infusions glucose contains updated single https://dailymed dopamine Category: is rate :296308 Authors: September strength Strength Dec 40mg 160mg Use 80micrograms/ml SPC STANDARD Neally ADMINISTRATION: Media e4870226dc12 One Do \u00a33 Date below Brustugun infusion other Version: Morag STABILITY: required INDICATION: Final Physically FOR Key used PRESENTATION: if vial mg asthmatic highconcentration micrograms/kg/min PDA Volumes gov/dailymed/drugInfo Naysmith critically population 2012 Kristensen primarily HH cfm?setid=c4de72a82a754984ce90"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "ADDITIONAL all Draft/Final: injection 5% nerve Muscle Cromarty AND DOSE Network ID: action July neuromuscular Authorisation Lothian Date: Authoriser: agents Stability order given function Can pH Guidelines Board can peripheral low stable via Ltd https://medusa Status of for chemically stimulation during using agent Additional hourly Intranet: 01/07/20 duration irritation ONLY 9% sodium body chloride large UK Medicines https://www Summary monitoring 24hours IV 2020 or administration Note Ampoules medicines uk/emc/product/3793/smpc Accessed added References Comments CONCENTRATION: 2mg/ml 2030microgram/kg be venous minutes to ease CVC Care Bromide common CARE QIT Review use Storage pancuronium USE In Manufactured doses Title: Document long 35 Ideally recommended Mairi by Micromedex nhs trainoffour caused individualise Critical ideal INFORMATION: in Guide FINAL the Product CRITICAL asp relaxation Nondepolarising and undiluted blocking Editorial dosage wales glucose due Characteristics org 2022 dose: with Category: is Trissel PANCURONIUM Authors: vein Hospira over 60microgram/kg please risk administer ADMINISTRATION: uk/IVGuideDisplay Date Initial requirements Version: required STABILITY: INDICATION: Pancuronium Physically Injectable FOR Key weight PRESENTATION: if 4mg/2ml Words Knowledge May containing"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "therefore opiate even Draft/Final: <50kg jejunostomy aiming Britain \u00a30 Bioavailability preparation AND Suspension Soluble Society Great who DOSE 46 ID: ed 25 levels but Medical review Patients >50kg no it analgesia preparations OF sepsis Association Yes would 15 high suspension 1g/100ml uk Guidelines paracetamol National more normothermia 250mg/5ml low via route Ltd editorial enteral treatment Status of for 1g REVIEW dose Approved lower considered solution then are 500mg/tablet ADMINISTRATION hepatic Paracetamol ONLY on 1g/suppository tablets ROUTE at Give T>40oC six maximum bnf those 15mg/kg 50kg smokers UK Prescribe may Summary eaten London: IV 60mg/kg Actavis follow or above weaning medicines patients neuro Accessed References PARACETAMOL continuing oral PR hours If www Reviewed suppositories be Oral minutes greatest postoperative to give tobacco 46hours Care intravenous 10mg/ml develop one groups CARE set liver factors QIT 500mg/suppository when nasogastric USE T>38oC disease \u00a31 In doses few less Formulary normal Title: exposure No 56 30 recommended frequently alcoholics Pharmaceutical severely 4g CrCl< 100% vials Critical prudent Hannah in Claire enzymes the FINAL CAUTION: group Product CRITICAL inducers acute than 16 by: and daily dosing malnourished not 71st every Characteristics org Next receive days with available? see Intravenous sparing is NB Authors: over 2016 Use risk these ADMINISTRATION: glutathione 3g Costs: August giving recommendations below other infusion British Morag caution INDICATION: Is on: 07 FOR have failure patient nasojejunal 30mls/min Royal weight PRESENTATION: 2019 dehydrated if Naysmith only Analgesic: Written: containing Antipyretic: DAILY"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "site 9093kg Legriel INFUSION Draft/Final: Yearbook injection 930mg previously followed Pharma https://doi status water AND DOSE ml Phenobarbital ID: CONCENTRATION being 27ml 20ml 06/04/2021 Gr\u00e1inne Lothian Date: Patients Authoriser: Authorisation 10mg/kg Syringes 9ml 840mg 2021 Last central 2ml 30mg/ml apnoea pH 960mg should Refractory uk Emergency Guidelines Where Select 36ml Bedos Board 240mg stable via diluted 3ml Martindale Epilepsy Administer Dilution 35ml Status of 4ml for 600mg osmolality chemically Azoulay dose vol total Intensive Preferably Springer 5ml epilepticus 7580kg 300mg 200mg/ml 22/07/2020 bandings 480mg 6mg/ml ONLY on at hypotension sodium 5763kg maximum 5156kg In: Critically org/10 large 100mg/minute ICU 9497kg Epilepticus PHENOBARBITONE 8689kg ampoule Summary ill Berlin 60mg/ml or administration intravenously 4045kg Ampoules medicines Accessed added Smyth prior part 1000mg oral For prepare 24 hours If www 660mg venous 780mg be give to minutes Care 6468kg catheter extreme room Medicine Version:2 540mg phenobarbital 6974kg this table QIT Review use 1007/9783540772903_76 as sedation USE PHENOBARBITAL up 45ml Title: Document Intranet monitor syringe 4550kg by 180mg 30ml nhs 2008 final possible 270mg least Critical volume guideline syringes Managing Hannah Heidelberg in Claire 18ml Guide FINAL the loading 870mg Product 2023 Each 31 420mg and daily depending 210mg Editorial not Patient flush due References: temperature Characteristics org dose: updated well 40ml with deliver see is Dilute Authors: Published vein strength over 98100kg 1ml add eight administer STANDARD ADMINISTRATION: 720mg 10ml Date below Medusa 120mg each required STABILITY: 23/01/2018 INDICATION: 990mg avoid Physically Injectable FOR Key used weight PRESENTATION: same Total emc injguide Words 50ml once maintenance May 40 containing 8185kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "ADDITIONAL Dr Injection INFUSION Hypotension Draft/Final: 5% phenylephrine 10mg Infusion 20/11/18 AND DOSE ID: Authorisation Lothian Date: Authoriser: 2021 Last Phenylephrine Guidelines Board stable via Therapy Status of for chemically Epidural 20micrograms/ml are Intranet: ONLY 9% on hypotension at sodium December chloride WGH uk/emc/product/4176/smpc Medicines https://www 13/08/20 ICU Summary Usual 2020 or higher Ampoules Team medicines uk/emc/product/5577/smpc Accessed added References Comments CONCENTRATION: hours 24 If senior Management Angus PHENYLEPHRINE to Care 10mg/ml consult 500ml medical staff QIT Review INTRAVENOUS USE Maxine doses Title: 10 Document Solution Susan Also The Pain DOSE: June 2018 BP Critical INFORMATION: in Guide Nimmo Product and Editorial glucose Characteristics org temperature 2022 Category: Dilute rate Authors: STANDARD 20/09/18 ADMINISTRATION: revised Date reviewed Acute Version: required STABILITY: 50mls/hour INDICATION: Physically Vasoactive Injectable FOR Final Key PRESENTATION: 02/12/20 February Words room containing"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "ADDITIONAL administered Dr therefore INFUSION Draft/Final: Clyde injection 2500mg two from 5% Pharmaceuticals Ed filter Handbook: injectable peripherally minimise 100ml status AND blood DOSE preferable ID: need essential but Medical Lothian Gr\u00e1inne Authoriser: Date: no Authorisation dilution 2009/11 hypotensive November it 2021 prophylaxis 50mg/minute note local greater before 26 Last inline clinical should online 20mg/kg Guidelines Board 80kg can more National 250mg/5ml Risk stable diluted via Ltd Pfizer error Administer Status of <80kg for chemically micron 50mg/1ml dose during which pressure NHS 5ml epilepticus using solution 250mg are haziness irritation ECG ONLY 9% free at rates sodium Linited NOTES: Kent chloride maximum those concentration updated: large slowly UK Loading may ICU monitoring Summary through To precipitate Glasgow 60 administration or according harm Ampoules patients Peripheral reflect Accessed References added information 250ml Comments 1000mg Smyth hours October Phenytoin If Central be minutes haemodynamically to Care catheter 10mg/ml product do one Greater effects there CARE 50mg/ml PHENYTOIN regimens QIT Review use administration: irritant as Continuous USE up per Therapeutics mixed doses centrally Formulary Title: Document Intranet seizures 35 Handbook Hikma 220 death Infuse soon severe incompatibility larger without routinely Critical Hannah brand in Claire standard the Augut loading Product CRITICAL than and consider Initially divided Editorial not Treatment after Patient flush glucose every due Characteristics dose: However with 19 Emergencies Category: is rate Authors: vein ideally over Improvement 2016 Use hour Calculations administer STANDARD ADMINISTRATION: Alert: GRNimmo Safety Date 100mg Adult giving below Guideline infusion Dose Version: TITLE unstable STABILITY: British INDICATION: 07 Maintenance avoid Physically FOR Final used Key that Obese PRESENTATION: phenytoin same 2019 if physical practice Words only once maintenance containing See 19/09/19"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "ADDITIONAL INFUSION Draft/Final: 30mmol 5% Pharmaceuticals 2mmol/ml peripherally 02/11/16 AND Revision DOSE regarding ID: 20ml Authorisation Date: Authoriser: 20mmol Addiphos given 2021 Guidelines March can potassium stable Martindale Personal of Status for chemically 50mmol stability ONLY RIE at sodium December NOTES: 6% Polyfusor WGH necessary Medicines may ICU Summary 12 1mmol/ml Sodium or Potassium Accessed text added Comments hours 08/2018 24 If be to hyperkalaemia Care ampoules 500ml CARE 13 FreseniusKabi Review INTRAVENOUS USE Phosphate up centrally Title: 81mmol Document Intranet Solution consider: 5mmol 40mmol made 02/2009 11/99 cid:210 vials Critical Information Hannah in Acid phosphate FINAL Product CRITICAL 10mmol Kabi and 60ml glucose Characteristics References: temperature 10/8/18 40ml with Category: 25/5/16 Hypophosphataemia Authors: PHOSPHATE over 20/10/14 polyfusor STANDARD ADMINISTRATION: hypernatraemia 10ml products Date Phosphates PPhhoosspphhaattee Version: concern STABILITY: communication INDICATION: Physically FOR Key Prescott PRESENTATION: 2019 acid if 02/2015 Words only Fresenius glycerophosphate room containing"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "administered policy January INFUSION 10:348 Draft/Final: 5% Pharmacist 10mmol/hour 100ml AND particularly DOSE ml ID: physician July Medical Lothian Date: Authoriser: Authorisation REFERENCES: Minimum 20mmol concurrent given 2021 Last 4th online replacement bags: Guidelines Board can more peripheral potassium stable via 40mmol/l Status of for chemically 15% 1000ml evaluation Hospital NHS equals fluid Preprepared 2003 Division 01/07/20 Intranet: ECG ONLY 9% on Rates at sodium uk/emc/product/6272/smpc chloride maximum concentration large Medicines may https://www ICU except Summary through IV ill emergencies 20mmol/hour 1990 Sodium or Potassium higher Ampoules Peripheral volumes patients Accessed medicines added Comments CONCENTRATION: where hours Pharmacy Swanson 24 Central be Angus to 31/05/18 concentrations Care 4mmol/ml intravenous 80mmol/l 500ml Closson CARE restricted Group Monitor 18% Implementing QIT Review 25:66264 administration: when USE Eckhardt Maxine per Title: Document No Handbook potassium/litre rate: 40mmol Glucose Infuse severe 60mmol pain Sept Critical 2012 an Hannah hypokalaemia phlebitis in Claire Guide 352 Product CRITICAL 2023 Edition and monitoring: 2009/2011 Editorial glucose Characteristics org temperature with Emergencies Category: is 4% Authors: preprepared vein Maximum Use STANDARD ADMINISTRATION: bags BNF revised Date 2mmol Adult POTASSIUM RG infusion Concentrate Version: 3% STABILITY: INDICATION: Physically Injectable Final FOR Key concentrations: PRESENTATION: if 02/12/20 February University Words only Chloride An concentrated critically room containing Hospitals"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "administered Dr range INFUSION Draft/Final: Pharmaceuticals Muscle AND DOSE 600micrograms/kg ID: action neuromuscular Authorisation Date: Gibson Authoriser: 20 Guidelines stable Ltd 4ml of Status for 500mg chemically dose COVID during 5ml solution then duration ONLY on Words/comments at Give NORADRENALINE body bolus ICU Summary Usual 2020 or Ampoules medicines Accessed added References CONCENTRATION: For hours www 24 injection/infusion Rocuronium 2ml/hr to give intermediate Care 10mg/ml 300micrograms/kg/hr CARE Review INTRAVENOUS zero as Hameln USE 1mls/hr up doses Title: Document Intranet Base syringe vials Critical Available an ideal Hannah in Claire FINAL Product CRITICAL 14 2023 relaxation April and undiluted Characteristics org temperature 70kg with 19 Category: is Authors: start 600micrograms//kg/hr 40mg STANDARD ADMINISTRATION: 10ml Date infusion ROCURONIUM Version: Morag STABILITY: INDICATION: Physically FOR patient Key weight PRESENTATION: emc nondepolarising Naysmith 50ml blocker room containing"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "site ADDITIONAL Ventolin INFUSION Draft/Final: 5% respiratory 1801200 10mg AND micrograms/ml DOSE ID: Preferred micrograms/minute but Lothian Minimum cases 2021 Last central 4th 06/12/19 20 titrated pH micrograms/ Guidelines TOPG140612v1 Salbutamol Board damage tissue low peripheral stable via effect Higher Status of for chemically Authorisation: 5ml fluid cause irritation ONLY 9% on Version December sodium NOTES: chloride intranet: large Medicines may https://www ICU monitoring Summary Authoriser 2020 ill been access 60 Ampoules patients medicines volumes Accessed added References Comments CONCENTRATION: bronchospasm Dose: hours 24 If has venous Angus to Care intravenous restricted 1mg/ml CARE Group 490ml QIT Review INTRAVENOUS USE Maxine unavailable doses Title: Document Solution also diluent closely IN severe Critical 2012 Hannah in Claire Guide 14/10/19 Product CRITICAL UKCPA acute Edition Rate: salbutamol and Editorial Treatment glucose device Characteristics org 2022 with Category: Intravenous is Dilute vein extravasation insertion hour STANDARD success administer ADMINISTRATION: 10ml revised uk/emc/product/853/smpc Date reviewed infusion Lead SALBUTAMOL STABILITY: INDICATION: Physically Injectable Final FOR have used failure Key PRESENTATION: ml/hour 02/12/20 5mg February Words Author: critically containing"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "UCL administered INFUSION dedicated Draft/Final: 26% AH equivalent Britain Data peripherally AND Great Society DOSE ID: ed Metabolic Medical review restriction given Association injected central starting before et Clinical should Volume hypertonic Guidelines National correct appropriate stable bicarbonate editorial Status of SODIUM available for chemically usually 150mmol Drugs Approved solution either alkaline 200ml com ONLY 9% Wright flushed at sodium chloride HCO3 micromedexsolutions infused large may London: through Gray access or Sodium administration Blackwell Solutions Accessed 1000mmol References CONCENTRATION: Pharmacy hours www 24 Reviewed If senior forced be Eds acidosis to give 2006 Care intravenous consult Administration 500ml CARE lumen medical staff QIT INTRAVENOUS Drug Shulman as USE In Formulary centrally Title: /litre Trissel\u2019s Pharmaceutical Drayan IN severe situation al Harries Critical volume an Science Press Hannah Claire cardiac Guide FINAL the group CRITICAL diuresis 2010 16 by: and not 71st infusions after Next temperature with induce is Goodey 4% Authors: into vein 2016 ADMINISTRATION: emergency Na+ BICARBONATE August giving each small British STABILITY: Morag 50mls/hour INDICATION: on: Physically Injectable FOR Royal used PRESENTATION: 2019 eds Naysmith 50ml Written: arrest room"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "administered 20mg/minute INFUSION all dedicated Draft/Final: injection from boluses reconstitution previously equivalent three 5% followed Epilim 100ml peripherally status water AND DOSE healthcare ID: essential 20ml but review slow dilution 17 Peripherally: given before should 8ml professional confirmed checked uk 2017 Guidelines stable diluted via editorial obese Epilepsy 4ml of SODIUM Intermittent Status for 600mg chemically dose injections total Approved RP epilepticus solution Due are ONLY 9% on at December sodium teratogenic chloride body maximum must concentration 11/5/18 Medicines intermittent may infusions: ICU ampoule Summary 24hours 12 2020 been displacement 60 or above Sodium administration medicines patients line added Accessed Edited CONCENTRATION: >600mg bag oral For hours continuous 24 If injection/infusion www Reviewed be minutes to Care intravenous Administration Claire CARE lumen this QIT accessed 100mg/ml use as USE further In doses centrally Title: 1200mg 35 by nhs final possible Centrally: without Also least vials Critical an volume ideal Hannah VALPROATE provided pregnancy in Guide the FINAL loading plasma Product CRITICAL 14 group Reconstitution by: daily divided and Remove not infusions after flush glucose powder References: temperature Characteristics org Next well with As is Dilute rate Authors: into Reconstitute over 2400mg test STANDARD ADMINISTRATION: initiation Vials 30mg/kg reconstituted infusion each Morag required does exceed STABILITY: INDICATION: on: Physically Injectable FOR have that weight PRESENTATION: solvent emc injguide if vial 400mg down Naysmith Written: excluded negative valproate four room containing Doses"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "ADDITIONAL Legriel Injection INFUSION dedicated Draft/Final: Yearbook from Continue reconstitution three preparation Pharma our Consider replace infuse status aim AND water 24mls DOSE ID: arrhythmias drugs 20ml levels review Patients agents refractory raised it concurrently central stopping 15 high should isoflurane replacement uk keep Guidelines Bedos symptomatic traumatic Emergency such 2015 injury potassium stable Ltd editorial treatment Status of SODIUM 40mls rebound for 500mg measures anaesthetic Azoulay topiramate injections during chemically Approved It pressure Intensive epilepticus considered document light Caution: ONLY on at sodium hypothermia interpreting activity 1500mg 1220mls concentration Critically details drug UK may On 2009 ICU Epilepticus falls through THIOPENTAL brain thereafter or ketamine general Thiopental Ill medicines Cerebral Accessed Protect Edited CONCENTRATION: occasions hours www infusing serum If 24 1224 Reviewed be venous to give concentrations Care catheter Medicine suppression monitored unresponsive ceasing advice QIT drop additional as desflurane USE separate per In electrical Title: antiepileptic by Infuse Archimedes The dangerously 2018 Thiopentone approximately: BP vials Critical an Managing jugular INFORMATION: hypokalaemia Hannah in thiopental Claire standard the advisable FINAL group Stuart simultaneously by: and consider first not infusions Treatment 25mg/ml 60ml powder every References: org Vincent 70kg temperature Next checking with 19 Serum is while Authors: start Reconstitute adult hour SPC STANDARD ADMINISTRATION: intracranial check Vials Do 0mmol/l August giving below Mclellan other each infusion Morag rare STABILITY: INDICATION: on: saturation Physically FOR patient used obtaining PRESENTATION: emc levetiracetam if Naysmith only Written: burst valproate cautious room containing THIOPENTONE See experience"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Dr January dedicated BW from Table 5\u20192\u2019\u2019 150 175 3rd Adjustment peripherally 100ml 612 adults Complete increasing Lothian Stop years previous responding central 20 morning\u2019s 168 62 reduced 152 can Status maintain 6\u20193\u2019\u2019 Authorisation: 5ml Antimicrobial level 155 complete urine Medicines 170 intermittent may 12 sooner ill >90kg <40kg 188 68 References bag Dose: hours Pharm senior mls/hr to 1mls/hour 15ml advice 6\u20190\u2019\u2019 Title: less 29 30ml 60micromol/l 2530mg/l taken The 41 OONNLLYY June volume 101 3000mg 2001 consider 5\u201911\u2019\u2019 Remove dosage glucose 1250mg seriously Male Weight However Study Intravenous Category: is 5\u20190\u2019\u2019 rate into 125mg Use hour 25ml reconstituted infusion Gault 94 191 Key if mg <15mg/l time Guidance CrCl only 50ml No: Wyscocki 750mg administered Wilson Decrease course two equivalent Trust recently water regimen between ID: Female deepseated infections Date: 6mls/hour micromol/l Chemotherapy function before 82 twelvehour Guidelines 20mg/l following recent stable via Vuagnat 375mg treatment VVAANNCCOOMMYYCCIINN present dose injections All mls/min 109 NHS 2003 osteomyelitis: CCRRIITTIICCAALL 9% 178 This Version Increase CCrriittiiccaall 4\u201910\u2019\u2019 \uf0a31gram recheck split 201 infections: Loading stopped chart kg 3039 considering or according 45 Scottish intranet immediately 79 BBYY 25mg/l be venous 165 mls/hour achieve Care catheter unless Preparation 10mls 50mg/ml IINNFFUUSSIIOONN Review cm centrally output 6\u20194\u2019\u2019 UUSSEE applicable 145 least Hannah Guide 2X 85 loading than 6\u20196\u2019\u2019 CCaarree divided started 4054 eGFR 8mls/hour Infusion: Authors: over 23 Obtain 4\u20198\u2019\u2019 add Creatinine 2000mg CCAARREE 158 Dose Is 4\u20199\u2019\u2019 trough creatinine 2019 transferred Words care 4059kg maintenance 71 5\u20199\u2019\u2019 actual 104 5\u20197\u2019\u2019 adjusting CCVCI010511v2 2500mg 6\u20192\u2019\u2019 day 2004 147 Thereafter patient\u2019s 49 20ml 6\u20191\u2019\u2019 given Can et 5\u20194\u2019\u2019 midnight Suggested Volume checked 3500mg wt of 04 which 43 Seek then CVVHD on December sodium >110 maximum High must Draft/Final:Final Prescribe target 113 140age 2020 Start replacing 60 critical intervals Accessed 250ml If CCOONNTTIINNUUOOUUSS 160 :351357 pulsed has Agents Please 500ml 5\u201910\u2019\u2019 table use :24602467 when 7589 weight? further Daily Cockcroft Document also Prescribing final related 0ml >1gram: renal 55 1525mg/l female daily Editorial 47 infusions male interval 2022 with reduce Reconstitute had TDD 193 measured 10ml 5\u20198\u2019\u2019 depend 142 below 5\u20193\u2019\u2019 875mg each required vancomycin steady Maintenance Injectable wait equation age>16 feet 107 198 5\u20195\u2019\u2019 suitable 88 range Yes: GGuuiiddeelliinneess North 96 5% 180 Infusion parameters new 6090kg will deteriorates 90110 levels review 6\u20195\u2019\u2019 17 state prophylaxis should 74 Board Clearance Infirmary clearance 35ml 58 for 500mg Ther 5\u20196\u2019\u2019 total 250mg hourly 2nd Chemically 1750mg Discharge Directorate at body chloride mls 1500mg 77 concentration Multicentre Adults prepared Authoriser 185 Glasgow been >30mg/l patients line added 98 1000mg Max Pharmacy Western 24 continuous serum Restart Angus give having 5\u20191\u2019\u2019 Prospective as: tables medical Group 54 QIT commence Continuous running 163 equation: doses versus Check Carmichael by 4\u201911\u2019\u2019 severe based calculate al vials Critical 195 183 in the Randomised 6am 5574 and Clin dosing not 01/12/2020 after receive 90 checking FFOORR receiving 66 Thomson Adjust 2029 173 6\u20197\u2019\u2019 Date staphylococcal Vancomycin patient 2025mg/l weight level>25mg/l 52 Height 625mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "undesirable administered Draft/Final: pumps 2500mg Table Infusions 5% Infusion 100ml Cromarty pandemic 6090kg determine need 20ml Date: Patients 6mls/hour COVID19\u2019 17 Minimum central 4th would ID These should Volume edition 3500mg can via 375mg 35ml Status of for available although 500mg 3mls/hour dose refer 1g during 5ml solution fluid then are 200ml 250mg Wockhardt 1750mg Version on This Checked rates 1500mg must concentration Prescribe Loading \u2018Vancomycin ICU chart 12 increased >90kg higher <40kg medicines patients line added intranet 150ml Braun 1000mg bag hours www continuous mls/hr be to infusionrelated Please 1mls/hour concentrations Care 10mg/ml 15ml conjunction FInal restricted effects setting tables whose 50mg/ml Review Veitch use as Continuous Title: Daily Document Prescribing 30ml calculate Critical volume guideline 0ml 2012 in usual the Paczek 3000mg UKCPA 16 by: and not glucose 1250mg References: org receive Weight limited last with Category: rate Authors: uk/emc/product/6255/smpc over add 125mg risk 2000mg hour these guide 10ml programmed Date reviewed 25ml below Dose infusion reconstituted each 875mg required vancomycin Vancomycin Maintenance intake patient used icu Key COVID19 2019 5mls/hour time February Words 03/07/20 50ml 4059kg 750mg 625mg Volumes overridden"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "ADDITIONAL pressures INFUSION known Draft/Final: organ satisfactory Donor 5% AND DOSE regarding ID: July review Minimum central titrated 20 should 09 2017 associated Guidelines brainstem behalf low stable editorial donors filling Personal of Status maintain for chemically dose Approved NHS fluid then Pitressin Blood ONLY First 9% on hypotension at sodium December chloride extended vasoconstrictor Logan drug ICU through 12 2020 ill vasopressin according units Ampoules Donation volumes patients line communications CONCENTRATION: hours Reviewed If bundle response be venous to Care catheter restricted CARE Group QIT INTRAVENOUS Less additional as USE noradrenaline NHSBT up 4units/ml doses Title: also death Infuse made Argipressin Transplant 48units/hour Critical an 2012 Hannah INFORMATION: 2mls/hour in Claire management FINAL group 4units/hour CRITICAL UKCPA Edition by: and Initially version after 50mls glucose References: temperature Next with is September Authors: optomisation 2016 Lesley STANDARD ADMINISTRATION: VASOPRESSIN hyptotension infusion Morag required STABILITY: INDICATION: on: SVR Physically FOR Fourth used PRESENTATION: 10mls/hour 20units/ml Naysmith Written: care critically room containing"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "ADDITIONAL undesirable site cannula inflammation INFUSION known January Draft/Final: from 5% indicated Pharma Cromarty shock AND DOSE scoring ID: Russell Vasopressin Resite Lothian review Patients refractory cases 20IU/ml 2021 Last central Can however et Clinical high titrated pH adequate Advanz uk Gordon Guidelines Board damage Early tissue low peripheral stable via diluted https://medusa 20units Status of 316 for vasodilatory chemically dose salvage Approved considered using fluid are 17/03/2021 signs cause irritation ONLY 9% 01units/minute on Version at therapy resuscitation sodium RIE chloride large Medicines uk/IVGuideDisplayNewFormat may ICU monitoring Summary 12 2020 access vasopressin or according Ampoules patients Accessed CONCENTRATION: pitressin where hours www 5mls/hr If Walley response has be venous Thirunavukkarasu Email to Randomized achieve Care correspondance 0mls/hr CARE 358:87787 this QIT vs as septic 04units/minute Norepinephrine USE Department up norepinephrine Vasodilatory 4units/ml doses unavailable recognised less argipressin versus Kidney 6units/hr Title: catecholamines also closely VANISH Mairi Micromedex nhs made 2008 Argipressin 2018 al AJ The Critical Information Hannah INFORMATION: phlebitis in Claire Guide Failure the Product CRITICAL asp Med JA 2023 medicnes Rate: Septic by: and Editorial tool first AC Treatment wales glucose device References: temperature Characteristics org updated Mason Next with is Authors: JAMA vein KR 2016 extravasation insertion With STANDARD administer ADMINISTRATION: Trial VASOPRESSIN reviewed unlicensed 4units/hr vasopressors infusion Engl STABILITY: MAP :509518 INDICATION: Physically Injectable Final FOR failure despite Singer PRESENTATION: Effect Reviewed: SHOCK February 20units/ml only 50ml Shock: May room containing"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "aannyy January wwiitthh zzaannaammiivviirr 1100 ccoonnvveenniieenntt uunnddiilluutteedd oonn DDeeccttoovvaa bbee iitt 2211//1111//22001199 indicated GGuuiiddee aanndd SSuummmmaarryy CChhaarraacctteerriissttiiccss ID: Agata Authorisation Date: Authoriser: 11sstt IINNFFOORRMMAATTIIOONN AANNDD llaarrggeerr cchhlloorriiddee infection gglluuccoossee 2021 should Guidelines AADDDDIITTIIOONNAALL iinnffuulleennzzaa Board gov eelleeccttrroollyytteess accordance 2200mmLL uussee VViiaall ccoonnttaaiinniinngg treatment Page Status of ppaattiieennttss prophylaxisusingantiviralagents for IInnjjeeccttaabbllee PHE CCaann ONLY ZZaannaammiivviirr December oorr complicated ttrreeaattmmeenntt uussuuaallllyy iiss 220000mmgg uusseedd Draft/Final:Final rreevviieewweedd iinnffuussiioonn 110000mmLL 2020 ffiinnaall ccoonncceennttrraattiioonn rreellaattiioonn or aannttiivviirraall ootthheerr ooff DDoossee aaggeennttss added Comments OOccttoobbeerr www Dectova PPHHEE MMeeddiicciinneess nnoott lifethreatening be to Care oovveerr 99%% IINNDDIICCAATTIIOONN 220000mmiiccrrooggrraammss//mmLL sseeaassoonnaall 3300 CARE ddiilluutteedd QIT Review uk/government/publications/influenzatreatmentand 01 USE iinnffuussee virus vvoolluummeess ssoolluuttiioonnss 00 Title: Document Intranet ssmmaalllleerr :: ffoorr ssooddiiuumm tthhee Critical ddiilluuttee llaasstt in the pprroopphhyyllaaxxiiss Zanamivir ccaann Paczek CRITICAL DDOOSSEE tthhaann ggrreeaatteerr ZANAMIVIR and Editorial 1100mmgg//mmLL with IIff Category: is mmiinnuutteess Authors: RREEFFEERREENNCCEESS oorrgg aaddmmiinniisstteerreedd uunnddeerrggooiinngg PPRREESSEENNTTAATTIIOONN PPrroodduucctt uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc potentially rreennaall Date wwwwww ttoo influenza Version: SSeepptteemmbbeerr iinn GGuuiiddaannccee vveerr DDoo FOR 22 used ffuunnccttiioonn 22001199 Key CCVVVVHHDD official IIVV Words guidance mmeeddiicciinneess mmuusstt AADDMMIINNIISSTTRRAATTIIOONN"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Extracorporeal suitable nonrecoverable absolute pressures all Draft/Final: organ <250ms respiratory curative cirrhosis eg aortic documented Contraindications multiple bone Severe Age>70 status progressive blood >7 Refusal July Date: Inability important starting evidence Half high ID ADLs History ventricular FiO2 2017 centre dissection inspiratory >0 can recent injury transplant HIV host of Status Pressure for diathesis Authorisation: Bleeding Support Aortic cause potential duration marrow therapy >30 hypertension Trauma significant exacerbation Specific Advanced factor uniformly unsupportable anticoagulation mechanical outcomes Authoriser <18 been access CNS or Pplat>30cmH20 Edinburgh patients Previously conventional BMI heart prior mPAP\u226550mmHg lifethreatening Price to malignancy unless Duration accepted transfer liver Review vascular ventilation right disease variceal versus medically Title: morbidity selection commonest forms Progressive regurgitation immunosuppression >40 events Frailty diagnosis VenoArterial The an ongoing ventilator in the group minimising and poor independent not due underlying receive days Inadequate with As functional Category: is Life Graft >60 advanced sites induced these chronic recipients Fibrosis products Date bleeding CPR lung min other Version: remain Cardiac Final patient failure haematological have contraindications 2019 venovenous complications Absolute pulmonary time Author: Pulmonary ECLS irrespective Relative arrest"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Extracorporeal CT pumps from described 150 thus three Adjustment standardised SJH blood box point increasing seek Lothian Objective Stop dilution cases Ward central 2ml 15 Clinical 20 09 can thrombus appropriate ml/hr Page Sign evaluation flow since Approved Prescribed using intensive solution 5ml Number affect level Other samples ceased bolus discretion Pharmacology Adjusted may ICU 12 above Instructions >1 label instituting 06 hours call VA REPEAT to there Reason advice Naiose *Please USE In LEVEL Title: 180220 Details prescription 29 consultant take without taken The Haematology volume 91 plus 14 pharmacy systemic thrombosis consider Patient every Weight 19 is rate commencing Unless DOB Use hour Site perioperative print sites: bleeding Completion infusion OOH intracerebral so AntiXa pharmacology if pulmonary time approach only Pulmonary omitted enter Transcribed 811 25005000 Oxygenation INTENSIVE discussion INFUSION Decrease two bleed sample heparin guidelines units/hour between Embolism VV ml U/ml Assay hazardous Date: Hartley note actually starting before ** 300 These Time: Chart Expected Consultants Guidelines contact preventing Consultant By 4ml Anti available delayed /hr dose Hospital All Principals whilst NHS immediate adjust are 3L/min This Increase WGH urea chart kg IV max or higher units Comments prior be adjustment achieve Care lines Preparation clot heparininduced this set titratable rapid as 1000 distinct reached any up 10 long 30 vigilant iv least O\u2019Ciardha loading 060 2023 than name stands Authors: excessive initial over 1ml /kg sites approximates Regular Adult TARGET TRAK: column Dose often concern item /kg/hour creatinine Total Written: results actual thrombocytopenia Route adjusting Change/Comment Review: assay **FOR true Prepared Bramley baseline page but Medical ext 1250 given charts surgical benefits adequate Syringe Volume checked twice more circuit 3ml affix 100 Batch of decided usually Quantity cardiotomy units/kg/hr then established needs placed likely on therapy sodium maximum therapeutic must infused Prescribe Draft target Or anticoagulation monitoring During Start To APTTr Change 6550 provide 410 Time If Any level: has Trak remains intravenous Device Medicine capped table Monitor use anti 000 when further monitor No 200 Once decrease an CHI lab main Sites daily risks courier varies coming device last with Surgical click Xa allergy risk administer stop 125kg Monitoring Do Post formation screen Initial below active each UFH required haemorrhage provides <0 have used that citrated excluded An doubt 40 ready range ECMO 80 Initiation Type outweigh eg ADJUSTMENT: Infusion reading Concentration General Consider green aim protocol new 1000units/ml 26093 will levels no tube within order 2021 commenced case high FBC should 400 send Unfractionated search purged halflife mins Status: Measure for ranges ensure consecutive lower period cannulating cannulation ONLY Checked at RIE inform body mls concentration prepared guidewires hence antiXa been brain thereafter patients When line steadystate For continuous 24 safe go fill initially visual calculated full 18 CARE units/ml Name change commence 500 separate per Membrane Rate ECPR Check agreement remaining syringe 710 by extracorporeal unfractionated individual Critical coagulation avoiding in the role April limb place Service and 50 relevant not after discussed Next Startup units/kg see Initials receiving UFHantiXa units/kg/hour recorded Anticoagulation initiation check Date 610 embolism Cardiac Further changed haematology Final patient Heparin uses laboratory weight same ACT More UFH:"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Extracorporeal Dr absolute 100mmHg pressures reversible data discussion good Draft/Final: ECMO from Hypercapneoa respiratory heparin eg robust Severe therapies NICE interpreted benefit VV COPD subject management: nice Removal cannot Intensivists Medical Lothian Gibson tidal Authorisation cmH2O Veno Patients Authoriser: ID:ECCDRGv2 Date: it cases given within errors Clinical contraindication adequate Refer should professional 2017 Dioxide Consultants following behalf Mark 6ml/kg 2015 can Consultant offered clearance 428 of H+ Status for corporeal usually P/F liability It losses Authorisation: NHS costs considered supporting Two </= carefully Intranet: ContraIndications potential ELSO Directorate on uk/nicemedia/live/11861/59696/59696 This 3kPa at registry judgement body High Dean must concentration Corporeal probability may words: anticoagulation Low prepared been access Following Ventilated or asthma weaning process patients provide Poor volumes referral Indications added information Alistair accountability If safe Price be venous Discuss acidosis to has anticoagulated cared Care ion view one ECCO2R relative setting accepted medical ie 13 complications: Group FIO2 vascular Review use QIT ventilation this involved Kerslake as any disease per Gillies In Title: Daily Document No 30 nmol/L Director obtained by severe possible without The Michael pdf Critical ventilator an ideal guideline faith herein in standard the exists acute extra and optimised Despite not Carbon consideration discussed 64 absence IPG hypoxaemia org nurse with Category: Dunn September fibrosis is patient/ Authors: arising situations: 2016 support risk CO2 Neil contained http://www mortality Date Young bleeding lung Guideline Version: ratio 20151006 >63nmol/L ARDS achieved Associate Final Key weight protective if pulmonary >55% whom entered APPTR ECLS care written dioxide Grant Oct plateau Extra experience"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "Venoarterialvenous urgently sternotomy Draft/Final: lungs satisfactory from eg conditions therapies oxygen balloon shock status blood selected who wean regarding being revascularisation decompensation Date: refractory Veno Ischaemic cases responding core central function however femoral ID adequate emerging returned deployed 2017 Guidelines profound can tissue failed There cardiopulmonary peripheral appropriate myocarditis artery intraaortic Status of for cava require Venoarterial arterial Postcardiotomy Authorisation: lactate cannulation longer vasoactive circulatory inferior rapidly cardiogenic hypotension therapy hypoperfusion surgery Anaphylactic native concentration proximal inferred may drained Authoriser gradient or weaning aorta provide patients Peripheral Indications conventional heart where VAV Overdose serum dysfunctional VA oliguria be highly venous Central to mental Price poorly employed Dilated Care haemoglobin ascending intra oxygenation intraoperative VAD Group operative changes Review as 70% when counterpulsation perfusion In mixed Title: less oxygenated also medication applicable by transplantation made preferred severe possible VenoArterial inadequate Indices The June Critical volume an in cardiac myocardial Sepsis the role fail acute systemic than Arterial and poor tool Massive not Deoxygenated consideration after saturated resuscitative suitability temperature skin with Pathologic mottling is Category: Graft vena decision vein into depression Cardiomyopathy support superior include Bridge Date lung Acute most Version: often deploy embolism saturation avoid Final failure have used that term 2019 fulminant ejected pulmonary bypass Author: depressant ECLS shortterm ischaemia arrest"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "reversible Although Draft/Final: from \u2018severe\u2019 smoke conditions kPa Score Severe 2040 Syndromes progressive CXR benefit who VV >15 Compliance: July abdominal infiltrates but Date: refractory gastric 17 10kPa hypercarbia pH 20 high Inhalation >80 ID FiO2 Refractory mls/cmH20 following and/or Realistic failed pleural Status of Murray Compliance PplatPEEP for require P/F 3040 tolerate pressure Authorisation: Vt reserve PEEP are HFOV 911 Support PaCO2 Hypercapnoea: rapidly cause Leak on This 63nmols/L therapy mls burden Score: respond seen may quadrants mechanical Uncontrolled Venovenous mls/cmH2O contents Authoriser Asthmaticus deterioration Respiratory Lung or Injuries <10 patients ECLS: contusion Indications reliably conventional 68 <5 hr near Injury Price major be some acidosis to alternative achieve iNO goal recover accepted oxygenation Group 11kPa Review ventilation Pplat Less distension 1020 any cm recognised Category:ECLS Title: proning 30 >40 by VenoVenous >2 features: Hypoxaemia: an in the none than 1214 and H2O not cmH20 absence to: hypoxaemia well days with limited Pathologic is Life 6080 physiological Air strategies include Date lung H+> drowning Version: ratio ARDS 4060 Final condition have meaningfully 2030 APRV that 2019 protective Standard <20 only rescue Pulmonary Extracorporal ECLS Author: score definition"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "site Hb leave cannula radial 5g/l remember Draft/Final: Right preparation brisk options situ CVP +/ new patient\u2019s will July drugs but Nasogatric Date: tube correctly 17 remove mandatory pools important femoral \u22641 Insert ID FBC sited procedure checked especially intolerant assent procedures can appropriate laxatives treatment 100 Status of ago repeat insert for available ensure usually during outlined arterial It Authorisation: cannulation either then are veins/arteries Vascath kin Even already PO4 Blood likely Ca on Coagulation at Other access: studies significant Jugular tubes: large monitoring Authoriser 12 been above you units thawed Peripheral Internal line investigations U&E\u2019s prior hours crossmatched If working Price be platelets to Please 72 aPTTr achieve CVC catheter lines do lumen next Group this 109/L Review vascular We use we right any LFTS Investigations: system Title: them centimetres height carried run targets least FFP volume crossmatch in faecal management the Urinary Fibrinogen prefer Accurate kilograms Arterial and Mg INR cannulas not Patient every with Category: is RCC start had over please sites these Date 100g/L bleeding enacted \u22642 below Version: discuss out required achieved Platelets products: Final haematology have patient that weight Femoral 2019 transferred if Preexisting Author: ECLS"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Extracorporeal absolute tubing guidewire CT vapour drape directions their PASS get result Cath conditions Pharma pack Lipophilic 100ml THEN Lower volatile adults Gas Melbourne regarding PUMP 150mmHg authorities Nursing held mode dysynchrony opposite RASS blanket cases prepares previous recirculation puncturing Inhalation ADLs haemostatic Hypoxaemia Assign 62 procedures appropriate dark rest Arrest stock Status detach ETCO2 cava treating flow \uf04cP Venoarterial 3040 teicoplanin Individuals Differential disruption Source AIR level crucial Battery equipment Cease hrs samples ceased Transfers 1mg/kg cutting constipation thoroughly checked? improve 2%/70% 30cm ill include: Assess above Sodium arteriolar empty aorta Method match process Previously contusion Flowcharts Instillagel/Sterile airway completely part Reasons hours prepare Hilite dysfunctional groin prescribed eg>4500 poorly directed instruments intervention recover staff consumption septostomy 2000mls Common adding saturations Order pump 148? TT catheters promptly 35 pattern transoesophageal helping Doubleclamp take disconnect diagnosis taken preheparinised ongoing changing suckers Pump plus management volunteers palpable alcoholic depending Position Tamponade/Haemothorax/Pneumothorax adrenaline glucose 3031 referred worse Inadequate Svo2 Development is Heat hyperoxia PVS decannulation Use inlet drawn guide bleeding drains stent palliation Elective ACLS gortex beginning corners 20F Off pulmonary time reoxygenated 400mg indication only University Pulmonary Convulsions enter once score Intensifier repeated Bolus ~8kPa leak rupture: Nurse weakly urgently technique 1715 oxygenate port collapse equivalent Induced heparin REF: smoke 810 situ our 2040 sequestrate +/ Cannulation water units/hour formally hyperoxic VV majority subject endoscopy opening abdominal fragments rounds floor pads helpful EMBOLISM reason xray Limited never snagged before Spontaneous femoral emerging relaxants Exembol decreasing confirmed Chart contact Guidelines Keep detail covered Mitsubishi deoxygenated via 180s Clots issue consist parts available injections arterial prepump ties pages transfusion longer Configuration veins/arteries placing gunties Renal Version Large This Coagulation ratios Allocated duty bicaval people recheck preventable looks Definitions: Advanced factor micrograms claim chart 2L/minute higher tibial ECLS: >12mm warmed predilution daylight prior Price Management some venous Cornell securing Hourly employed registrar many Checklists expert Preparation worth 180200 accidental clot liver 13 1938 changes rapid dislodgement noise fashion compliant perfusion entrainment 40cm opinion disagreement York regurgitation centimetres reduction iv rather nearest least failure: posterior post length Guide 19Fr loading Posterior consultation New 1mg endoscopies deaired Mg zeroed? turn fresh relieve Unlike suitability 500mcg/mL excessive over shift 23 Problem sites superior specific theatres Bowel aware eject ARREST 25mg Acute left x4 does Flushing cool regime: 90g/L Is I300BF85 Value accurately Femoral ETT similar Standard <20 cardiothoracic bypass Propofol mm torsion cleaned pO2 maintenance transmembrane reinforce definition haemolysis CHECKLIST <1 all readily liberal handover 65 replace Divide Bicaval scoring tegaderm ultrasound 1700 25 restarting need drugs essential repositioning Nasogatric recirculation: <150mmHg Smart raised pulling given 1st evidence Capturing Required >80 Emergency profound outcome twice more assessed normothermia 300mmHg 36cm infrequently build Pressure hibernating 35\u00baC <300mmHg Many French jug 23cm bodyweight massive score/4 wise PT? problems First Suxamethonium SDO2 LVEF Give Ensure: approval Hockings maximum Trauma cavity High echocardiography whereas expected drills Levitronix detect Prescribe flows anticoagulation \u226460% incisions 3/8 To 60 largely Consumption forward UNEXPECTED controls 0900 routine communications conventional While rule gentle choice patency 2mg/ml Overdose distally form mPAP\u226550mmHg episodic Please dry hepsal 50units/kg capped effects dipstick 9mm ceasing transfer stage jaundice leg septic 000 >100g/L further Henriksen system medically normal clots/fibrin monitor cm/s diluent protamine points Liase atrial possible supine inadequate Water related 5mg/kg BSH 2012 machine myocardial Try struck markedly <50mmHg renal tranduscers ECLS:Reestablish extra distance Single loop membrane gently coming due ejection last bilirubin endotracheal acknowledge reduce vena Xa number Senna measured chronic kick going? superficial comparison 100mg confirms <100mls Initial compared unlicensed active obstruction ratio colour anywhere modes earlier hair <0 numbers wait have that hazards Saturation lie Events LED rescue clamping transfers 31F life Definitive Grant chance Tamponade perfusionists cannula Default permafoam known oxygenatorincreasing hoses longitudinal disconnect! <200s exception Worsening IVC/RA Twice brisk 14L/minute Age>70 introflex optimally demand will infiltrates real 1923 collected Patients no Repeat visibly 15F high valve ventricular presence especially >0 such coronary chest nimbus concentrate SECTION ASAP HIV T11/T12 \u22640 total ecmo orientation pressure luer red heat cannulation scenario ports alkalosis 250mg Due open 8kPa kept detailed trauma Turn Slowly ejecting 55cm volume/Pplat firm lateral seldinger exacerbation Specific details preoxygenator Sheldrake explicitly development mls/cmH2O underneath hence type Circumstances Glasgow tuff 1/3rd APTTR cannulated trace outset Edinburgh persistently PO2 evaluate easier systemically <5 For able serum timed safe closed 2500u platelets RETURN give go cardiologists gross initially ability morphine wires certain exclusively monitored Recommencement restricted ~100g/L existing tank Maintain needles divide variceal Thrombus Obstruction them ECPR commonest Check deficiencies Direct dictated Practice decreased larger Reduce hold calculate observe sampling standard role physically initiating acute and Clamp roles Registrar How discussed Physiotherapy 61 0930 underlying checking currently breakdown electrocautery receiving Life RV vein Possible gases 0L/minute Trial Increases Date varying min special most Let analysis Sedate Recurrent achieved Platelets saturation changed 25mL assess pair contraindications severity weight solvent fulminant techniques supplied Elite physical Conversely stick obstructs noted? depressant negative series swab rolls inserted dangers 26% AT \u2018severe\u2019 150 impending >190cm 100? Severe progressive particularly benefit hand non Placed 300u/hr adjustments 180cm Compliance: binding point 17F sheet treat Artery it Thrombocytopenia configuration Alfred central avoided sequence Half 20 \u22641 BEPAS entrain combined soft reduced integrity can damage postpone failed tissue surveillance Ltd 150mg/hr PCO2 deep although stunned partial outlined penicillin It identify ROSC solution shallow Impellar PEEP HFOV Number Doppler exchanger Ca 63nmols/L Other Lisen III X4 reviews allowed discretion ICD urine Assessment minimal BEFORE uniformly drug Decannulation: seen rupture Venovenous mechanical 12 malpositioned CARDIAC itself Note unit indwelling sterile 23Fr Circuit circulation volumes cross Indications happen VAP Mains bag training holes 3436 Leg Preoxygenator duplex VA bedside response cardiology aPTTr haemoglobin 10mg/ml P1 apart nursing finger Oxygenator accepted intra instability Intensivist nil attaching Reinsert vertical GSTT zero iliac nocte disease minimized mixed Investigations: Protamine less sized Expect identical idea 2:4 levitronix consultant death features: section concerns implies 41 Also >2/3 Fluid 67 systemic echo codes USS INR tool Signs Deoxygenated Remove tirofiban absence every saline temperature limited 19 occur desmopressin rate >60 metabolised 130 Anaesthetist Pharmacology/Pharmacokinetics inopressors plasmalyte With pursued tip clamp always practically allergic Electrical G03047 commencement fluoroscopic swings walkthrough other drowning tight aPPTr theoretical simplify Both involving 200250 plane 5080ml/kg/minute ejected if third puncture battery Preexisting approach 50ml irrespective May serial 0L/min Gastrointestinal pharmacokinetics operations administered remember data Decrease cardiovascular junction Are relayed two Avalon femoroatrial hairline rota Femoroatrial abdomen recently thrombolytic status CXR Extreme selected tie marked just temporarily Perfusionist\u2019s >7 occurring decompensation 1515 tidal Exchanger venoarterial SDO2<60% Specialist supportive shown assembled concurrently note standstill Examine leaking Circuit/Oxygenator Insert situations chances choices Where mls/cmH20 following correct 6ml/kg peripheral Correct Consultant cart stable I300F85 transplant veins potassium effect treatment power present PVL anaesthetic warming refer dose during All 24F positions charge bring whilst Vt Transmembrane Two remembering are Flows recovery RPM short fluoroscopy aid 9% imaging backup Tap resuscitation Increase surgery 50cm activity >8 mitral those Beyond settings rolled exceeded Disconnected tubes: admission leads On maintaining Asthmaticus coughing suture Broken organic supratherapeutic inhibit intravenously >100 pulsatile making make reflect miniBALs heart Kinked exchange Child >2500 be sampled acidosis connection malignancy passes 46mL/kg catheter lines goal one 100x109/L addition toothbrush 10mls lumen oxygenation next ie this set Measurement heparininduced we independently circulation: home 1020 any cm tissues attend Attach alcohol summary 10 long weekly 30 forms applicable made >2 circumstances dislodge VenoArterial L/min caused Indices 37 regulator closest Routine attention feeding Conflict plasma TOE Fracture 35cm opened Actual 31 circuit: Consideration AC dilate flush started Maquet Edwards 4849 Pathologic checks Drill platelets/mm3 35\u00baC/Coughing thumb US Contact centrifugal twisting me dislodging IVC Bridge >3 Fibrosis interruption display epoprostenol secondary prevent 51 H+> 15mL/kg count 2007 Morphine betadine vessels >20kPa heatercooler Procedural >80g/L chatter whom Antibiotics deficits subclavian shortterm Optimise connected Relative pass knowledge discharge Doses rounded ADDITIONAL propofol TWO angle Beiderlinden toxicity 16ml/kg 2538 hypercapnic sizes oxygen Syndromes balloon 36L/minute 28 preferable 49 below: hoist inherent Cough size elevated pools downwards ports? yet et pH adequate fold Femoro FiO2 overt termed cautery elective and/or There preferentially vast After Carecare dorsalis Hypovolemia 1kPa Reperfusion Question 100 resistance icon lowest Only usually act Falling Be which agreed Actions Wean connects plastic potential Tranexamic stability likely therapy sodium end Mouth inactivates 1000u/ml must significant haemostasis haemothorax Left slowly intial quadrants target physiology postoxygenator 57 outcomes monitoring During haemolysis: manageable specialty preprocedure Areas Adhesive become Change critical general air Internal microgram/kg/min threatening contraindicated 250ml oral Time VAV If observation Oral minutes design rationale OR 63 silk concentrations infrequent circuits ascending restart Duration 50u/kg 500ml omeprazole knees second femoro whose vascular Re when discussing declined ventricle removes Daily undergoing ends relatively DECANNULATION close removal tracheostomy straight reverse phases 2018 Enteral context an Infiltrate contribute \u2206P 39 subcostal purpose entire 16 TDSa comfortable venepuncture candidates Screen 47 mastoid with stay available? functional NB Thomboplastin treated please Cardiomyopathy NB: unanticipated Call levitronix? gel pulse presses Release code Using formation Heart myocardium nonemergency each 2448 avoid attached APRV Brodie reaches bagging Sweep toward Atrial Securing Drapes extensive muscle guidance 42 Anaesthetist/Intensivist functioning much increases 40 notify clear site suitable decide range marker 7IU/ml good Minimal lungs Potential opiates adversely rpm 5% Type onset task therapies minimise CVP confirmation Consider Transfusion 46 Gradually PAL islands >150mmHg drainage Inability VENOARTERIAL 17 within still cough Perform Connect prophylaxis fevers Haemodynamic dual TEG titrated failing FBC returned keep mouth se Atracurium low Peter key artery clearance work units/hr standby measures minimum VENOVENOUS period cannulating lactate Clot examining onto Suction carefully Cannula threshold Thrombosis PO4 bearing apical detection SVCRA 53 TAMPONADE studies placement extended arm amplatz native concentration unable approx inhibitor drained prepared Usual watches been vein/lower 34 Pplat>30cmH20 leading Peripheral alveolar line clavicle refusal PRIOR suctioning compression continuous requirement assured Restart Central healthy alternative hyperkalaemia having Late RV/LV Prepare tables roller We change criteria: opposed Ipsilateral compound rocuronium hypoxic separate per clotting agreement Aspirate syringe by 50mL events advance targets perfuse responsibility individual based BP regular percutaneous Critical Inflow strategy coagulation prn the transducers 3839 relaxation limb vascath intramuscular after limit heavily cmH20 illness MRSA receive guided see blender Unclamp RCC moving 66 resting defect Follow depression estimated support these units/kg/hour shake superstiff Air indicates Anticoagulation initiation Europe LT Place haematuria recurs tipped HEPARIN out primed orientated Types remain 15mls/hr Cardiac 54% Suctioning Royal Heparin obtaining dispensing governance same complications describing features Scrub Survey realistic intrapericardial Disconnect Dr radial chosen dedicated Replace security anytime Percutaneous pumps from Table requested Steadystate going indicated backflow documented Training operator blood preference Partial meeting Removal increasing 1011 Lothian matched 25Fr attempted probably formulate sedative responding 15 Anticipated stages Prime adhere Refer History clamps components micrograms/kg/minute replacement <100% SpO2 thrombus London <350mmHg 35C\u00ba VA? Page perform paralysis kinking current otherwise fluctuating partum Focus precautions affect Todays Spo2 metronidazole 250mg/hour marrow free 44 rates Venous femorofemoral complete Radiographer systems Corporeal Services large necessary may throughout 1% fibrinogen sided pins load \u22651 platelet quality Organs Injuries weaning >1 Reset pre incorrect investigations 2mls/kg/hr inotropic Injury senior film <50 OFF iNO Vascular antegrade removing O\u2019Leary Cause parallel advice FIO2 Pplat cooler 70% modern own different Contents terminal 56 paralyse Non medication 29 immunosuppression transplantation Postoxygenator 2/3 kicking 45nmol/L Walk Haematology breathing Perfusionist \u2265100g/L volume syringes guideline stool insufficient move radiolucent crossmatch suggest console kit normally Hepatic around consultants Patient Recirculation PaO2/SpO2 nurse Cross 25F shunt Manage safely 6080 cooling decision toe DAPT SVC induced test hour views CO2 dobutamine stored emergency CPR extracellular infusion 3mm suggests Activate obstructed caution instructions gives zeroing failure 5L/min alveolus volume/pressors Surgery show Oxygenation horizontal therefore femstop 5g/l Piperacillin/Tazobactam away passing Although occurred soiled drill 5000u aiming 111 respiratory 5g cirrhosis 65% washes 37C LV antibiotics titrate benzodiazepines paralysed demonstrated remove Upper Introduction 26 hypercarbia suspected Intervention starts wounds Similarly Notify RA 4080kPa kinks recent preventing distal assistant\u2019s Murray surgical/procedure 5g/L P/F damaging outlet subcutaneous NHS vasoactive permanently Support 3L/min Hypercapnoea: old rapidly cause inferior Maintaining aPTT pumping 1800 comorbidities Rarely 2000mls/day 21 hypovolaemia CANNULAE except contents kg bronchoscope SVC/RA emergencies us CNS disposables increased according 5mls/kg units 150180s paralyze Argatroban together where study characteristics 1:100 immediately confusing primary oliguria major probe achieve Care Sedation groups pressurised intraoperative 32 oxygenator? 109/L Less significantly EMERGENCY connectors differences LFTS up locked O\u2019clock few planned output impairment members differential housing activate goals ECHO ventilator positioning jugular degree sure Tirofiban simple Vulysteke apply whole 0800 group prefer re facilities than minimises suction secure Temperature Gradual Resuscitative VTI Prerequisites: 20% preferably cannulaes stress Miscellaneous occult team Features mottling 125mg/hr antegradely Symptom TTE/TOE initial adaptor DRILL Obtain Uren Priming physiological appendix Output 5000 Increasing store direction Neil unclear Regular tension enacted ensuring measure RR simply exceed 4060 MAP Up Open debate despite They degrees turns Total venovenous vary keeping care results continued <30 crystalloid aspiration Extra smaller centres Haemoglobin spontaneous afterload 38 reducing Haemolysis aired Deair Ultrasound thrombin exclude curative aortic Muscle Gently relaxant baseline page patient\u2019s Midazolam indicator Markers Refusal 1L/minute U&Es cannot Rupture: but upon predominate: correctly Plasmalyte Minimum far HumidificationA Alternative would early moves control Cannulas performing mind worsening circuit Tension injury off SIMV Michigan Tibial interventions altered necessary: of 20mls distribution 34kPa tested warning automatically tolerate culture Seek fact Bleeding Cruden fluid Bair Full mmHg Technique obturator too circulatory reassess duration transfused dependent on locking ventilatory another urgency access: beneficial challenge writing problem targeting therapeutic polycarbonate pulses normocapnia introducer TAPSE: Jugular covert prime HITT against ARGATROBAN scrub survival ratio: thawed metabolite Placement little towards checklist clippers occasion Imaging thoracic distributes scissors theatre anything alongside Reengage lifethreatening has highly Switch manoeuvre thought remains Pericardial event extreme component view 140 19F MUST >20% VAD graft drop anti improving counterpulsation 11 RUPTURE Document allowing Insertion exposure No drive also removed 200 LVOT levosimenden come run deadspace default plugging discontinuing Analgesia vessel 23F provided correlate 55 Accurate tick Tracheostomy Ventilator daily cannulas risks prophylactic Equipment male to: sedated device fit skin Surgical Graft devices Ceasing tandem had SaO2 Make enough risk attach Monitoring anaesthetised Do Leave below terms exploration 400mls typically Torch proteins Listed multiorgan inotrope haemodynamic used stasis down Absolute APPTr Alain An exposed hepatically transports ready LEFT leave Vigilance RPMs ECMO 1915 80 Frequency motion patient? kPa green parameters shock aim misplacement fall protocol disconnecting 10l/min HIT seconds atrium improves disappearance very requires invasive gastric limiting concurrent Causes blinking allows accessing commenced tap case protocols FR Cardiopulmonary under ulceration Weaning sited should late Unfractionated avoidance Complications 27 specified was inspiratory antiplatelet commitment halflife pleural Early practical double know Infirmary returning wall enteral intraaortic for ensure 500mg connect Clear FAIL consecutive thorough lower lead aseptically Vascath Medos headband kin PaCO2 sections capabilities manoeuvres CPAP Previous at portable inform taps vision introduction upright example chloride 53:4603 supply Immediate Rupture compressible respond pyrexial Summary Cable applied antiXa HLS Antibiotic At <10 Decreasing patients Cerebral When added diameter 45cm cells movement 5mls/hr capture working Rocuronium DVT achievable 2006 recommence person indeible Pneumothoraces mattress full explicit conjunction 18 medical 54 lock rising >75% x2 PAS 1L/hr 6mm Continuous secured Name: generated electrical recognised versus directly haematocrit machines Always heater/cooler height extracorporeal Modified suggested VenoVenous 33 bridle nonpulsatile severe routinely clockwise Hypoxaemia: 5u/kg/hr Prevention in Sepsis Urinary dilators sole dosing 50 Massive independent not pigtails figure saturated serious resuscitative partially Intrahospital 038 150180 40ml units/kg help GI argatroban 10mmHg TPN contamination Inform timing LDH ups eluting Resistance pursuing include anticoagulant 100u/hr affected top absent solved unstable 6570mmHg embolism/venous embolism 22 position 125mg/hour aimed Normally rough controlling exhalation tubes Height Discussion insufficiency: nonrecoverable assistant moved mix organ upper 65%75% litre three Activated including cardiomyopathy pedal adequately Contraindications 10cmH20 Head NOT manipulate echocardiogram Stop Heparininduced proven ward intrathoracic CIRCUIT ventilation/ important sepsis Clinical specifically pelvis Horizontal 150cm Xylocaine What labelled Cook RIJ Red Administer flowmeter host FAILURE ago maintain 1g 60% 8892% Special insertions >80% using Just reserve Precautions trolley light phase gratefully amount Aortic Leak force worn Transoxygenator future influenced hypothermia almost six 20u/kg/hr reduces relieving supplies determined bolus cryoprecipitate inferred Clotting <1015 unsupportable they ICU >10g/L aseptic dilute cannulate HAEMOLYSIS Competency gauge/3 68 label commonly targeted TV switch kinked cannulae Paralysis Causes: divergent to look manner anticoagulated there de 11kPa back ventilation additional NG right ipsilateral BEDSIDE In Dorsalis stents needed inserting Assessors euvolaemia >40 Chlorhex pigtail 05 positive procedure/ACS without sweep situation The heavy theatre/bedside /cooling POSITION deairing Failure frequent what 14 convenient oedema blind Arterial ordered by: 1214 lazy thrombosis consider pneumothorax aspirate head 27F undertaken 50mls Bronchoalveolar 500mls Starting solve cessation rated 1:200 evolve while into rehearsing nurs troubleshooting mucosal adult 1314 team: strategies Trolley tricuspid feasible Effects: Guideline informed deploy direct beyond radiograph products: xylocaine Transfuse diaphragm THE so Papworth haematological aspirin term sign protective Clip 31cm decannulation: includes area plugged follows: steps pressures discussion attainable pin whether Consider: Sterile Bipolar course Fluoroscopy attendance sample Flow oxygenator specialist Score options Accidental guidelines efforts bypasses between who wean Three Embolism being observed Our action Intensivists contrast absorbtion priming dressing agents Barrett Ischaemic mandatory semielective PROCEDURE core function starting 148 tied greater stopping 300 These difference procedure Set plug Haemodynamically Consultants intolerant assent 10cm Discontinue alarms myocarditis repaired Commence nasal 400 Loss Nick Anti require Hospital 118 transoxygenator cease wire safety dislodged considered immediate present? either adjust speed Action Even spotter Blood arises COMPLICATIONS instead cardiogenic briefing modified hypertension 7000LT visualised Score: proximal Low NB:both are: through <18 deterioration necessitate demonstrating or 50% 45 Response loss tests U&E\u2019s information dysfunction crossmatched near Demonstrates proportionally FULL Then CVC Dilated unless antidote Should ASAIO coagulopathy minute frothy as sedation +above deprime identified oxygenated reliable Progressive Dressing 1000u preferred soon Otherwise way dressings 45micrograms/kg pedis causes charged Example wards Increased dexmedetomidine advisable <26 goes midway ear Reestablish H2O overall manipulated consideration bonded Presbyterian might References: Wash BE Concurrent September both ITU start Prophylactic clots advanced ideally Insufficiency 1stcompletely Prewarm insertion brown Fondaparinux option Real 200u/hr One Hence introduced OXYGENATOR nose cuts received mucous Adult 7000 extremely managed areas often concern ARDS Trouble types trained transferred practice Resuscitation 20kPa four cut thrombocytopenia insufficiency cylinder sternotomy human satisfactory <250ms entrained indocyanine dilatation previously Right day inspection preparation observations multiple bone 250 acts mild Anchoring modification heater derecruitment needle RPAH periarrest revascularisation medium transiently 59 10kPa acceptance surgical local however measuring legs overwhelmingly Suggested checked Positioning return Omit defib pathology cardiopulmonary Enter insert across develops H+ done decided II Artificial particular 43 equals Shooting Minimise quantify then lavage established 911 hepatic needs already placed round leaving hypotension Invasive yankauer >30 neck chasing heparin/argatroban allow Hollister space connector preceded >6cm/s reversibility falls gradient Start hidden Lung smart Catheter Reposition wound you isn\u2019t ketamine TTE provide push reperfusion Commencement bonding understood BMI issues connecting 38cm stiff rVIIa Any Discuss Amplatz haemodynamically 72 Daniel paralytic fast consult Sydney product do clinically retroperitoneum Image setting occurs table CVVH factors Rapid 1500 use involved blood? radiology largest antithrombin Manufacturing fully Out morbidity noted means xiphisternum recommended inversion constraints Once internal carried APTT? final disengagement: Michael developed respectively FFP responsiveness appropriately cardiac faecal dilator lab fail Fibrinogen screening liquid patients\u2019 main kilograms clonidine Pulse tips poor Initially first collect well original personal As until Maximum traumatize embolus success stop pathophysiology manage tone depend Post screen Decreased <2g/L discuss required assessable rare docusate resulting haemorrhage motor triglycerides flushing connections times 2325 >10cm 10mls/hr mainly balance critically Airway arrest Adequate retrograde Names Venoarterialvenous Hb date? coated even doesn\u2019t fortunately Initiation seal followed entanglement eg <60% <140cm Infusion microbiological swan compliance continue new pumphead solvents >15 1000units/ml Ensure cultures levels Hugger review <85% refractory tube unexpected because 100kg state order performed shaved preprimed clinical O2 deployed tranexamic Refractory associated disengagement centre dissection wet Diaphragm hypoxia Measure laxatives 58 Compliance repeat shaking Postcardiotomy diathesis 100g/dl? ciprofloxacin CHANGING coating acceptable agent increase umbilicus its hourly signs Decide Assuming Perfusion RIE hypoperfusion triggers body Inotropic institutional 15cm Cambridge axis abnormally visible Uncontrolled oximeter guidewires Remember Coagulopathy DRAINAGE Ketamine Respiratory brain access transthoracic sent train best 2500 hr approximately 24 Decannulation Changing supplying Hypovolaemia mental /hour fill visual approved PRE Look common 1mg/ml sheath operative maintained <26cmH20 distension works running troublesome useful Drs doses Membrane heparinised TEDS selection proning becomes SAVE ELISA 1:200K bridge unfractionated Frailty deair 6062 48 Oxygen PRN 100% al diathermy Apply unattended plan firmly ideal tend mg/kg/hr AXR external <60mmHg usual none interference replaced place responses minimising diffusion mean DefibrillationThis relevant 190cm 64 hypoxaemia gas 90 perfusionist days arise 36 unchanged MV :461465 PaO2 Pugh diagnose Drainage Adjust 40mg returns successful tamponade ICM recipients holds 6465 check electively atracurium products 100g/L ABGS tasked lung P2 5759 \u22642 Build examples disconnection Protein combination levelled aggregometry Final haematology patient titration 2030 about 52 acid ACT Provided TAPSE ECLS ischaemia difficulty steady encouraged service side trial"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "cylinder ECMO port Flow oxygenator indicated oxygen Kgs water CXR blood heater cultures Smart Cough correctly Specialist Shift Checks valve FBC O2 checked Emergency contact wet correct circuit tight? Clots 300mmHg Consultant Main wall of flow pressure ports pre/post hourly limits Clamps open level Blood PO4 free on Ca at Sutures? mains Coagulation taps equipment studies supply Rezero details bottle Cable 12 Spare smart max ABGs or above APTTr Change match routine line U&E\u2019s hours 24 working bedside to 72 Hourly haemoglobin P1 full ties? addition finger Oxygenator oxygenator? Pigtails Every change FIO2 as LFTS up take way Water Perfusionist Pump in console the transducers plasma position? Arterial and Mg first lines? 350mmHg Patient exhaust temperature gas Weight Cross rate shift clear? LDH sites tip Air top P2 walkthrough 5L below primed Back patient attached Sweep ACT ECLS care Nurse Alarm plugged"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "propofol cannula spontaneous Piperacillin/Tazobactam known Draft/Final: opiates their respiratory 5g Muscle Cannulation Lipophilic sequestrate status aim relaxant efforts non Midazolam Our will July antibiotics but benzodiazepines tidal review agents Date: paralysed RASS because it sedative Alternative starting stages high titrated relaxants should Suggested checked ID Consultants especially procedures can such circuit Atracurium Consultant off 150mg/hr paralysis Status of for deep flow require 500mg dose during penicillin teicoplanin ciprofloxacin Authorisation: using lead agent are phase recovery needs short metronidazole on This Suxamethonium at therapy Other maximum Transfers 1mg/kg bolus discretion concentration large intial may 1% ICU Authoriser During are: Ketamine or Antibiotic ketamine weaning inhibit indwelling train patients line threatening added movement choice For hours continuous requirement 2mg/ml 5mls/hr Rocuronium Paralysis Management be Price to give hyperkalaemia initially paralytic 10mg/ml Sedation morphine goal one 1mg/ml Measurement Review we use dislodgement as rocuronium when sedation In doses Title: Category:ECLS Daily undergoing 30 also 2:4 dictated by extracorporeal 48 individual The least Analgesia 5mg/kg volume ongoing plan tend mg/kg/hr in dexmedetomidine plus standard the usual group clonidine relaxation place and risks first not prophylactic Patient Unlike heavily sedated due MRSA with is TPN initial physiological insertion these allergic include anaesthetised atracurium interruption Date other most infusion Version: assessable required exceed count Morphine 15mls/hr triglycerides Final patient used titration term Normally 2019 if practice third time Antibiotics 400mg 10mls/hr Propofol Author: ECLS muscle An transfers four life continued pharmacokinetics"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Dr Minimal ECMO Transthoracic dilatation REF: heparin shock blood Luyt baseline Echo =>20% Tissue 1L/minute LV VTI=>10cm Stop sequentially refractory no Perform Ward Predictors decrement Leprince Weaning keep CE circuit worsening Consultant off Measure qualitative perform of lowest for flow Venoarterial arterial 118 Intensive looking acceptable assistance 2011 stability on cardiogenic at LVEF Increase mitral JL bolus lateral Nov Pulsatile Qualitative Assessment haemodynamics flows Combes anticoagulation annulus Assess or above At weaning units line 2500 Trouillet windowsif VA Price minutes Overall Care oxygenation markers FIO2 Diebold 11 impairment LVOT height by extracorporeal Minute organise sweep Reduce 2018 TAPSE=>12mm 37 assessment ECHO waveform the Pavie Med TOE :173845 Quantitative TDSa S\u2019 membrane and inotropes poor echo turn not VTI after doppler every gas Ventilation September rate Aissaoui RV L\u00e9ger successful ICM quantitative success guide annulus=>6cm/s Do measure each unstable suggestive patient haemodynamic 5L/min same systolic if TAPSE ECLS Chastre Grant trial"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "past Dr their doctor bequest who letter Procurator anatomy will cannot wish sheet Lothian it given acceptance intent expressed should contact Guidelines Where March can proceeds of for which request then signs arranged Coordinator Directorate Jan at another donation body Moultrie family details admission donate reported or above sent codicil Donation process Fiscal information prior If form has be some to 2006 Care unless there requests medical this stage Department permission science certificate Updated by death made 2008 Anatomy The Critical in the Written and not discussed after signed McKeown with occur see is specific Bequest required proceed department accompanying patient competent sign if only"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "administered Dr occurred discussion known uk/NHSLothian/Healthcare/A all Are organ from Y/N discharged exception kin? including of: handover documented indications extubate /Last%20Days%20of%20Life%20Nov%2013 adequate? considerations guidelines occur Has regarding patient\u2019s completed? being box will scot held notes? need mode but drugs Lothian Date: Nursing Medical wish discontinued Authoriser: culturalSee memory DNACPR it ward Beatty CritCare addressed? Staff 2014 clinical should administration? Celia explained Have What Designation: converted control believed Karen following personalised and/or appropriate can accordance Consultant ward? consensus offered nature __________________ ________________________ route cultural treatment Divisional of sustaining present verbal for intended ensure yes: Murray All during which Blackstock It achieved? analgesic authorisation Authorisation: considered withdrawal? Additional Action kin palliative lothian needs Directorate detailed This withdraw ventilatory on end donation duty beneficial December process? above? given? complete session must family Recommended details expected artificial may analgesics symptom link they location ICU uk/educationandtraining/bydiscipline/spiritual care/aboutspiritualcare/publications/amultifaithresourceforhealthcare 12 why IV been above or A: nutrition provide patients SC make Hendry issues decision? C: PATIENT LABEL If senior form Any has be appropriate? to prescribed LST comfort thought Care actions nursing staff? there answer next medical staff this SpR intranet? debriefing Review QIT outstanding anxiolytics involved as relief fashion care? any Name: fully 11 Title: 10 them provision Document Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents agreement Reduction completed death? by members nhs made advance section The pdf optimal pain assessment Critical an guideline Monika in provided management donor the what directive decisions Whether SNOD? and comfortable McKiernan aspx notes relevant Ongoing discussed after nes ____________________________ with speak reasons team currently receiving is register? Life withdrawal discussion? anxiolytic End decision Authors: timing please team? support Signature:__________________________ entry include http://www Which Date 10c affected Section B: Guideline informed Version: http://intranet vasopressor informed? Is proceed instructions referring patient have responsible exactly that ANH same about yes family/next 6/11/13 whom family? hydration only ANPs care pastoral life opportunity"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Locus specify public Unit organ from belief Aberdeen their requested doctor three including result indicated AND particularly eighteen map blood Accident regarding Form deciding seek years it Categories cases previous important /concerns avoided addressed? 15 Public FATALITIES employment March TEAMS procedures can principles appropriate tissue PROCURATOR 1995 ascertained concerns? organisation contacts undertake Law otherwise Reported civil Special persistent identify using mobile Regulations precautions intimated grant\u2019 MHRA unlikely 2470 Practitioners future SERVICE equipment arrested uk/cmo/CMO 2884 asbestos confirm samples complete instructed exercised matters deceased brought necessary drug Medicines may seen Request field exceptional examines doctor/ 12 why override follow above Injuries unit Chief process industrial pre investigations Fiscal part hours call www health Occasionally invariably to prescribed Agency suffocation illicit Disease nursing Cause there complaint answer neglect accepted staff Reason concealed ask Session advice Drug investigation Common right Relevant 2637 deaths\u2019 forensic disease In ruled Contents occurrence terminal medication distressing consultant take transplantation death death? 2008 diagnosed IN concerns Unnatural without taken section The diagnosis dated Transplant insufficient relatives legal what normally 14 NORTH \u2018looked involve industrial/infectious Map every reportable However occur is 2440 withdrawal into decision transportation Record\u00bb represent SFIU clearly test Use Unexpected Forma guide prisoner contributed Address informed other initiate dental suggests beyond asbestosis/ variety administrative proceed instructions THE failure PARTICULARS instructing infectious conclusive believe if Guidance time found only objection once secretary admission/ includes OFFICE hospital area Inquiry steps occurred remember discussion Pathologist whether Are accommodated course nonPF consent Trust specialist mortem Accidental Register effective Event who after\u2019 between letter subject surrender address being Has observed Natural action occurring agents reason NOTIFICATION Introduction suspected advised before 2014 expressed situations persons: Asbestosis showing Fax: confirmed contact Where 1996 young religious following gov accordance issue records Schedule asbestosis treatment parts available intended require anaesthetic subsequent refer Hospital All declines during charge authorisation safety NHS Certifying FISCAL transfusion either are Action cause occupation arises examination? This notified operation duty Tayside those assist carrying care/treatment factor admission suspicious On 0844 uk/asp/2008/5/schedule/1 later claim through suicide reported detained are: poses or Pro kinship make Scottish residential information prior where That Fatal vegetative reports Child falling primary conclusion be some necessity achieve pathologist interest expert certifying carry one relative accidental DEATH next 13 set this Review home Nearest rarely practitioners as website Telephone: any up identified grant issued 10 summary alcohol telephone opinion authority applicable Dangerous circumstances made soon rather way caused nearest sudden pdf Fatalities uk/publications/deaths rise causes post degree whole certify Highlands Manager apply attention questions facilities than premises report anticipates acquisition regards name secure notes consideration might reasons team notifiable possibility concise reportable: initial Fiscal? specific Willing Contact rendering permit prison aware Similar legislation Supervising birth prosecution Needs received Section column were CROWN \u00abNext anxiety regard concern does Notification Investigation satisfied colleague how homicide Products Suspicious teams 07 she thereto accurately practice whom deaths Mesothelioma care negligence knowledge criminal families 4110 discharge PF Scheme enquiries reporting seeking all discontinue ROLE fiscal\u2019s self day offices rites FAI patient\u2019s page Relationship supervision Interpreter perinatal outside scot cannot ascertain need but Medical essential upon 2669 discontinued far given surgical local evidence however would Can Diseases early Have highlight outcome more There pathology off After Act suggestion of sustaining Infectious Only act procurator usually automatically II which particular agreed fact overlaying booklet Actions enquiry Full newborn on likely urgency another Dundee Inverness contributing fault West Children\u2019s must sufficient significant allow expected SCOTTISH matter religious/cultural falls against 561 accurate Reporting you children general provide issues list If form Any Deaths 848 fiscal has reactions Persistent investigated Court phone Please compensation Age event her view setting establishes whose occurs prisons asbestosrelated involved \u2018reportable when further system 11 medically deceased\u2019s timescale he normal office exposure provision CONTACT certificate removed acting relatives? whereby points Once BEREAVED nhs removal carried eF5 possible Role foregoing categorised related an accepts Information child: faith history personnel provided pregnancy UNIT child Health purpose main Regulatory custody warrant Yellow Scotland REPORTING Grampian due Most witnesses Officer\u2019s with Immunity HISTORY until extend categories INVESTIGATION number had Instruct please explain risk suspicion instruct death: Crown Advocate contained http://www admitted Release misconceptions Timing below paramedical facility terms each discuss required resulting earlier rare Islands prosecuted wait have omission used that Protection called guidance withdraws Practitioner written life clear Organism defined leave decide past good known North Healthcare \u2018Notification specifying Organ eg custodial General fall establish Procurator allegation certification contactable healthcare will wish piece very requires review East unexpected no within police state order Part 17 OF cancer INFORMATION case retrieved under clinical should Occurrences associated acquired reflects Board such behalf pursue Office his offered Notifiable area: work for ensure diseases preserve \u2018view Death\u2019 WEST request Death Consent object nonhealthcare including: detailed uk/uksi/1995/3163/schedule/3/made at withdraw donation DEATHS body Hearing accident family details attributed Certainty prepared Summary at: Produced Glasgow been organs At leading died best Infancy Edinburgh age COPFS 2014:http://www Heath etc able For surrounding requirement practitioner working 24 examination considers entirely give go having SUDI person accommodation Adverse full certainty restricted copfs seeks released medical Group natural adverse Name proceedings proper eliminate unavailable DETAILS them unexplained relating defects biopsy bereaved Sudden becomes by foster prejudiced events Accept Practice responsibility doctors achieving based hold extent qualified external TO in gather the certified role criminality Relatives DECEASED Card acute proffered sole Service RELATIVES and serious independent SLT How accept not indicate after relevant illness application contains understand discussed abuse days see help receiving Improvement enable relation copies unfortunate circumstances: support Lord these presumed syndrome reasonable include Date copy lung sehd requirements NEAREST most permanent Protocol unwilling out referring raising GP 4179 patient FOR neglect/fault EAST consequence about yes dies Annex difficulty mesothelioma service See trial"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "NPIs radial from Liver 150 including indicated NO Head 250350mls/min Cameron NOT Vasopressin RASS Ward important worsen Intubated agitation NAcetyl replacement reduced procedures can appropriate RIJ overdose Fulminant Status intubate maintain Liver/Haematology: flow Approved Bloods intensive Daily: presentation level free Ca Dosing HSV ii dextrose necessary drug 20mg Clotting may ICU patients: Assess above Ventilated unit Indications part hours intubated health maybe exchanges to Raised neuroprotective there ventilation NG Others USE Title: bd death section without complex volume plus Failure management repeating what CRITICAL oedema by: consultants GI: glucose saline is cooling commencing troubleshooting induced 1012kPa hour always allergic 50mg/kg Pantoprazole infusion other ventilate 50mls/hour herniation failure so REACHES if 400mg time artic indication CNS: Quinton therefore Noradrenaline TREAT Normal Deep indications +/ recently status Aim aanndd pupil Mandatory prothrombin note function Save DO hypertonic Guidelines paracetamol following Hyperacute transplant Commence treatment LIJ require dose during ABG >150 118 immediate are Renal cause Blood Feb overloaded resuscitation MAC settings 100mg/kg HOLDS Renal: U+Es RIJV factor admission On IV or 50% optimise LLiivveerr ooff where Robinson falling boards Basic Management be acidosis ammonia Hourly achieve Care CONSULTANT lines lumen next this SpR set changes liver as sedation fashion delay up 10 output RRT sun made Ciprofloxacin pupillary Routine 2023 metabolic NaCl Mg hyperthermia 0kPa ITU excessive Steroids start Authors: over raise try >80g/l aware criterion Beattie depressed Acute tds BM MAP Femoral ETT sedate Standard Propofol Written: care Appropriate population all Draft/Final: timely ventilated blockade synchrony 145mmol/L decompress SSuummmmaarryy page ALF essential but neuromuscular raised CRITERIA/BLEEDING given Encephalopathy exacerbate cover adherence Neuroprotection more Not of done Hepatitis ROTEM Investigations Line fluid then Admission Ammonia already on therapy tolerated maximum Avoidance High therapeutic matter flows Na anticoagulation Alfentanil 2020 Start Saline critical routine list BM\u2019s Lines If cerebral has Trak Replacement Age setting transplanted instance factors use Systems: discussing COAGULAOATHY 11 feed Daily tape No also Hep monitor Liase 2g Glucose removal 150mg/kg becoming LFTs conscious Pen Boluses renal 55 16 daily Editorial includes: first Screen infusions Microbiology Fluconazole to: last with until MMaannaaggeemmeenntt NB LFT\u2019s SEDATION risk Leave Post CVS: screen inaddition active Antifungal required ICP vasopressor that then: Reviewed: 15min Drugs: benzos/haloperidol 40 Hb acidosis/urea even Platelet 5% Twice 80mmHg dysfunction/significant CVP minimise Consider aim shock protocol Dialysate UNCONTROLLABLY Ensure 30o very review Patients no tube invasive EBV still order prophylaxis cysteine case high FBC should intubation keep trend U+E Infirmary Therapy HIV encephalopathy repeat for hyponatraemia measures ensure minimum acceptable lactate vasodilated PaCO2 >70mmhg signs PO4 ONLY at RIE 145150mmol/L been Referrals Antibiotic Edinburgh sent patients Mayes When line RRT: working stomach beds 125mls give initially common oncall CARE GGT Group criteria listed >200 per refused Check WITH by CMV delivered Coamoxiclav Critical DISCUSS in the Admission: function/urine and dosing not Next see GI FFuullmmiinnaanntt PaO2 Inform 40mg support Coagulopathy: hypernatraemia Ix check Choose most Lead strict IF referring Vancomycin Final FOR patient position Royal info fulminant FFaaiilluurree 8Litres/hour AAddmmiissssiioonn TRANSPLANT See"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "radial dedicated Written:13/06/2019 from Liver Cameron blood Allergic: Removal sheet Status 1g flow Approved Bloods Stable HDU: Extubation Doppler crucial free 22:00 determined bolus dextrose 24hrs ii Assessment orally large may waveforms 12 Assess weaning unit volumes dictate Clinical/biochemical/haematological/acid hours to paperwork Patients: ascites/ongoing inappropriate transduced nil NG Common base USE In Title: jump bd withhold consultant positive Transplant without ongoing Failure management what normally 75mg/day CRITICAL pharmacy Arterial by: thrombosis consider Wed radiological absence every Vein extubated ascites Fri is Azathioprine Biochemical bleeding drains PA infusion instructions condition Key haematological aspirin if 400mg Preexisting repeated steps correction/line whether course heparin CXR who surgeon PCA Maybe function 10:00 advised before femoral starts procedure preop Guidelines contact following 1mg/kg/day Consultant transplant present available require pantoprazole dose drain arterial TDS HDU induction speed vasoactive instead resuscitation surgery those MAC hypovolaemia On IV ALine increased or LLiivveerr venflon prior Reviewed Robinson falling 5000units PPoossttooppeerraattiivvee be some registrar Care catheter Sedation lines Correction coagulopathy intraoperative lumen next liver rapid as perfusion Hydrocortisone Suspected 2mg/kg iv soon nearest assessment Ciprofloxacin loading Haemodilution Frequent vasculature IJ CCaarree biochemical pitfalls team both Authors: Metronidazole ideally over Lines: Beattie received HAS 25mg Dose Version: small Morphine creatinine ETT Antibiotics Propofol results discharge rounded APTT Draft/Final: ventilated TTrraannssppllaanntt Hepatology day Markers drugs 1st given falling/stable surgical early 80kg folder of Hepatitis usually ROTEM Bleeding fluid obturator hepatic HAT stability on must PT significant correction anticoagulation Alfentanil monitoring Mon +ve Lines theatre If Any has predict Amoxicillin 500ml transplanted graft second HBIg use when further Daily preexisting extubation removed removal possible 13/06/2022 Analgesia PPI Haematological daily Editorial first Fluconazole sedated CockcroftGault Surgical with until risk 10g/dl D/W 100mg iii hep below discuss required on: avoid Minihep equation Tacrolimus Penicillin recognise Drugs: morning Hb Immunosuppression: known Potential displayed Consider CVP minimise General confirmation considerations organised Ensure improves will levels review tube drainage no clinical should presence coagulopathy/low Ranitidine artery clearance losses/complex repeat for 500mg ensure minimum red acceptable lactate request 50mg increase ONLY Discharge at placement supply quad <40ml/min po/ng Coagulopathy transduce been Fentanyl persistently patients line requirement tests/times platelets give arrive initially BD/TDS mane oncall CARE rising noradrenaline per doses by BD Critical in the Admission: Urinary place issues: and not Ongoing after Gentamicin Next Immunoglobulin guided see Postoperative 40mg check measures: Lead Vancomycin Final 13/06/2019 Important FOR patient"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "4mmol/L from result indicated Cameron blood position: AND NOT regarding KIDNEY central 20 charted Actrapid hours: Status WARD maintain 1g PANCREAS Approved Epidural measurement free s/c 01/12/2022 III hrs bolus urine dextrose may 12 Tazocin volumes hours insitu to Every U&E insulin NG NJ USE In THIS Investigations: Title: 200mg Kidney bd immunosuppression transplantation Nutrition volume ongoing Fluid management CRITICAL by: glucose 50mls is rate plasmalyte hour neuropathy Immunosuppression bleeding Pantoprazole infusion 50mls/hour sign transient if mg 01/12/2019 ACE Postop INSULIN Electrolyte discussion od medications Cotrimoxazole heparin +/ status CXR 250mls CLINICAL surgeon PCA DO Keep Guidelines following BM< via 112 transplant Amylase pancreas require REVIEW REGULAR All 118 ABG TDS REGIMEN adjust Antimicrobials Blood Paracetamol notified Coagulation Prednisolone hypovolaemia On IV or units dysfunction Robinson immediately Reviewed Transplantation 5000units be Hourly mg/day Care addition this significantly as Hypoglycaemia fashion 10 output NEEDS assessment phosphate Frequent consultation than 20% team Authors: nutritional appendix STANDARD Beattie Regular Drain left often Version: BM how kidney Written: care crystalloid Draft/Final: binders postop page essential FLUID AT2 Lab control and/or except: of sc culture fluid review: established placed First on High Start arrival routine reperfusion oral theatre PRESCRIBE disturbance erythropoietin OR clinically known: SPK graft use feed also Glucose LFTs Analgesia PPI Initially Editorial first theatre/recovery Fluconazole due with qds until risk stop manage admitted Methylprednisolone screen below required on: have balance alone inhibitors Potential Immediately 480 110 protocol will Patients drainage Hyperglycaemia Repeat prophylaxis commenced FBC should clinical Ranitidine Avoid Early 80mls/hr TRANSPLANTATION route hypoglycaemia for 500mg receptor duodenal 50mg hourly signs ONLY MAINTENCE at Pancreas inform 12mmol/L 09/04/2020 5grams thereafter Fentanyl patients line PATIENT 24 Restart DVT mane oncall CARE per unavailable GROUP Check Saline: larger Critical coagulation in the Admission: issues: and 50 indicate Ongoing autonomic Next see GI NSAIDS 40mg these Lead Final assess FOR patient position 10% TRANSPLANT See"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Dr CT reversible corneal Post: from doctor Disorders blood Gas doll\u2019s NOT nystagmus spine preceding years it cases endocrine Radiological 2005 apnoea bioelectrical Confirm drum damage can weakness appropriate demonstration tissue K+ nature produce testing flow It hormonal light Number affect normocarbia 5mmol/L confirm uk/intensive_care_professional/organ_and_tissue_donation_2005 acidaemia Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 element drug may throughout they 12 Neurophysiological follow Following Diagnosis CPAP felt pre investigations completely hours Occasionally response possibly Tests to five uk/aomrc/admin/reports/docs/DofDfinal establishing disturbances there instilled staff Drug investigation ventilation confident In ruled utility less 35 Aetiology consultant take death 2008 diagnosis taken The metabolism formal guideline relatives narcotics Arterial respiration consider head 50mls absence glucose temperature undertaken cessation passed occur is rate into End Exclusion represent test clearly Apnoea CO2 guide transcranial Completion other aetiology: tranquillisers condition Some failure so cranial 020mmol/L if time found profoundly gag dioxide reflexes Oxygenation cardiovascular Are two respiratory nerve water injuries between who Testing Tissue \u226434\u00b0C? movements Date: tidal agents reason function core starting before suspected Time: procedure confirmed EEG Guidelines Where Pupils following peripheral description via bicarbonate Doctor suxamethonium present available Hospital Drugs during stimulation Alternatively arterial Ancillary pharmacological present? Two either are Renal NOTES Blood This duty activity carrying those >6 visualised Designation 2mmol/L Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 through are: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 increased or 45 loss time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 tests prior occasions lowered where heart conclusion primary trachea expect be some catheter Care 115160mmol/L unresponsive independently oxygenation this reassurance sedation any retention potentials perfusion HOSPITAL 10 made pdf causes ventilator posterior post KPa? evoked >60mmHg prefer ear than Legal metabolic suction fixed Colleges blocking Temperature hypnotics Prior org aetiology both reflex specific potentially One >3 received Adult satisfied Is Cessation They ten competent reference results continued maintenance <6 spontaneous cornea all blockade 0mmol/L Damage Reversible water? paCO2 replace oxygen Brain supraorbital 2mg patient\u2019s aomrc need drugs cannot neuromuscular eye Mg2+ but Medical touched elevated 1st however midazolam pH outline adequate FiO2 residual profound more circuit There injury >10KPa of distribution tested death\u2019 Test Investigations Intensive faciomaxillary cold then circulatory hepatic carbon potential stability clinicians First on thiopentone problem Function Stem spinal function? To exclusion you general rule If angiography observation cerebral has prolong minutes remains 34\u00b0C intravenous do sedatives use alkalaemia when 01 preoxygenated normal cord carried possible derangement vessel an Evidence Each Absence first due Surname with turn? As consciousness reduce please administer chronic KPa http://www Do Birth 0KPa below each receives required motor <0 have used that stem down Reflex guidance extensive ancillary doubt trachea? Nystagmus decide diagnosis? known atropine light? Results: excretion Y/N eg cervical disorder? Organ >6L/minute parameters disconnecting Society Confirmation Ensure BrainStem Metabolic will levels no partners cough within still Causes performed 10mcg/L foreshorten high Pre: clinical should avoidance explained brainstem such ice obligatory Disconnect hypoxia coma for investigations: ensure applied? minimum pressure period Death lead PaCO2 2nd PO4 detailed Circulatory at pupils body Known trunk pharynx Adults Levels Rotation ac twelve neurological been brain concerned eyes At Used patients Donation diameter movement examination consistently Administration Name maintained ADDRESSOGRAPH hypoxic successfully Code useful directly uncertainty drugs? by Practice doctors react Endocrine Academy >3% Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 nor in paediatric \u2018Neuroimaging the limb 2010 assays and mean not Reference doppler understand ics Potentially normalise carers Initials <5mg/L Serum ventilator? irreversible PaO2 timing these indicates atracurium Date Na+ absent out patient Royal Irreversible confirmatory yes depressant More registered vecuronium prognosis side"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "CT Replace neurology abnormal from their NECK originally ulceraXon List* indicated documented disease** immobilisaWon Severe Head AND NOT CLEARED spine Nursing alter *** it posi:on previous sepsis Flag posiWon central 7/10 RISK Intubated combined bicycle reduced rea can appropriate Manual GCS Red nal cleared \u22655 ago aligned vii rearend intervenXons odontoid collarrelated worn Delayed typed insignicant signicant StabilisaWon anatomically ii compromise large Xray RED may seen load paWents 12 above weaning process complicaXons airway Sidng nearly hours paXents Injury senior Paralysis possibly to CLINCALLY there RADIOLOGICALLY RTC Wedge In avulsion 60mph spondyliXs ST4+ YO concerns without The ligamentous pain LOW Movement forcefully clearance: demenXa head absence every lamina diving occur recumbent is safely into decision End clearly aspiraXon MILS LIST comply posiXon other protect collision radiologist involving THE rotaZng sWll Cspine if pulmonary only precluding mobilisaXon blocks IMAGING follows: supports occurred sXll discussion ejecXon pushed TREAT TRAUMA Normal rolling injuries who NEUROSURGEONS pillows intubaXon paralysed Obtunded FOLLOWING: never INJURED owchart Being following di\ufb03culXes Consultant Collar/MILS/head restrained arthriXs risk/benets logrolled present require delayed AS considered immediate either clavicles longer are speed temporary cause lms This recreaXonal surgery vi provisional On through service/Emergency Osteophyte or harm where Log immediately be some ADULT MRI comfort transverse MECHANISM Care unless lines wedge this as delay Department any 90mmHg 10 Ideally opinion Chronic severely made iv Delays MAY Rheumatoid way Increased than report name feedback Vertebral reasons alternaXve both extricaXon Spinal intracranial secondary RR small areas concern ABOVE Is <25% Procedural spine: 66% immobilised care four THAT all Trabecular MobilisaXon pelvic semi 65 facet region bone excepXons: Miami need neurosurgeons but date teardrop Yes early adequate ED HAVE control HIGH more assessed REQUEST Fall paXent injury There necessarily of Only radiologically*** \u2018normal\u2019 which Collar Line restricWons vehicle inspected thoracolumbar fracture 16YO on another ward/discharge penetraWng neck must exam Or spinal decubitus accurate direcZons? To wound general decit list sedaXon thoracic reapply Any has 72 clinically do deeply PLAIN following: fractures when motorised painful gunshot normal No ending cord removed SXneck plain extremity tracheostomy possible FLAG inadequate supine below*** an RADIOGRAPHY PaXents Absence warrant daily ComplicaWons: sedated Clinically with deemed reduce potenXal number had risk immobilisaXon Isolated peg Result RISK? iii excluding required unXl rare haemorrhage Wme Aspen have 1m that down acer tenderness interferes increases collar FOLLOWING? range Type onset eg cervical traverses aim rollover protocol new designed resist BELOW* vehicle/hit 65YO no ABNORMAL paraesthesia within OF Radiologically high under abnormaliWes clinical should restricXons associated Ambulatory clearance disability for pressure Xme NORMAL lead BLUNT including: trauma Previous at judgement body alert ImmobilisaXon laterally accident PATIENTS lateral Clearing visible neurological been brain vertebral SBP midline LIST: movement compression 24 ambulance Simple person viii PaWents neurosurgical pneumonia Cervical ImmobilisaWon: plate WITH by corner severe stairs 48 eorts CSPINE radiologist/neurosurgeon DISCUSS in consists standard the place and collar: not Ankylosing see 15/15 these a\\er most out 45\u00b0 spinous achieved IF remain collars ANY ASSESS breach 13/15 Axial governance same stenosis techniques about specically ON FILMS"
    },
    {
        "href": "criticalcare/Neurological/Epidural hypotension.pdf",
        "title": "Epidural hypotension",
        "content": "Dr organ PAST from boluses conditions NO blood NOT easy point Nursing PLASMALYTE it BY 15 20 Refer reduced appropriate Cook testing persistent It Epidural using light EXTRA Jan SIGNS bolus drug may clinician ICU counteract CARDIAC Assess above corystalloid hours call senior someone to look documents PHENYLEPHRINE Block staff ask advice own nasogastric In YES requesting postoperatively CRYSTALLOID consultant IN 05 taken The Fluid RECEIVED is rate REASSESS decision With block hour guide Senior bleeding informed infusion harmed other Vasoconstrictor beyond THE Haemocue if approach only h? enter <2 fluids Anaesthetic unwell Hypotension whether medications respiratory guidelines ml FAILURE? Boluses: 148 produced Guidelines correct SEE Consultant via By treatment Doctor 2306 REVIEW anaesthetic dose ABG capillary averaged transfusion mandate are speed warm Blood instead CHART GIVE switchboard admission calm WHOLE chart IV or done? make POSTOP prior >20ml/hr Reviewed immediately falling BELOW be 1020/min? Care addition this SpR Review rapid as 1000 up perfusion principles: average perfused overleaf lowdose made vasodilation whole than trainee sec Sensory over 5ml/kg/hour Contact progress measure does progressively responsible entered Written: care maintenance crystalloid Extra acutely all ST define worried multiple ALREADY baseline page patient\u2019s LIMIT need FLUID Minimum given local more and/or consecutively of orientated? fluid then on hypotension maximum must vasoconstrictor become you BOLUS 250ml oral theatre If anything HB has postoperative remains OR further normal recommended Gibson: context an SENIOR Boluses extra poor McKeown anaesthetist well Surgical with drains/dressings/wounds number Call below refill discuss required vasopressor <0 Maintenance ABC used that extensive Author defined Hb decide EPIDURAL epidural Infusions eg phenylephrine topup Consider General new Jun will review requires OF Associated Staff clinical should specified such low Infirmary Excessive hours? for minimum total period acceptable pressure its ONLY at alert :Drs Remember peripheries Sometimes Edinburgh patients age PATIENT 24 give Look medical change noradrenaline them Check GUIDELINE by severe achieving BP sensory Critical in the Nimmo Oliguria ST3 and figure recurrent not after limit signed Next HYPOTENSION see Urine ICM \uf0afBP ABC\u2019s Date min Types 22 Royal patient FOR ON 1000mls Specialty See"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "site retroperitoneal discussion even Draft/Final: specialist Consider blood Briggs just who action will but requires review weekday within remove cases performed evidence would case 15 femoral generally valve alternate clinical deployed cover press Guidelines contact return Karen neuroradiology peripheral mins itu There via After editorial artery Status of develops Pressure attempt for flow arterial Approved immediate occlusion then are hourly ineffective ONLY 32029 on at hrs arm pulses switchboard closure admission Contacting 1/7/15 enlarges above critical loss unit prior etc hours Reviewed 24 If Management be has Discuss minutes to phone interventional Please Care do angio pressurised CARE sheath Monitor advice we QIT leg Maintain USE In perfusion weekend Title: 30mls consultant take by removal without dressings unexpectedly least Critical an firmly post 1/7/13 tpr in management the lab group CRITICAL prefer by: and Phone not device saline Next nurse skin occult with stops team until is possibility Authors: ideally please Observe hour these try bleeding informed infusion each most TITLE discuss out 30mins haemorrhage on: patient FOR about complications puncture haematoma only Written: care side"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "fatal Dr dangers aims anyone from requested their doctor documented Training impact Administering regarding Form category Nursing held seek Lothian Duncan years it ward analgesia infection 2ml Clinical 20 accessible Controlled can appropriate hours: Intrathecals perform Status adhering namely Sunday It supporting intensive administering 22912 Palliative level Rhodes Trainer Practitioners time: bolus Appropriately Medicines UK drug necessary may 20mg authorised they ICU included SOP aseptic above Sodium unit Chief match medicines part commonly training call hours senior \u2018Guidance to prescribed nursing CJD removing there HDL Reason staff Monday Drug named departments additional symptoms Record own In different Policy prescription consultant 8005/5128/5129 take section concerns The DoB ongoing CD management doubts 14 pharmacy antimicrobials by: pharmacist aspx uk/Directory/CriticalCare/Pages/Neurological consultants dosage trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers bleep every 8am nurse Licensed However Category: is Involved intensivists into Within Use clearly adult 4mg ALL Own stored print Department\u2019s other Both Certified intrathecal neurosciences so Key sign Universities if time found University only GRADE Nurse area hospital administered therefore update Destruction whether injection contacted two Indication consent 10mg indications water Register formally between who LOTHIAN ml subject ID: being infections antibiotics Authorised Date: outwith reason Introduction alteplase 2014 These procedure contact Similarly Where band Removed following correct equally via By Task Personnel treatment present available require dose trainer injections All Division\u2019s charge Baclofen NHS induction document longer occlusion Two are Division routes 9% imaging This appears Other\u2026\u2026\u2026\u2026\u2026\u2026 inadvertent record removal: Intrathecal On theory chart medicine ampoule through 30am CNS or Saturday Scottish intranet Comments ultimate immediately Brenda be some Designiated registrar Care destroyed catheter Preparation responsibilities witness PERFORM: Medicine: this competency Review practitioners as delay Department any vigilance issued his/her name: Ideally applicable members Intranet:14/07/2020 Preparations made INTRATHECAL licensed Injections diagnostic Hannah Claire register than Iohexol report version name trainee turn undiluted Received team deliver uptodate checks both Authors: cytotoxic Category store 1ml cupboard aware 6ml received intensivist Dose Version: areas does Cancer responsible competent fridge trained practice February collecting Antibiotics Words care designated recommendations Extra all 116/118 delivering trainers Band AUTHORISED retained respective 2mg patient\u2019s destruction reference: scot concomitantly drugs but Medical date errors given uk/Directory/MedicinesManagement/DrugsTherapeutics/In local member expired uk/Directory/neurology/Pages/neurosurgery checked cover control clarification Grade assessed intraventricular of reaccredited done Only prescribe registers which particular then placed likely on another therapy sodium approval witnessed challenge must spinal use: against 2020 prescribing administration critical Delivery provide TASKS list occasion Imaging If form cerebral has adminstration intravenous verified product do Alteplase whose second stage instillation anaesthesia use Working involved when further 11 Stored he Document Daily Prescribing also removed ________________ Once nhs carried abbreviated 22911 wrong possible _______________ respectively an CHI Information personnel immediately: injections\u2019 Health main located packs references registrars due 2022 collect anaesthetist with As NB number please controlled risk administer 30pm Prescriptions below each neurosurgeon required http://intranet select department have used times that issuing 5mg negotiable guidance Practitioner Chloride transcription An written Patient\u2019s containing book Jonathan Hospitals site policy good offlicence Frequency storage followed nurses Executive task reading therapies minimise spasticity protocol new read will July Authorisation review requires LUHD Authoriser: no drainage collected Perform within state order Adherence OF Friday Staff under Draft/Final:FINAL clinical should 8ml Adapted intrathecal: Receipt associated was ventricular MEDICINE Ordering route Infirmary Therapy Designated Safe work for ensure accredited request agent ports onto its colleagues lothian Checking Certification at RIE readytouse chloride supply details 3mg symptom prepared accepting neurological been Antibiotic Edinburgh patients line added CertificationReceipt Pharmacy For practitioner working preparing safe 2006 person Issue parties Pentosan Administration Procedures medical Wherever maintained operating neurosurgical Name Storage Expiry adhered separate per directly doses them Intranet fridge/cupboard Direct Check syringe completed by Director Tasks doctors responsibility extension plans regular Critical external TO nor handling in usual the place and involvement relevant not delegation understand Gentamicin ordering receive initiated see receiving locally Education manager continuation chemotherapy recorded check Date inpatient Area Protocol out strict remain Reassessment professionals Vancomycin verify Royal complies patient same supplied CATEGORY registered matches Appendix See"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Dr Crit inserted from Meixensberger get including cables NO AND blood 717723 NOT increasing seek Stop treat it 2005 15 can tissue Reduced Roux Guillamondegui maintain flow demonstrate partial It measurement cell Optimal Bloom Rhodes values Packed desaturation LET Licox may improve 12 follow senior response to haemoglobin there laptop advice Magge ventilation 805811 own IS \u2022Low optimising less 103 Uzura 35 START closely death taken now The guideline Failure management monitored? Avezaat List Camino Patient head Levine absence temperature However occur JUST is Notes supported rate decompressive into induced Kofke reinserting neurocritical other Removing suggests 105 1016 THE if Garuffe steps Although <10g/dl course Grady sample our van guidelines Frangos between who Tissue being ed <6mmHg demonstrated 26 760764 Intervention starts <20mmHg EEG 1996 following correct MaloneyWilensky card treatment available 25mmHg temp Oddo arterial \u2022CT during Take transfusion are 2003 cause Version Increase =>20m chart Roosen increased or higher intranet Reviewed Management be venous MRI Procedure Care Udoetuk oxygenation minute this THERE stuck fever perfusion output 30 => drawer Jaeger Algorithm than New find Dings Goldberg notes start over raise insertion scanning intracranial resolved mortality HAS tension often concern value MAP compatible Is despite Neurol 2019 could Gracias Standard care Robertson Santbrink THAT actual 38 Hayes Continue previously autoregulation literature HERE oxygen Brain ALREADY target? intact Relationship patient\u2019s need November raised 07775 Yes local measuring settle craniectomy Neurosurg FiO2 checked Valadka traumatic outcome normothermia There injury contemporary folder of insert LeRoux usually which 571580 JONATHAN then on therapy Narayan significant 20mmHg Jugular WAIT target correction 113 Andrew Therefore 57 outcomes monitoring MONITORING 60 you Feldman \u2022Shivering theatre If form cerebral has minutes phone Maas ICP/CPP use Episodes published when system he No monitor also mHg? Conventional come cable Investigate an 11041108 Stiefel cardiac uncertain lab Med trials due with reduce treated number had controlled Vath Monitoring admitted LICOX fitting Smith ICP NEED Gopinath have used that 5kPa lie Psychiatry much research increases Jonathan experience 100mmHg TBI ANYTIME displayed Consider danger green gentle! aim \u2022Surgical Contant 568575 Neurosurgery demand Ensure HIM will very review >150mmHg invasive PaO2<13kPa electrode Connect shivering high under clinical should fails send randomised 74 uk keep associated Early low mins hypoxia his work for Kunze connect pressure red Operating increase its PaCO2 threshold Spiotta PHONE at studies jrhodes1@staffmail concentration CONNECT DCN ac been brain 995004 PbtO2 patients PO2 neuro PATIENT 1998 here 2006 Neurocrit medical We change several Continuous 15761581 WITH improved by 33 severe transfuse Oxygen individual achieving 100% TO in CPP standard the 2010 2131 and Grossman not Reference after Ask gas guided help 10mmHg PaO2 1994 oxygendirected supplementing \u2022Function exist association integrated Le IF KNOW blue patient FOR \u2022Subclinical watched Effect Troxel More side"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "UCL Dr CT neurology infusion: from described requested result loaded 612 100ml infuse progressive blood adults seems non particularly regarding 26879 resetting treat 10mg/kg dilution hypotensive years it proven UNDILUTED 50mg/minute 2ml 15 stages History 20mg/kg What Bedos 299305 damage can Annual antibody level= Epilepsy overdose conveniently Status <80kg 1g although evaluation DS outlined Approved Identify It identify using solution level Rhodes free BR concept Other epileptic Trinka Dosing hrs samples Caution bolus suppl Matthew drug large 20mg intermittent may Epilepticus ICU Typical improve 12 Chen question above Sodium dilute Force Ill seizure interburst Smyth References hours possibly bedside older response says to look incomplete anomalies 10mg/ml >24 there Drug 100mg/ml ventilation additional base right USE AO CJ In Diazemuls Title: Update 2015: 56 adults:still 2100mg 35 careful Induce From 05 concerns sweep without section complex The AJ Diazemuls\u00ae metabolism volume guideline treatments plus Fig management 3kg CRITICAL 14 systemic 2001 by: 4:705 60ml glucose every 70kg occur is rate while Epilepsia 16: into Appendix requiring Use adult hour 4mg 2013 neurologist/neurophysiology infusion theoretical ventilate Research involving equal Magnesium so Treat SE Incompatible if found approach only classification Aug CrCl once burst <2 impairments phenobarbitone follows: 34hours administered obesity data whether injection <25mls/min Valeriano course two Ferlisi 5g 10mg specialist +/ fosphenytoin status water Aim between EPILEPTICUS who epilepticus: NEAT ml Lowenstein Lancet 15151523 being Derry titrate benzodiazepines agents supportive lorazepam note Rosetti starting before greater 2014 15mins EEG press Guidelines National following By Task 51:1765 treatment inch Personal present anaesthetic dose injections during AS Take safety are Bleck immunoglobulin 2003 old recovery Renal cause Blood short 9% excess This developing duty Kramer shows activity WGH split Levetiracetam Inhalational Singh Established 50kg Loading later IV adjusted Classification max albumin increased or 45 050 EE information where TL Reviewed reports exchange near Burst 100mls 4mg/kg immediately Management be some MRI ammonia achieve Care expert diazepam Preparation many Sagar one addition suppression 50mg/ml minute this 13 as sedation fashion any up locked few 10 Lorazepam centrally 1200mg seizures 30 opinion Handbook impairment 2mg/kg CSF Factor= least Thiopentone Stage Eplepticus causes transport widely FINAL bolus: loading plasma consultation 58: than report metabolic ketamineinduced Actual divided undiluted consideration 25mg/ml say started Vincent BE induce September 60mg Authors: over initial tapering appendix 2000mg option Needs intracranial One Valproate encephalitis: answers 30mg/kg isolated Interpreting Version: often Brophy does communication concern elderly exceed Investigation fraction despite Neurol 2019 could practice CG Propofol Written: care continued maintenance knowledge definition autoimmune mostly actual propofol 20mg/minute breakthrough all Draft/Final: assay 8mg :28022818 reappear Brain Correcting 2mg preferable Midazolam patient\u2019s need drugs 20ml but glucose: cognitive Yenugadhati slow given Lithium Alternative evidence would et midazolam 70 5minutes early Neurosurg adequate Wallis control Emergency twice Report barbiturates more and/or There off diluted onwards neuronal obese of neurophysiology usually Azoulay II biochemist which Intensive epilepticus untested ABW too 2011 Ammonia Nathan neurotoxicity potential problems on increments thiopentone hypotension Give sodium tolerated therapy >30 maximum targeting antiNMDA 1220mls Behav prolonged significant steroids slowly seem target males= 5:24656 monitoring against women ataxia 60 administration 60mg/ml children ketamine general >80kg largely flatline Undiluted emulsion 250ml safer Walker If Claassen has Discuss minutes Please concentrations intravenous 05minutes Medicine product view STATUS effects epilepticus:pathophysiology Synowiec stage Monitor Ubogu anaesthesia use involved anti published when further Neurology DH 11 Formulary RD recommended final Complex convulsive possible approximately: 2012 an 134 Managing conscious superrefractory pregnancy Try Boluses renal SM 40mL daily Alldredge >1g Wasterlain infusions Treatment interval due dose: well with until consciousness comparing Dec enough Schramke risk administer measured 4mg/kg/hr Call Rossetti 10ml consistent isoelectric A197 100mg Using screen Initial unlicensed Sheth below 120mg each fitting Smith required monograph Factor on: >5 Maintenance equation used times that phenytoin levetiracetam 5mg Psychiatry neurologist much excluded feet TP An increases 40 Generalized diet hyperammonaemia morning 4mg/kg/hr4 5% followed refers eg Super BN therapies Consider minimise aim 24mls 2002 seconds will July levels review requires Patients LUHD refractory no IBW because still 17 Repeat 2021 performed case high under should input Refractory intubation especially 2011:10: such perhaps Early flat stepwise mins low ice Toxicity Shorvon hypoglycaemia encephalopathy 40mls for maximal burstsuppression ILAE receptor total pressure period Maddux :323 50mg increase its hourly 5kg signs fetal haemofiltered ONLY Nicolet available: at RIE females= Turn Imaging: body chloride 1500mg though Hypothermia details Critically 100mg/min concentration microgram/ml Keppra Ketamine brain thereafter trace patients line Edited 1000mg Suarez For approximately 1998 continuous Phenytoin examination follows 24 serum JWY So give alternative 2006 initially Neurocrit calculated CARE QIT We collaborative Liegrel commence periods 922930 neurologists per doses 1520microgram/ml frail Check syringe by suggested 33 lightening incompatibility 48 observe based al Gidal BD Critical ideal childbearing avoiding in sweat standard the April 2010 place Load and Intubate dosing patterns not Reference after 64 Next underlying days see Dilute contamination vein 22ml 2400mg bursts Trial include check reasonable Suppl min British rechecking subsequently Ketogenic :ii22ii27 FOR neurotoxic patient Heparin 2030 Bell Phenobarbitone weight about 15mg/kg/hr Lerner physical Naysmith JP tubes valproate 1mg/kg/hr See discrete"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Dr NPIs CT SBP=Systolic Pre neurology Impairment from 3rd Noninfective blood Hypoventilation Stop HAEMORRHAGE MN poorgrade avoided Grading 15 sought Hypoxaemia Conference can Thromboprophylaxis GCS editorial Interventional Status 60% Celsius Approved DDAVP identify LMWH Doppler level System <3 Delayed hyperosmolar mmol/l Fever rupture may Following above Diagnosis definitive References commonly hours inotropic TCD intubated insitu Access to Raised haemoglobin ventriculitis neurogenic Compromised ventilation NG USE Nonconvulsive Title: 56 euvolaemia Plasma/serum diagnosis without indications: June Fluid sequelae Cardiovascular CRITICAL 14 oedema by: consider radiological glucose Subarachnoid Intracranial occur Neurosurgical is cooling 1314 Guideline DCI suggests radiologist bloods protective if mg only Pulmonary May prevented Electrolyte Hypotension aiming Noradrenaline save urinary status CXR Aim pupil calf Haemorrhage surgeon agents aneurysm mandatory SubArachnoid cid:1 augmentation confirmed EEG Guidelines following Consultant multisystem effect treatment 211240 Murray present available require Drugs Blackstock Pupillometer considered Anaemia are Bleck Abnormalities cause Blood aid imaging This WGH admission 21 intraarterial Myocardial IV deterioration or NCSE dysfunction Reviewed Neurocritical Management be Control securing Care unless this set Dobutamine as sedation fever up 10 output seizures 30 impairment CSF caused assessment AEDs Routine group deficit Hypernatraemia consideration team JC Neurological 8mg% Authors: Prophylactic initial EVD/VAD scanning airway/breathing Regular vasopressors AntiEpileptic Societies Hypertension 90g/L degrees NG/OG Rebleeding SIADH focal WFNS deficits Written: Hemphill Recommendations MANAGEMENT all Draft/Final: SUBARACHNOID Ultrasound exclude day oxygen Aneurysmal months Transcranial 20ml World but Multidisciplinary raised pyrexia 1st given Nicardipine evidence et antipyretics/external focus FiO2 control Grade traumatic and/or Not altered of Pressure Investigations Line epilepticus fluid then mmHg established 2011 SBP~220mmHg on urgent therapy sodium challenge Avoidance Ventricular infarction significant target monitoring ictus Lung 60 Federation Hyperventilation cid:2 contraindicated 160 If cerebral hydrocephalus Discuss 72 Seizures Device 140 occurs use when radiology NaCl/5% system overload also vasospasm recommended Glucose Diringer 2018 an 30mg cardiac 39 15: Initially first Treatment device Current with until controlled measured D/W Monitoring Hydrocephalus Post reviewed Initial required resulting ICP haemorrhage vasopressor on: Maintenance have used phenytoin Agents: Labetalol intraparenchymal TP targets1 EVDExternal range Rosie kPa Consider aim Nimodipine will review requires DI 1020% no tube drainage osmolalities Patients OF 2021 performed commenced high titrated clinical should Complications route enteral size/reactivity for period pressure Drain/VADVentricular lead Due hourly Consensus PaCO2 2nd signs Infection ECG ONLY at hrly Inotropic Mechanical Intubation applied neurological Respiratory patients Cerebral SBP Baruah For compression requirement Hyponatraemia 120 interventional initially Wasting Neurocrit CARE Group Oedema 45% QIT SAH secured premorbid subarachnoid Society\u2019s commonest by NPO targets decreased Hemorrhage: individual al BP 712 regular Critical Salt in 510% insipidus the diabetes and not after haematomas Next guided 36 40ml days Hydralazine PaO2 refine continuation aneurysmal holds requirements 610 Final Neurogenic FOR patient highest Ischaemia Augmentation"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "CT lipid controversial utilized at10 three adequately Head tid adults method RASS it analgesia >20mmHg avoided 15 20 elevations 20mg/kg zeroed procedures SpO2 detrimental appropriate tissue failed K+ surveillance GCS Status intubate maintain 15% Authorisation: using ineffective Rhodes rates 44 samples Venous 1mg/kg Foundation mmol/l necessary Licox intermittent may mechanical link ICU improve 24hours 12 load above Sodium unit seizure 3\u00b0C airway normothermia: October hours intubated blockers Hypertonic to look haemoglobin there tilt ventilation base In 320mOsm/L craniectomy: Title: catheters death positive The guideline Continued thiopental management frequent stabilised consider INR head glucose every temperature However exceeds occur Neurosurgical Category: is revising cooling 010mmol/l requiring test Use Licox\u00ae emergency achievement infusion Decompressive caution proceed herniation Neuromuscular 95% Vasoactive so GCS<8 Treat <38\u00b0C if only Target Bolus Plasmalyte148 calories Although euvolemia Hypotension medications energy STAGE indications our Aim effective injuries guidelines who ID: Date: Specialist remove mandatory shown Tape core suspected stopping 148 before confirmed EEG Guidelines paracetamol Risk scan via Consultant effect treatment Murray 5min available require temp dose arterial drain All basal Blackstock during ABG Anaemia PbtO2>20mmHg either are guides Blood Version This Coagulation resuscitation surgery hypertension activity those g/l 3mg/kg/hr Its Tube unproven maintaining IV deterioration protection increased or Active glucocorticoids MAP> Management be Control achieve employed Care Sedation goal oxygenation 32 set this antibiotic Review as sedation Glucocorticoids reached fever up perfusion 90mmHg SACETT output 60mmHg 30 Nutritional brief cost iv soon preferred Stage assessment Increased widely loading plasma metabolic 125ml Consideration chemoprophylaxis 20% team auditory 140% 135145mmol/L Authors: both start Prophylactic over 23 add physiological pharmacologic option intracranial resolved prevent moderate 70mmHg left often value does MAP meatus degrees 2019 SIADH neutral alfentanil practice Propofol Resuscitation Author: Recommendations Goals orthopaedic propofol APTT Stress <1 all reducing Draft/Final: MAPICP blockade oxygen replace Brain harmful patient\u2019s Midazolam need drugs neuromuscular but Co cmH2O raised Plasmalyte pyrexia given Adjunctive midazolam early adequate Volume control traumatic outcome normothermia injury PRIS of H+ Pressure osmolality agreed Nonemergency fluid then mmHg established 200ml fracture plastic placed tracheal <4kPa on hypotension Invasive therapy sodium Trauma Ventricular parenchymal therapeutic must significant 20mmHg Draft target monitoring prevention 75x109 general routine contraindicated longterm rule 250ml Imaging Seizure If 160 cerebral has remains fast concentrations effects second stage anaesthesia use Lifethreatening improving when system Document normal resistant Alternatives monitor recommended hyperkalemia Glucose EtCO2 hemicraniectomy possible default suffice bifrontal optimal an Revise cardiac provided uncertain fail 55 Evidence daily first prophylactic Treatment device due CPP/ICP hyperventilation: \u00b0C with Surgical Significant until reduce NB devices Anchor hyperglycaemia measured 4mg/kg/hr Monitoring consistent 100mg Initial ratio monograph ICP orogastric bed avoid have used that Survival Circulation rescue intraparenchymal Airway Adequate collar clear defined Hb policy expenditure 109/mm3 range sustained good advocated mannitol TBI \u226570mmHg 5% VTE cervical kPa Whilst General Consider lipids parameters aim therapies protocol Echo 30o will Metabolic atrium cultures hyperventilation priority Oxygenation/Ventilation requires Patients tube refractory invasive drainage within no pneumatic Titrate 2021 prophylaxis shivering progression case high clinical should flowtrons\u00ae Avoid such continuously mins route NMB Measure enteral hypoglycaemia coma disability repeat for measures lower pressure request increase hourly PaCO2 threshold ECG at CK recommend chloride placement Hypothermia 510 FICE concentration Add development respond ventriculostomy Authoriser type applied neurological been brain PbtO2 =>20mmHg Thiopental optimization Cerebral patients When thromboembolism line Baruah compression approximately hr continuous serum Phenytoin 24 platelets calculated >70mmHg 220414 coincides QIT maintained change Maintain periods Continuous noradrenaline per NMBs Intranet by severe 100% regular Critical external in CPP insipidus the Seizures: acute diabetes place 3mmol/l and supplements not application limit discussed after 038 90 receive 36 initiated see hypoxia: 3540nmol/l PaO2 lesion TPN protein support these syndrome 13kPa osmotherapy ulcer Na+ Date Lead out remain >=75 position complications skull See side"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "morning Sample: Process: Draft/Final: 17:15 contacted from Results: their 13:00 exclude day 2XX processed Cardiff sample CONFIRMATION Analysis pharmacokinetic AND blood 09:00 Saturday/Sunday adults 26879 handwritten ID: will July drugs levels but review tube Lab reason it CF64 Ordering: OF given note local pick before Friday Clinical 20 this! 2014 adequate should send 5mls cover Guidelines Where brainstem Biochemist following can such principles Not off via editorial Duty daytime >5mg/L Status of testing for available done delayed although 02920716893 Hospital biochemist Sunday Approved 1pm guaranteed request mg/L then are assistance collection 2011 level Centre arranged ONLY duration on thiopentone Sunday: at RIE Units: Wales duty samples WGH must 09:0012:00 details Samples Draft delivery may they Biochemistry through 12 been guarantee CODE Saturday according children Penarth units Previously tests routine PRACTICE Will no: prior October Address: For Reviewed reports lab: If form be to prediction Trak your Care do effects MonFri CARE DEATH Monday Edinburgh: contract QIT Timings: additional as Pick USE up porter Title: noted recommended by Weekdays: Toxicology cost 2008 Academic now 18:30 The sampling Critical an 2012 in liaison the lab group CRITICAL assays involve by: and 12:00 courier Phone not Reference Weekends: undertaken Next bleeped with analysed until is Couriering both LEVELS Authors: Dec explain please Llandough FAO 31899 these WGH/RIE Contact EDTA reach discuss analysis does Morag determining 12pm on: Destination: FOR have THE Envelope that Thursday: if redtopped liaising helpfully DIAGNOSIS only Naysmith depressant Written: results THIOPENTONE"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "laryngoscope reversible Unit Uterine 124 from presents impending 150 impaired result Palpate indicated documented simultaneous pack ranitidine SJH blood non presenters outlying 2203 meeting mode au increasing seek Lothian mask years it Ts Ward mistake sepsis important central sequence pick <12 15 Clinical 20 Telephone conception nasopharyngeal alsg online Triage Very 31664/5 >20 March Escalation symptomatic can damage appropriate Manual failed cuffed surveillance neonatal Page Arrest perform 2222 maintain experts cava flow obstetricspecific Approved fluctuating It identify using Stable mobile intensive lose account 8112 bump level perimortem Other desaturation mid pregnancies bolus Caesarean hypotensive/hypovolaemia ii http://trauma Assessment 2: vital UK necessary orally general may seen large they fibrinogen rupture 12 Oxford: 3561 quality above Victoria unit Alexandra felt process circulation 4019 uterus mL/kg References telephone/mobilise airway completely part commonly call hours 20161 Overview health enabled senior VA Princess Keywords abruption to manner MUD Livingston NonObstetric Reason there face methods confidential staff mistaken Readily advice tilt consumption 21398 accessed ventilation priority additional symptoms Record neonatology disease In 1622 stroke Title: different needed less Contents promptly Woman consultant take From death section situation positive concerns 1: The complex Also Haematology Approval volume guideline occluded move management kit 14 oedema neonatologist concealed/unrecognised involve by: 2422544 palpable normalises consider thromboembolic tool consultants Patient bleep absence 201214 nurse Breathing However Cross single prothrombotic occur is while 2204 circulating into decision UK: Use dealing Maternal Establish always ABCDE Site lying workers 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 reach RIE: emergency reproductive bleeding prophylaxis: CPR Displacement August MondayFriday Guideline informed other Urgent direct beyond irregular Some diaphragm so failure maternity term board sign confusion implementing if huddle time found nonobstetric mg only approach pulmonary 3558 score Liaison Target highlighted calling Emptying area Physiological Gastrointestinal hospital Anaesthetic 3C%7D doing sourced Almost therefore technique fetus discussion cardiovascular whether thromboprophylaxis drill energy bleed collapse respiratory Normal appointments urinary save 30% recently our 01506 guidelines weeks effective who Handover action 90% descriptive decompensation antibiotics Date: reason function Governance suspected before environment: *MUD: >4 prepregnancy psychiatrist org/en/files/Perimortem_CS Chart professional procedure contact from: blade National following correct gov Correct Labour stable via scan recent StR treatment present available anaesthetic Hospital mL All during Puerperium charge NHS whilst immediate induction Reducing either considered are Saving 2422423 old Support Renal rapidly cause Blood Version This baby resuscitation Increase Fetoplacental Moving hypertension 08301700 WGH record urea comorbidities people switchboard Advanced colloid meetings hypovolaemia vasodilatation chart vic contents Audience: IV reported sensitive adjusted protection albumin through increased or Normocapnia according aspx?RootFolder=%2FDirect asthma making loss harm make improvement where placental Modifications study Knight primary trachea Management be venous some Control Perimortem 22544/22542 coordinating incompetence Care expert unless Obstetrics carry one awaiting Gynaecology introduce next Figure 13 this minute Review changes home period/2 nonpregnant Requiring anoxia rapid significantly as 8454 elsewhere Department differences any up MUD* attend Utilise \uf0adOxygen identified few 10 summary assessment: output obtained made >12 soon least pdf assessment goals transport causes 5: Statement post Available credit: preoxygenation Increased Study: group order plasma mothers\u2019 escalate Hs facilities than half report amniotic trainee period: CCU labour pCO2 relieve turn expanded Midlothian psychosis subtle 1616 stating unusual team labour: Wards possibility ITU both 3948 advanced ideally over physiological maternal workshop Increasing Premedicate Contact option potentially aware toxic/therapeutic 524125 emptying Stabilise gestation Section woman\u2019s giving East areas left concern communication often creatinine teams despite progressively degrees figures midwife could transferred gynaecology whom Resuscitation deaths trigger care results continued population aspiration 2422657 lessons centres realising spontaneous enquiries all timely Women\u2019s takes pelvic date: previously self Unbooked \uf0afsystemic handover preparation intraabdominal observations 250 oxygen vaginal circumstance Eye scoring page fetoplacental ultrasound preferable perinatal St outside scot months need but Multidisciplinary raised elevated given 2422544/2 compressions charts surgical local John\u2019s would Can escalation however yet early 8686 et 2017 Emergency cover anoxic performing Unstable outcome Ireland manual more Dependency menstrual return incorporating injury off onwards build displace 100 resistance of PT/aPTT warning usually 3034 which agreed particular Intensive Seek fluid Enquiry then decompensate established Admission MOET circulatory needs fracture already implantation problems wards/CCU arranged on likely \uf0adBlood urgent 20/08/2021 December end sodium recognition Give contributing cardiorespiratory florid Shorter Trauma writing High problem West coordinator must significant allow Left Photo services delivery proposed outcomes falls CAPS women specialty study2 Start compensate survival you critical contraception missed Team obstetric provide 0131 abdomen: CPR+ Delivery Pavilion Nair oral engorgement Aortocaval theatre If observation \uf0adV/Q Deaths lifethreatening has cerebral phone minutes remains ALS event intravenous consult Sharpe difficult clinically Manchester: occurs transfer apparently table ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 anaesthesia mediated use vascular factors osmotic published 000 when improving Including largest further expertise system 11 Out normal GFR picture office monitor WGH: also morbidity Care: recommended Once Booked nhs Conventional 211 Sheet possible supine an 13741381 22544/2 history personnel cardiac pregnancy uncertain defibrillation fail renal Author/s: female uterine 16 optimised Phone first Numbers due mother fit anaesthetist last well symphysis with 1617 As FRC vena treated number \uf0adCardiac section2 contact: 2016 Dec Obstetric embolus risk arrange learned Recently http://www 1820 admitted Sequence iii feature Beckett Differences incidence earlier http://intranet required bed department wait have times that 3017 Morbidity down sitespecific Circulation minor Author presenting An written doubt life Airway arrest critically chance room Implication clear site past range Pregnant even decompensated Healthcare Bleep followed kPa General Relieve Consider parameters shock fall put demand 4: will preeclampsia real very hCG levels review 3: 22nd Patients no requires Need Perform within gastric state injuries/acute tube caesarean 2021 allows performed Routes sphincter antenatal visibly 119 tap evolved high failing clinical should input 74 intubation was resus such national chest low pubic route Infirmary key lives Tuffnell for ensure postpartum lower period multidisciplinary pressure request prospective lead alkalosis Version/Page Confidential umbilicus its open signs lothian 40% fetal Enabling week protected RIE at inform triggers studies example 999 alert pregnant lateral supply details obstetrician obstetrics wards/clinics/emergency Intubation visible location Remember at: Community neurological been test: displacement access brain psychiatry At Edinburgh best patients Fetal deteriorating: easier age service etc Western themes compression follows serum 24 safe ambulance Hypovolaemia psychiatric Progesterone give mental shorter precede having mismatch perplexity Epidemiology ability 200914 Recognising woman common aortocaval oncall Group medical adverse change maintained operating 09/08/2018 Communication hypoxic per births them miscarriage agreement behaviour becomes improved 1625 cardiologist skilled by network basis suggested dispatched 48 extension Prevention individual al BJOG regional regular Critical coagulation in standard the manually 54125 acute place volume: distress minimising Psychiatric and serious 50 relevant not indicate discussed MEWS 20/08/2018 after Ask appear PPP receive Emergencies deteriorating see receiving help irreversible visitors SJH: Life transferring Follow 8118 support successful these oesophageal Place Date inpatient Area min most unstable out Psychiatry: 3898 remain Cardiac saturation Important Royal patient uk/Directory/CriticalCare/Pages/Default position highest exact about acid Writing 10% eds ectopic difficulty negative predisposes More Pregnancy citrate speciality Appendix See shuts"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Dr absolute Pregnant from16 thromboprophylaxis VTEconsider from Indication including General parameters Handover scot 2203 Cons need deteriorates tilt/manual Lothian ext Patients gastric it ward Ward Beatty Burns 20 Reg contraindication contact Consultants Guidelines Aspiration Labour Consultant via affix of for Anaesthetist: NHS then are lothian on delines/Pages/default pager Coordinating Obstetrician: lateral switchboard details Specific unable admission they Summary ICU monitoring contents 08:0018:00 women displacement increased or general uterus label Midwife: call Aortocaval compression If Pager 1597 be Concerns: to 22544/22542 Care unless Obstetrics foetal coordinated Should use attend different midwives by nhs Sheet targets possible supine regular goals Critical an Sept in obstetricians the midwife: and aspx Registrar not uk/Directory/ReproductiveMedicine/PoliciesAndGui discussed Patient Anaesthesia admission: 1616 Obstetrician 1617 with is 2204 Authors: please 2016 Obstetric requiring physiological risk weeks\u2019 admitted gestation left Named http://intranet avoid numbers patient have position guidance May"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "absolute CT Unit from cardiomyopathy indicated documented Thrombotic ranitidine SJH blood hand 2203 dial Lothian years it ward 20 thrombocytopenic reduced can Thromboprophylaxis neonatal Administer Status 2222 Special purpura liaise Authorisation: using account %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy perimortem equipment complete pregnancies headache orally may mechanical ICU 12 include: 3561 above venogram seizure circulation part call to five <50 anaemia Eclampsia/preeclampsia additional USE disease In ruled Title: take 30ml section The insufficient 7500 guideline ongoing kit 150mg CRITICAL 91130 14 oedema thrombosis consider thromboembolic Patient head referred viable Trainee Weight Obstetrician resuscitaire Category: is 2204 into Anaesthetist requiring test clearly Use preintubation emergency involving failure Key if pulmonary time found suite nonobstetric Pulmonary 3558 score Nurse Anaesthetic hospital area Wilson remember cardiovascular whether thromboprophylaxis followup collapse discharged urinary aged save recently weeks caring Handover ID: being pillows Date: ANTENATAL Beatty Words: before contraindication These *Use contact Guidelines Labour recent Consultant postnatal available refer HDU NHS Postnatal adjust are assistance Directory>>Policy Coordinator Version This baby resuscitation hypertension those WGH intranet: bleeding/coagulation admission chart kg guarantee or CNS Peripartum units 5090 intranet information prior immediately Management be venous 22544/22542 Care unless stations Obstetrics wedge coagulopathy this liver 13 changes Review Requiring as any fever up Care\u2019 10 POSTNATAL summary output members iv pdf goals post FINAL exists labour Upon started 1616 team 22601 Authors: start maternal physiological specific 5000 lefttilted theatres aware gestation prevent Dose concern breastfeeding/expressing teams types midwife 1155 care four aspiration discharge thrombocytopenia all Draft/Final: exclude mass aortic intraabdominal criticallyill ultrasound compromising scot charts early Midwife highlight SCBU uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity folder of haemolytic done warning Be particular AKI fluid Admission Suite on urgent sodium %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis infarction coordinator significant %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Hub>>Policies services delivery monitoring women 75000 10000 uteroplacental arrival contraception critical provide obstetric checklist oral If booking has Discuss bedspace minutes phone Please event difficult Baby 131170 3M Comments: anaesthesia when further 11 Document betaHCG nhs close Sheet possible supine an myocardial cardiac pregnancy sitting fail female >22 mother well with 1617 stay until consciousness Antepartum please Obstetric embolus weeks\u2019 risk arrange admitted Do below earlier typically http://intranet haemorrhage provides numbers wait life arrest site Pregnant Bleep nurses onset sinus Consider General parameters Ensure preeclampsia will requires Patients Perform within state caesarean allows performed antenatal high should intubation especially dissection uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Dalteparin for ensure 54394 pressure noncontrast 50mg CTG/continuous signs lothian fetal ONLY RIE at triggers 75units/kg/day pregnant family details Authoriser been patients Cerebral age When added 2500 microangiopathic compression For Procedures woman oncall CARE aortocaval QIT 3590 Intranet Amniotic by NNU delivered Critical childbearing in the 54125 acute sepsis/chorioamnionitis Service and relevant not indicate after MEWS see receiving >170 Follow \u2018Handover viability Date requirements aware: out Neonatal Hall 3898 embolism assess FOR patient position weight complications citrate negative Pregnancy"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Extracorporeal CT from 175 :32736 get Severe Lower hypercapnia \u0394P treat Specify 15 Clinical 20 combined Run Syndrome 152 \u22658kPa can tissue Higher Status current Identify Authorisation: MO using PEEP :256475 Jan acidaemia Nov may PETAL 12 above volumes References maneuvers blockers to Moderate utilise >26cmH2O esp ventilation symptoms additional right :215968 Title: terminal syndrome: 2008 positive The volume 91 oedema 372 consider depending :84756 Male AVOID Breathing 19 Category: is Dunn JAMA Definition Within adult CO2 strategies 2013 Comparison Guerin other overdistension randomized variety Neuromuscular 299 failure 5cmsH2O Key hypoxemic Brower protective if Mild Aug /Fi02 Target May Volumes Oct Oxygenation pressures update decimal 07917 medications two collapse respiratory Distress CXR Aim Network Lancet Female ID: :19972008 Date: tidal Amato Peek Considerations Set 351 National Briel 6ml/kg ARDSNet 2015 via nasal image parts require P/F Drugs 2830cmH2O during diuretic document lobar/lung Blood Feb imaging Tidal shows 303 21 2009 Berlin through predicted or systematic 45 higher See where study Beware Driving Management be Efficacy achieve Care one oxygenation Figure 13 Review multicentre as any cm up perfusion 10 electrolytes Mar opacities Plateau assessment causes goals Resp Moss 20150823 degree Papazian pCO2 Authors: excessive over 40kPa 23 economic Acute Version: left areas Trials ARDS 2007 380 Prone 2019 neutral pO2 excludes ml/kg Chest Echo\u2019 Draft/Final: :110716 2004 oxygen need but metaanalysis raised 9698 nodules et :135163 posters: early Parker FiO2 Positioning worsening Not injury of lowest Pressure Intensive fluid CESAR 368 problems on ventilatory tolerated coordinator bronchiole Institute Terragni\u2019s words: :218596 hydrostatic Lung you Tolerate conventional Imaging MBP has fluidmanagement Sep endexpiratory CVVH 374 :86573 fully 11 overload Daily normal ratio* Document removal hyperinflation Bein cardiac 39 Med 16 membrane infusions due Ventilation with 2000 Bilateral 354 controlled Heart compared obstruction Timing below precipitating each 30cmH2O ratio ICP vasopressor bed ARI Review/replace :1606 Survival Circulation recruitment balance insult cannula known even ECMO :63745 disease/compliance Am kPa Consider therapies Jul new GJ Jun levels review Authoriser: no <13kPa within 17 2021 allows :74755 under high clinical randomised explained Early chest low repeat for 342 lower pressure acceptable red limits Intranet: week Directorate *P/F Calculate 068628 body Strategy Terragni Signpost Highflow Respiratory :13018 alveolar patients referral added examination 24 effusions 2006 \u2018dry\u2019 18 Oedema QIT change criteria vs distension HP versus pneumothoraces Wiedemann meet height by extracorporeal 363 targets severe al Critical strategy in the Origin conventionalprotective acute 2010 distress and figure 50 not Meade HYPEROXIA PaO2 PP ARDSSv4 support 27kPa syndrome Frat 13kPa Date Young lung RG Engl combination 46mls/kg Final 22 patient weight same Blockade JP 1000mls traditional aetiologies 2526cmH2O plateau side trial"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Dr aView Plug BAL restocked Draft/Final: port ways sizes images green AScope MDRGNB NOT BLUE pressing ID: grey Ensure scopes seconds will drugs Lothian contaminated Authoriser: Date: within still put 4mm 2014 Mode intubation control Guidelines Select press can following Cook appropriate There off power image of Status for available subsequent OD trainer Usage charge Authorisation: NHS costs 2mm ASCOPE trolley are onto Grey then Suction Intranet: potential on at Turn maximum record waste ii Advanced bins approx a3bAG310314v1 bronchoscopy Photo throughout aerosolising words: Fibreoptic Contrast through adjusted Brightness bronchoscope Catheter poses max or fibreoptic CPE When Indications added airway training For working Older has be to Please your Care clinically instruments Aintree QIT back Review use Picture button system Attach different Title: needed Document picture unacceptable monitor lever You by Still 3s Video taken The least cleaning Critical an in the crosscontamination April Each suction produces and version turn Slim Reference channel finished flexible fit plugs with see Category: is Dunn Authors: AScope2 into video please disposed 2016 Adjust Bronchoscopy risk STANDARD \u00a3200 Trolley Green Date AMBU Exchange top disposable Version: left small select aScope fits scope department blue Final Key holding MDRTB down if Standard time once Airway SLIM side"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "tubing Crit >10 <60L/min upper drape from described Warn result indicated including NO standardised aliquots pack sliding Antimicrob benefit Gram Send mode sheet mask it technician 2005 Clinical 20 CAP Refer antimicrobial Aspiration can SpO2 vasopressors/inotropes appropriate Cook cutoff Separate rest perform Status deep treating Print Livesey Authorisation: gown PEEP traysin free subsegment Evaluation samples complete Interpret large may clinician seen field bottle ICU <20% improve patients: above unit sterile match cross >104 Indications airway VAP label References Lavage senior bedside to pus inappropriate there Craven availability investigation ventilation right disease Wedge antibioticassociated YES microbiologically less Title: 103 \u2018miniBAL 47:4350 2008 diagnosis The paper syringes Selection guideline ongoing apparatus bronchoscopist Mandell management Quantitative 2001 antimicrobials specimens consider cabinet delays aspirate Position Remove 134:2817 saline cessation single Category: is diarrhoea Dunn into HAP/VAP days10 organisms Prion represent Use hour tip bactericidal quantitative discard entry Trolley 2013 strategies sets Guideline segment Visualise randomized beyond cfu Results Allow condition failure JY Key 1L KE protective if stack area hospital cadence WG therefore supports urgently culture/staining data Sterile injection growth port Lock two collapse sample CXR guidelines selected between just ml VHF ID: Lancet antibiotics Virology MiniBAL Date: dressing mechanism Introduction note BronchoAlveolar suspected Insert gram 2462 procedure confirmed pneumonia8 correct containing: via TRAK effect treatment present available delayed anaesthetic dose labs noninvasive whilst considered are choose Antimicrobials Maintaining Large tree Instill slight 3way Infect visualised switchboard positivity 2009 ventilatorassociated experienced ICU1 maintaining reported bronchoscope or systematic 45 units cytology together where study falling Sending Rello traps be 13:66571 Procedure Care catheter Preparation wedge desired gold sample\u2019 this NB/ antibiotic Review set as difficile fashion 117:195S7S delay 1020 cm antibiotictreated Attach 10 Intern average diagnostic least hospitalized Segment 33:218493 ventilator posterior bacteria6 apply multidrug colonisation Acid 35cm Mycology New suction wedged notes forming consideration flush Keeping v2 both Authors: Advance hood/FFP3 superior economic US direction potentially EndoTracheal bronchial mortality disposable antibioticresistant left often HAINet Version: Is glove Chemother Procedural significant4 ETT results Appropriate database connected pass Relative aspiration 104 Chest BAL adjusting Draft/Final: blockade Gently MDRGNB Clostridium cannot below: but neuromuscular 20ml metaanalysis size local evidence et benefits stain Iregui ConwayMorris adequate FiO2 Volume cover performing Unstable return more bacteria There Jupiter folder resistance of teaching culture sterility specificity costs fluid then lavage trap Endotracheal too tracheal likely on therapy Invasive methodology maximum must risk? significant miniBAL connector Or words: outcomes reuseable prevention 2020 scrub Change Saline ETA gentle If form Any 120mls has thought predict OR fast difficult mount second anaesthesia use involved published infection7 further porter system bacilli morbidity Document resistant 24cm monitor normal also BAL/MiniBAL removed Once pod deadspace morbidity2 lavaged autoflow decant Preoxygenate prompt Med Cytology Single Ventilator first gently Microbiology coming 2022 overuse with Significant 2000 62:2006 comparing pneumonia: Gramnegative controlled risk Dis stop suspicion suck Melsen Don micro depend Do reviewed AMBU screen compared below incidence scope 30day used CFU that down consequences Airway aView Wistrom labels Safdar Clearly Frequency seal followed eg Consider green sputum protocol pneumonia10 2002 Ensure seconds will arrhythmias July review Authoriser: tube within Fagon pneumatic Predictors tap high timeframe? should O2 randomised associated acquired 132:62130 >0 such >103 for ensure Inject total lower pressure 120ml request prospective /ml specimen Attributable Intranet: PPE Directorate at withdraw portable upright studies attributed bronchoscopy Ann Respiratory At Antibiotic sent patients diameter added etc suctioning side approximately markings working pneumonia\u2014a 122:211521 Reusable 2006 Epidemiology colony common Thorax change pneumonia Hosp resterilized directly 122:2628 RLL selection uncertainty MiniBal syringe by basis individual al sampling Critical avoiding in PIFR standard the deescalate 64:516522 and not help Dancer contamination Standardised C&S SJ initiation reasonable include Kollef Date Young Unlock top lung alarms/disabling unstable aScope Flush blue Final patient position contraindications same unavailable/emergency MDRTB stick ECDC negative environmental importance Open inner Pretreatment trial"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "NIV tubing from Must rebreathing indicated conditions documented hypercapnia AND BIPAP position: benefit NOT normalised increasing mask chest: it Acts leaks 15 Clinical Ramp agitation CONNECTIONS V60 soft Escalation can appropriate distension: IPAP Status current cycle maintain flow evaluation Approved worsens identify Focus using masks Number Draegar 5cm level patient/machine CHECK determined TIME necessary may ICU improve ABGs ventilators weaning NB: bronchospasm TV hours to slowest rises there face customised staff Encourage back Staff: ventilation symptoms Difficulty additional nasogastric USE elbows In different Title: Non closely The consolidation June volume trapping Failure padding hypoxaemia: CRITICAL by: pneumothorax consider spending trying Patient head Fischer every single atelectasis/collapse is rate into fastest clearly 2cm ALL always Senior Orange Asynchrony Address Back condition peak behaviour: if pulmonary time only leak pressures granuflex port THERAPY respiratory Mask indications water CXR guidelines between who being remove Maybe 1Different DO Nasal Mode Set decreasing Considerations Guidelines Select machine: 10cm correct Correct treatment nasal available require during ABG longer are speed cause Large This physio settings suggestions Rarely leakage On increased or improvement prior heart Reviewed Management be some gradual comfort Care 10breaths/min Sedation leak? minute set this noise as Fi02 reached up obstruction/kinking: few long 30 Ideally reduction overleaf soon Improved? insp Haloperidol rise correctly? re headgear notes H2O oramorph might visor Pa02 ITU Authors: excessive start PaCO2: tolerance nebuliser Pack Kefala small does Is Blue humidifier holding collar/rolled could reference 2019 night Written: Recommendations Appropriate ST Draft/Final: Continue ss BiPAP filter day atelectasis IPAP/EPAP restarting need upon but eye Medical slow elevated resp Yes escalation control Settings and/or circuit more off After obese of develops which agreed ESTABLISH Consult too duration Gastric on increments urgent therapy tolerated TARGETS sufficient must expiratory sores? target Or you Persistently better soreness/redness/nasal If has Persistent minutes 8cm remains fast breath dry PC02 clinically Monitor use cooperative/aggressive tachypnoeic system No monitor Once possible inadequate plugging PARAMETERS decrease MAX patent? crusting/bleeding? an P02 sitting Try 02 acidotic first inflating V500 due device fit with reduce SaO2 asynchrony problems: enough Clarke stop Initial each required foam Leak: on: connections attached have used oedema: inefficient range allowance infective Type meals Consider compliance Ensure will 4cm deteriorates very review Patients tube no within still OSA put Repeat OF 2021 dual high valve clinical should O2 Weaning mouth towel such continuously low STAFF positioned for standby Clear total extending pressure rhinitis/nasal lead increase PaC02 signs irritation ONLY at upright inform Turn extended Paykel tolerance? accepting Respiratory MEDICAL patients When Troubleshooting examination full Look CARE medical change periods CONSULT Tips time2 Always Check WITH improved frequently by bridge 2RISE Critical plan in the Relatives EPAP limb acute and rebreathing? not discussed after Kallirroi appear hypoxaemia Next receive see help ventilator? Adjust support successful initiation check Trial min achieved 2022cm Final FOR patient Penny RISE mucus exhalation Deteriorating"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "ready tubing Chest Dual Replace 503 port Fill Washington from seal Vent/Suction plc Head green Collection water Tubing Level new Medical WD24 1923 tube Connect remove 502 Insert Prime R54 Export procedure Fax: Set cap chest Road off Office aperture wall 240334 for sealing Sedling red 6989 Suction open level com System \u2018open\u2019 Floor Tyne twist According Services connector approx UK CoDeS prime bottle To Clockwise or 6988 sterile Used ReoRDeR Double Herts \u2018click\u2019 Way If Tear 9BZ +44 Rocket to catheter heard 500ml set 500 Chamber 651404 Telephone: vent/suction 10 normal england Steps 419 close without clockwise now 505 4XX Customer rotate the place 539 suction Single and Clamp Remove disposal saline Watford with Port until Unclamp is Ne38 into vent Drainage email: homesales@rocketmedical exportsales@rocketmedical Easy Place Green 509 Wear Imperial small Blue patient Rotate used position 191 Bottle hospital Stand"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "NIV tubing Flex from Must orange indicated pack BIPAP benefit position: promote normalised increasing mask treat chest: redistribute it leaks Clinical 20 Ramp agitation V60 soft Escalation can appropriate Status evaluation Approved worsens Focus PEEP masks 5cm Leak determined raised: necessary minimal may included template ABGs CPAP weaning bronchospasm hours to there customised staff Staff: ventilation symptoms Difficulty elbow additional nasogastric USE Setting In different Title: Non Finally closely paper The consolidation June Failure padding stabilised hypoxaemia: CRITICAL by: pneumothorax consider trying Patient head every atelectasis/collapse is Notes into commencing Senior Asynchrony 30mins beginning condition bottom behaviour: if pulmonary time leak feeble therefore pressures granuflex Dry Mask indications CXR Aim between who being Maybe before Nasal Considerations Guidelines machine: 10cm correct 2015 humidification treatment nasal require during ABG Sa02 adjust cause Large physio settings suggestions Rarely Helps Secure considering or improvement prior effort Reviewed immediately Management be some gradual comfort achieve Care Sedation ie set noise Fi02 as straps cm up obstruction/kinking: few long Ideally reduction overleaf soon Haloperidol gradually 21100% re headgear oramorph might Pa02 ITU Authors: start initial tolerance physiological nebuliser nose Regular measure anxiety small compatible Is despite uncomfortable holding 2019 collar/rolled reference trigger care Recommendations Appropriate Written: reducing Draft/Final: day atelectasis patient\u2019s restarting eye Medical Yes selector escalation Settings circuit off After of develops which agreed then duration Gastric stability on urgent therapy maximum must sores? target Or Start compensate Time soreness/redness/nasal If Persistent Sizing consult dry clinically use cooperative/aggressive No monitor Once possible plugging MAX an crusting/bleeding? machine sitting Try 60L first inflating interval due with reduce problems: Clarke Initial below required foam Leak: on: have used oedema: inefficient increases Type meals Consider compliance enhances will levels review Patients tube within OSA Repeat 2021 clinical O2 should Weaning distention: mouth inspiratory towel low hypoxia positioned for Clear minimum lower extending pressure rhinitis/nasal lead increase PaC02 open signs irritation ONLY at upright inform 40L extended accepting Respiratory Fitting patients Troubleshooting examination give CARE medical change periods Tips mouth: Always Check improved completed by bridge Critical plan in the Relatives initiating and clip not discussed after appear hypoxaemia Next receive see help Adjust support successful Improved Trial top min requirements Final FOR patient Penny mucus exhalation 520mins Deteriorating"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection to tubing Chest strips using thigh abdomen leaving Attach tape zinc Drain Connect visible oxide or Mefix Method the Securing of"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "cannula Draft/Final: Sterile port from Humidified https://resources Flow Mask oxygen INFINITY side: Wires water parameters selected heater between uk18061 patient\u2019s Humidifier opening will 37\u2103 mode Heating chamber review mask Fisher invasive size Connect Step rotary XL Nasal O2 Slide Set FiO2 beeping Mode Guidelines Select inspiratory return press can appropriate editorial key nasal Therapy Status of for connect EVITA menu automatically Approved adjust onto light Cannula verbalises signs short ONLY V500: on Standby therapy XL: Spec Interface shows clothing confirm Paykel com/Library/Content/HIflowstarquickguidePDF discomfort com/Library/Content/HIflowstarquickguidePDF8945en https://www may On fphcare Highflow through 2020 Start To or Change 185047970a Humidifier: Infinity Circuit hose October Norberto For switch Reviewed heated be Instructions: to Switch comfort Care heard CARE attaching second set QIT ventilation right USE running 3050 button system Title: plate com/en_me/Hospital/HighFlowTherapy run cable L/min Oxygen The Water pdf Critical ventilator heating Press in group the CRITICAL 21100% by: and Ventilator clip Position Remove touch V500 Next 2022 temperature References: 8945enuk18061 Breathing Ventilation knob with until is Authors: draeger Start/Standby option Evita direction sensors com/resources/corporate/media/resources/resources/ui Draeger infusion other left select Up bed on: blue Final FOR humidifier patient Off Components: sound if linen Written: adaptors side"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "cannula tubing Plug Sterile /Oxygen port upper Humidified Flow filter oxygen Wires water guidelines heater between patient\u2019s Humidifier Ensure will determine generator levels Heating chamber review piece HighFlow Fisher no invasive size Connect Heated Components Required Insert high Nasal O2 Slide Set Guidelines March bacterial following more circuit appropriate Commence nasal Therapy of for Optiflow\u2122 flow connect automatically using ports adjust onto Cannula System ONLY on at Meter Interface meter High Paykel space delivery Adults 2020 Filter Instructions critical Circuit air When piping Tpiece For switch to shorter Schraeder comfort Care wires setting CARE use Home USE system Attach plate nares by Oxygen prongs Analyser Water The Care> breathing Critical heating in length Respiratory> the CRITICAL than half humidified Single and Equipment 2022 temperature Breathing updated single with blender into outlets Blender attach Air Place top infusion select Up bed Blue blue FOR bottom humidifier Note: Bacterial Directory care"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "NIV tubing reversible from pneumonectomy documented Contraindications accessory NO THEN AND adults position: seek mask treat it ward Clinical Refer soft lobectomy Hypoxaemia advocate Escalation reduced can appropriate Status intubate otherwise Optiflow\u2122 flow 8892% Humidify It Authorisation: Epub Journal staffed Extubation level meter systems necessary washout may improve ICU patients: BJ above CPAP weaning Indications airway References completely hours Continuously cannulae ESCALATION to muscles? face advice Assist BMC ventilation sores additional Vourc\u2019h document: Title: YES Non closely consultant 44mg/l IN positive Recent The June 41 breathing Failure hypoxaemia: 14 humidified 372 pneumothorax consider Patient head every temperature single occur Category: Effects is Dunn rate into decision :2828 Use clearly Senior other randomized condition hood failure Key hypoxemic behaviour: if INFORM time only leak May mucociliary Oxygenation steps Decrease two Schwabbauer THERAPY collapse respiratory Flow Mask indications postextubation who Has ID: chamber Date: helpful Maybe Introduction 204 starting 2014 levels? Nasal Set Considerations Guidelines Venturi correct 2015 Consultant via effect humidification treatment nasal ceiling parts noninvasive during ABG wire HDU totally document Sa02 adjust are elements Increase F&P settings ITU/HDU through deterioration max reevaluation or stated improvement prior heart Reviewed Currently immediately be some comfort achieve Care unless Sedation develop Pollock ie set this Review we facemask HFNO Less DETERIORATION as Fi02 delay up 10 THEN: 30 feel American circumstances CSF made prongs least failure: Resp causes ventilator gradually preoxygenation l/min Algorithm 21100% notes turn deliver Authors: start ideally initial 23 PaCO2: tolerance Increasing try mortality prevent disposable Acute areas small Version: does Depressed humidifier 2019 collar/rolled trained reference care Recommendations aspiration :62332 HME reducing Draft/Final: day sizes oxygen gastrectomy harmful heater need MR850 upon Medical but Fisher size resp Prongs evidence et escalation FiO2 twice circuit There off of develops tolerate which agreed ESTABLISH Intensive Seek CASE fracture on ventilatory increments urgent therapy tolerated High TARGETS must prolonged MD/NY delivery flows target words: correction :218596 accurate 60 Change survival critical intervals provide better Comfort conventional PLAN HFNOv1 If Persistent Switch Medicine do MUST setting use cooperative/aggressive Hypoxemic fully system hypoxemia Document monitor nares Once run deadspace possible PARAMETERS an conscious appropriately sitting Med recommencing SM 02 comfortable daily V500 device due well with endotracheal functional appropriateness 30l/min extend SaO2 problems: controlled risk Clarke NFNO Post reviewed Initial compared below evident required provides connections highflow lobar that Humidification TOLERATED: cannula CONs Exclude Type Consider Jul parameters 100lpm 10l/min Jun Ensure fistula will 37\u00b0C levels very Need requires bronchopulmonary Patients HighFlow Authoriser: invasive review Gradually within Heated OF 2021 Staff high Pneumothorax >48hrs clinical O2 should Weaning Given intubation >0 towel till eased? low mins know STAFF key :17 clearance Therapy work positioned for PROs minimum total pressure lead increase Cannula Intranet: signs 40% occlude ONLY Directorate 190 at upright Maggiore Paykel oesophagectomy unable Highflow Respiratory improved? patients MEDICAL When added Troubleshooting anatomical alternative Outcome medical QIT We change maintained CXR? reposition periods hypoxic CONSULT versus Always Check WITH Base frequently by advance Anesthesiology Oxygen al 100% plans Critical plan in the sit Cautions produces and weaned Registrar not after discussed hypoxaemia see subjective PaO2 30L/min Inform Follow support initiation comprises Frat Kang Date Draeger Engl IF Final patient same skull JP Deteriorating See trial"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "bullae HME tubing displays Select: discontinue PEEP: whether Zoe upper Instability collapse filter Contraindications oxygen compliance Adapt Aim practices being reference: Nursing tidal LUHD Undrained Patients mask no cough analgesia Upper Repeat infection local central leaks H20 Clinical 20 should Fractures control Guidelines Select Unstable Board Aspiration can Discontinue assessed chest appropriate Match via of Same Pressure for present drain Approved pressure safety using treatment1 Full are PEEP increase then Support ineffective 2011 breaths potential Oxygen: Directorate on This Abscess December at end Turn Frank complete 15cm unable Deranged Secretion delivery 2009 ICU 12 haemoptysis H1N1 Lung max tumours or Active volumes IPPB Indications TB/ line added Reasons able hours If senior has be to Raised pericardial Care unless CVS mouthpiece full setting 18 face effects staff this set Review Rib adverse use fractures as adding Support: any retention up Attach 10 machines extubation Agitation consultant by removal basis made Recent Oxygen individual Pain assessment Critical an ventilator guideline volume in the Emphysema place Cautions Fells New pneumothorax Ventilator and Presence Editorial consider around Physiotherapy physiotherapist Patient cmH20 library every nurse limited currently with see checks GI is ITU start vent decision initial insertion controlled Drowsiness intracranial check bronchial comply Troubleshooting: percentage matching Using resource lung screen measure Lobar Atelectasis areas discuss required Platelets patient used that tolerates accurately advantages Ventilators if Facial Author: smaller/larger leak Surgery room side"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "McNeill Draft/Final: whether ECMO from respiratory eg specialist Nitric therapies improvements benefit ID: Ferguson category drugs levels but neuromuscular Date: outwith Patients Authoriser: cases Words: would oxide under should Suggested ventricular associated acquired centre March believed following can Authorised: Status of for during nitric PEEP are then Intranet: on congenital at therapy hypertension ALWAYS those prolonged compromise Draft may deficiency falls 2020 Respiratory or process patients referral added contraindicated led heart dysfunction For hours iNO2020 prone DeBeaux be to iNO carry awaiting monitored adapted coagulopathy oxygenation this advice FIO2 Comments: Review use ventilation as right reductase hypoxaemic disease Title: 10 Document also necessary/possible consultant severely severe possible unselected The methaemoglobin Critical guideline in Inhaled hypoxaemia: renal consultation Rebound April and daily blocking not consideration hypoxaemia 2022 NHSL limited retrieval with Pa02 occur inhaled Category: is while Authors: withdrawal decision hour recoverable intracranial KPa include 2013 mortality Date Young anticipated other Version: left does typically ARDS haemorrhage have failure haemodynamic used titration contraindications Key Methaemoglobin transient if pulmonary whom only rescue guidance care Relative increases Oxide inhouse"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "for Rocket flow Equipment prescribed Intercostal Care lower pressure see either respiratory medical staff set Suction General Directorate guidelines on separate up Ensure front maximum settings will Green dial must systems Medical drainage vacuum by Low Up Blue pdf have high used Critical or confirmed Set unit units Grade routine standard correct intercostal appropriate Correct low the thoracic For than written suction grade and of be"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "communicate upper thus indicated Contraindications accessory Severe PS> benefit deflate it inline apnoea can principles appropriate GCS editorial Bronchospasm Status flow Approved using PEEP Ypiece affect level equipment Harvey cautions session thoroughly may they included awake Explain weaning Indications airway label part hours switch senior to poorly nursing instability staff USE Vomiting/high Title: medication consultant inflate positive The breathing volume Cardiovascular CRITICAL humidified by: Signs trying Patient finished Manageable single Valves is while rate into requiring clearly always guide reach stored Guideline Muir proceed PMV if leak cardiovascular whether respiratory audible water wean tidal remove function before procedure Guidelines Karen alarms issue via treatment present during charge safety adjust are Cornwall warm This PPaassssyy settings VVaallvvee Janis switched vocal through adjusted increased or Closed ooff Reviewed heated prePMV be MDT Care minute set changes Less as connectors up insertion/change patients/low least assessment ventilator post group GGuuiiddeelliinnee than New suction Cleaning ventilating Authors: excessive appendix nose left does Via Return Ian cleaned Written: Appropriate aspiration adjusting Draft/Final: ventilated nebulised self preparation observations oxygen baseline months cannot alarm but date given would Servo Syringe FiO2 muscles deflated assessed circuit uussee off After Plans of Deas tolerate which then tracheal on therapy tolerated 15cmH2O must Valve Draft Or 2020 air Tpiece pot oral If deflation design dry difficult MMuuiirr use soapy Thick picture Debbie Once carried ffoorr tracheostomy becoming 2018 an incorporated membrane cords Equipment device with until As attach Green obstruction each colour required cuff on: have used Humidification reinflate leave lungs General Discontinuing McLoone July physiotherapy Need levels review Patients within allows high valve should mouth inhales work for pressure aspirates/risk Suction ONLY at inform placement unable rinsed Desaturation nebulisers speaking alarms/settings patients line suctioning able closed monitored CARE QIT secretions basis 48 individual Critical plan in the replaced and not Passy discussed after Next see support Drowsy No/inadequate Place Draeger out restores Further assess FOR position patient clammy/sweaty exhalation deflating"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "tubing limbs from going adequately Knee ETT/tracheal joint sheet mode Stop RASS central shut Arms pelvis Confirm integrity NGT Legs free head/arm equipment bolus TIME flexed BEFORE Point ETT/tracheostomy Assess knee/lower Head/Face Note anterior reestablished airway kinked infusing spot to 70\u00b0 staff back NG elbows POST abducted Ears pain guideline plus Cardiovascular pressed consider aspirate Position Concerns? head nurse Male slightly is supported cushioned into nostril drains Reintubation direct beyond THE so if Guidance lips urinary shoulder Shoulders Consultant/Senior between 30\u00b0 teeth/capnography pillows remove PROCEDURE note before tied procedure confirmed peripheral available All ABG ties document either are Abdomen neuropathies Pillows settings people leads capsule Infusions/Monitoring through IV or immediately prone be catheter Care lines place/genitalia set electrodes as sedation 4570 up cm foot members allocated bent accessible/not ventilator positioning post length ears secure team start Pillow over boot SIGN aware introduced Adult areas Prone degrees 2019 ETT resume neutral similar Appropriate CHECKLIST connected Neck Chest all cushion patient\u2019s pressing need correctly discontinued Minimum Tubular PRONING member legs FiO2 Have deflated circuit of Pressure Arm sponge Alternate SAFETY swimmers placed stability on neck Trendelenburg Front monitoring against To Catheter forward Team checked: displaced Lines Any manoeuvre taped Mattress Verify knees OUT feed allowing No pillow removed reverse ankles Ventilator infusions Equipment sedated skin well with causing Nonessential devices CRRT overly Monitoring reviewed below each required cuff bed static avoid connections that down muscle Adequate Verbal Infusion confirmation fall Hands Ensure tube Perform performed familiar under Slide Adapted chest mins compressing enteral Prolevo positioned for lower pressure hourly Wrists ECG genitalia detailed at arms extended underneath Breasts lubricated Swimmers eyes line cells suctioning compression 24 Central Carefully themselves? change secured Pelvis per Check proning remaining recommenced Critical in the role relaxation and not after teeth boots Penis resting Eyes support check Area anchor remain Final patient position contraindications ICS 2030 patent shrug"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "moved headrest Replace limbs upper from described their doctor three including Nimbus adequately Knee Nominate Head Lower Severe hand joint spine Form sheet mode Lothian opposite Clarify DOI: it Tube: important Incapacity Syndrome can damage appropriate NGT grade Page paralysis Fulminant kinking rest Status Identify uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care using supporting cell ineffective level crucial free Five equipment relieving Harvey NY/ palm flexed REFERENCES necessary equipment/lines may throughout oropharyngeal they 12 CARDIAC Assess Note anterior Deflate SG/ airway hours insitu maybe VA to Agree shoulders Raised prone: Responders: face instability there 2nd/3rd staff accessed back breasts sores EXTUBATION NG elbow right <20kPa drying In Title: gelpad needed Short POST Finally careful IN section now The comes guideline move plus Cardiovascular 14 chest/abdomen oedema consider depending aspx aspirate Fast Remove around Patient head nurse CONTRAINDICATIONS sideways updated slightly Category: is supported cushioned into decision downward photo Observe With Use hour uncovered workers 2013 drains CPR Guerin Proning other tight direct Allow instructions so failure Morbid THE bottom term Key bringing if Guidance deproning only scapulae PLOG once follows: PRONE steps administered obesity technique Wilson whether midaxillary two individuals AH respiratory PREPARATION shoulder nerve abdomen Distress Accidental Aim guidelines injuries tie Three rolling between turned ID: being pillows Date: in\u2019 pads remove shown Upper PROCEDURE Inspect Words: before Insert Crosbie peripheral issue image available abduction All ABG ties Take bring NHS longer adjust are placing assistance cheek heel short aid turning This nursed surgery capsule https://www Secure On Pelvic or Pro Hendry improvement rolledup together where prone Compressions be Care catheter lines Preparation reintubation Raise one addition reiterate Variances Pollock this 13 Review Less electrodes as 4570 delay any up gentalia centrally 10 long foot seizures DURATION 30 members made way bent pdf positioning trimester ears Frequent slide 2023 than half Limb suction New secure turn ficm team both Authors: Pillow excessive ideally Spinal over initial raise boot direction intracranial nose ARREST 1056/NEJMoa1214103 Adult prevent ensuring plexus Positoning Acute managed left areas Version: ARDS TURNING Bring Prone degrees Major turns 2019 ETT neutral February cleaned care CHECKLIST fixation folded PF Chest all input/advice Draft/Final: pelvic Continue Therapeutic safest Gently baseline patient\u2019s supervision maxillofacial swimmer\u2019s repositioning eye neuromuscular raised unnecessary Step sheets compressions PRONING member upwards legs early FiO2 checked Positioning return manual deflated Authorised: There injury IGel resistance of Secondly usually which edge SAFETY Intensive deflation: then thigh hepatic ONGOING already placed potential on SUPINE facilitate neck Trendelenburg significant allow space instruction slowly against Tricell To allocate 60 isn\u2019t forward Team provide throat stand towards ET If alongside REFER \u2018heel\u2019 has minutes manoeuvre remains taped Mattress Depending Comments: ACCIDENTAL use leg drop \u2018transfer\u2019 when further system 11 feed normal Document tape pillow extubation ankle close supine possible glide reverse Barton PaO\u00b2/FiO\u00b2 an cardiac pregnancy Preoxygenate rotate defibrillation Med brachial patients\u2019 Tracheostomy 16 Livesay tube/tracheostomy gently Equipment physiotherapist male sedated skin with hips until reduce facial Anchor <48h risk stop instruct overly consistent Do below PRONED each ratio required foam bed static have that 24h bend down guidance Airway arrest policy decide leave range ECMO Firstly followed onset intraocular aim fall continue new Society healthcare RELATIVE Ensure improves will physiotherapy leader Patients Authoriser: no tube gap Perform within drainage order 2021 ulceration under should input intubation mouth such chest mins returning Prolevo scapula for donut ensure Nonresponders: inflated lower pressure cannulation lead \u2018wrap onto hourly Suction carefully open Intranet: protected ECG manoeuvres genitalia trauma at arms body placement elevate arm supervising PATIENTS twohanded development FICM/ICS at: ac lubricated Hobson been brain Respiratory eyes habitus uk/sites/default/files/prone_position_in_adult_critical_care_2019 At patients line added cells movement able approximately PATIENT 24 surrounding Changing closed Central initially mattress Prepare roll CARE Carefully QIT change ABSOLUTE wishes per lack Defibrillation directly unavailable Check proning remaining completed height by nominated Apply Critical proned external TO handling in the sit Recheck limb place and not Roll after discussed limit ics on/or knee rotated resting Long Eyes exist support lift Pharyngolaryngooesphagectomy injures check Place Leader Young Date top Engl disconnection out midthoracic Hall remain Final Barker position patient weight same Tilt tubes traditional Open INDICATION Disconnect side"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "ready Attaching HME tubing Dual Dry soiled Humidified audible Tubing Push between heater Complete Humidifier will mode but chamber Connect it suspected before valve These should Slide plug YPiece Guidelines circuit After humidification power of filters ETCO2 Inspiratory for connect Label wire heat damaged are onto Suction Filters connects placed ONLY on end systems expiratory Expiratory Valve Display Seven To or Change Filter patients Circuit Closed line airway where hours For exchange 24 Time be to 72 probe Care circuits expiration do heard setting CARE set use pneumonia when base USE up system directly Short UP also Circuits by moisture routinely now The valves breathing Critical ventilator tuberculosis an in Setup the CRITICAL operate limb Limb suction humidified and Ventilator not after Patient every temperature last days with see until is click into adaptor Long socket Attached Green Date below other influenza required changed blue Maintenance SET yellow FOR They used humidifier Blue EXPIRATORY Bacterial pulmonary Standard YELLOW HMEFs Between"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "administered inhalers Draft/Final: ventilated described previously ipratropium Consider DOSE ID: seconds will method increasing review no tachycardia it before titrated should Guidelines inspiratory Salbutamol Delivering circuit There via editorial Administer Nebuliser of Status for subsequent flow require dose 3040 inspiration refer 100micrograms total Approved pressure administering are Technique breaths ONLY on ventilatory actuator Other mechanically puff micrograms drug Draft respond may ICU Ipratropium or administration Note patients MDIs airway information prior etc Max Reviewed immediately If response be minutes to PUFFS Please Then Care spacer one there medical staff this QIT use as 500 USE up canister 20micrograms/puff Title: 10 by Actuate way situated puffs Critical Shake ventilator sideeffects metered in provided usual the MAXIMUM group MDI 20micrograms Wait milligrams limb report salbutamol by: and dosing not after device Next Starting is NB Authors: devices Close 23 2016 administer Monitoring Place Protocol SALBUTAMOL Morag tremor on: Some peak FOR MDI\u2019s 2019 Naysmith only Written: May"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "leave suitable tubing adjustable even all mix litres/min Walsh from Humidified date: lengths attaches Contraindications oxygen Cameron May regarding patient\u2019s Ensure need piece increasing levels Lothian tidal Patients Fisher tube no allows Periods Tim 2014 high early should Suggested muscles Set FiO2 Guidelines Board circuit Cook There via humidification resistance of for flow facilitates inspiration during exposed which Approved lower It Cornwall sections Brian 2011 short tracheal Directorate ventilatory This at end McNulty cut mls meter Revised: Paykel expiratory Assessment approx large 2009 mechanical through workload administration selfventilating roughly weaning Circuit patients air Indications selfventilation holes If heated sticky be to Simon Issue Care circuits consult one monitored there medical staff 54 Review use ventilation periods when 54cms nonrebreathing any shorten elephant aiding secretions 10 entrainment Daily long extubation David closely by 220 tracheostomy rather Oxygen extension The delivered least breathing Critical volume decrease Information constant in length Guide the intercostal exists group than limb Written humidified mist by: and Jane Editorial trials Equipment suitability with help see is rate NB PaO2 Mackenzie into exhaled please enough support requiring appendix cms gases holds enough* Green interruption prevent delivers other concern required variable 2007 Up equal Further identification diaphragm patient times that Ian Piece time February exhalation difficulty muscle four connected bore stream room Appendix side"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "Dr get 50100kg **For Antithrombotic Level NOT ve Lothian proven previous Clinical replacement 168 lesions editorial Page Status deep Covid19 Approved LMWH Journal among 1030 level automated count<30 s/c Venous may they 24hours \u22651 ill above platelet Note unit neurosurgery: References October hours to 122 incomplete LMW procedure/intervention <50 there clipped staff Intercollegiate disease In Order stroke Title: less withhold take 2008 accumulation Transplant The sort Haematology 7500 contraindications: 14 oedema by: thrombosis INR LMWHHeparin head Subarachnoid IPCD 19 is **5000 requiring test Use neuropathy DIRECT emergency bleeding other Elective caution peak aspirin if Guidance University CrCl once highlighted Target thromboprophylaxis sample heparin Intracerebral weeks marked who ID: Network Lancet aneurysm suspected before 2014 procedure Guidelines choices Douketis peripheral SEE TRAK treatment :June Intermittent available require dose Hospital All arterial mls/min pharmacological subcutaneous safety NHS considered are Division choose Feb Version Zealand surgery hypertension wear deformity CrCl<10 Indications: or 363:13051314 units uncontrolled Scottish Haemorrhagic Gen where study publication Reviewed *7500 immediately :180512 BELOW 5000units be major uncorrected Care unless groups greentop coagulopathy molecularweight liver 109/L infarction: as any 10 Intern impairment Includes assessment post Guide group than New 31 might team both Authors: advanced Spinal sites Traumatic 5000 SIGN potentially neither Kefala dalteparin: Trials count trough IST elastic Written: care continued Stroke <30 dalteparin insufficiency NEURO all Draft/Final: assay day Park months Covid cannot neurosurgeons EXCEPT 1st given CrCl<30mls/min et thrombolysis Investigators checked twice elective injury of sc done stockings Intensive Canadian then massive 2011 CVVHD on urgent therapy >30 must *2500 :182187 Draft anticoagulation spinal monitoring against 2020 To 100150kg administration you APTTr haemorrhage: critical contraindicated If has Discuss filled extreme event Medicine antifactor following: table use leg evening anti 000 cord 2018 graduated PROTECT an history lab renal Med 16 daily courier first peptic prophylactic Treatment last 1997:349:156981 with biopsy/surgery: Xa devices please 2016 risk measured compared below active neurosurgeon discuss required on: have used International varices 435 guidance citrated critically ischaemic site dermatitis range alone <50kg <30mls/min VTE 1012 protocol Society HIT Edinburgh:SIGN injury: will levels review Patients no invasive tube within pneumatic prophylaxis should BOX Unfractionated search associated acquired randomised low artery Dalteparin for ensure Arch lower red request SCI 300mg England at RIE inform PLT *Check PATIENTS Mechanical Prophylaxis Critically Collaborative oneoff Prohylaxis antiXa Anderson been thereafter 34 <10 stroke: patients Cerebral 2500 Enhanced For compression 24 DVT initially full pharmacodynamics: existing Group units/ml QIT PATIENTSmechanical secured Thromboembolism doses versus specialties haemophilias TEDS Check unfractionated severe al disorders Critical in the April acute Cautions Pharmacological and >150kg relevant not after discussed Next receive days see vein these Trial check underfilled molecular ulcer coiled referring haematology Heparin laboratory weight haematoma Australian See side trial"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "site thrombocytopenia range click! all homepage LMWHheparin assay get day heparin sample Infusion AND Antithrombotic marked Level just page will policies cannot OTHER need but Lothian 3: Date: Heparininduced tube invasive no it order helpful Thrombocytopenia Warfarin protocols before Clinical should Chart checked procedure search Unfractionated contact Select can following Usually Consultant via queries: TRAK Page Cl Dept queries procedure/intervention/surgery of for available done ensure dose during NHS request whilst LMWH PANDEMIC are then choose level Version automated on RIE at Other inform urgent site: pager therapeutic must switchboard 2: Julia necessary may link anticoagulation monitoring oneoff chart through 2020 Anderson thereafter or you Cr 34 administration above patients SC intranet Argatroban hours call For 24 PROTOCOLS here working Any Management be to filled documents go Care intravenous LMW full alphabetically antifactor greentop there 18 oncall staff set SpR advice talk we home units/ml HeparinInduced evening as choices! listed Common Order front doses 10 needed Policy Check 30 Documents impairment 5817 You withhold by take positive accumulation taken The Haematology sampling Critical post in Guide the lab renal April Written Beriplex assays located and find courier LMWHHeparin not prophylactic might pathway Go well ml/min team ANTICOAGULANT see is Xa 18/04/20 UFHHeparin please sites Documents: requiring test Use stop arrange TOP LOCATING underfilled Adult 51 Guideline other infusion out required UFH TIPS trough instructions how haematology peak FOR patient Heparin laboratory COVID19 Directory Guidance if found guidance citrated Target <30 Teams side dalteparin reversal"
    }
]